activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	750634	CHEMBL649030	Inhibition of Aurora kinase B	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	750634	CHEMBL649030	Inhibition of Aurora kinase B	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	1504930	CHEMBL831066	Inhibitory activity against Aurora kinase B	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	135.0	CHEMBL2185	Homo sapiens	IC50	nM	135.0
	1504932	CHEMBL827046	Inhibition of Aurora kinase B	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	135.0	CHEMBL2185	Homo sapiens	IC50	nM	135.0
	1722956	CHEMBL860193	Inhibition of Aurora2	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	6700.0	CHEMBL2185	Homo sapiens	Ki	nM	6700.0
	1722967	CHEMBL860193	Inhibition of Aurora2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	6700.0	CHEMBL2185	Homo sapiens	Ki	nM	6700.0
	1722968	CHEMBL860193	Inhibition of Aurora2	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	6700.0	CHEMBL2185	Homo sapiens	Ki	nM	6700.0
	1722969	CHEMBL860193	Inhibition of Aurora2	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	6700.0	CHEMBL2185	Homo sapiens	Ki	nM	6700.0
	1722970	CHEMBL860193	Inhibition of Aurora2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	6700.0	CHEMBL2185	Homo sapiens	Ki	nM	6700.0
	1722971	CHEMBL860193	Inhibition of Aurora2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	6700.0	CHEMBL2185	Homo sapiens	Ki	nM	6700.0
	1744515	CHEMBL867289	Inhibition of Aurora2	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	6700.0	CHEMBL2185	Homo sapiens	Ki	uM	6.7
	1765520	CHEMBL871548	Inhibition of Aurora2 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1		CHEMBL386661	>	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	uM	25.0
	1765530	CHEMBL871548	Inhibition of Aurora2 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL215943	>	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	uM	25.0
	1779365	CHEMBL854975	Inhibition of recombinant Aurora B by ELISA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	=	IC50	nM	8900.0	CHEMBL2185	Homo sapiens	IC50	uM	8.9
	1779387	CHEMBL854975	Inhibition of recombinant Aurora B by ELISA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
Not Determined	1781954	CHEMBL911832	Inhibition of Aurora B kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)Cc3ccccc3)C4)cc2)CC1		CHEMBL190252		IC50			CHEMBL2185	Homo sapiens	IC50		
	1781955	CHEMBL911832	Inhibition of Aurora B kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](F)c3ccccc3)C4)cc2)CC1		CHEMBL385266	=	IC50	nM	300.0	CHEMBL2185	Homo sapiens	IC50	nM	300.0
	1781959	CHEMBL911832	Inhibition of Aurora B kinase	B	CO[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL384575	=	IC50	nM	630.0	CHEMBL2185	Homo sapiens	IC50	nM	630.0
	1781960	CHEMBL911832	Inhibition of Aurora B kinase	B	C[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL217748	=	IC50	nM	1210.0	CHEMBL2185	Homo sapiens	IC50	nM	1210.0
	1781961	CHEMBL911832	Inhibition of Aurora B kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	79.0	CHEMBL2185	Homo sapiens	IC50	uM	0.079
	1781962	CHEMBL911832	Inhibition of Aurora B kinase	B	C[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL427787	=	IC50	nM	99.0	CHEMBL2185	Homo sapiens	IC50	nM	99.0
	1781963	CHEMBL911832	Inhibition of Aurora B kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](O)c3ccccc3)C4)cc2)CC1		CHEMBL385872	=	IC50	nM	48.0	CHEMBL2185	Homo sapiens	IC50	nM	48.0
	1790086	CHEMBL855347	Inhibition of Aurora-B immunoprecipitated from mitotic cells	F	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	IC50	nM	250.0	CHEMBL2185	Homo sapiens	IC50	uM	0.25
	1790089	CHEMBL873732	In vitro inhibition constant for Aurora-B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	umol	0.018
	1790093	CHEMBL873736	Inhibition of in vitro Aurora-B kinase activity	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	IC50	umol	0.1
	1790330	CHEMBL912714	Percent residual activity, relative to control, of Aurora-B at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	53.0	CHEMBL2185	Homo sapiens	Activity	%	53.0
	1790384	CHEMBL912714	Percent residual activity, relative to control, of Aurora-B at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	103.0	CHEMBL2185	Homo sapiens	Activity	%	103.0
	1790436	CHEMBL912724	Inhibition of human Aurora-B	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	M	0.000025
	1790476	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(C(F)(F)F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL405120	=	Ki	nM	510.0	CHEMBL2185	Homo sapiens	Ki	uM	0.51
	1790479	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC[C@@H]1CO		CHEMBL385049	=	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790487	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC[C@H]1CO		CHEMBL214940	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790490	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCN(CCO)CC1		CHEMBL386310	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790493	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC(O)CC1		CHEMBL214842	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790496	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC(CCO)CC1		CHEMBL384054	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790499	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC[C@@H]1CO		CHEMBL424899	=	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790503	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCNCCO		CHEMBL386253	=	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790506	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN(C)CCO		CHEMBL214601	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790509	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL215275	=	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790514	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL217804	=	Ki	nM	2.0	CHEMBL2185	Homo sapiens	Ki	uM	0.002
	1790517	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214848	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790524	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214849	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790534	CHEMBL856404	Inhibition of human recombinant Aurora B	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN(CCO)CC(C)C		CHEMBL216053	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790539	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2c1		CHEMBL215322	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790542	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2c1		CHEMBL214637	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790546	CHEMBL856404	Inhibition of human recombinant Aurora B	B	O=C(Cc1cc(Nc2ncnc3cc(OCCCN4CCC[C@@H]4CO)ccc23)n[nH]1)Nc1cccc(F)c1F		CHEMBL215022	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790559	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790582	CHEMBL856404	Inhibition of human recombinant Aurora B	B	CCCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215495	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1790585	CHEMBL856404	Inhibition of human recombinant Aurora B	B	O=C(Cc1cc(Nc2ncnc3cc(OCCCN4CCC[C@@H]4CO)ccc23)n[nH]1)Nc1cccc(F)c1		CHEMBL215203	<	Ki	nM	1.0	CHEMBL2185	Homo sapiens	Ki	uM	0.001
	1824465	CHEMBL913839	Inhibition of Aurora 2	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2185	Homo sapiens	Ki	uM	10.0
	1824599	CHEMBL913839	Inhibition of Aurora 2	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL2185	Homo sapiens	Ki	uM	10.0
	1824694	CHEMBL913839	Inhibition of Aurora 2	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL2185	Homo sapiens	Ki	uM	10.0
	1914972	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	IC50	nM	2300.0	CHEMBL2185	Homo sapiens	IC50	uM	2.3
	1914973	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=C1C(c2c(O)[nH]c3c(I)cccc23)=Nc2ccccc21		CHEMBL379160	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914974	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(I)cccc32)\Nc2ccccc2\1		CHEMBL395077	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914975	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(I)cccc32)\Nc2ccccc2\1		CHEMBL244191	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914976	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=Nc1c(-c2c(O)[nH]c3c(I)cccc23)[nH]c2ccccc12		CHEMBL209648	=	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	1914977	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=C1C(c2c(O)[nH]c3c(F)cccc23)=Nc2ccccc21		CHEMBL210446	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914978	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(F)cccc32)\Nc2ccccc2\1		CHEMBL243985	=	IC50	nM	8000.0	CHEMBL2185	Homo sapiens	IC50	uM	8.0
	1914979	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(F)cccc32)\Nc2ccccc2\1		CHEMBL397720	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914980	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=Nc1c(-c2c(O)[nH]c3c(F)cccc23)[nH]c2ccccc12		CHEMBL212174	=	IC50	nM	7000.0	CHEMBL2185	Homo sapiens	IC50	uM	7.0
	1914981	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=C1C(c2c(O)[nH]c3c(Cl)cccc23)=Nc2ccccc21		CHEMBL378191	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914982	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(Cl)cccc32)\Nc2ccccc2\1		CHEMBL397719	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914983	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(Cl)cccc32)\Nc2ccccc2\1		CHEMBL243776	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914984	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=Nc1c(-c2c(O)[nH]c3c(Cl)cccc23)[nH]c2ccccc12		CHEMBL213650	=	IC50	nM	8000.0	CHEMBL2185	Homo sapiens	IC50	uM	8.0
	1914985	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=C1C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21		CHEMBL214173	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914986	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(Br)cccc32)\Nc2ccccc2\1		CHEMBL395766	=	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	uM	20.0
	1914987	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(Br)cccc32)\Nc2ccccc2\1		CHEMBL243556	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	1914988	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=Nc1c(-c2c(O)[nH]c3c(Br)cccc23)[nH]c2ccccc12		CHEMBL373834	=	IC50	nM	4600.0	CHEMBL2185	Homo sapiens	IC50	uM	4.6
	1914989	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	IC50	nM	900.0	CHEMBL2185	Homo sapiens	IC50	uM	0.9
	1914990	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CC(=O)O/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21		CHEMBL209849	=	IC50	nM	2100.0	CHEMBL2185	Homo sapiens	IC50	uM	2.1
	1914991	CHEMBL894338	Inhibition of human recombinant aurora B kinase	B	CO/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21		CHEMBL211243	=	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	uM	3.0
	1916293	CHEMBL894117	Inhibition of recombinant Aurora2 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080	=	IC50	nM	8620.0	CHEMBL2185	Homo sapiens	IC50	uM	8.62
	1916346	CHEMBL894117	Inhibition of recombinant Aurora2 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	uM	50.0
	1981704	CHEMBL899270	Inhibition of AURORA B assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	72.0	CHEMBL2185	Homo sapiens	Activity	%	72.0
	1981754	CHEMBL899269	Inhibition of AURORA B assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	76.0	CHEMBL2185	Homo sapiens	Activity	%	76.0
	1997522	CHEMBL899964	Inhibition of recombinant aurora B kinase	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL392525	=	IC50	nM	198.0	CHEMBL2185	Homo sapiens	IC50	uM	0.198
	2029839	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029978	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029979	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029980	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029981	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029982	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029983	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029984	CHEMBL886306	Inhibition of aurora B at 10 uM	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029985	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029986	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029987	CHEMBL886306	Inhibition of aurora B at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029988	CHEMBL886306	Inhibition of aurora B at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029989	CHEMBL886306	Inhibition of aurora B at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029990	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2029991	CHEMBL886306	Inhibition of aurora B at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	Inhibition	%	40.0
	2077627	CHEMBL945000	Inhibition of Aurora B	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Inhibition	%	22.0	CHEMBL2185	Homo sapiens	Inhibition	%	22.0
Not Active	2100670	CHEMBL933052	Activation of human AURB mediated histone H3 phosphorylation by phosphoimager analyzer	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Active	2100675	CHEMBL931974	Activation of human AURB autophosphorylation activity	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368		Activity			CHEMBL2185	Homo sapiens	Activity		
	2104573	CHEMBL931997	Inhibition of Aurora B kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1.8	CHEMBL2185	Homo sapiens	Ki	nM	1.8
	2104576	CHEMBL931997	Inhibition of Aurora B kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Ki	nM	79.0	CHEMBL2185	Homo sapiens	Ki	nM	79.0
	2120718	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	2120719	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1C(N)=O		CHEMBL260532	=	IC50	nM	390.0	CHEMBL2185	Homo sapiens	IC50	nM	390.0
	2120720	CHEMBL951285	Inhibition of Aurora B	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(C(N)=O)cc34)ccc12		CHEMBL260531	=	IC50	nM	233.0	CHEMBL2185	Homo sapiens	IC50	nM	233.0
	2120721	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1C(N)=O		CHEMBL272250	=	IC50	nM	185.0	CHEMBL2185	Homo sapiens	IC50	nM	185.0
	2120722	CHEMBL951285	Inhibition of Aurora B	B	COc1ccc2c(Oc3ccc4c(C(N)=O)cccc4c3)ccnc2c1		CHEMBL272252	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
Not Determined	2120723	CHEMBL951285	Inhibition of Aurora B	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)ccc34)ccc12		CHEMBL272251		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	2120724	CHEMBL951285	Inhibition of Aurora B	B	COc1ccc2c(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)ccnc2c1		CHEMBL270342		IC50			CHEMBL2185	Homo sapiens	IC50		
	2120725	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2ncnc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL270556	=	IC50	nM	680.0	CHEMBL2185	Homo sapiens	IC50	nM	680.0
	2120726	CHEMBL951285	Inhibition of Aurora B	B	COCCNC(=O)c1cccc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12		CHEMBL412278	=	IC50	nM	385.0	CHEMBL2185	Homo sapiens	IC50	nM	385.0
	2120727	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2ncnc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL411284	=	IC50	nM	360.0	CHEMBL2185	Homo sapiens	IC50	nM	360.0
	2120728	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL271984	=	IC50	nM	220.0	CHEMBL2185	Homo sapiens	IC50	nM	220.0
Not Determined	2120729	CHEMBL951285	Inhibition of Aurora B	B	COCCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271189		IC50			CHEMBL2185	Homo sapiens	IC50		
	2120730	CHEMBL951285	Inhibition of Aurora B	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271188	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
	2120731	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NCC(F)(F)F)cccc4c3)c2cc1OC		CHEMBL410840	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
Not Determined	2120732	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC(C)(C)C)cccc4c3)c2cc1OC		CHEMBL406914		IC50			CHEMBL2185	Homo sapiens	IC50		
	2120733	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC(C)C)cccc4c3)c2cc1OC		CHEMBL408211	=	IC50	nM	190.0	CHEMBL2185	Homo sapiens	IC50	nM	190.0
Not Determined	2120734	CHEMBL951285	Inhibition of Aurora B	B	CCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL409103		IC50			CHEMBL2185	Homo sapiens	IC50		
	2120735	CHEMBL951285	Inhibition of Aurora B	B	CCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL269871	=	IC50	nM	46.0	CHEMBL2185	Homo sapiens	IC50	nM	46.0
	2120736	CHEMBL951285	Inhibition of Aurora B	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL270754	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	nM	110.0
	2120737	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NCC5CC5)cccc4c3)c2cc1OC		CHEMBL270755	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	2120738	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5(C)CC5)cccc4c3)c2cc1OC		CHEMBL428961	=	IC50	nM	62.0	CHEMBL2185	Homo sapiens	IC50	nM	62.0
Not Determined	2120739	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CCCC5)cccc4c3)c2cc1OC		CHEMBL410903		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	2120740	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CCC5)cccc4c3)c2cc1OC		CHEMBL259252		IC50			CHEMBL2185	Homo sapiens	IC50		
	2120741	CHEMBL951285	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198	=	IC50	nM	118.0	CHEMBL2185	Homo sapiens	IC50	nM	118.0
	2121151	CHEMBL933003	Inhibition of Aurora B	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	2136752	CHEMBL921091	Inhibition of Aurora kinase B in MCF7 cells	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	IC50	nM	1250.0	CHEMBL2185	Homo sapiens	IC50	uM	1.25
Not Active	2147115	CHEMBL922652	Inhibition of Aurora B Ser10 phosphorylation in human HCT116 cells at 0.25 uM after 24 hr	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	2147116	CHEMBL922654	Inhibition of Aurora B Ser10 phosphorylation in human HCT116 cells at 4 uM after 24 hr	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Active	2147117	CHEMBL922653	Inhibition of Aurora B Ser10 phosphorylation in human HCT116 cells at 1 uM after 24 hr	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL2185	Homo sapiens	Activity		
	2147118	CHEMBL922655	Inhibition of Aurora B Ser10 phosphorylation in human HeLa cells after 1 hr	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	5700.0	CHEMBL2185	Homo sapiens	IC50	uM	5.7
Active	2147165	CHEMBL931565	Inhibition of Aurora B in human HCT116 cells assessed as appearance of unusually large nuclei at 4 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Active	2172618	CHEMBL921636	Inhibition of human recombinant Aurora B kinase at 10 uM	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)cc1C		CHEMBL427726		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Active	2172627	CHEMBL921636	Inhibition of human recombinant Aurora B kinase at 10 uM	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)C(C)C2)c1		CHEMBL254582		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Active	2172628	CHEMBL921636	Inhibition of human recombinant Aurora B kinase at 10 uM	B	COc1ccccc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL402228		Activity			CHEMBL2185	Homo sapiens	Activity		
	2206910	CHEMBL974018	Inhibition of Aurora B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	2232169	CHEMBL973636	Inhibition of aurora 1 kinase	B	COc1cc2nccc(Oc3ccc4c(NC(=O)c5cccc(C(F)(F)F)c5)nn(C)c4c3)c2cc1OC		CHEMBL462168	=	IC50	nM	45.0	CHEMBL2185	Homo sapiens	IC50	uM	0.045
Not Determined	2240210	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)c1cccc(C(F)(F)F)c1		CHEMBL472194		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	2240213	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)Nc1ccccc1Cl		CHEMBL472546		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	2240214	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472377		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	2240215	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	C#Cc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1		CHEMBL471337		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	2240216	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	COc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1		CHEMBL470119		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	2240217	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	CN(C(=O)Nc1ncc(CCNc2ncnc3ccsc23)s1)c1ccccc1		CHEMBL472203		IC50			CHEMBL2185	Homo sapiens	IC50		
	2240222	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472193	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
	2240231	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL471169	=	IC50	nM	580.0	CHEMBL2185	Homo sapiens	IC50	nM	580.0
	2240233	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1cccc(CCN2CCC2)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL519728	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	nM	120.0
	2240234	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1cc(CN2CCCC2)cc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL486850	=	IC50	nM	22.0	CHEMBL2185	Homo sapiens	IC50	nM	22.0
	2240235	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)NC1CCCCC1		CHEMBL487892	=	IC50	nM	61.0	CHEMBL2185	Homo sapiens	IC50	nM	61.0
	2240236	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)Nc1cccc2cc[nH]c12		CHEMBL486877	=	IC50	nM	19.0	CHEMBL2185	Homo sapiens	IC50	nM	19.0
	2240237	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ccc(F)c(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL520053	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	2240238	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL505037	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	2240239	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL518051	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	2240240	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1cccc(F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL512184	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	2240241	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	Cc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1		CHEMBL513078	=	IC50	nM	54.0	CHEMBL2185	Homo sapiens	IC50	nM	54.0
	2240242	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472202	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	nM	120.0
	2240243	CHEMBL972584	Inhibition of Aurora B by radiometric assay	B	O=C(Cc1ncc(CCNc2ncnc3ccsc23)s1)Nc1cccc(C(F)(F)F)c1		CHEMBL471511	=	IC50	nM	442.0	CHEMBL2185	Homo sapiens	IC50	nM	442.0
	2251197	CHEMBL1009895	Inhibition of Aurora B at 3.0 nM	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Inhibition	%	58.0	CHEMBL2185	Homo sapiens	INH	%	58.0
	2251241	CHEMBL1009881	Inhibition of Aurora B	B	c1ccc2[nH]c(-c3cc[nH]n3)nc2c1		CHEMBL495758	=	IC50	nM	6500.0	CHEMBL2185	Homo sapiens	IC50	uM	6.5
	2251242	CHEMBL1009881	Inhibition of Aurora B	B	CC(=O)Nc1c[nH]nc1-c1nc2ccccc2[nH]1		CHEMBL504155	=	IC50	nM	510.0	CHEMBL2185	Homo sapiens	IC50	uM	0.51
	2251243	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1		CHEMBL522891	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	uM	0.18
	2251244	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)c1ccccc1		CHEMBL496569	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	uM	0.015
	2251245	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(F)cc1		CHEMBL522563	=	IC50	nM	75.0	CHEMBL2185	Homo sapiens	IC50	uM	0.075
	2251246	CHEMBL1009881	Inhibition of Aurora B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	uM	0.017
	2251247	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1ccccc1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL458420	=	IC50	nM	54.0	CHEMBL2185	Homo sapiens	IC50	uM	0.054
	2251248	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1ccccc1F)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL516003	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	uM	0.01
	2251249	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)Nc1c(F)cccc1F		CHEMBL458421	=	IC50	nM	2.6	CHEMBL2185	Homo sapiens	IC50	uM	0.0026
	2251250	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CCCCC1		CHEMBL496754	=	IC50	nM	5.2	CHEMBL2185	Homo sapiens	IC50	uM	0.0052
	2251251	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1cccnc1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL523923	=	IC50	nM	24.0	CHEMBL2185	Homo sapiens	IC50	uM	0.024
	2251252	CHEMBL1009881	Inhibition of Aurora B	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CCOCC1		CHEMBL522214	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	uM	0.01
	2268428	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL522629	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268844	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1		CHEMBL464619	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268845	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL517021	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268846	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL516635	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268847	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460959	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268848	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460958	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268849	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Fc1ccc(CNc2ccccc2-c2cn(-c3cccc(Cl)c3)nn2)cc1F		CHEMBL460751	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268850	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F		CHEMBL454403	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268851	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F		CHEMBL523320	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268852	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491872	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268853	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491871	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268854	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl		CHEMBL522133	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268855	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	c1ccc(-c2cn(-c3ccc4[nH]ncc4c3)nn2)c(NCc2ccncc2)c1		CHEMBL516645	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268856	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1		CHEMBL461605	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268857	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	CC(C)(C)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL461392	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268858	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	CC(C)(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL461391	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268859	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	CC(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL518652	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268860	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)Oc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491681	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268861	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL522304	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268862	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491680	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268863	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL491502	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268864	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523133	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268865	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL490969	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268866	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL490968	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268867	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523301	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2268868	CHEMBL960832	Inhibition of Aurora B at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL489329	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2270260	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1		CHEMBL443906	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270261	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC		CHEMBL522785	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270262	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473761	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270263	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	CNc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc(OC)c(OC)cc2n1		CHEMBL514941	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270264	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OC		CHEMBL473553	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270265	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Cc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1Cl		CHEMBL473354	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270266	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1-c1nc2ccccc2s1		CHEMBL474544	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270267	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2c1		CHEMBL514016	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270268	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Clc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL474346	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270269	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL514929	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270270	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]cnc23)ccc1-c1nc2ccccc2s1		CHEMBL475352	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270271	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]cnc45)cc3)nc2c1		CHEMBL515598	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270272	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)c(OC)c2)c2cc[nH]c2n1		CHEMBL475351	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270273	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc[nH]c2n1		CHEMBL462338	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270274	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]ccc23)ccc1-c1nc2ccccc2s1		CHEMBL462162	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270275	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]ccc45)cc3)nc2c1		CHEMBL518803	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270276	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	CN1CCN(c2ccnc(Nc3ccc(-c4nc5ccccc5s4)cc3)n2)CC1		CHEMBL459886	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270277	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	CN(C)c1ccnc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL462161	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270278	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	CNc1ccnc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL462160	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270279	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	CNc1nccc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL512933	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270280	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	CNC(=O)c1cc(Nc2ccc(-c3nc4ccccc4s3)cc2)ccn1		CHEMBL464210	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270281	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	CNc1cc(Nc2ccc(-c3nc4ccccc4s3)cc2)ccn1		CHEMBL464014	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2270446	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	=	IC50	nM	7400.0	CHEMBL2185	Homo sapiens	IC50	uM	7.4
	2270447	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3ccc(-c4nc5ccccc5s4)cc3)n2)n[nH]1		CHEMBL461109	=	IC50	nM	7000.0	CHEMBL2185	Homo sapiens	IC50	uM	7.0
	2270456	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]ccc23)cc(-c2nc3ccccc3s2)c1		CHEMBL490555	=	IC50	nM	6400.0	CHEMBL2185	Homo sapiens	IC50	uM	6.4
	2270471	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OC		CHEMBL473351	=	IC50	nM	4200.0	CHEMBL2185	Homo sapiens	IC50	uM	4.2
	2270474	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	=	IC50	nM	3700.0	CHEMBL2185	Homo sapiens	IC50	uM	3.7
	2270483	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc(Nc2nccc(Nc3cc(C)[nH]n3)n2)ccc1-c1nc2ccccc2s1		CHEMBL461110	=	IC50	nM	3100.0	CHEMBL2185	Homo sapiens	IC50	uM	3.1
	2270501	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1		CHEMBL491686	=	IC50	nM	2000.0	CHEMBL2185	Homo sapiens	IC50	uM	2.0
	2270506	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Cc1cc(Nc2cc(Nc3ccc(-c4nc5ccccc5s4)cc3)ccn2)n[nH]1		CHEMBL461991	=	IC50	nM	1800.0	CHEMBL2185	Homo sapiens	IC50	uM	1.8
	2270536	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(N4Cc5ccccc5C4)cc3)c2cc1OC		CHEMBL491677	=	IC50	nM	920.0	CHEMBL2185	Homo sapiens	IC50	uM	0.92
	2270550	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ccnc2c1		CHEMBL474543	=	IC50	nM	750.0	CHEMBL2185	Homo sapiens	IC50	uM	0.75
	2270551	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5ccsc45)cc3)nc2c1		CHEMBL472946	=	IC50	nM	720.0	CHEMBL2185	Homo sapiens	IC50	uM	0.72
	2270560	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(Cl)ccc12		CHEMBL473557	=	IC50	nM	510.0	CHEMBL2185	Homo sapiens	IC50	uM	0.51
	2270569	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2ccsc12		CHEMBL474347	=	IC50	nM	290.0	CHEMBL2185	Homo sapiens	IC50	uM	0.29
	2270575	CHEMBL960143	Inhibition of Aurora B by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556	=	IC50	nM	135.0	CHEMBL2185	Homo sapiens	IC50	uM	0.135
	2279712	CHEMBL960120	Inhibition of STK12	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
Not Active	2301928	CHEMBL949871	Inhibition of Aurora B	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2301952	CHEMBL949871	Inhibition of Aurora B	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2301976	CHEMBL949871	Inhibition of Aurora B	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2302000	CHEMBL949871	Inhibition of Aurora B	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2302024	CHEMBL949871	Inhibition of Aurora B	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2302048	CHEMBL949871	Inhibition of Aurora B	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2302072	CHEMBL949871	Inhibition of Aurora B	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2302096	CHEMBL949871	Inhibition of Aurora B	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	2302120	CHEMBL949871	Inhibition of Aurora B	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155	=	IC50	nM	69000.0	CHEMBL2185	Homo sapiens	IC50	uM	69.0
Not Active	2302141	CHEMBL949870	Inhibition of Aurora B up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	2302189	CHEMBL950858	Inhibition of Aurora B at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	2353899	CHEMBL953197	Inhibition of Aur2	B	COc1ccc2c(OCc3nnc4ccc(-c5cc(F)c(F)c(F)c5)nn34)ccnc2c1		CHEMBL494979	>	Activity	uM	10.0	CHEMBL2185	Homo sapiens	Activity	uM	10.0
	2393710	CHEMBL957097	Inhibition of Aurora B	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	IC50	nM	78.0	CHEMBL2185	Homo sapiens	IC50	nM	78.0
	2395451	CHEMBL961278	Binding affinity to Aurora B at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	10.0	CHEMBL2185	Homo sapiens	Activity	%	10.0
	2396063	CHEMBL1006302	Inhibition of AURKB at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	36.0	CHEMBL2185	Homo sapiens	INH	%	36.0
Dose-dependent effect	2396090	CHEMBL1006296	Inhibition of Aurora kinase B in human HCT116 cells assessed as reduced phosphorylated histone H3 levels by Western blot	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560		Activity			CHEMBL2185	Homo sapiens	Activity		
	2408038	CHEMBL955916	Inhibition of Aurora B	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)cc2)C1		CHEMBL476451	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	2408039	CHEMBL955916	Inhibition of Aurora B	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(F)c2)C1		CHEMBL1964272	=	IC50	nM	1600.0	CHEMBL2185	Homo sapiens	IC50	nM	1600.0
	2408040	CHEMBL955916	Inhibition of Aurora B	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL514868	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	2461677	CHEMBL966177	Inhibition of recombinant Aurora B	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	0.42	CHEMBL2185	Homo sapiens	IC50	10'-7g/ml	4.2
	2461711	CHEMBL966177	Inhibition of recombinant Aurora B	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	0.98	CHEMBL2185	Homo sapiens	IC50	10'-7g/ml	9.8
	2461712	CHEMBL966177	Inhibition of recombinant Aurora B	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	=	IC50	ug.mL-1	3.0	CHEMBL2185	Homo sapiens	IC50	10'-6g/ml	3.0
	2461713	CHEMBL966177	Inhibition of recombinant Aurora B	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL2185	Homo sapiens	IC50	10'-5g/ml	1.0
	2461714	CHEMBL966177	Inhibition of recombinant Aurora B	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL2185	Homo sapiens	IC50	10'-5g/ml	1.0
	2461715	CHEMBL966177	Inhibition of recombinant Aurora B	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	1.5	CHEMBL2185	Homo sapiens	IC50	10'-6g/ml	1.5
	2461716	CHEMBL966177	Inhibition of recombinant Aurora B	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	=	IC50	ug.mL-1	1.1	CHEMBL2185	Homo sapiens	IC50	10'-6g/ml	1.1
	2461717	CHEMBL966177	Inhibition of recombinant Aurora B	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	1.1	CHEMBL2185	Homo sapiens	IC50	10'-6g/ml	1.1
	2461718	CHEMBL966177	Inhibition of recombinant Aurora B	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	1.3	CHEMBL2185	Homo sapiens	IC50	10'-6g/ml	1.3
	2461719	CHEMBL966177	Inhibition of recombinant Aurora B	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	0.22	CHEMBL2185	Homo sapiens	IC50	10'-7g/ml	2.2
	2462921	CHEMBL965367	Inhibition of recombinant Aurora B phosphorylation in human HT29 cells	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	1.0	CHEMBL2185	Homo sapiens	IC50	10'-6g/ml	1.0
	2464991	CHEMBL962088	Inhibition of human recombinant Aurora B	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	17000.0	CHEMBL2185	Homo sapiens	IC50	uM	17.0
	2465023	CHEMBL962088	Inhibition of human recombinant Aurora B	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc1		CHEMBL452812	=	IC50	nM	4900.0	CHEMBL2185	Homo sapiens	IC50	uM	4.9
	2465024	CHEMBL962088	Inhibition of human recombinant Aurora B	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL509435	=	IC50	nM	9800.0	CHEMBL2185	Homo sapiens	IC50	uM	9.8
	2465025	CHEMBL962088	Inhibition of human recombinant Aurora B	B	COc1cc(C2=C(c3cn(COc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488811	=	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	uM	20.0
	2465026	CHEMBL962088	Inhibition of human recombinant Aurora B	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	43000.0	CHEMBL2185	Homo sapiens	IC50	uM	43.0
	2465027	CHEMBL962088	Inhibition of human recombinant Aurora B	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL521201	=	IC50	nM	2100.0	CHEMBL2185	Homo sapiens	IC50	uM	2.1
	2465028	CHEMBL962088	Inhibition of human recombinant Aurora B	B	COc1cc(C2=C(c3c[nH]c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL529663	=	IC50	nM	46000.0	CHEMBL2185	Homo sapiens	IC50	uM	46.0
	2470112	CHEMBL1032255	Inhibition of AURKB at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
Not Evaluated	2476734	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Evaluated	2478573	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2185	Homo sapiens	Activity		
	2478776	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	0.15	CHEMBL2185	Homo sapiens	Activity	%	0.15
	2479580	CHEMBL1025767	Inhibition of AURB	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	2479631	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	30.85	CHEMBL2185	Homo sapiens	Activity	%	30.85
	2479834	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	4.7	CHEMBL2185	Homo sapiens	Activity	%	4.7
Active	2480631	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	2480833	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2185	Homo sapiens	Activity		
	2488247	CHEMBL946774	Inhibition of Aurora B	B	COc1cc(N2CCC(N3CCN(S(C)(=O)=O)CC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1		CHEMBL507714	=	IC50	nM	200.0	CHEMBL2185	Homo sapiens	IC50	nM	200.0
	2488263	CHEMBL946774	Inhibition of Aurora B	B	CCc1cc(Nc2nccc(-c3c(-c4cccc(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1		CHEMBL448929	=	IC50	nM	1300.0	CHEMBL2185	Homo sapiens	IC50	nM	1300.0
	2488269	CHEMBL946774	Inhibition of Aurora B	B	CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1		CHEMBL466397	=	IC50	nM	4500.0	CHEMBL2185	Homo sapiens	IC50	nM	4500.0
	2512031	CHEMBL970564	Inhibition of Aurora B at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	59.0	CHEMBL2185	Homo sapiens	INH	%	59.0
	2512039	CHEMBL973507	Inhibition of N-terminal flag-tagged Aurora B E161T mutant expressed in Escherichia coli BL21-DE3	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	IC50	nM	55.0	CHEMBL2185	Homo sapiens	IC50	uM	0.055
	2512041	CHEMBL973507	Inhibition of N-terminal flag-tagged Aurora B E161T mutant expressed in Escherichia coli BL21-DE3	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	IC50	nM	57.0	CHEMBL2185	Homo sapiens	IC50	uM	0.057
	2512065	CHEMBL969659	Inhibition of N-terminal flag-tagged Aurora B expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	9.3	CHEMBL2185	Homo sapiens	IC50	uM	0.0093
	2512066	CHEMBL969659	Inhibition of N-terminal flag-tagged Aurora B expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991	=	IC50	nM	1400.0	CHEMBL2185	Homo sapiens	IC50	uM	1.4
	2512067	CHEMBL969659	Inhibition of N-terminal flag-tagged Aurora B expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	IC50	nM	1900.0	CHEMBL2185	Homo sapiens	IC50	uM	1.9
	2512068	CHEMBL969659	Inhibition of N-terminal flag-tagged Aurora B expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170	=	IC50	nM	3800.0	CHEMBL2185	Homo sapiens	IC50	uM	3.8
	2512069	CHEMBL969659	Inhibition of N-terminal flag-tagged Aurora B expressed in Escherichia coli BL21-DE3 by ELISA	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	IC50	nM	3700.0	CHEMBL2185	Homo sapiens	IC50	uM	3.7
	2512070	CHEMBL969659	Inhibition of N-terminal flag-tagged Aurora B expressed in Escherichia coli BL21-DE3 by ELISA	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	IC50	nM	3400.0	CHEMBL2185	Homo sapiens	IC50	uM	3.4
	2512096	CHEMBL973504	Inhibition of Aurora B in human HCT116 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	5000.0	CHEMBL2185	Homo sapiens	IC50	uM	5.0
	2512097	CHEMBL973504	Inhibition of Aurora B in human HCT116 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991	>	IC50	nM	12000.0	CHEMBL2185	Homo sapiens	IC50	uM	12.0
	2512098	CHEMBL973504	Inhibition of Aurora B in human HCT116 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	>	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	uM	25.0
	2512099	CHEMBL973504	Inhibition of Aurora B in human HCT116 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170	>	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	uM	25.0
	2512100	CHEMBL973504	Inhibition of Aurora B in human HCT116 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	>	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	uM	25.0
	2512101	CHEMBL973504	Inhibition of Aurora B in human HCT116 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	uM	50.0
	2512102	CHEMBL973505	Inhibition of Aurora B in human HT29 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	2512103	CHEMBL973505	Inhibition of Aurora B in human HT29 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	2512104	CHEMBL973505	Inhibition of Aurora B in human HT29 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	2512105	CHEMBL973505	Inhibition of Aurora B in human HT29 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	>	IC50	nM	27000.0	CHEMBL2185	Homo sapiens	IC50	uM	27.0
	2512106	CHEMBL973505	Inhibition of Aurora B in human HT29 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	>	IC50	nM	27000.0	CHEMBL2185	Homo sapiens	IC50	uM	27.0
Not Determined	2512124	CHEMBL973505	Inhibition of Aurora B in human HT29 cells assessed as complete loss of phospho-histamine H3 staining by immunofluorescence assay	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		IC50			CHEMBL2185	Homo sapiens	IC50		
	2525605	CHEMBL983958	Inhibition of Aurora B kinase	B	Cc1cc2c(-c3ccc(S(=O)(=O)N(C)CCO)cc3)ccnc2[nH]1		CHEMBL520308	=	IC50	nM	1584.89	CHEMBL2185	Homo sapiens	pIC50		5.8
	2526314	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
	2526315	CHEMBL993739	Inhibition of aurora B kinase	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	IC50	nM	250.0	CHEMBL2185	Homo sapiens	IC50	nM	250.0
	2526316	CHEMBL993739	Inhibition of aurora B kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	2526317	CHEMBL993739	Inhibition of aurora B kinase	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	172.0	CHEMBL2185	Homo sapiens	IC50	nM	172.0
	2526318	CHEMBL993739	Inhibition of aurora B kinase	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2c1		CHEMBL215322	=	IC50	nM	7.5	CHEMBL2185	Homo sapiens	IC50	nM	7.5
	2526319	CHEMBL993739	Inhibition of aurora B kinase	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526320	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1100.0	CHEMBL2185	Homo sapiens	IC50	nM	1100.0
	2526321	CHEMBL993739	Inhibition of aurora B kinase	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	2526322	CHEMBL993739	Inhibition of aurora B kinase	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	IC50	nM	19.0	CHEMBL2185	Homo sapiens	IC50	nM	19.0
	2526323	CHEMBL993739	Inhibition of aurora B kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	290.0	CHEMBL2185	Homo sapiens	IC50	nM	290.0
Not Determined	2526324	CHEMBL993739	Inhibition of aurora B kinase	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482		Ki			CHEMBL2185	Homo sapiens	Ki		
	2526325	CHEMBL993739	Inhibition of aurora B kinase	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	27.0	CHEMBL2185	Homo sapiens	Ki	nM	27.0
	2526326	CHEMBL993739	Inhibition of aurora B kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCCCC3)n2)cc1		CHEMBL484951	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	2526327	CHEMBL993739	Inhibition of aurora B kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCOCC3)n2)cc1		CHEMBL482778	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
	2526328	CHEMBL993739	Inhibition of aurora B kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCNCC3)n2)cc1		CHEMBL482779	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	2526329	CHEMBL993739	Inhibition of aurora B kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL484609	=	IC50	nM	20.0	CHEMBL2185	Homo sapiens	IC50	nM	20.0
	2526330	CHEMBL993739	Inhibition of aurora B kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(CC)CC3)n2)cc1		CHEMBL485351	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
	2526331	CHEMBL993739	Inhibition of aurora B kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C4CC4)CC3)n2)cc1		CHEMBL485186	=	IC50	nM	9.5	CHEMBL2185	Homo sapiens	IC50	nM	9.5
	2526332	CHEMBL993739	Inhibition of aurora B kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C(C)(C)C)CC3)n2)cc1		CHEMBL484006	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
Not Determined	2526333	CHEMBL993739	Inhibition of aurora B kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)Cc3ccccc3)C4)cc2)CC1		CHEMBL190252		IC50			CHEMBL2185	Homo sapiens	IC50		
	2526334	CHEMBL993739	Inhibition of aurora B kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](F)c3ccccc3)C4)cc2)CC1		CHEMBL385266	=	IC50	nM	300.0	CHEMBL2185	Homo sapiens	IC50	nM	300.0
	2526335	CHEMBL993739	Inhibition of aurora B kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](O)c3ccccc3)C4)cc2)CC1		CHEMBL385872	=	IC50	nM	48.0	CHEMBL2185	Homo sapiens	IC50	nM	48.0
	2526336	CHEMBL993739	Inhibition of aurora B kinase	B	C[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL427787	=	IC50	nM	99.0	CHEMBL2185	Homo sapiens	IC50	nM	99.0
	2526337	CHEMBL993739	Inhibition of aurora B kinase	B	C[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL217748	=	IC50	nM	1210.0	CHEMBL2185	Homo sapiens	IC50	nM	1210.0
	2526338	CHEMBL993739	Inhibition of aurora B kinase	B	CO[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL384575	=	IC50	nM	630.0	CHEMBL2185	Homo sapiens	IC50	nM	630.0
	2526339	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL381724	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526340	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3nc(C(=O)Nc4ccccc4)cs3)ncnc2cc1OCCCN1CCOCC1		CHEMBL484601	=	IC50	nM	530.0	CHEMBL2185	Homo sapiens	IC50	uM	0.53
	2526341	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3ccc(C(=O)Nc4ccccc4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL485337	=	IC50	nM	57.0	CHEMBL2185	Homo sapiens	IC50	uM	0.057
	2526342	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3ncc(C(=O)Nc4ccccc4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL482774	=	IC50	nM	42.0	CHEMBL2185	Homo sapiens	IC50	uM	0.042
	2526343	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3ncc(CC(=O)Nc4ccccc4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL518981	<	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526344	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	uM	0.007
	2526345	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL216769	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	uM	0.002
	2526346	CHEMBL993739	Inhibition of aurora B kinase	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL215275	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526347	CHEMBL993739	Inhibition of aurora B kinase	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL217804	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	uM	0.002
	2526348	CHEMBL993739	Inhibition of aurora B kinase	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214848	<	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526349	CHEMBL993739	Inhibition of aurora B kinase	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214849	<	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526350	CHEMBL993739	Inhibition of aurora B kinase	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN(CCO)CC(C)C		CHEMBL216053	<	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526351	CHEMBL993739	Inhibition of aurora B kinase	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472193	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
	2526352	CHEMBL993739	Inhibition of aurora B kinase	B	O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472202	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	nM	120.0
	2526429	CHEMBL981431	Inhibition of aurora B in human SW620 cells assessed as inhibition of histone H3 phosphorylation	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	uM	0.017
	2526430	CHEMBL981431	Inhibition of aurora B in human SW620 cells assessed as inhibition of histone H3 phosphorylation	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL216769	=	IC50	nM	680.0	CHEMBL2185	Homo sapiens	IC50	uM	0.68
	2526431	CHEMBL981431	Inhibition of aurora B in human SW620 cells assessed as inhibition of histone H3 phosphorylation	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL215275	=	IC50	nM	270.0	CHEMBL2185	Homo sapiens	IC50	uM	0.27
	2526432	CHEMBL981431	Inhibition of aurora B in human SW620 cells assessed as inhibition of histone H3 phosphorylation	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL217804	=	IC50	nM	290.0	CHEMBL2185	Homo sapiens	IC50	uM	0.29
	2526433	CHEMBL981431	Inhibition of aurora B in human SW620 cells assessed as inhibition of histone H3 phosphorylation	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214848	=	IC50	nM	45.0	CHEMBL2185	Homo sapiens	IC50	uM	0.045
	2526434	CHEMBL981431	Inhibition of aurora B in human SW620 cells assessed as inhibition of histone H3 phosphorylation	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214849	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	uM	0.018
	2526435	CHEMBL981431	Inhibition of aurora B in human SW620 cells assessed as inhibition of histone H3 phosphorylation	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN(CCO)CC(C)C		CHEMBL216053	<	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	2526449	CHEMBL993739	Inhibition of aurora B kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	79.0	CHEMBL2185	Homo sapiens	IC50	nM	79.0
	2526453	CHEMBL993741	Inhibition of aurora B in human HCT116 cells assessed as inhibition of histone H3 Ser10 phosphorylation by immunofluorescence method	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	4000.0	CHEMBL2185	Homo sapiens	IC50	uM	4.0
	2559685	CHEMBL982976	Inhibition of Aurora B	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	nM	50000.0
	2567147	CHEMBL970766	Inhibition of Aurora B	B	Cc1cc(-c2nc3cc4c(cc3[nH]2)C(C)(C)C(=O)N4)n[nH]1		CHEMBL452478	=	IC50	nM	150.0	CHEMBL2185	Homo sapiens	IC50	uM	0.15
	2567148	CHEMBL970766	Inhibition of Aurora B	B	Cc1[nH]nc2c1CCCC1c3ccccc3NC21		CHEMBL512833	=	IC50	nM	22.0	CHEMBL2185	Homo sapiens	IC50	uM	0.022
	2567149	CHEMBL970766	Inhibition of Aurora B	B	Cc1[nH]nc2c1Cc1c-2[nH]c2ccccc12		CHEMBL469204	=	IC50	nM	880.0	CHEMBL2185	Homo sapiens	IC50	uM	0.88
	2567150	CHEMBL970766	Inhibition of Aurora B	B	Cc1cc(-c2cc3ccccc3[nH]2)n[nH]1		CHEMBL454457	=	IC50	nM	510.0	CHEMBL2185	Homo sapiens	IC50	uM	0.51
	2567151	CHEMBL970766	Inhibition of Aurora B	B	Cc1[nH]nc2c1CCc1c-2[nH]c2ccccc12		CHEMBL510472	=	IC50	nM	220.0	CHEMBL2185	Homo sapiens	IC50	uM	0.22
	2567152	CHEMBL970766	Inhibition of Aurora B	B	CCN1C(=O)C(C)(C)c2cc3[nH]c(-c4cc(C)[nH]n4)nc3cc21		CHEMBL469197	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	uM	0.13
	2567153	CHEMBL970766	Inhibition of Aurora B	B	Cc1[nH]nc2c1CCCc1c-2[nH]c2cc3c(cc12)C(C)(C)C(=O)N3		CHEMBL469206	=	IC50	nM	86.0	CHEMBL2185	Homo sapiens	IC50	uM	0.086
	2567154	CHEMBL970766	Inhibition of Aurora B	B	Cc1[nH]nc2c1CCCc1c-2[nH]c2cc3c(cc12)NC(=O)C3(C)C		CHEMBL469205	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	uM	0.002
	2567174	CHEMBL970766	Inhibition of Aurora B	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	uM	0.005
	2567181	CHEMBL970775	Inhibition of Aurora B assessed as loss of phospho histone H3 in human H29 cells	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	IC50	uM	0.1
	2567182	CHEMBL970776	Inhibition of Aurora B assessed as loss of phospho histone H3 in human HCT cells	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	310.0	CHEMBL2185	Homo sapiens	IC50	uM	0.31
	2567184	CHEMBL970766	Inhibition of Aurora B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	uM	0.03
	2567191	CHEMBL970775	Inhibition of Aurora B assessed as loss of phospho histone H3 in human H29 cells	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	740.0	CHEMBL2185	Homo sapiens	IC50	uM	0.74
	2567192	CHEMBL970776	Inhibition of Aurora B assessed as loss of phospho histone H3 in human HCT cells	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	310.0	CHEMBL2185	Homo sapiens	IC50	uM	0.31
Not Evaluated	2577252	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Evaluated	2577455	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2185	Homo sapiens	Activity		
	2593660	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	17.2	CHEMBL2185	Homo sapiens	Activity	%	17.2
Not Evaluated	2593926	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Evaluated	2594129	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Evaluated	2594869	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Evaluated	2595072	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2185	Homo sapiens	Activity		
	2596269	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	26.7	CHEMBL2185	Homo sapiens	Activity	%	26.7
Not Evaluated	2596472	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Evaluated	2597741	CHEMBL982762	Binding affinity to human AURB at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2185	Homo sapiens	Activity		
	2602487	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL515880	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602925	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1		CHEMBL458532	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602926	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1		CHEMBL512380	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602927	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL458531	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602928	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL517399	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602929	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462528	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602930	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462527	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602931	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1		CHEMBL518204	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602932	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1		CHEMBL462315	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602933	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)c(F)c1		CHEMBL460191	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602934	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL512863	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602935	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F		CHEMBL470441	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602936	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL470440	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602937	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL512862	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602938	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL473268	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602939	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(NC1=CC2C=NNC2C=C1)c1nscc1NCc1ccncc1		CHEMBL443921	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602940	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc2ccccc2n1)c1nscc1NCc1ccncc1		CHEMBL474709	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602941	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1		CHEMBL509737	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602942	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1		CHEMBL473288	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602943	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1		CHEMBL473287	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602944	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nscc1NCc1ccncc1		CHEMBL475709	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602945	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1		CHEMBL475708	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602946	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1		CHEMBL475510	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602947	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL516243	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602948	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL475509	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602949	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccccn1		CHEMBL474494	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602950	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1cccnc1		CHEMBL474293	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602951	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL475704	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602952	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccccn1		CHEMBL475703	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2602953	CHEMBL1034909	Inhibition of Aurora B at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1		CHEMBL514986	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	2603066	CHEMBL1023861	Inhibition of AURKB	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	2613484	CHEMBL1031526	Inhibition of Aurora B	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	2616310	CHEMBL1029844	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	IC50	nM	80.0	CHEMBL2185	Homo sapiens	IC50	nM	80.0
	2616314	CHEMBL1029844	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	2626901	CHEMBL999785	Binding affinity to human Aurora B at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	2626928	CHEMBL999785	Binding affinity to human Aurora B at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	2635925	CHEMBL1004137	Inhibition of Aurora B at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	<	Residual_activity	%	25.0	CHEMBL2185	Homo sapiens	Residual_activity	%	25.0
	2635993	CHEMBL1004137	Inhibition of Aurora B at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	<	Residual_activity	%	25.0	CHEMBL2185	Homo sapiens	Residual_activity	%	25.0
	2636061	CHEMBL1004137	Inhibition of Aurora B at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	50.0	CHEMBL2185	Homo sapiens	Residual_activity	%	50.0
	2638277	CHEMBL1011426	Inhibition of Aurora B	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL466496	=	IC50	nM	3200.0	CHEMBL2185	Homo sapiens	IC50	uM	3.2
	2638278	CHEMBL1011426	Inhibition of Aurora B	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467079	=	IC50	nM	6000.0	CHEMBL2185	Homo sapiens	IC50	uM	6.0
	2638279	CHEMBL1011426	Inhibition of Aurora B	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL511410	=	IC50	nM	1400.0	CHEMBL2185	Homo sapiens	IC50	uM	1.4
	2638280	CHEMBL1011426	Inhibition of Aurora B	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3F)c2)c(=O)c1=O)c1ccccc1		CHEMBL468125	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	uM	50.0
	2638281	CHEMBL1011426	Inhibition of Aurora B	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccco3)c2)c(=O)c1=O)c1ccccc1		CHEMBL519113	=	IC50	nM	8800.0	CHEMBL2185	Homo sapiens	IC50	uM	8.8
	2638282	CHEMBL1011426	Inhibition of Aurora B	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccsc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481248	=	IC50	nM	10800.0	CHEMBL2185	Homo sapiens	IC50	uM	10.8
	2644558	CHEMBL1031310	Inhibition of Aurora-B by time dependent kinetic study	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1.8	CHEMBL2185	Homo sapiens	Ki	nM	1.8
	2644566	CHEMBL1031310	Inhibition of Aurora-B by time dependent kinetic study	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C(C)(C)C)CC3)n2)cc1		CHEMBL484006	=	Ki	nM	0.8	CHEMBL2185	Homo sapiens	Ki	nM	0.8
	2658109	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL549322	=	Ki	nM	590.0	CHEMBL2185	Homo sapiens	Ki	nM	590.0
	2658110	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccccc3Cl)nc3ccccc23)n[nH]1		CHEMBL562415	=	Ki	nM	445.0	CHEMBL2185	Homo sapiens	Ki	nM	445.0
	2658111	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3cccc(Cl)c3)nc3ccccc23)n[nH]1		CHEMBL562416	=	Ki	nM	185.0	CHEMBL2185	Homo sapiens	Ki	nM	185.0
	2658112	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccc(Cl)cc3)nc3ccccc23)n[nH]1		CHEMBL562157	>	Ki	nM	1100.0	CHEMBL2185	Homo sapiens	Ki	nM	1100.0
	2658113	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3cccc(Cl)c3Cl)nc3ccccc23)n[nH]1		CHEMBL564459	=	Ki	nM	675.0	CHEMBL2185	Homo sapiens	Ki	nM	675.0
	2658114	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccc(Cl)cc3Cl)nc3ccccc23)n[nH]1		CHEMBL551633	>	Ki	nM	1100.0	CHEMBL2185	Homo sapiens	Ki	nM	1100.0
	2658115	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3c(Cl)cccc3Cl)nc3ccccc23)n[nH]1		CHEMBL561834	>	Ki	nM	1100.0	CHEMBL2185	Homo sapiens	Ki	nM	1100.0
	2658116	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccc(Cl)c(Cl)c3)nc3ccccc23)n[nH]1		CHEMBL552385	>	Ki	nM	40.0	CHEMBL2185	Homo sapiens	Ki	nM	40.0
	2658117	CHEMBL1031295	Inhibition of Aurora-B	B	COc1ccccc1Sc1nc(Nc2cc(C)[nH]n2)c2ccccc2n1		CHEMBL551634	=	Ki	nM	995.0	CHEMBL2185	Homo sapiens	Ki	nM	995.0
	2658118	CHEMBL1031295	Inhibition of Aurora-B	B	COc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL552500	=	Ki	nM	575.0	CHEMBL2185	Homo sapiens	Ki	nM	575.0
	2658119	CHEMBL1031295	Inhibition of Aurora-B	B	COc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1OC		CHEMBL564290	=	Ki	nM	120.0	CHEMBL2185	Homo sapiens	Ki	nM	120.0
	2658120	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccc4ccccc4c3)nc3ccccc23)n[nH]1		CHEMBL559900	>	Ki	nM	40.0	CHEMBL2185	Homo sapiens	Ki	nM	40.0
	2658121	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccc(NS(C)(=O)=O)cc3)nc3ccccc23)n[nH]1		CHEMBL552033	=	Ki	nM	230.0	CHEMBL2185	Homo sapiens	Ki	nM	230.0
	2658122	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)OC(C)(C)C)cc3)nc3ccccc23)n[nH]1		CHEMBL556460	=	Ki	nM	250.0	CHEMBL2185	Homo sapiens	Ki	nM	250.0
	2658123	CHEMBL1031295	Inhibition of Aurora-B	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	27.0	CHEMBL2185	Homo sapiens	Ki	nM	27.0
	2658124	CHEMBL1031295	Inhibition of Aurora-B	B	CC(=O)N(C)c1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL549668	=	Ki	nM	105.0	CHEMBL2185	Homo sapiens	Ki	nM	105.0
	2658125	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL564941	=	Ki	nM	57.0	CHEMBL2185	Homo sapiens	Ki	nM	57.0
	2658126	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nc3ccccc23)n[nH]1		CHEMBL564449	=	Ki	nM	51.0	CHEMBL2185	Homo sapiens	Ki	nM	51.0
	2658127	CHEMBL1031295	Inhibition of Aurora-B	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc[nH]n3)c3ccccc3n2)cc1		CHEMBL560158	>	Ki	nM	1100.0	CHEMBL2185	Homo sapiens	Ki	nM	1100.0
	2658128	CHEMBL1031295	Inhibition of Aurora-B	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)cc1		CHEMBL561421	=	Ki	nM	15.0	CHEMBL2185	Homo sapiens	Ki	nM	15.0
	2658129	CHEMBL1031295	Inhibition of Aurora-B	B	CC(=O)Nc1ccc(Sc2nccc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL549469	=	Ki	nM	207.0	CHEMBL2185	Homo sapiens	Ki	nM	207.0
	2658130	CHEMBL1031295	Inhibition of Aurora-B	B	CC(=O)Nc1ccc(Sc2nc(C)cc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL562497	=	Ki	nM	220.0	CHEMBL2185	Homo sapiens	Ki	nM	220.0
	2658131	CHEMBL1031295	Inhibition of Aurora-B	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3ccccc3)n2)cc1		CHEMBL557279	=	Ki	nM	83.0	CHEMBL2185	Homo sapiens	Ki	nM	83.0
	2658132	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(C)cc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL560556	=	Ki	nM	153.0	CHEMBL2185	Homo sapiens	Ki	nM	153.0
	2658133	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(C3CC3)n2)cc1		CHEMBL561617	=	Ki	nM	59.0	CHEMBL2185	Homo sapiens	Ki	nM	59.0
	2658134	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(C(C)(C)C)n2)cc1		CHEMBL565183	=	Ki	nM	115.0	CHEMBL2185	Homo sapiens	Ki	nM	115.0
	2658135	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3ccccc3)n2)cc1		CHEMBL554941	=	Ki	nM	145.0	CHEMBL2185	Homo sapiens	Ki	nM	145.0
	2658136	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3cccnc3)n2)cc1		CHEMBL557682	=	Ki	nM	52.0	CHEMBL2185	Homo sapiens	Ki	nM	52.0
	2658137	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3ccncc3)n2)cc1		CHEMBL560630	=	Ki	nM	49.0	CHEMBL2185	Homo sapiens	Ki	nM	49.0
	2658138	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCC3)n2)cc1		CHEMBL563682	=	Ki	nM	23.0	CHEMBL2185	Homo sapiens	Ki	nM	23.0
	2658139	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCCCC3)n2)cc1		CHEMBL484951	=	Ki	nM	8.0	CHEMBL2185	Homo sapiens	Ki	nM	8.0
	2658140	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCOCC3)n2)cc1		CHEMBL482778	=	Ki	nM	14.0	CHEMBL2185	Homo sapiens	Ki	nM	14.0
	2658141	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCNCC3)n2)cc1		CHEMBL482779	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	2658142	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL484609	=	Ki	nM	20.0	CHEMBL2185	Homo sapiens	Ki	nM	20.0
	2658143	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(CC)CC3)n2)cc1		CHEMBL485351	=	Ki	nM	25.0	CHEMBL2185	Homo sapiens	Ki	nM	25.0
	2658144	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C4CC4)CC3)n2)cc1		CHEMBL485186	=	Ki	nM	9.5	CHEMBL2185	Homo sapiens	Ki	nM	9.5
	2658145	CHEMBL1031295	Inhibition of Aurora-B	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C(C)(C)C)CC3)n2)cc1		CHEMBL484006	=	Ki	nM	11.0	CHEMBL2185	Homo sapiens	Ki	nM	11.0
	2658146	CHEMBL1031295	Inhibition of Aurora-B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	2661407	CHEMBL1058613	Inhibition of Aurora B	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	4175.0	CHEMBL2185	Homo sapiens	IC50	uM	4.175
	2661579	CHEMBL1060443	Inhibition of Aurora B after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	uM	50.0
	2672290	CHEMBL1026221	Inhibition of recombinant Aurora B	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	2.4	CHEMBL2185	Homo sapiens	IC50	ug ml-1	2.4
	2672296	CHEMBL1026221	Inhibition of recombinant Aurora B	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	=	IC50	ug.mL-1	1.8	CHEMBL2185	Homo sapiens	IC50	ug ml-1	1.8
	2672304	CHEMBL1026221	Inhibition of recombinant Aurora B	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	=	IC50	ug.mL-1	0.76	CHEMBL2185	Homo sapiens	IC50	ug ml-1	0.76
	2672305	CHEMBL1026221	Inhibition of recombinant Aurora B	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	=	IC50	ug.mL-1	0.65	CHEMBL2185	Homo sapiens	IC50	ug ml-1	0.65
	2892448	CHEMBL1051264	Selectivity for AURKB as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Selectivity		0.0173	CHEMBL2185	Homo sapiens	Selectivity		0.0173
Antagonist	2897260	CHEMBL1051320	Inhibition of Aurora B in the presence of 100uM ATP	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	40.0	CHEMBL2185	Homo sapiens	IC50	uM	0.04
Antagonist	2897261	CHEMBL1061937	Inhibition of Aurora B in the presence of 20uM ATP	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	35.0	CHEMBL2185	Homo sapiens	IC50	uM	0.035
Antagonist	2897262	CHEMBL1061937	Inhibition of Aurora B in the presence of 20uM ATP	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	2500.0	CHEMBL2185	Homo sapiens	IC50	uM	2.5
Antagonist	2897263	CHEMBL1061937	Inhibition of Aurora B in the presence of 20uM ATP	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	19.0	CHEMBL2185	Homo sapiens	IC50	uM	0.019
Antagonist	2898286	CHEMBL1051271	Percentage Aurora B activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	17.0	CHEMBL2185	Homo sapiens	Activity	%	17.0
	2898287	CHEMBL1051271	Percentage Aurora B activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	81.0	CHEMBL2185	Homo sapiens	Activity	%	81.0
	2898288	CHEMBL1051271	Percentage Aurora B activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	59.0	CHEMBL2185	Homo sapiens	Activity	%	59.0
Antagonist	2898289	CHEMBL1061947	Percentage Aurora B activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	22.0	CHEMBL2185	Homo sapiens	Activity	%	22.0
Antagonist	2898290	CHEMBL1061947	Percentage Aurora B activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	3.0	CHEMBL2185	Homo sapiens	Activity	%	3.0
	2898291	CHEMBL1061947	Percentage Aurora B activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	80.0	CHEMBL2185	Homo sapiens	Activity	%	80.0
	2898292	CHEMBL1061947	Percentage Aurora B activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	89.0	CHEMBL2185	Homo sapiens	Activity	%	89.0
	2898293	CHEMBL1061947	Percentage Aurora B activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	80.0	CHEMBL2185	Homo sapiens	Activity	%	80.0
Antagonist	2898294	CHEMBL1061947	Percentage Aurora B activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	17.0	CHEMBL2185	Homo sapiens	Activity	%	17.0
	2898295	CHEMBL1061947	Percentage Aurora B activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	65.0	CHEMBL2185	Homo sapiens	Activity	%	65.0
	2898296	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	70.0	CHEMBL2185	Homo sapiens	Activity	%	70.0
	2898297	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	87.0	CHEMBL2185	Homo sapiens	Activity	%	87.0
	2898298	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	71.0	CHEMBL2185	Homo sapiens	Activity	%	71.0
Antagonist	2898299	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	4.0	CHEMBL2185	Homo sapiens	Activity	%	4.0
	2898300	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	88.0	CHEMBL2185	Homo sapiens	Activity	%	88.0
	2898301	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	70.0	CHEMBL2185	Homo sapiens	Activity	%	70.0
	2898302	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	70.0	CHEMBL2185	Homo sapiens	Activity	%	70.0
	2898303	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	57.0	CHEMBL2185	Homo sapiens	Activity	%	57.0
Antagonist	2898304	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	38.0	CHEMBL2185	Homo sapiens	Activity	%	38.0
	2898305	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	78.0	CHEMBL2185	Homo sapiens	Activity	%	78.0
	2898306	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	64.0	CHEMBL2185	Homo sapiens	Activity	%	64.0
	2898307	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	78.0	CHEMBL2185	Homo sapiens	Activity	%	78.0
	2898308	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	63.0	CHEMBL2185	Homo sapiens	Activity	%	63.0
	2898309	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	80.0	CHEMBL2185	Homo sapiens	Activity	%	80.0
Antagonist	2898310	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	50.0	CHEMBL2185	Homo sapiens	Activity	%	50.0
	2898311	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	2898312	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	83.0	CHEMBL2185	Homo sapiens	Activity	%	83.0
	2898313	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	95.0	CHEMBL2185	Homo sapiens	Activity	%	95.0
Antagonist	2898314	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	15.0	CHEMBL2185	Homo sapiens	Activity	%	15.0
Antagonist	2898315	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	45.0	CHEMBL2185	Homo sapiens	Activity	%	45.0
	2898316	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	70.0	CHEMBL2185	Homo sapiens	Activity	%	70.0
	2898317	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	80.0	CHEMBL2185	Homo sapiens	Activity	%	80.0
	2898318	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	86.0	CHEMBL2185	Homo sapiens	Activity	%	86.0
	2898319	CHEMBL1062890	Percentage Aurora B activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	60.0	CHEMBL2185	Homo sapiens	Activity	%	60.0
	2898320	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	82.0	CHEMBL2185	Homo sapiens	Activity	%	82.0
	2898321	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	85.0	CHEMBL2185	Homo sapiens	Activity	%	85.0
	2898322	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	84.0	CHEMBL2185	Homo sapiens	Activity	%	84.0
Antagonist	2898323	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	7.0	CHEMBL2185	Homo sapiens	Activity	%	7.0
Antagonist	2898324	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	7.0	CHEMBL2185	Homo sapiens	Activity	%	7.0
Antagonist	2898325	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	3.0	CHEMBL2185	Homo sapiens	Activity	%	3.0
	2898326	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	64.0	CHEMBL2185	Homo sapiens	Activity	%	64.0
	2898327	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	85.0	CHEMBL2185	Homo sapiens	Activity	%	85.0
	2898328	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	90.0	CHEMBL2185	Homo sapiens	Activity	%	90.0
	2898329	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	83.0	CHEMBL2185	Homo sapiens	Activity	%	83.0
	2898330	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	94.0	CHEMBL2185	Homo sapiens	Activity	%	94.0
	2898331	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	78.0	CHEMBL2185	Homo sapiens	Activity	%	78.0
Antagonist	2898332	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	49.0	CHEMBL2185	Homo sapiens	Activity	%	49.0
	2898333	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	60.0	CHEMBL2185	Homo sapiens	Activity	%	60.0
Antagonist	2898334	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	15.0	CHEMBL2185	Homo sapiens	Activity	%	15.0
	2898335	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	84.0	CHEMBL2185	Homo sapiens	Activity	%	84.0
	2898336	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	81.0	CHEMBL2185	Homo sapiens	Activity	%	81.0
	2898337	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	90.0	CHEMBL2185	Homo sapiens	Activity	%	90.0
	2898338	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	106.0	CHEMBL2185	Homo sapiens	Activity	%	106.0
	2898339	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	90.0	CHEMBL2185	Homo sapiens	Activity	%	90.0
	2898340	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	60.0	CHEMBL2185	Homo sapiens	Activity	%	60.0
	2898341	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	70.0	CHEMBL2185	Homo sapiens	Activity	%	70.0
Antagonist	2898342	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	17.0	CHEMBL2185	Homo sapiens	Activity	%	17.0
Antagonist	2898343	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	40.0	CHEMBL2185	Homo sapiens	Activity	%	40.0
	2898344	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	91.0	CHEMBL2185	Homo sapiens	Activity	%	91.0
	2898345	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	96.0	CHEMBL2185	Homo sapiens	Activity	%	96.0
	2898346	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	106.0	CHEMBL2185	Homo sapiens	Activity	%	106.0
	2898347	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	86.0	CHEMBL2185	Homo sapiens	Activity	%	86.0
Antagonist	2898348	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	10.0	CHEMBL2185	Homo sapiens	Activity	%	10.0
Antagonist	2898349	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	11.0	CHEMBL2185	Homo sapiens	Activity	%	11.0
Antagonist	2898350	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	35.0	CHEMBL2185	Homo sapiens	Activity	%	35.0
	2898351	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	82.0	CHEMBL2185	Homo sapiens	Activity	%	82.0
	2898352	CHEMBL1051365	Percentage Aurora B activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	73.0	CHEMBL2185	Homo sapiens	Activity	%	73.0
	2898353	CHEMBL1062796	Percentage Aurora B activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	2898354	CHEMBL1062796	Percentage Aurora B activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	78.0	CHEMBL2185	Homo sapiens	Activity	%	78.0
	2898355	CHEMBL1062891	Percentage Aurora B activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	87.0	CHEMBL2185	Homo sapiens	Activity	%	87.0
	2898356	CHEMBL1062860	Percentage Aurora B activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	59.0	CHEMBL2185	Homo sapiens	Activity	%	59.0
	2899819	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	390.0	CHEMBL2185	Homo sapiens	Kd	nM	390.0
	2899820	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899821	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899822	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	7.2	CHEMBL2185	Homo sapiens	Kd	nM	7.2
	2899823	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899824	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899825	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	280.0	CHEMBL2185	Homo sapiens	Kd	nM	280.0
	2899826	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899827	CHEMBL1062834	Binding constant for AURKB kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4200.0	CHEMBL2185	Homo sapiens	Kd	nM	4200.0
	2899828	CHEMBL1062834	Binding constant for AURKB kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899829	CHEMBL1062834	Binding constant for AURKB kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899830	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899831	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899832	CHEMBL1062834	Binding constant for AURKB kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1400.0	CHEMBL2185	Homo sapiens	Kd	nM	1400.0
	2899833	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899834	CHEMBL1062834	Binding constant for AURKB kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899835	CHEMBL1062834	Binding constant for AURKB kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899836	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899837	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899838	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	160.0	CHEMBL2185	Homo sapiens	Kd	nM	160.0
	2899839	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899840	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899841	CHEMBL1062834	Binding constant for AURKB kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899842	CHEMBL1062834	Binding constant for AURKB kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	43.0	CHEMBL2185	Homo sapiens	Kd	nM	43.0
	2899843	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899844	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	62.0	CHEMBL2185	Homo sapiens	Kd	nM	62.0
	2899845	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899846	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899847	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899848	CHEMBL1062834	Binding constant for AURKB kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899849	CHEMBL1062834	Binding constant for AURKB kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899850	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	440.0	CHEMBL2185	Homo sapiens	Kd	nM	440.0
	2899851	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	19.0	CHEMBL2185	Homo sapiens	Kd	nM	19.0
	2899852	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	340.0	CHEMBL2185	Homo sapiens	Kd	nM	340.0
	2899853	CHEMBL1062834	Binding constant for AURKB kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	380.0	CHEMBL2185	Homo sapiens	Kd	nM	380.0
	2899854	CHEMBL1062834	Binding constant for AURKB kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	7.4	CHEMBL2185	Homo sapiens	Kd	nM	7.4
	2899855	CHEMBL1062834	Binding constant for AURKB kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2899856	CHEMBL1062834	Binding constant for AURKB kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	2921435	CHEMBL1059262	Inhibition of AURKB assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	85.0	CHEMBL2185	Homo sapiens	Activity	%	85.0
	2924821	CHEMBL1056878	Inhibition of AURORA B assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	67.0	CHEMBL2185	Homo sapiens	Activity	%	67.0
	2924822	CHEMBL1056878	Inhibition of AURORA B assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	67.0	CHEMBL2185	Homo sapiens	Activity	%	67.0
	2924823	CHEMBL1056878	Inhibition of AURORA B assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	92.0	CHEMBL2185	Homo sapiens	Activity	%	92.0
	2924824	CHEMBL1056878	Inhibition of AURORA B assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	68.0	CHEMBL2185	Homo sapiens	Activity	%	68.0
Active	2925558	CHEMBL1050146	Inhibition of Aurora B	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	2943699	CHEMBL1044078	Inhibition of Aurora B	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	microM	10.0
	2943711	CHEMBL1044078	Inhibition of Aurora B	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	microM	10.0
	2981344	CHEMBL1043449	Inhibition of Aurora B	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1		CHEMBL570002	=	IC50	nM	1840.0	CHEMBL2185	Homo sapiens	IC50	uM	1.84
	2981345	CHEMBL1043449	Inhibition of Aurora B	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL569720	=	IC50	nM	850.0	CHEMBL2185	Homo sapiens	IC50	uM	0.85
	2981346	CHEMBL1043449	Inhibition of Aurora B	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL578201	=	IC50	nM	270.0	CHEMBL2185	Homo sapiens	IC50	uM	0.27
	2981347	CHEMBL1043449	Inhibition of Aurora B	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL576257	=	IC50	nM	680.0	CHEMBL2185	Homo sapiens	IC50	uM	0.68
	2983214	CHEMBL1046242	Inhibition of Aurora B	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	=	IC50	nM	2900.0	CHEMBL2185	Homo sapiens	IC50	uM	2.9
	2999019	CHEMBL1043722	Inhibition of Aurora B assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	101.0	CHEMBL2185	Homo sapiens	Activity	%	101.0
	2999809	CHEMBL1043722	Inhibition of Aurora B assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	22.0	CHEMBL2185	Homo sapiens	Activity	%	22.0
	2999883	CHEMBL1049885	Inhibition of Aurora B assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	93.0	CHEMBL2185	Homo sapiens	Activity	%	93.0
	2999959	CHEMBL1049885	Inhibition of Aurora B assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	93.0	CHEMBL2185	Homo sapiens	Activity	%	93.0
	3052530	CHEMBL1047781	Residual activity of Aurora-B at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	20.0	CHEMBL2185	Homo sapiens	Residual activity	%	20.0
	3052782	CHEMBL1047808	Residual activity of Aurora-B at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	3.0	CHEMBL2185	Homo sapiens	Residual activity	%	3.0
	3054091	CHEMBL1066609	Residual activity of Aurora-B at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	40.0	CHEMBL2185	Homo sapiens	Residual activity	%	40.0
	3055378	CHEMBL1047781	Residual activity of Aurora-B at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	18.0	CHEMBL2185	Homo sapiens	Residual activity	%	18.0
	3055630	CHEMBL1047808	Residual activity of Aurora-B at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	5.0	CHEMBL2185	Homo sapiens	Residual activity	%	5.0
	3056935	CHEMBL1066609	Residual activity of Aurora-B at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	48.0	CHEMBL2185	Homo sapiens	Residual activity	%	48.0
	3058255	CHEMBL1047781	Residual activity of Aurora-B at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	24.0	CHEMBL2185	Homo sapiens	Residual activity	%	24.0
	3058507	CHEMBL1047808	Residual activity of Aurora-B at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	3.0	CHEMBL2185	Homo sapiens	Residual activity	%	3.0
	3059777	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	=	EC50	nM	5000.0	CHEMBL2185	Homo sapiens	EC50	uM	5.0
	3059778	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059779	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	=	EC50	nM	5000.0	CHEMBL2185	Homo sapiens	EC50	uM	5.0
	3059780	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059781	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059782	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059783	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059784	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059785	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059786	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059787	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3059788	CHEMBL1073384	Inhibition of Aurora-B in human HCT116 cells by cellular proliferation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	>	EC50	nM	10000.0	CHEMBL2185	Homo sapiens	EC50	uM	10.0
	3062442	CHEMBL1048635	Binding affinity to human aurora kinase B at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	5.8	CHEMBL2185	Homo sapiens	Activity	%	5.8
	3063577	CHEMBL1045163	Binding affinity to human aurora kinase B at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	0.0	CHEMBL2185	Homo sapiens	Activity	%	0.0
	3063667	CHEMBL1038878	Binding affinity to human aurora kinase B at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	33.0	CHEMBL2185	Homo sapiens	Activity	%	33.0
	3065848	CHEMBL1068654	Inhibition of AURKB at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	3066914	CHEMBL1068654	Inhibition of AURKB at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	3072614	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556	=	IC50	nM	135.0	CHEMBL2185	Homo sapiens	IC50	uM	0.135
	3072615	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	=	IC50	nM	3700.0	CHEMBL2185	Homo sapiens	IC50	uM	3.7
	3072616	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OC		CHEMBL593293	=	IC50	nM	4200.0	CHEMBL2185	Homo sapiens	IC50	uM	4.2
	3072617	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OC)cc12		CHEMBL596059	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3072618	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595615	=	IC50	nM	60.0	CHEMBL2185	Homo sapiens	IC50	uM	0.06
	3072619	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3C)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595406	=	IC50	nM	440.0	CHEMBL2185	Homo sapiens	IC50	uM	0.44
	3072620	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3O)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595142	=	IC50	nM	270.0	CHEMBL2185	Homo sapiens	IC50	uM	0.27
	3072621	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	=	IC50	nM	90.0	CHEMBL2185	Homo sapiens	IC50	uM	0.09
	3072622	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3OC(F)(F)F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593245	=	IC50	nM	520.0	CHEMBL2185	Homo sapiens	IC50	uM	0.52
	3072623	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	uM	0.028
	3072624	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(C)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596087	=	IC50	nM	260.0	CHEMBL2185	Homo sapiens	IC50	uM	0.26
	3072625	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	=	IC50	nM	59.0	CHEMBL2185	Homo sapiens	IC50	uM	0.059
	3072626	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	=	IC50	nM	300.0	CHEMBL2185	Homo sapiens	IC50	uM	0.3
	3072627	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	=	IC50	nM	27.0	CHEMBL2185	Homo sapiens	IC50	uM	0.027
	3072628	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	=	IC50	nM	78.0	CHEMBL2185	Homo sapiens	IC50	uM	0.078
	3072629	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1ccc2nc(-c3ccc(Nc4ncnc5cc(OCCCN6CCN(C)CC6)c(OC)cc45)cc3)sc2c1		CHEMBL593306	=	IC50	nM	48.0	CHEMBL2185	Homo sapiens	IC50	uM	0.048
	3072630	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	=	IC50	nM	41.0	CHEMBL2185	Homo sapiens	IC50	uM	0.041
	3072631	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593275	=	IC50	nM	64.0	CHEMBL2185	Homo sapiens	IC50	uM	0.064
	3072632	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	=	IC50	nM	62.0	CHEMBL2185	Homo sapiens	IC50	uM	0.062
	3072633	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	uM	0.12
	3072634	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593909	=	IC50	nM	90.0	CHEMBL2185	Homo sapiens	IC50	uM	0.09
	3072635	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(N(C)c3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593770	=	IC50	nM	8000.0	CHEMBL2185	Homo sapiens	IC50	uM	8.0
	3072636	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	uM	0.13
	3072637	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	IC50	nM	63.0	CHEMBL2185	Homo sapiens	IC50	uM	0.063
	3072638	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	IC50	nM	162.0	CHEMBL2185	Homo sapiens	IC50	uM	0.162
	3072784	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593292	=	IC50	nM	510.0	CHEMBL2185	Homo sapiens	IC50	uM	0.51
	3072785	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OCCCN1CCN(C)CC1		CHEMBL595374	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3072786	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OCCCN1CCN(C)CC1		CHEMBL593294	=	IC50	nM	800.0	CHEMBL2185	Homo sapiens	IC50	uM	0.8
	3072787	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OCCCN3CCN(C)CC3)cc12		CHEMBL593910	=	IC50	nM	1900.0	CHEMBL2185	Homo sapiens	IC50	uM	1.9
	3072788	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3F)c2cc1OCCCN1CCN(C)CC1		CHEMBL594661	=	IC50	nM	410.0	CHEMBL2185	Homo sapiens	IC50	uM	0.41
	3072789	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604485	=	IC50	nM	640.0	CHEMBL2185	Homo sapiens	IC50	uM	0.64
	3072790	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593911	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3072791	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593760	=	IC50	nM	670.0	CHEMBL2185	Homo sapiens	IC50	uM	0.67
	3072792	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604893	=	IC50	nM	4800.0	CHEMBL2185	Homo sapiens	IC50	uM	4.8
	3072793	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593971	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	uM	0.5
	3072794	CHEMBL1073377	Inhibition of Aurora-B by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593905	=	IC50	nM	2100.0	CHEMBL2185	Homo sapiens	IC50	uM	2.1
	3072853	CHEMBL1066609	Residual activity of Aurora-B at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	45.0	CHEMBL2185	Homo sapiens	Residual activity	%	45.0
	3084414	CHEMBL1073277	Inhibition of AuroraB	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	4300.0	CHEMBL2185	Homo sapiens	IC50	uM	4.3
	3089485	CHEMBL1070555	Inhibition of Aurora B kinase	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	41000.0	CHEMBL2185	Homo sapiens	IC50	nM	41000.0
	3094276	CHEMBL1073147	Inhibition of Aurora 2 kinase	B	COc1c(O)cc2c3c(cc4ccc(O)cc4c13)NC2=O		CHEMBL388956	=	IC50	nM	2140.0	CHEMBL2185	Homo sapiens	IC50	nM	2140.0
	3117915	CHEMBL1072191	Inhibition of Aurora B	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3117968	CHEMBL1072191	Inhibition of Aurora B	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3118021	CHEMBL1072191	Inhibition of Aurora B	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3127436	CHEMBL1074431	Inhibition of Aurora B by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3127470	CHEMBL1074431	Inhibition of Aurora B by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3130832	CHEMBL1066171	Inhibition of Aurora B at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3131743	CHEMBL1065748	Inhibition of Aurora B at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3186455	CHEMBL1113300	Inhibition of Aurora kinase 2	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12		CHEMBL1082237	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	3203232	CHEMBL1101132	Inhibition of AURKB	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	40000.0	CHEMBL2185	Homo sapiens	Kd	uM	40.0
	3213875	CHEMBL1111291	Inhibition of auroraB at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL2185	Homo sapiens	INH	%	4.0
	3219864	CHEMBL1113991	Inhibition of Aurora B	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	nM	50000.0
	3219865	CHEMBL1113991	Inhibition of Aurora B	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	nM	50000.0
	3219997	CHEMBL1115846	Inhibition of Aurora B	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	25500.0	CHEMBL2185	Homo sapiens	IC50	uM	25.5
	3224742	CHEMBL1102601	Inhibition of Aurora B at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3225009	CHEMBL1102601	Inhibition of Aurora B at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3225983	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	Clc1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1078060	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	3225984	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	FC(F)(F)c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1077729	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	nM	6.0
	3225985	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1ccc2sc(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079271	=	IC50	nM	2500.0	CHEMBL2185	Homo sapiens	IC50	nM	2500.0
	3225986	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1ccc2oc(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079150	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	nM	120.0
	3225987	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	Cn1c(Nc2ccc(CCNc3ncnc4ccsc34)cc2)nc2ccccc21		CHEMBL1079052	=	IC50	nM	280.0	CHEMBL2185	Homo sapiens	IC50	nM	280.0
	3225988	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1cc2nc(Nc3ccc(CCNc4ncnc5ccsc45)cc3)[nH]c2cn1		CHEMBL1079051	=	IC50	nM	140.0	CHEMBL2185	Homo sapiens	IC50	nM	140.0
	3225989	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1cnc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1077955	=	IC50	nM	83.0	CHEMBL2185	Homo sapiens	IC50	nM	83.0
	3225990	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1078906	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	3225991	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1ccc2[nH]c(Nc3ccc(CNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1078327	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	3225992	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1cc(CCNc2ncnc3ccsc23)cc(Nc2nc3ccccc3[nH]2)c1		CHEMBL1078927	=	IC50	nM	1400.0	CHEMBL2185	Homo sapiens	IC50	nM	1400.0
	3225993	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1cc(CNc2ncnc3ccsc23)cc(Nc2nc3ccccc3[nH]2)c1		CHEMBL1078926	=	IC50	nM	580.0	CHEMBL2185	Homo sapiens	IC50	nM	580.0
	3225994	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	FC(F)(F)c1ccc2nc(Nc3ncc(CCNc4ncnc5ccsc45)s3)[nH]c2c1		CHEMBL1078828	=	IC50	nM	620.0	CHEMBL2185	Homo sapiens	IC50	nM	620.0
	3225995	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1ccc2[nH]c(Nc3ncc(CCNc4ncnc5ccsc45)s3)nc2c1		CHEMBL1078827	=	IC50	nM	420.0	CHEMBL2185	Homo sapiens	IC50	nM	420.0
	3225996	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL518051	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	3225997	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472193	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
	3225998	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472202	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	nM	120.0
	3226079	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	Fc1cc(CCNc2ncnc3ccsc23)ccc1Nc1nc2cc(C(F)(F)F)ccc2[nH]1		CHEMBL1078061	=	IC50	nM	21.0	CHEMBL2185	Homo sapiens	IC50	nM	21.0
	3226080	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	FC(F)(F)c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)nc3)nc2c1		CHEMBL1081880	=	IC50	nM	63.0	CHEMBL2185	Homo sapiens	IC50	nM	63.0
	3226081	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	FC(F)(F)c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cn3)nc2c1		CHEMBL1081881	=	IC50	nM	600.0	CHEMBL2185	Homo sapiens	IC50	nM	600.0
	3226082	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	FC(F)(F)c1cnc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079538	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	3226083	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	Clc1cnc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079713	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	3226084	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	Cc1nc(Nc2ccc(CCNc3ncnc4ccsc34)cc2)[nH]c1C		CHEMBL1080080	=	IC50	nM	5600.0	CHEMBL2185	Homo sapiens	IC50	nM	5600.0
	3226085	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	c1ccc(-c2c[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)n2)cc1		CHEMBL1080980	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	3226086	CHEMBL1112281	Inhibition of Aurora B after 60 mins	B	FC(F)(F)c1cccc(Nc2nc3ccc(CCNc4ncnc5ccsc45)cc3[nH]2)c1		CHEMBL1080981	=	IC50	nM	1400.0	CHEMBL2185	Homo sapiens	IC50	nM	1400.0
	3239032	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	32.0	CHEMBL2185	Homo sapiens	IC50	nM	32.0
	3239033	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	c1cc(-c2cn[nH]c2)c2cc[nH]c2n1		CHEMBL1089985	=	IC50	nM	13398.0	CHEMBL2185	Homo sapiens	IC50	nM	13398.0
	3239034	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	Cn1cc(-c2ccnc3[nH]ccc23)cn1		CHEMBL1089986	=	IC50	nM	6161.0	CHEMBL2185	Homo sapiens	IC50	nM	6161.0
Not Active	3239035	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090156		IC50			CHEMBL2185	Homo sapiens	IC50		
	3239036	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	CN(C)Cc1cccc(-c2cc3c(-c4cnn(C)c4)ccnc3[nH]2)c1		CHEMBL1090670	=	IC50	nM	104.0	CHEMBL2185	Homo sapiens	IC50	nM	104.0
	3239037	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	CN(C)Cc1ccc(-c2cc3c(-c4cnn(C)c4)ccnc3[nH]2)cc1		CHEMBL1090508	=	IC50	nM	169.0	CHEMBL2185	Homo sapiens	IC50	nM	169.0
	3239038	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	CN(C)Cc1ccc(-c2cc3c(-c4cnn(C)c4)c(Cl)cnc3[nH]2)cc1		CHEMBL1090832	=	IC50	nM	9.0	CHEMBL2185	Homo sapiens	IC50	nM	9.0
	3239039	CHEMBL1110578	Inhibition of aurora B assessed as inhibition of histone H3 phosphorylation by ELISA based cellular mechanistic assay	B	CN(C)Cc1cccc(-c2cc3c(-c4cnn(C)c4)c(Cl)cnc3[nH]2)c1		CHEMBL587029	=	IC50	nM	67.0	CHEMBL2185	Homo sapiens	IC50	nM	67.0
	3239903	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Cc1cc(N)cc(-c2ccc3[nH]nc(/C=C/c4cccc(CN5CCN(C)CC5)c4)c3c2C)c1		CHEMBL1093821	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	uM	0.031
	3239904	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Cc1c(C#N)ccc2[nH]nc(/C=C/c3cccc(CN4CCN(C)CC4)c3)c12		CHEMBL1093515	=	IC50	nM	59.0	CHEMBL2185	Homo sapiens	IC50	uM	0.059
	3239905	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	O=S(=O)(Cc1ccccc1)Nc1ccc2[nH]nc(/C=C/c3ccccc3)c2c1		CHEMBL1093514	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	uM	0.031
	3239906	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	COc1ccc(OC)c(CC(=O)Nc2cc3c(/C=C/c4ccccc4)n[nH]c3cc2C)c1		CHEMBL1091617	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	uM	0.18
	3239907	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Cc1c(NC(=O)Cc2cccs2)ccc2[nH]nc(/C=C/c3cccc(CN4CCN(C)CC4)c3)c12		CHEMBL1091233	=	IC50	nM	99.0	CHEMBL2185	Homo sapiens	IC50	uM	0.099
	3239908	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	CN1CCN(Cc2cccc(/C=C/c3n[nH]c4ccc(NC(=O)Cc5cccs5)cc34)c2)CC1		CHEMBL1091232	=	IC50	nM	26.0	CHEMBL2185	Homo sapiens	IC50	uM	0.026
	3239909	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Cc1cc2[nH]nc(/C=C/c3cccc(CN4CCN(C)CC4)c3)c2cc1NC(=O)Cc1cccs1		CHEMBL1091231	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	uM	0.13
	3239910	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Cc1cc2[nH]nc(/C=C/c3cccc(NC(=O)N4CCN(C)CC4)c3)c2cc1NC(=O)Cc1cccs1		CHEMBL1093265	=	IC50	nM	46.0	CHEMBL2185	Homo sapiens	IC50	uM	0.046
	3239911	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	O=C(Cc1cccs1)Nc1cc2c(/C=C/c3ccccc3)n[nH]c2cc1N1CCCC1		CHEMBL1090237	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	uM	0.11
	3239912	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	CN1CCN(C(=O)Nc2cccc(/C=C/c3n[nH]c4cc(N5CCCC5)c(NS(C)(=O)=O)cc34)c2)CC1		CHEMBL1093854	=	IC50	nM	62.0	CHEMBL2185	Homo sapiens	IC50	uM	0.062
	3239913	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Nc1cc2c(/C=C/c3ccccc3)n[nH]c2cc1N1CCCC1		CHEMBL1091975	=	IC50	nM	81.0	CHEMBL2185	Homo sapiens	IC50	uM	0.081
	3239914	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	O=[N+]([O-])c1cc2c(/C=C/c3ccccc3)n[nH]c2cc1N1CCCC1		CHEMBL1091974	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	uM	0.11
	3239915	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	C(=C/c1n[nH]c2cc(N3CCCC3)c(NCc3ccccn3)cc12)\c1ccccc1		CHEMBL1093879	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	uM	0.13
	3239916	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	CN1CCN(c2cc3[nH]nc(/C=C/c4ccccc4)c3cc2NCc2ccccn2)CC1		CHEMBL1093878	=	IC50	nM	810.0	CHEMBL2185	Homo sapiens	IC50	uM	0.81
	3239917	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	C(=C/c1n[nH]c2cc(N3CCCC3)c(-c3ccncc3)cc12)\c1ccccc1		CHEMBL1090679	=	IC50	nM	46.0	CHEMBL2185	Homo sapiens	IC50	uM	0.046
	3239918	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Cc1cc2[nH]nc(C#Cc3ccccc3)c2cc1NC(=O)Cc1cccs1		CHEMBL1093877	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	uM	0.11
	3239919	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	Cc1cc2[nH]nc(/C=C/c3ccccc3)c2cc1NC(=O)Cc1cccs1		CHEMBL1090568	=	IC50	nM	47.0	CHEMBL2185	Homo sapiens	IC50	uM	0.047
	3239920	CHEMBL1113417	Inhibition of GST tagged recombinant Aurora B expressed in Hi-5 cells after 1 hr by TRF assay	B	O=C(Cc1ccccc1)Nc1ccc2[nH]nc(C3CC3c3ccccc3)c2c1		CHEMBL1090911	=	IC50	nM	1640.0	CHEMBL2185	Homo sapiens	IC50	uM	1.64
	3240790	CHEMBL1109653	Inhibition of Aurora 2	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	IC50	nM	660.0	CHEMBL2185	Homo sapiens	IC50	uM	0.66
	3242212	CHEMBL1108796	Inhibition of Aurora B	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	uM	50.0
	3251270	CHEMBL1110593	Inhibition of Aurora B	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	22200.0	CHEMBL2185	Homo sapiens	IC50	uM	22.2
	3260095	CHEMBL1108073	Inhibition of Aurora B at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	33.0	CHEMBL2185	Homo sapiens	Activity	%	33.0
	3261378	CHEMBL1108073	Inhibition of Aurora B at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	21.0	CHEMBL2185	Homo sapiens	Activity	%	21.0
	3271032	CHEMBL1104634	Inhibition of Aurora B	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	uM	50.0
	3271034	CHEMBL1104634	Inhibition of Aurora B	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	=	IC50	nM	45100.0	CHEMBL2185	Homo sapiens	IC50	uM	45.1
	3291447	CHEMBL1109161	Inhibition of Aurora B assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
Not Active	3293111	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096459		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293127	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL1096460		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293143	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096466		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293159	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccccc3)ccc21		CHEMBL1096672		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293175	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1ccc(Nc2ccc3c(c2)Cc2ccccc2CC3=O)cc1		CHEMBL1096769		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293191	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)C(=O)Cc1ccccc1C2		CHEMBL1096770		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293207	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1096771		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293223	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1097085		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293239	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	O=C1Cc2ccc(Nc3ccccc3)cc2Cc2ccccc21		CHEMBL1097086		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293255	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097087		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293271	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097088		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293287	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	O=C1Cc2cc(Nc3ccccc3)ccc2Cc2ccccc21		CHEMBL1096988		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293303	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098461		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293319	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098462		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293335	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	O=C1Cc2ccccc2Cc2cc(-c3ccccc3)ccc21		CHEMBL1096442		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	3293351	CHEMBL1108234	Inhibition of Aurora B at 10 uM	B	O=C1Cc2ccccc2Cc2cc(NCc3ccccc3)ccc21		CHEMBL1097171		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	3294176	CHEMBL1104796	Competitive inhibition of Aurora B ATP binding site	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1.8	CHEMBL2185	Homo sapiens	Ki	nM	1.8
	3294180	CHEMBL1104796	Competitive inhibition of Aurora B ATP binding site	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	172.0	CHEMBL2185	Homo sapiens	IC50	nM	172.0
	3294181	CHEMBL1104796	Competitive inhibition of Aurora B ATP binding site	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	3294184	CHEMBL1104796	Competitive inhibition of Aurora B ATP binding site	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Ki	nM	0.38	CHEMBL2185	Homo sapiens	Ki	nM	0.38
	3294206	CHEMBL1104790	Inhibition of human Aurora B assessed as dissociation half life by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(NC(C)=O)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099343	=	Activity	min	320.0	CHEMBL2185	Homo sapiens	Activity	min	320.0
	3294209	CHEMBL1104790	Inhibition of human Aurora B assessed as dissociation half life by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099345	=	Activity	min	520.0	CHEMBL2185	Homo sapiens	Activity	min	520.0
	3294230	CHEMBL1104793	Competitive inhibition of human Aurora B ATP binding site by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Ki	nM	0.38	CHEMBL2185	Homo sapiens	Ki	nM	0.38
	3294235	CHEMBL1104790	Inhibition of human Aurora B assessed as dissociation half life by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Activity	min	480.0	CHEMBL2185	Homo sapiens	Activity	min	480.0
	3294237	CHEMBL1104790	Inhibition of human Aurora B assessed as dissociation half life by rapid dilution method	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Activity	min	30.0	CHEMBL2185	Homo sapiens	Activity	min	30.0
	3294238	CHEMBL1104790	Inhibition of human Aurora B assessed as dissociation half life by rapid dilution method	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Activity	min	30.0	CHEMBL2185	Homo sapiens	Activity	min	30.0
	3294239	CHEMBL1104790	Inhibition of human Aurora B assessed as dissociation half life by rapid dilution method	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)cc1		CHEMBL1095157	=	Activity	min	200.0	CHEMBL2185	Homo sapiens	Activity	min	200.0
	3294241	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	3294263	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	O=C(Nc1ccccc1)Nc1ccc(-c2n[nH]cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1095192	=	IC50	nM	32.0	CHEMBL2185	Homo sapiens	IC50	nM	32.0
	3294264	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1ncc(-c2ccnc3[nH]ccc23)c1-c1ccc(NC(=O)Nc2ccccc2)cc1		CHEMBL1095828	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
	3294265	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1089116	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	3294266	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CC(C)(C)n1ncc(-c2ccnc3[nH]ccc23)c1-c1ccc(NC(=O)Nc2ccccc2)cc1		CHEMBL1098666	=	IC50	nM	40.0	CHEMBL2185	Homo sapiens	IC50	nM	40.0
	3294267	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CC(C)(C)n1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1095498	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
	3294268	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC(F)(F)F)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1095817	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
	3294269	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CCO)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1099010	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	3294270	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC(O)CO)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1097106	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	3294271	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CCCO)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1097454	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	3294272	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC3CCCO3)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1964276	=	IC50	nM	97.0	CHEMBL2185	Homo sapiens	IC50	nM	97.0
	3294273	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	NC(=O)Cn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094505	=	IC50	nM	64.0	CHEMBL2185	Homo sapiens	IC50	nM	64.0
	3294274	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCNC(=O)Cn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094506	=	IC50	nM	64.0	CHEMBL2185	Homo sapiens	IC50	nM	64.0
	3294275	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC(=O)N3CCOCC3)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1094507	=	IC50	nM	85.0	CHEMBL2185	Homo sapiens	IC50	nM	85.0
	3294276	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090156	=	IC50	nM	26.0	CHEMBL2185	Homo sapiens	IC50	nM	26.0
	3294277	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(NC(C)=O)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099343	=	IC50	nM	44.0	CHEMBL2185	Homo sapiens	IC50	nM	44.0
	3294278	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(NC(C)=O)cc4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099344	=	IC50	nM	44.0	CHEMBL2185	Homo sapiens	IC50	nM	44.0
	3294279	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099345	=	IC50	nM	20.0	CHEMBL2185	Homo sapiens	IC50	nM	20.0
	3294280	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cc(CN(C)C)ccc4C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099346	=	IC50	nM	60.0	CHEMBL2185	Homo sapiens	IC50	nM	60.0
	3294281	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099347	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	nM	23.0
	3294282	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099348	=	IC50	nM	26.0	CHEMBL2185	Homo sapiens	IC50	nM	26.0
	3294283	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCCC5)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099349	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
	3294284	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099350	=	IC50	nM	57.0	CHEMBL2185	Homo sapiens	IC50	nM	57.0
	3294285	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099351	=	IC50	nM	66.0	CHEMBL2185	Homo sapiens	IC50	nM	66.0
	3294286	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)cc1		CHEMBL1095157	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	3294287	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4)cc23)cc1		CHEMBL1094838	=	IC50	nM	1.7	CHEMBL2185	Homo sapiens	IC50	nM	1.7
	3294288	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1095149	=	IC50	nM	3.6	CHEMBL2185	Homo sapiens	IC50	nM	3.6
	3294289	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4cccc(CN5CCCC5)c4)cc23)cc1		CHEMBL1095475	=	IC50	nM	1.4	CHEMBL2185	Homo sapiens	IC50	nM	1.4
	3294290	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCCC5)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1095788	=	IC50	nM	2.1	CHEMBL2185	Homo sapiens	IC50	nM	2.1
	3294291	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4ccc(CN5CCCC5)cc4)cc23)cc1		CHEMBL1097191	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
	3294292	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN5CCCC5)cc4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1097521	=	IC50	nM	4.5	CHEMBL2185	Homo sapiens	IC50	nM	4.5
	3294293	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)cc1		CHEMBL1094700	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	3294294	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1094701	=	IC50	nM	4.7	CHEMBL2185	Homo sapiens	IC50	nM	4.7
	3294295	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)cc1		CHEMBL1094702	=	IC50	nM	4.7	CHEMBL2185	Homo sapiens	IC50	nM	4.7
	3294296	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1094703	=	IC50	nM	8.1	CHEMBL2185	Homo sapiens	IC50	nM	8.1
	3294297	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(C(=O)NCCN4CCOCC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094704	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	3294298	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(C(=O)NCCCN4CCN(C)CC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094705	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	3294299	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(C(=O)NCCN4CCN(C)CC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094706	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	3294300	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(CN(C)C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1097839	=	IC50	nM	58.0	CHEMBL2185	Homo sapiens	IC50	nM	58.0
	3294301	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(CNCCO)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094904	=	IC50	nM	46.0	CHEMBL2185	Homo sapiens	IC50	nM	46.0
	3294302	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(CNCCN(C)C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1096491	=	IC50	nM	276.0	CHEMBL2185	Homo sapiens	IC50	nM	276.0
	3294303	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(CNCCS(C)(=O)=O)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1096492	=	IC50	nM	24.0	CHEMBL2185	Homo sapiens	IC50	nM	24.0
	3294304	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(CNCCN4CCOCC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1095988	=	IC50	nM	22.0	CHEMBL2185	Homo sapiens	IC50	nM	22.0
	3294305	CHEMBL1104788	Inhibition of human Aurora B by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(CNCCCN4CCN(C)CC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1095989	=	IC50	nM	83.0	CHEMBL2185	Homo sapiens	IC50	nM	83.0
	3294393	CHEMBL1108275	Inhibition of human Aurora B assessed as residence time by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1089116	=	TIME	hr	0.1283	CHEMBL2185	Homo sapiens	Time	min	7.7
	3294403	CHEMBL1104790	Inhibition of human Aurora B assessed as dissociation half life by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1089116	=	Activity	min	7.7	CHEMBL2185	Homo sapiens	Activity	min	7.7
	3301989	CHEMBL1119043	Inhibition of Aurora B at 1 uM	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	Inhibition	%	60.0	CHEMBL2185	Homo sapiens	INH	%	60.0
	3302026	CHEMBL1118617	Inhibition of human recombinant Aurora B expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1		CHEMBL1086579	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	uM	0.025
	3302663	CHEMBL1120721	Inhibition of Aurora B	B	CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1		CHEMBL1084451	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	IC50	uM	0.1
	3302672	CHEMBL1120721	Inhibition of Aurora B	B	CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084452	=	IC50	nM	47.0	CHEMBL2185	Homo sapiens	IC50	uM	0.047
	3302681	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	IC50	nM	77.0	CHEMBL2185	Homo sapiens	IC50	uM	0.077
	3302690	CHEMBL1120721	Inhibition of Aurora B	B	CN(C)CC(C)(C)CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084453	=	IC50	nM	759.0	CHEMBL2185	Homo sapiens	IC50	uM	0.759
	3302699	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	IC50	nM	9.0	CHEMBL2185	Homo sapiens	IC50	uM	0.009
	3302708	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccncc4[nH]3)c3ccccc23)n1		CHEMBL1086334	=	IC50	nM	454.0	CHEMBL2185	Homo sapiens	IC50	uM	0.454
	3302717	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	uM	0.023
	3302726	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1		CHEMBL456463	=	IC50	nM	134.0	CHEMBL2185	Homo sapiens	IC50	uM	0.134
	3302735	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1		CHEMBL456683	=	IC50	nM	143.0	CHEMBL2185	Homo sapiens	IC50	uM	0.143
	3302744	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1		CHEMBL463323	=	IC50	nM	56.0	CHEMBL2185	Homo sapiens	IC50	uM	0.056
	3302753	CHEMBL1120721	Inhibition of Aurora B	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)NC(C)(C)C)c3ccccc23)n1		CHEMBL1084633	=	IC50	nM	55.0	CHEMBL2185	Homo sapiens	IC50	uM	0.055
	3302762	CHEMBL1120721	Inhibition of Aurora B	B	CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12		CHEMBL1084634	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	uM	0.13
	3302771	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1		CHEMBL1084451	=	Inhibition	%	9.0	CHEMBL2185	Homo sapiens	INH	%	9.0
	3302772	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084452	=	Inhibition	%	4.0	CHEMBL2185	Homo sapiens	INH	%	4.0
	3302773	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	3302774	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CN(C)CC(C)(C)CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084453	=	Inhibition	%	43.0	CHEMBL2185	Homo sapiens	INH	%	43.0
	3302775	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	Inhibition	%	1.0	CHEMBL2185	Homo sapiens	INH	%	1.0
	3302776	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccncc4[nH]3)c3ccccc23)n1		CHEMBL1086334	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	3302777	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099	=	Inhibition	%	2.0	CHEMBL2185	Homo sapiens	INH	%	2.0
	3302778	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1		CHEMBL456463	=	Inhibition	%	12.0	CHEMBL2185	Homo sapiens	INH	%	12.0
	3302779	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1		CHEMBL456683	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	INH	%	13.0
	3302780	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1		CHEMBL463323	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	INH	%	5.0
	3302781	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)NC(C)(C)C)c3ccccc23)n1		CHEMBL1084633	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	INH	%	5.0
	3302782	CHEMBL1120733	Inhibition of Aurora B at 1 uM relative to control	B	CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12		CHEMBL1084634	=	Inhibition	%	11.0	CHEMBL2185	Homo sapiens	INH	%	11.0
	3305018	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	9.2	CHEMBL2185	Homo sapiens	Ki	nM	9.2
	3305019	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)n2)s1		CHEMBL1083484	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	3305020	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(C)nc4C)n3)cc2)CC1		CHEMBL1083786	=	Ki	nM	13.0	CHEMBL2185	Homo sapiens	Ki	nM	13.0
	3305021	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1083785	=	Ki	nM	9.7	CHEMBL2185	Homo sapiens	Ki	nM	9.7
	3305022	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(N)nc4C)n3)cc2)CC1		CHEMBL1084969	=	Ki	nM	3.8	CHEMBL2185	Homo sapiens	Ki	nM	3.8
	3305023	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1084630	=	Ki	nM	6.0	CHEMBL2185	Homo sapiens	Ki	nM	6.0
	3305024	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1084629	=	Ki	nM	9.4	CHEMBL2185	Homo sapiens	Ki	nM	9.4
	3305025	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1085626	=	Ki	nM	9.0	CHEMBL2185	Homo sapiens	Ki	nM	9.0
	3305026	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CCNc1nc(C)c(-c2ccnc(Nc3ccc(CNC(C)=O)cc3)n2)s1		CHEMBL1084715	=	Ki	nM	4.0	CHEMBL2185	Homo sapiens	Ki	nM	4.0
	3305027	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CCNc1nc(C)c(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)s1		CHEMBL1086088	=	Ki	nM	6.0	CHEMBL2185	Homo sapiens	Ki	nM	6.0
	3305028	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CNc1nc(C)c(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)s1		CHEMBL1083152	=	Ki	nM	3.0	CHEMBL2185	Homo sapiens	Ki	nM	3.0
	3305029	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	COc1cc(Nc2nccc(-c3sc(C)nc3C)n2)cc(OC)c1OC		CHEMBL1083151	=	Ki	nM	2.0	CHEMBL2185	Homo sapiens	Ki	nM	2.0
Not Determined	3305030	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N)cc3)n2)s1		CHEMBL1084454		Ki			CHEMBL2185	Homo sapiens	Ki		
	3305031	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	CNc1ccc(Nc2nccc(-c3sc(C)nc3C)n2)cc1		CHEMBL1083150	=	Ki	nM	33.0	CHEMBL2185	Homo sapiens	Ki	nM	33.0
	3305032	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1		CHEMBL46817	=	Ki	nM	15.0	CHEMBL2185	Homo sapiens	Ki	nM	15.0
	3305033	CHEMBL1119478	Inhibition of human recombinant Aurora B after 60 mins	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	57.0	CHEMBL2185	Homo sapiens	Ki	nM	57.0
Active	3305782	CHEMBL1120453	Inhibition of Aurora B phosphorylation in human A549 cells at 0.15 to 5 uM after 1 hr by Western blot analysis in presence of nocodazole and proteasome inhibitor MG132	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	3306923	CHEMBL1117947	Inhibition of Aurora B at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	41.0	CHEMBL2185	Homo sapiens	INH	%	41.0
	3308635	CHEMBL1117730	Inhibition of aurora B at 10 uM	B	Cc1c(-c2ccnc(N)n2)sc2ccc(Cc3cccc(O)c3)cc12		CHEMBL1082758	=	Inhibition	%	82.0	CHEMBL2185	Homo sapiens	INH	%	82.0
	3331833	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3333248	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3334653	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3336073	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3337456	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3337704	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3339036	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3339292	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3340601	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	76.0	CHEMBL2185	Homo sapiens	INH	%	76.0
	3342017	CHEMBL1168792	Inhibition of AURKB at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	3344659	CHEMBL1167718	Inhibition of Aurora B assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	73.0	CHEMBL2185	Homo sapiens	Activity	%	73.0
	3344660	CHEMBL1167719	Inhibition of Aurora B assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	98.0	CHEMBL2185	Homo sapiens	Activity	%	98.0
Active	3345445	CHEMBL1166285	Inhibition of GST-tagged human recombinant Aurora B kinase at 20 uM	B	O=C(OCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1		CHEMBL1165533		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	3345447	CHEMBL1166285	Inhibition of GST-tagged human recombinant Aurora B kinase at 20 uM	B	O=C(OCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1		CHEMBL1164468		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	3345449	CHEMBL1166285	Inhibition of GST-tagged human recombinant Aurora B kinase at 20 uM	B	O=C(OCCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1		CHEMBL1165527		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	3345451	CHEMBL1166285	Inhibition of GST-tagged human recombinant Aurora B kinase at 20 uM	B	O=C(OCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1		CHEMBL1164100		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	3345495	CHEMBL1166285	Inhibition of GST-tagged human recombinant Aurora B kinase at 20 uM	B	COc1cc(C(=O)OCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O		CHEMBL1164563	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
Active	3352641	CHEMBL1175613	Inhibition of aurora B at 100 uM	B	Cc1cc(CNC(=O)c2nn(CCCN)c3c2CCc2cnc(Nc4cccc(CC(=O)N(C)C)c4)nc2-3)ccn1		CHEMBL1172241		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	3358460	CHEMBL1174074	Inhibition of AURKB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	24.0	CHEMBL2185	Homo sapiens	INH	%	24.0
	3358902	CHEMBL1174074	Inhibition of AURKB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	4.6	CHEMBL2185	Homo sapiens	INH	%	4.6
Active	3365194	CHEMBL1175885	Inhibition of Aurora B in human HCT116 cells assessed as 4N DNA content after 48 hrs by flow cytometry	B	OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1		CHEMBL1172781		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	3365195	CHEMBL1176119	Inhibition of Aurora B in human HCT116 cells assessed as 8N DNA content after 48 hrs by flow cytometry	B	OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1		CHEMBL1172781		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	3365197	CHEMBL1175881	Inhibition of Aurora B phosphorylation in human HCT116 cells assessed as phosphorylated histone H3 level by Western blotting	B	OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1		CHEMBL1172781		Activity			CHEMBL2185	Homo sapiens	Activity		
	3370114	CHEMBL1176695	Inhibition of AuroraB at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	98.5	CHEMBL2185	Homo sapiens	INH	%	98.5
	3370115	CHEMBL1176694	Inhibition of AuroraB	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	IC50	nM	1.19	CHEMBL2185	Homo sapiens	IC50	nM	1.19
	3407599	CHEMBL1219722	Inhibition of recombinant aurora B	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1215071	=	IC50	nM	1720.0	CHEMBL2185	Homo sapiens	IC50	uM	1.72
	3407600	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCCC4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215072	=	IC50	nM	441.0	CHEMBL2185	Homo sapiens	IC50	uM	0.441
	3407601	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCCCC4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215073	=	IC50	nM	495.0	CHEMBL2185	Homo sapiens	IC50	uM	0.495
	3407602	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCOCC4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215145	=	IC50	nM	1870.0	CHEMBL2185	Homo sapiens	IC50	uM	1.87
	3407603	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCc5ccccc54)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215146	=	IC50	nM	292.0	CHEMBL2185	Homo sapiens	IC50	uM	0.292
	3407604	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215148	=	IC50	nM	156.0	CHEMBL2185	Homo sapiens	IC50	uM	0.156
	3407605	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)Cc4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215216	=	IC50	nM	402.0	CHEMBL2185	Homo sapiens	IC50	uM	0.402
	3407606	CHEMBL1219722	Inhibition of recombinant aurora B	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	=	IC50	nM	214.0	CHEMBL2185	Homo sapiens	IC50	uM	0.214
	3407607	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C1Nc2ccc(NS(=O)(=O)c3ccccc3)cc2/C1=C/c1[nH]c2c(c1CCC(=O)N1CCCC1)C(=O)CCC2		CHEMBL1215280	=	IC50	nM	719.0	CHEMBL2185	Homo sapiens	IC50	uM	0.719
	3407608	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C1Nc2ccc(NS(=O)(=O)c3ccccc3)cc2/C1=C/c1[nH]c2c(c1CCC(=O)N1CCOCC1)C(=O)CCC2		CHEMBL1215281	=	IC50	nM	906.0	CHEMBL2185	Homo sapiens	IC50	uM	0.906
	3407609	CHEMBL1219722	Inhibition of recombinant aurora B	B	CNC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215282	=	IC50	nM	320.0	CHEMBL2185	Homo sapiens	IC50	uM	0.32
	3407610	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C1Nc2ccc(S(=O)(=O)N3CCc4ccccc43)cc2/C1=C/c1[nH]c2c(c1CCC(=O)N1CCOCC1)C(=O)CCC2		CHEMBL1215283	=	IC50	nM	3154.0	CHEMBL2185	Homo sapiens	IC50	uM	3.154
	3407611	CHEMBL1219722	Inhibition of recombinant aurora B	B	O=C1Nc2ccc(NS(=O)(=O)c3ccccc3)cc2/C1=C/c1[nH]c2c(c1CCCN1CCCC1)C(=O)CCC2		CHEMBL1215284	=	IC50	nM	310.0	CHEMBL2185	Homo sapiens	IC50	uM	0.31
	3407612	CHEMBL1219722	Inhibition of recombinant aurora B	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	=	IC50	nM	235.0	CHEMBL2185	Homo sapiens	IC50	uM	0.235
	3407613	CHEMBL1219722	Inhibition of recombinant aurora B	B	CCN(CC)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215347	=	IC50	nM	356.0	CHEMBL2185	Homo sapiens	IC50	uM	0.356
	3407614	CHEMBL1219722	Inhibition of recombinant aurora B	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCc5ccccc54)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215348	=	IC50	nM	312.0	CHEMBL2185	Homo sapiens	IC50	uM	0.312
	3407615	CHEMBL1219722	Inhibition of recombinant aurora B	B	CCN(CC)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCc5ccccc54)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215349	=	IC50	nM	616.0	CHEMBL2185	Homo sapiens	IC50	uM	0.616
	3407616	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1CCC(=O)O		CHEMBL1214853	=	Inhibition	%	17.5	CHEMBL2185	Homo sapiens	INH	%	17.5
	3407617	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(Br)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214854	=	Inhibition	%	6.8	CHEMBL2185	Homo sapiens	INH	%	6.8
	3407618	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc([N+](=O)[O-])cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214855	=	Inhibition	%	3.4	CHEMBL2185	Homo sapiens	INH	%	3.4
	3407619	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	COc1cc(-c2ccc3c(c2)/C(=C/c2[nH]c4c(c2CCC(=O)O)C(=O)CCC4)C(=O)N3)ccc1O		CHEMBL1214856	=	Inhibition	%	12.4	CHEMBL2185	Homo sapiens	INH	%	12.4
	3407620	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	COc1ccc(-c2ccc3c(c2)/C(=C/c2[nH]c4c(c2CCC(=O)O)C(=O)CCC4)C(=O)N3)cc1OC		CHEMBL1214925	=	Inhibition	%	5.1	CHEMBL2185	Homo sapiens	INH	%	5.1
	3407621	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214926	=	Inhibition	%	12.8	CHEMBL2185	Homo sapiens	INH	%	12.8
	3407622	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NC(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214927	=	Inhibition	%	14.2	CHEMBL2185	Homo sapiens	INH	%	14.2
	3407623	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214928	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	3407624	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	C=CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214994	=	Inhibition	%	32.5	CHEMBL2185	Homo sapiens	INH	%	32.5
	3407625	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214995	=	Inhibition	%	11.2	CHEMBL2185	Homo sapiens	INH	%	11.2
	3407626	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4ccc(F)cc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214996	=	Inhibition	%	15.5	CHEMBL2185	Homo sapiens	INH	%	15.5
	3407627	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214997	=	Inhibition	%	34.1	CHEMBL2185	Homo sapiens	INH	%	34.1
	3407628	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1215070	=	Inhibition	%	2.6	CHEMBL2185	Homo sapiens	INH	%	2.6
	3407629	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1215147	=	Inhibition	%	7.3	CHEMBL2185	Homo sapiens	INH	%	7.3
	3407630	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccc5ccccc5c4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215217	=	Inhibition	%	21.0	CHEMBL2185	Homo sapiens	INH	%	21.0
	3407631	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1C(=O)CCC2		CHEMBL1214708	=	Inhibition	%	2.3	CHEMBL2185	Homo sapiens	INH	%	2.3
	3407632	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214781	=	Inhibition	%	3.0	CHEMBL2185	Homo sapiens	INH	%	3.0
	3407633	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1C(=O)CCC2		CHEMBL1214782	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	INH	%	13.0
	3407634	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214783	=	Inhibition	%	11.6	CHEMBL2185	Homo sapiens	INH	%	11.6
	3407635	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	CC1(C)CC(=O)c2c([nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c2CCC(=O)O)C1		CHEMBL1214784	=	Inhibition	%	17.3	CHEMBL2185	Homo sapiens	INH	%	17.3
	3407636	CHEMBL1219723	Inhibition of recombinant aurora B at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)CCCC2		CHEMBL1214785	=	Inhibition	%	2.0	CHEMBL2185	Homo sapiens	INH	%	2.0
	3420229	CHEMBL1226925	Inhibition of Aurora-B	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	3439097	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977	=	IC50	nM	66.0	CHEMBL2185	Homo sapiens	IC50	nM	66.0
	3439098	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Cl)cc2C)n1		CHEMBL1242978	>	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	nM	25000.0
	3439099	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(Cl)c3)cc2C)n1		CHEMBL1243008	=	IC50	nM	430.0	CHEMBL2185	Homo sapiens	IC50	nM	430.0
	3439100	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccc(Cl)cc3)cc2C)n1		CHEMBL1243009	=	IC50	nM	335.0	CHEMBL2185	Homo sapiens	IC50	nM	335.0
	3439101	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Oc3ccccc3)cc2C)n1		CHEMBL1243042	=	IC50	nM	56.0	CHEMBL2185	Homo sapiens	IC50	nM	56.0
	3439102	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(Oc4ccccc4)c3)cc2C)n1		CHEMBL1243073	=	IC50	nM	251.0	CHEMBL2185	Homo sapiens	IC50	nM	251.0
	3439103	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccc(Oc4ccccc4)cc3)cc2C)n1		CHEMBL1243108	=	IC50	nM	542.0	CHEMBL2185	Homo sapiens	IC50	nM	542.0
	3439104	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2C)n1		CHEMBL1243137	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	nM	17.0
	3439105	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)c(C)c2)n1		CHEMBL1243167	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	nM	110.0
	3439106	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1		CHEMBL1243200	=	IC50	nM	9.0	CHEMBL2185	Homo sapiens	IC50	nM	9.0
	3439107	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccccc4)c4ccccc34)cc2)n1		CHEMBL1243294	=	IC50	nM	22.0	CHEMBL2185	Homo sapiens	IC50	nM	22.0
	3439108	CHEMBL1247955	Inhibition of Aurora B by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
Not Active	3439131	CHEMBL1247977	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level at up to 1200 nM after 24 hrs using Hoechst staining by flow cytometry	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977		Activity			CHEMBL2185	Homo sapiens	Activity		
	3439132	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977	>	EC50	nM	1200.0	CHEMBL2185	Homo sapiens	EC50	nM	1200.0
Not Determined	3439133	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Cl)cc2C)n1		CHEMBL1242978		EC50			CHEMBL2185	Homo sapiens	EC50		
	3439134	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(Cl)c3)cc2C)n1		CHEMBL1243008	>	EC50	nM	1200.0	CHEMBL2185	Homo sapiens	EC50	nM	1200.0
	3439135	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccc(Cl)cc3)cc2C)n1		CHEMBL1243009	>	EC50	nM	1200.0	CHEMBL2185	Homo sapiens	EC50	nM	1200.0
	3439136	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Oc3ccccc3)cc2C)n1		CHEMBL1243042	>	EC50	nM	1200.0	CHEMBL2185	Homo sapiens	EC50	nM	1200.0
	3439137	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(Oc4ccccc4)c3)cc2C)n1		CHEMBL1243073	>	EC50	nM	1200.0	CHEMBL2185	Homo sapiens	EC50	nM	1200.0
Not Determined	3439138	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccc(Oc4ccccc4)cc3)cc2C)n1		CHEMBL1243108		EC50			CHEMBL2185	Homo sapiens	EC50		
	3439139	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2C)n1		CHEMBL1243137	=	EC50	nM	89.0	CHEMBL2185	Homo sapiens	EC50	nM	89.0
	3439140	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)c(C)c2)n1		CHEMBL1243167	=	EC50	nM	1450.0	CHEMBL2185	Homo sapiens	EC50	nM	1450.0
	3439141	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1		CHEMBL1243200	=	EC50	nM	15.0	CHEMBL2185	Homo sapiens	EC50	nM	15.0
	3439142	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccc(F)cc3)cc2)n1		CHEMBL1243231	=	EC50	nM	28.0	CHEMBL2185	Homo sapiens	EC50	nM	28.0
	3439143	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cc(F)ccc3Nc3ccccc3)cc2)n1		CHEMBL1243265	=	EC50	nM	20.0	CHEMBL2185	Homo sapiens	EC50	nM	20.0
	3439144	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccccc4)c4ccccc34)cc2)n1		CHEMBL1243294	=	EC50	nM	15.0	CHEMBL2185	Homo sapiens	EC50	nM	15.0
	3439145	CHEMBL1247978	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level after 24 hrs by Hoechst staining	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326	=	EC50	nM	24.0	CHEMBL2185	Homo sapiens	EC50	nM	24.0
Active	3439171	CHEMBL1247993	Inhibition of aurora B autophosphorylation in human HeLa cells at 0.313 uM after 24 hrs by Western blotting	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	3439173	CHEMBL1247995	Inhibition of aurora B autophosphorylation in human HeLa cells at 1 uM after 24 hrs by Western blotting	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	3439174	CHEMBL1247996	Inhibition of aurora B in human HeLa cells assessed as reduction of histone H3 phosphorylation at Ser10 at 0.313 uM after 24 hrs by Western blotting	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	3439175	CHEMBL1247997	Inhibition of aurora B in human HeLa cells assessed as increase of >= 4N DNA level at 0.313 uM after 24 hrs using Hoechst staining by flow cytometry	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326		Activity			CHEMBL2185	Homo sapiens	Activity		
	3443341	CHEMBL1243993	Inhibition of AURKB at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	INH	%	5.0
	3443558	CHEMBL1243993	Inhibition of AURKB at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	3.0	CHEMBL2185	Homo sapiens	INH	%	3.0
	3444713	CHEMBL1243993	Inhibition of AURKB at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL2185	Homo sapiens	INH	%	2.0
	3445034	CHEMBL1244730	Binding affinity to AURKB	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	16.0	CHEMBL2185	Homo sapiens	Kd	nM	16.0
	3445337	CHEMBL1243993	Inhibition of AURKB at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	2.0	CHEMBL2185	Homo sapiens	INH	%	2.0
	3445554	CHEMBL1243993	Inhibition of AURKB at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	INH	%	13.0
	3445771	CHEMBL1243993	Inhibition of AURKB at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	3445961	CHEMBL1243993	Inhibition of AURKB at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	18.0	CHEMBL2185	Homo sapiens	INH	%	18.0
	3447186	CHEMBL1249642	Inhibition of Aurora B kinase	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	uM	0.007
	3448883	CHEMBL1244730	Binding affinity to AURKB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	62.0	CHEMBL2185	Homo sapiens	Kd	nM	62.0
	3449104	CHEMBL1244730	Binding affinity to AURKB	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	380.0	CHEMBL2185	Homo sapiens	Kd	nM	380.0
	3449105	CHEMBL1244730	Binding affinity to AURKB	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	440.0	CHEMBL2185	Homo sapiens	Kd	nM	440.0
	3449566	CHEMBL1244730	Binding affinity to AURKB	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	3449991	CHEMBL1244730	Binding affinity to AURKB	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	uM	10.0
	3450919	CHEMBL1244730	Binding affinity to AURKB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O	Outside typical range	CHEMBL1240703	=	Kd	nM	750000.0	CHEMBL2185	Homo sapiens	Kd	uM	750.0
	3463175	CHEMBL1251635	Inhibition of AURKC at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	17.0	CHEMBL2185	Homo sapiens	INH	%	17.0
	3463394	CHEMBL1251635	Inhibition of AURKC at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	16.0	CHEMBL2185	Homo sapiens	INH	%	16.0
	3463938	CHEMBL1251635	Inhibition of AURKC at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	96.0	CHEMBL2185	Homo sapiens	INH	%	96.0
Active	3504223	CHEMBL1260162	Inhibition of aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	3504317	CHEMBL1260199	Inhibition of aurora B	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	45.0	CHEMBL2185	Homo sapiens	IC50	uM	0.045
	3505269	CHEMBL1261377	Inhibition of human aurora B	B	CS(=O)(=O)NCc1cccc(-c2cn3c(Cl)cnc3c(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1230687	=	IC50	nM	10540.0	CHEMBL2185	Homo sapiens	IC50	uM	10.54
	3515243	CHEMBL1273369	Binding affinity to aurora B	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	Km	nM	34000.0	CHEMBL2185	Homo sapiens	Km	uM	34.0
	3521134	CHEMBL1272504	Inhibition of Aurora B	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521135	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1270796	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521136	CHEMBL1272504	Inhibition of Aurora B	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO		CHEMBL1232515	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521137	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOCC3(C)C)ns2)n1		CHEMBL1270897	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521138	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3(C)C)ns2)n1		CHEMBL1270996	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521223	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(C)CC3)ns2)n1		CHEMBL1270997	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521224	CHEMBL1272504	Inhibition of Aurora B	B	CCOC(=O)N1CCN(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1271103	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521225	CHEMBL1272504	Inhibition of Aurora B	B	CC(=O)N1CCN(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1271104	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521226	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(S(C)(=O)=O)CC3)ns2)n1		CHEMBL1271203	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521227	CHEMBL1272504	Inhibition of Aurora B	B	CCNC(=O)N1CCN(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1271204	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521228	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(CCO)CC3)ns2)n1		CHEMBL1271306	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521229	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(C)CC3=O)ns2)n1		CHEMBL1271307	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521230	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(C)C(=O)C3)ns2)n1		CHEMBL1271413	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521231	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOC[C@@H]3CO)ns2)n1		CHEMBL1271414	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521232	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOCC34CCC4)ns2)n1		CHEMBL1269880	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521233	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1269881	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521234	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3C[C@@H]4CC[C@H](C3)O4)ns2)n1		CHEMBL1269988	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521235	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3C[C@H](C)OC[C@@H]3C)ns2)n1		CHEMBL1269989	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521236	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOC(C)(C)C3)ns2)n1		CHEMBL1270096	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521237	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(C)N3CCOCC3)ns2)n1		CHEMBL1270097	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521238	CHEMBL1272504	Inhibition of Aurora B	B	CCC(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCOCC1		CHEMBL1270205	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521239	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCOCC3)ns2)n1		CHEMBL1270206	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521240	CHEMBL1272504	Inhibition of Aurora B	B	COCC(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCOCC1		CHEMBL1270299	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521241	CHEMBL1272504	Inhibition of Aurora B	B	CCOCC(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCOCC1		CHEMBL1270300	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521242	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C3(N4C[C@H](C)O[C@H](C)C4)CC3)ns2)n1		CHEMBL1270398	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
	3521243	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270399	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521244	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(C)N3CCOC(C)(C)C3)ns2)n1		CHEMBL1270491	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3521245	CHEMBL1272504	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270492	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	3526995	CHEMBL1275116	Inhibition of AUR2	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	3556615	CHEMBL1285571	Inhibition of AURKB at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	3601420	CHEMBL1292328	Inhibition of Aurora B	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	=	IC50	nM	270.0	CHEMBL2185	Homo sapiens	IC50	uM	0.27
	5123787	CHEMBL1649027	Inhibition of AURKB at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	5132501	CHEMBL1648517	Inhibition of aurora B assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	42.0	CHEMBL2185	Homo sapiens	Activity	%	42.0
	5133725	CHEMBL1648517	Inhibition of aurora B assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	33.0	CHEMBL2185	Homo sapiens	Activity	%	33.0
	5133820	CHEMBL1648517	Inhibition of aurora B assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	41.0	CHEMBL2185	Homo sapiens	Activity	%	41.0
	5142635	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
	5142636	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN(CC(F)F)C(C)(C)CO)ns2)n1.Cl		CHEMBL1650534	=	IC50	nM	306.0	CHEMBL2185	Homo sapiens	IC50	nM	306.0
	5142637	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN(CC(F)(F)F)C(C)(C)CO)ns2)n1.Cl		CHEMBL1650535	=	IC50	nM	198.0	CHEMBL2185	Homo sapiens	IC50	nM	198.0
	5142638	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1.Cl		CHEMBL1650536	=	IC50	nM	45.0	CHEMBL2185	Homo sapiens	IC50	nM	45.0
	5142639	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)CC3)ns2)n1.Cl		CHEMBL1650537	=	IC50	nM	86.0	CHEMBL2185	Homo sapiens	IC50	nM	86.0
	5142640	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)CC3)ns2)n1.Cl		CHEMBL1650538	=	IC50	nM	74.0	CHEMBL2185	Homo sapiens	IC50	nM	74.0
	5142641	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC(F)C3)ns2)n1.Cl		CHEMBL1650539	=	IC50	nM	193.0	CHEMBL2185	Homo sapiens	IC50	nM	193.0
	5142642	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650540	=	IC50	nM	79.0	CHEMBL2185	Homo sapiens	IC50	nM	79.0
	5142643	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(C(F)(F)F)CC3)ns2)n1.Cl		CHEMBL1650541	=	IC50	nM	218.0	CHEMBL2185	Homo sapiens	IC50	nM	218.0
	5142644	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC3)ns2)n1.Cl		CHEMBL1650542	=	IC50	nM	88.0	CHEMBL2185	Homo sapiens	IC50	nM	88.0
	5142645	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC[C@H](F)C3)ns2)n1.Cl		CHEMBL1650543	=	IC50	nM	93.0	CHEMBL2185	Homo sapiens	IC50	nM	93.0
	5142646	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC[C@@H](F)C3)ns2)n1.Cl		CHEMBL1650544	=	IC50	nM	82.0	CHEMBL2185	Homo sapiens	IC50	nM	82.0
	5142647	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	=	IC50	nM	91.0	CHEMBL2185	Homo sapiens	IC50	nM	91.0
	5142648	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)(F)C(F)(F)C3)ns2)n1.Cl		CHEMBL1650546	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
	5142649	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)C3)ns2)n1.O=C(O)C(F)(F)F		CHEMBL1650547	=	IC50	nM	191.0	CHEMBL2185	Homo sapiens	IC50	nM	191.0
	5142650	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)(F)C3)ns2)n1.O=C(O)C(F)(F)F		CHEMBL1650548	=	IC50	nM	76.0	CHEMBL2185	Homo sapiens	IC50	nM	76.0
	5142651	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CNCCC(F)(F)F)ns2)n1.Cl		CHEMBL1650549	=	IC50	nM	63.0	CHEMBL2185	Homo sapiens	IC50	nM	63.0
	5142652	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CNCC(F)(F)C(F)(F)F)ns2)n1.Cl		CHEMBL1650550	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	5142653	CHEMBL1656183	Inhibition of Aurora B	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142654	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN(CC(F)F)C(C)(C)CO)ns2)n1.Cl		CHEMBL1650534	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142655	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN(CC(F)(F)F)C(C)(C)CO)ns2)n1.Cl		CHEMBL1650535	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142656	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1.Cl		CHEMBL1650536	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142657	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)CC3)ns2)n1.Cl		CHEMBL1650537	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142658	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)CC3)ns2)n1.Cl		CHEMBL1650538	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142659	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC(F)C3)ns2)n1.Cl		CHEMBL1650539	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142660	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650540	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142661	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(C(F)(F)F)CC3)ns2)n1.Cl		CHEMBL1650541	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142662	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC3)ns2)n1.Cl		CHEMBL1650542	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142663	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC[C@H](F)C3)ns2)n1.Cl		CHEMBL1650543	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142664	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC[C@@H](F)C3)ns2)n1.Cl		CHEMBL1650544	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142665	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142666	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)(F)C(F)(F)C3)ns2)n1.Cl		CHEMBL1650546	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142667	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)C3)ns2)n1.O=C(O)C(F)(F)F		CHEMBL1650547	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142668	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)(F)C3)ns2)n1.O=C(O)C(F)(F)F		CHEMBL1650548	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142669	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CNCCC(F)(F)F)ns2)n1.Cl		CHEMBL1650549	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5142670	CHEMBL1656183	Inhibition of Aurora B	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CNCC(F)(F)C(F)(F)F)ns2)n1.Cl		CHEMBL1650550	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5143778	CHEMBL1656567	Inhibition of Aurora B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence assay	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	=	IC50	nM	63.0	CHEMBL2185	Homo sapiens	IC50	nM	63.0
	5143780	CHEMBL1656183	Inhibition of Aurora B	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	5151004	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3ccc([N+](=O)[O-])cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651483	=	IC50	nM	930.0	CHEMBL2185	Homo sapiens	IC50	uM	0.93
	5151046	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3cccnc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651482	=	IC50	nM	12700.0	CHEMBL2185	Homo sapiens	IC50	uM	12.7
	5151050	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	CC(=O)Nc1ccc(Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651480	=	IC50	nM	15000.0	CHEMBL2185	Homo sapiens	IC50	uM	15.0
	5151051	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(CC(F)(F)F)c(=O)c3ccccc23)n[nH]1		CHEMBL470718	=	IC50	nM	15000.0	CHEMBL2185	Homo sapiens	IC50	uM	15.0
	5151053	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(C)c(=O)c3ccccc23)n[nH]1		CHEMBL1651488	=	IC50	nM	17000.0	CHEMBL2185	Homo sapiens	IC50	uM	17.0
	5151055	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2n[nH]c(=O)c3ccccc23)n[nH]1		CHEMBL1651468	=	IC50	nM	22000.0	CHEMBL2185	Homo sapiens	IC50	uM	22.0
	5151056	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3csc(C)n3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651487	=	IC50	nM	24000.0	CHEMBL2185	Homo sapiens	IC50	uM	24.0
	5151057	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3ccncc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651481	=	IC50	nM	27000.0	CHEMBL2185	Homo sapiens	IC50	uM	27.0
	5151058	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	COc1cccc(Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)c1		CHEMBL1651479	=	IC50	nM	28000.0	CHEMBL2185	Homo sapiens	IC50	uM	28.0
	5151059	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(C(C)C)c(=O)c3ccccc23)n[nH]1		CHEMBL1651489	=	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	5151060	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3ccc(S(C)(=O)=O)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651477	=	IC50	nM	34000.0	CHEMBL2185	Homo sapiens	IC50	uM	34.0
	5151061	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(CC(C)C)c(=O)c3ccccc23)n[nH]1		CHEMBL1651490	=	IC50	nM	34000.0	CHEMBL2185	Homo sapiens	IC50	uM	34.0
	5151062	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	CC(=O)Nc1ccc(Cn2nc(Nc3cc[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651491	=	IC50	nM	34000.0	CHEMBL2185	Homo sapiens	IC50	uM	34.0
	5151063	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	COc1ccc(Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651478	=	IC50	nM	46000.0	CHEMBL2185	Homo sapiens	IC50	uM	46.0
	5151064	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	COc1cccc(C(=O)Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)c1		CHEMBL1651485	=	IC50	nM	67000.0	CHEMBL2185	Homo sapiens	IC50	uM	67.0
	5151065	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3ccc(F)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651476	=	IC50	nM	69000.0	CHEMBL2185	Homo sapiens	IC50	uM	69.0
	5151066	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(-c3ccccc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1615165	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151067	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	COc1ccc(-n2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651469	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151068	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1ccc(-n2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651470	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151069	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cccc(-n2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)c1		CHEMBL1651471	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151070	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(-c3ccc(Cl)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL452355	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151071	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(-c3ccc(F)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651473	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151072	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3ccccc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651461	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151073	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3cc(F)cc(F)c3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651462	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151074	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(Cc3cc(F)ccc3F)c(=O)c3ccccc23)n[nH]1		CHEMBL516231	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151075	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	COc1ccc(C(=O)Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651484	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151076	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(CC(=O)c3ccc(C(F)(F)F)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651486	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151077	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(CC(=O)c3ccccc3)c(=O)c3ccccc23)n[nH]1		CHEMBL474651	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	5151103	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1cc(Nc2nn(-c3ccc(C(C)(C)C)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651472	>	IC50	nM	50000.0	CHEMBL2185	Homo sapiens	IC50	uM	50.0
Not Determined	5151108	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	Cc1ccc(-n2nc(Nc3cc[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651474		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	5151112	CHEMBL1656338	Inhibition of Aurora B by ELISA	B	O=c1c2ccccc2c(Nc2n[nH]c3ccccc23)nn1-c1ccccc1		CHEMBL1651475		IC50			CHEMBL2185	Homo sapiens	IC50		
	5191401	CHEMBL1664057	Inhibition of Aurora B at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	11.0	CHEMBL2185	Homo sapiens	INH	%	11.0
	5191402	CHEMBL1664057	Inhibition of Aurora B at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	79.0	CHEMBL2185	Homo sapiens	INH	%	79.0
	5239280	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	CCCc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682335	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5239281	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	COCc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682336	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5239282	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	OCCCc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682337	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5239283	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1cc2[nH]ncc2cc1-n1cc(C2CC2)nn1		CHEMBL1682338	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5239284	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1cc2[nH]ncc2cc1-n1cc(C2CCCC2)nn1		CHEMBL1682339	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5239285	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1cc2[nH]ncc2cc1-n1cc(CC2CCCCC2)nn1		CHEMBL1682340	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5239286	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	1577.0	CHEMBL2185	Homo sapiens	Ki	uM	1.577
	5239287	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1ccc(CCc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682342	=	Ki	nM	524.0	CHEMBL2185	Homo sapiens	Ki	uM	0.524
	5239288	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1ccc(CCCc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682343	=	Ki	nM	1930.0	CHEMBL2185	Homo sapiens	Ki	uM	1.93
	5239289	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1cc2[nH]ncc2cc1-c1c[nH]nn1		CHEMBL1682344	=	Ki	nM	493.0	CHEMBL2185	Homo sapiens	Ki	uM	0.493
	5239290	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	73.0	CHEMBL2185	Homo sapiens	Ki	uM	0.073
	5239291	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	252.0	CHEMBL2185	Homo sapiens	Ki	uM	0.252
	5239292	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Clc1ccccc1Cn1cc(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682347	=	Ki	nM	553.0	CHEMBL2185	Homo sapiens	Ki	uM	0.553
	5239293	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Clc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682348	=	Ki	nM	160.0	CHEMBL2185	Homo sapiens	Ki	uM	0.16
	5239294	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Clc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682349	=	Ki	nM	186.0	CHEMBL2185	Homo sapiens	Ki	uM	0.186
	5239295	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Fc1ccccc1Cn1cc(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682350	=	Ki	nM	16.0	CHEMBL2185	Homo sapiens	Ki	uM	0.016
	5239296	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Fc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682351	=	Ki	nM	42.0	CHEMBL2185	Homo sapiens	Ki	uM	0.042
Not Determined	5239297	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Fc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682352		Ki			CHEMBL2185	Homo sapiens	Ki		
	5239298	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Cc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682353	=	Ki	nM	15.0	CHEMBL2185	Homo sapiens	Ki	uM	0.015
	5239299	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Clc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1Cl		CHEMBL1682354	=	Ki	nM	66.0	CHEMBL2185	Homo sapiens	Ki	uM	0.066
Not Determined	5239300	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Clc1ccc(Cl)c(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682355		Ki			CHEMBL2185	Homo sapiens	Ki		
	5239301	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Clc1cc(Cl)cc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682356	=	Ki	nM	240.0	CHEMBL2185	Homo sapiens	Ki	uM	0.24
	5239302	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	323.0	CHEMBL2185	Homo sapiens	Ki	uM	0.323
	5239303	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	Nc1n[nH]c2ccc(-c3cc(Cc4ccccc4)no3)cc12		CHEMBL1682358	=	Ki	nM	26.0	CHEMBL2185	Homo sapiens	Ki	uM	0.026
	5239304	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	2366.0	CHEMBL2185	Homo sapiens	Ki	uM	2.366
	5239305	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	CNC(=O)c1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1681795	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5239306	CHEMBL1685401	Inhibition of Aurora kinase 2 after 1 hr using biotinylated kemptide as substrate	B	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241255	CHEMBL1685429	Inhibition of aurora 2	B	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241256	CHEMBL1685429	Inhibition of aurora 2	B	c1ccc(-c2c(-c3ccc4[nH]ncc4c3)nc3ncccn23)cc1		CHEMBL1682541	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241257	CHEMBL1685429	Inhibition of aurora 2	B	Cc1nc(-c2ccc3[nH]ncc3c2)cs1		CHEMBL1682542	=	Ki	nM	4450.0	CHEMBL2185	Homo sapiens	Ki	uM	4.45
	5241258	CHEMBL1685429	Inhibition of aurora 2	B	Nc1nc(-c2ccc3[nH]ncc3c2)cs1		CHEMBL1682543	=	Ki	nM	2125.0	CHEMBL2185	Homo sapiens	Ki	uM	2.125
	5241259	CHEMBL1685429	Inhibition of aurora 2	B	CCNc1nc(-c2ccc3[nH]ncc3c2)cs1		CHEMBL1682544	=	Ki	nM	3406.0	CHEMBL2185	Homo sapiens	Ki	uM	3.406
	5241260	CHEMBL1685429	Inhibition of aurora 2	B	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	834.0	CHEMBL2185	Homo sapiens	Ki	uM	0.834
	5241261	CHEMBL1685429	Inhibition of aurora 2	B	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	588.0	CHEMBL2185	Homo sapiens	Ki	uM	0.588
	5241262	CHEMBL1685429	Inhibition of aurora 2	B	c1ccc(CCNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682547	=	Ki	nM	810.0	CHEMBL2185	Homo sapiens	Ki	uM	0.81
	5241263	CHEMBL1685429	Inhibition of aurora 2	B	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)c(-c3ccccc3)s2)cc1		CHEMBL1682548	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241264	CHEMBL1685429	Inhibition of aurora 2	B	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)c(-c3ccccc3)s2)cc1		CHEMBL1682549	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241265	CHEMBL1685429	Inhibition of aurora 2	B	c1ccn2c(NC3CCCCC3)c(-c3ccc4[nH]ncc4c3)nc2c1		CHEMBL1682550	=	Ki	nM	8666.0	CHEMBL2185	Homo sapiens	Ki	uM	8.666
	5241266	CHEMBL1685429	Inhibition of aurora 2	B	c1cn2c(NC3CCCCC3)c(-c3ccc4[nH]ncc4c3)nc2cn1		CHEMBL1682551	=	Ki	nM	2066.0	CHEMBL2185	Homo sapiens	Ki	uM	2.066
	5241267	CHEMBL1685429	Inhibition of aurora 2	B	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	5333.0	CHEMBL2185	Homo sapiens	Ki	uM	5.333
	5241268	CHEMBL1685429	Inhibition of aurora 2	B	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	4340.0	CHEMBL2185	Homo sapiens	Ki	uM	4.34
	5241269	CHEMBL1685429	Inhibition of aurora 2	B	CCCCNc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682554	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241270	CHEMBL1685429	Inhibition of aurora 2	B	Clc1ccc(Nc2c(-c3ccc4[nH]ncc4c3)nc3ncccn23)cc1		CHEMBL1682555	=	Ki	nM	2805.0	CHEMBL2185	Homo sapiens	Ki	uM	2.805
	5241271	CHEMBL1685429	Inhibition of aurora 2	B	c1cn2c(NC3CCCCC3)c(-c3ccc4[nH]ncc4c3)nc2s1	Outside typical range	CHEMBL1682556	=	Ki	nM	1800000.0	CHEMBL2185	Homo sapiens	Ki	uM	1800.0
	5241272	CHEMBL1685429	Inhibition of aurora 2	B	CN(C)CCn1cnc(-c2ccc(F)cc2)c1-c1ccc2[nH]ncc2c1		CHEMBL1682557	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241273	CHEMBL1685429	Inhibition of aurora 2	B	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241274	CHEMBL1685429	Inhibition of aurora 2	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682559	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5241275	CHEMBL1685429	Inhibition of aurora 2	B	Fc1ccc(-c2ncn(C3CCN(Cc4ccccc4)C3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682560	>	Ki	nM	4900.0	CHEMBL2185	Homo sapiens	Ki	uM	4.9
	5293782	CHEMBL1696299	Inhibition of Aurora B	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	3480.0	CHEMBL2185	Homo sapiens	IC50	uM	3.48
Not Active	6149662	CHEMBL1764763	Inhibition of Aurora2	B	C[C@H]1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12		CHEMBL1738841		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	6168386	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1COCCN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614773	=	IC50	nM	25118.86	CHEMBL2185	Homo sapiens	pIC50		4.6
	6168387	CHEMBL1768780	Inhibition of aurora B	B	C[C@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765727	=	IC50	nM	25118.86	CHEMBL2185	Homo sapiens	pIC50		4.6
	6168388	CHEMBL1768780	Inhibition of aurora B	B	CC[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765728	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6168389	CHEMBL1768780	Inhibition of aurora B	B	CC(C)[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765729	=	IC50	nM	7943.28	CHEMBL2185	Homo sapiens	pIC50		5.1
	6168390	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1CCCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765730	=	IC50	nM	25118.86	CHEMBL2185	Homo sapiens	pIC50		4.6
	6168391	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCO[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1614774	=	IC50	nM	3162.28	CHEMBL2185	Homo sapiens	pIC50		5.5
	6168392	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCO[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765731	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6168393	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765732	=	IC50	nM	1258.93	CHEMBL2185	Homo sapiens	pIC50		5.9
	6168394	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765733	=	IC50	nM	1584.89	CHEMBL2185	Homo sapiens	pIC50		5.8
	6168395	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCCC3)C2)n1		CHEMBL1765734	=	IC50	nM	3981.07	CHEMBL2185	Homo sapiens	pIC50		5.4
	6168396	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCC3)C2)n1		CHEMBL1765735	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6168397	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1CC[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614775	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	pIC50		6.0
	6168398	CHEMBL1768780	Inhibition of aurora B	B	C[C@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765736	=	IC50	nM	5011.87	CHEMBL2185	Homo sapiens	pIC50		5.3
	6168399	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765737	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	6168400	CHEMBL1768780	Inhibition of aurora B	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)Nc3ccccc3)CC[C@H]2C)n1		CHEMBL1765738	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	6168401	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1CC[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765739	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	pIC50		6.0
	6168402	CHEMBL1768780	Inhibition of aurora B	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	3162.28	CHEMBL2185	Homo sapiens	pIC50		5.5
	6168403	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765741	=	IC50	nM	316.23	CHEMBL2185	Homo sapiens	pIC50		6.5
	6168404	CHEMBL1768780	Inhibition of aurora B	B	CC[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765742	=	IC50	nM	1584.89	CHEMBL2185	Homo sapiens	pIC50		5.8
	6168405	CHEMBL1768780	Inhibition of aurora B	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)OC[C@H]2C)n1		CHEMBL1765743	=	IC50	nM	5011.87	CHEMBL2185	Homo sapiens	pIC50		5.3
	6168406	CHEMBL1768780	Inhibition of aurora B	B	CC[C@@H]1CO[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765744	=	IC50	nM	1584.89	CHEMBL2185	Homo sapiens	pIC50		5.8
	6168407	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC(NC(=O)c3ccccc3)C2)n1		CHEMBL1765745	=	IC50	nM	25.12	CHEMBL2185	Homo sapiens	pIC50		7.6
	6168408	CHEMBL1768780	Inhibition of aurora B	B	CC(C)(C)OC(=O)NC1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765746	=	IC50	nM	398.11	CHEMBL2185	Homo sapiens	pIC50		6.4
	6168409	CHEMBL1768780	Inhibition of aurora B	B	CC(C)(C)OC(=O)N[C@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765747	=	IC50	nM	316.23	CHEMBL2185	Homo sapiens	pIC50		6.5
	6168410	CHEMBL1768780	Inhibition of aurora B	B	CC(C)(C)OC(=O)N[C@@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765748	=	IC50	nM	5011.87	CHEMBL2185	Homo sapiens	pIC50		5.3
	6168411	CHEMBL1768780	Inhibition of aurora B	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	=	IC50	nM	158.49	CHEMBL2185	Homo sapiens	pIC50		6.8
	6168412	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1CC[C@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765749	=	IC50	nM	50.12	CHEMBL2185	Homo sapiens	pIC50		7.3
	6168413	CHEMBL1768780	Inhibition of aurora B	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	pIC50		6.0
	6168414	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1C[C@@H](NC(=O)OC(C)(C)C)CN(c2cc(-c3ccc4c(N)[nH]nc4c3)nc(N)n2)C1		CHEMBL1614777	=	IC50	nM	1584.89	CHEMBL2185	Homo sapiens	pIC50		5.8
	6168415	CHEMBL1768780	Inhibition of aurora B	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@H](C)C[C@@H](N(C)C(=O)OC(C)(C)C)C2)n1		CHEMBL1765750	=	IC50	nM	251.19	CHEMBL2185	Homo sapiens	pIC50		6.6
	6168416	CHEMBL1768780	Inhibition of aurora B	B	C[C@@H]1C[C@@H](N(C)C(=O)CC(C)(C)C)CN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765751	=	IC50	nM	199.53	CHEMBL2185	Homo sapiens	pIC50		6.7
	6168417	CHEMBL1768780	Inhibition of aurora B	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	3162.28	CHEMBL2185	Homo sapiens	pIC50		5.5
	6168418	CHEMBL1768780	Inhibition of aurora B	B	Cc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765756	=	IC50	nM	12589.25	CHEMBL2185	Homo sapiens	pIC50		4.9
	6168419	CHEMBL1768780	Inhibition of aurora B	B	CC(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765757	=	IC50	nM	7943.28	CHEMBL2185	Homo sapiens	pIC50		5.1
	6168420	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765758	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	6168421	CHEMBL1768780	Inhibition of aurora B	B	COc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765759	=	IC50	nM	7943.28	CHEMBL2185	Homo sapiens	pIC50		5.1
	6168422	CHEMBL1768780	Inhibition of aurora B	B	CNc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765760	=	IC50	nM	12589.25	CHEMBL2185	Homo sapiens	pIC50		4.9
	6168423	CHEMBL1768780	Inhibition of aurora B	B	CCNc1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614771	=	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6168424	CHEMBL1768780	Inhibition of aurora B	B	CC(C)Nc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765761	=	IC50	nM	15848.93	CHEMBL2185	Homo sapiens	pIC50		4.8
	6168425	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(NC2CCCC2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765762	=	IC50	nM	7943.28	CHEMBL2185	Homo sapiens	pIC50		5.1
	6168426	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(Nc2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765876	=	IC50	nM	3162.28	CHEMBL2185	Homo sapiens	pIC50		5.5
	6168427	CHEMBL1768780	Inhibition of aurora B	B	CN(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765877	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6168428	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCOCC2)n1		CHEMBL1614772	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6168429	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC2)n1		CHEMBL1765878	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6168430	CHEMBL1768780	Inhibition of aurora B	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCCC2)n1		CHEMBL1765879	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	6169207	CHEMBL1768985	Inhibition of human aurora-B assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	46.0	CHEMBL2185	Homo sapiens	Activity	%	46.0
	6169240	CHEMBL1768780	Inhibition of aurora B	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	3162.0	CHEMBL2185	Homo sapiens	IC50	nM	3162.0
	6198104	CHEMBL1776515	Inhibition of Aur-B assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	6204389	CHEMBL1781279	Inhibition of aurora B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	6204390	CHEMBL1781279	Inhibition of aurora B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	290.0	CHEMBL2185	Homo sapiens	IC50	nM	290.0
	6204391	CHEMBL1781279	Inhibition of aurora B	B	Cc1cc(Nc2cc(C)c(C#N)c(NC(C)CCCC(C)(C)O)n2)n[nH]1.Cl		CHEMBL1778662	=	Ki	nM	101.0	CHEMBL2185	Homo sapiens	Ki	nM	101.0
	6264910	CHEMBL1799793	Inhibition of AURKB at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL2185	Homo sapiens	INH	%	65.0
	6265634	CHEMBL1799793	Inhibition of AURKB at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL2185	Homo sapiens	INH	%	65.0
	6268118	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nccn3c(-c4cnn(C)c4)cnc23)sn1		CHEMBL1801100	=	IC50	nM	260.0	CHEMBL2185	Homo sapiens	IC50	uM	0.26
	6268119	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CC(C)c1cc(Nc2nccn3c(-c4cnn(C)c4)cnc23)sn1		CHEMBL1801101	=	IC50	nM	700.0	CHEMBL2185	Homo sapiens	IC50	uM	0.7
	6268120	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cn1cc(-c2cnc3c(Nc4cc(C5CCNCC5)ns4)nccn23)cn1		CHEMBL1801102	=	IC50	nM	200.0	CHEMBL2185	Homo sapiens	IC50	uM	0.2
	6268121	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cn1cc(-c2cnc3c(Nc4cc(C5CCN(S(C)(=O)=O)CC5)ns4)nccn23)cn1		CHEMBL1801103	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	uM	0.11
Not Active	6268122	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1nsc(Nc2nccn3c(-c4cnn(C)c4)cnc23)n1		CHEMBL1801104		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Active	6268123	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1csc(Nc2nccn3c(-c4cnn(C)c4)cnc23)n1		CHEMBL1801105		IC50			CHEMBL2185	Homo sapiens	IC50		
	6268124	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1csc(Nc2nccn3c(-c4cnn(C)c4)cnc23)c1		CHEMBL1801106	=	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	uM	3.0
Not Active	6268125	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CN(C)c1cccc(Nc2nccn3c(-c4cnn(C)c4)cnc23)c1		CHEMBL1801107		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Active	6268126	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CN(C)S(=O)(=O)c1ccc(Nc2nccn3c(-c4cnn(C)c4)cnc23)cc1		CHEMBL1801108		IC50			CHEMBL2185	Homo sapiens	IC50		
	6268127	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nccn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1234822	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	uM	0.013
	6268128	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CS(=O)(=O)N1CCC(c2cc(Nc3nccn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1801109	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	uM	0.018
	6268129	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	O=S(=O)(c1ccc(Nc2nccn3c(-c4cn[nH]c4)cnc23)cc1)N1CCOCC1		CHEMBL1801110	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	uM	0.12
	6268130	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1270796	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	6268131	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(CN3CCOCC3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801111	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	nM	110.0
	6268132	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C(F)(F)F)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801112	=	IC50	nM	252.0	CHEMBL2185	Homo sapiens	IC50	nM	252.0
	6268133	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CCc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1801113	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	6268134	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(CCN)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801114	=	IC50	nM	33.0	CHEMBL2185	Homo sapiens	IC50	nM	33.0
	6268135	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801115	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	6268136	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C#N)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801128	=	IC50	nM	219.0	CHEMBL2185	Homo sapiens	IC50	nM	219.0
	6268137	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(-c3cccnc3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1800086	=	IC50	nM	62.0	CHEMBL2185	Homo sapiens	IC50	nM	62.0
	6268138	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	6268139	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc([S+](C)[O-])cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801129	=	IC50	nM	185.0	CHEMBL2185	Homo sapiens	IC50	nM	185.0
	6268140	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(S(C)(=O)=O)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801130	>	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	nM	3000.0
	6268141	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CCSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1801131	=	IC50	nM	24.0	CHEMBL2185	Homo sapiens	IC50	nM	24.0
	6268142	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(SCCN(C)C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801132	=	IC50	nM	81.0	CHEMBL2185	Homo sapiens	IC50	nM	81.0
	6268143	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(SC(C)(C)C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801133	=	IC50	nM	272.0	CHEMBL2185	Homo sapiens	IC50	nM	272.0
	6268144	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(Sc3ccc(F)cc3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801134	=	IC50	nM	129.0	CHEMBL2185	Homo sapiens	IC50	nM	129.0
	6268145	CHEMBL1805333	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C(=O)N3CCCC3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801135	=	IC50	nM	26.0	CHEMBL2185	Homo sapiens	IC50	nM	26.0
Not Active	6307611	CHEMBL1816865	Inhibition of recombinant Aurora-b assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@]1(C)C=C2[C@@H](O)[C@@H]3OC(=O)[C@@]4(C)CC[C@H]5C[C@]5([C@@H]34)[C@@]2(O)C(=O)C1		CHEMBL1812030		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	6307612	CHEMBL1816865	Inhibition of recombinant Aurora-b assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1		CHEMBL516554		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	6307613	CHEMBL1816865	Inhibition of recombinant Aurora-b assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL466154	=	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	uM	3.0
	6307614	CHEMBL1816865	Inhibition of recombinant Aurora-b assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL454440	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	uM	0.5
	6325306	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	99.0	CHEMBL2185	Homo sapiens	INH	%	99.0
	6325335	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	97.0	CHEMBL2185	Homo sapiens	INH	%	97.0
	6325367	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	94.0	CHEMBL2185	Homo sapiens	INH	%	94.0
	6325399	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	81.0	CHEMBL2185	Homo sapiens	INH	%	81.0
	6325431	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	77.0	CHEMBL2185	Homo sapiens	INH	%	77.0
	6325460	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	98.0	CHEMBL2185	Homo sapiens	INH	%	98.0
	6325490	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	6325518	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	22.0	CHEMBL2185	Homo sapiens	INH	%	22.0
	6325861	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	97.0	CHEMBL2185	Homo sapiens	INH	%	97.0
	6325891	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	6325921	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	6325950	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	6325979	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	12.0	CHEMBL2185	Homo sapiens	INH	%	12.0
	6326008	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	12.0	CHEMBL2185	Homo sapiens	INH	%	12.0
	6326037	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	6326067	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	15.0	CHEMBL2185	Homo sapiens	INH	%	15.0
	6326095	CHEMBL1819985	Inhibition of AurB expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	6.0	CHEMBL2185	Homo sapiens	INH	%	6.0
	6340016	CHEMBL1827254	Activity of AURKB kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	88.0	CHEMBL2185	Homo sapiens	Activity	%	88.0
	6342726	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cc(F)cc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822660	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	6342728	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cc(F)cc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822660	=	Kd	nM	21.0	CHEMBL2185	Homo sapiens	Kd	nM	21.0
	6342731	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822659	=	IC50	nM	58.0	CHEMBL2185	Homo sapiens	IC50	nM	58.0
	6342733	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822659	=	Kd	nM	17.0	CHEMBL2185	Homo sapiens	Kd	nM	17.0
	6342743	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822658	=	IC50	nM	44.0	CHEMBL2185	Homo sapiens	IC50	nM	44.0
	6342745	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822658	=	Kd	nM	8.0	CHEMBL2185	Homo sapiens	Kd	nM	8.0
	6342748	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cccc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822657	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	6342750	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cccc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822657	=	Kd	nM	10.0	CHEMBL2185	Homo sapiens	Kd	nM	10.0
	6342753	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccccc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822656	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	6342755	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccccc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822656	=	Kd	nM	9.0	CHEMBL2185	Homo sapiens	Kd	nM	9.0
	6342758	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(=NO)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822655	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	6342760	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(=NO)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822655	=	Kd	nM	5.0	CHEMBL2185	Homo sapiens	Kd	nM	5.0
	6342763	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822654	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	nM	23.0
	6342765	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822654	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd	nM	4.0
	6342768	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OCC5CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822653	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	nM	23.0
	6342770	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OCC5CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822653	=	Kd	nM	2.0	CHEMBL2185	Homo sapiens	Kd	nM	2.0
	6342773	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822652	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	nM	23.0
	6342775	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822652	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd	nM	4.0
	6342778	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	COCCO[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822651	=	IC50	nM	49.0	CHEMBL2185	Homo sapiens	IC50	nM	49.0
	6342780	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	COCCO[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822651	=	Kd	nM	2.0	CHEMBL2185	Homo sapiens	Kd	nM	2.0
	6342783	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	CCC(C)(C)O[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822650	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	6342785	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	CCC(C)(C)O[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822650	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd	nM	4.0
	6342788	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C(F)(F)F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822649	=	IC50	nM	27.0	CHEMBL2185	Homo sapiens	IC50	nM	27.0
	6342790	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C(F)(F)F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822649	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd	nM	4.0
	6342793	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822648	=	IC50	nM	47.0	CHEMBL2185	Homo sapiens	IC50	nM	47.0
	6342795	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822648	=	Kd	nM	1.0	CHEMBL2185	Homo sapiens	Kd	nM	1.0
	6342802	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822647	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
	6342804	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822647	=	Kd	nM	5.0	CHEMBL2185	Homo sapiens	Kd	nM	5.0
	6342807	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](N)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822646	=	IC50	nM	15000.0	CHEMBL2185	Homo sapiens	IC50	nM	15000.0
	6342809	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](N)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822646	=	Kd	nM	144.0	CHEMBL2185	Homo sapiens	Kd	nM	144.0
	6342812	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822645	=	IC50	nM	637.0	CHEMBL2185	Homo sapiens	IC50	nM	637.0
	6342814	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822645	=	Kd	nM	15.0	CHEMBL2185	Homo sapiens	Kd	nM	15.0
	6342817	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](SC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822644	=	IC50	nM	1790.0	CHEMBL2185	Homo sapiens	IC50	nM	1790.0
	6342819	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](SC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822644	=	Kd	nM	39.0	CHEMBL2185	Homo sapiens	Kd	nM	39.0
	6342822	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822643	=	IC50	nM	2490.0	CHEMBL2185	Homo sapiens	IC50	nM	2490.0
	6342824	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822643	=	Kd	nM	69.0	CHEMBL2185	Homo sapiens	Kd	nM	69.0
	6342827	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822642	=	IC50	nM	78.0	CHEMBL2185	Homo sapiens	IC50	nM	78.0
	6342829	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822642	=	Kd	nM	21.0	CHEMBL2185	Homo sapiens	Kd	nM	21.0
	6342832	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H]5C[C@H]5[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822641	=	IC50	nM	179.0	CHEMBL2185	Homo sapiens	IC50	nM	179.0
	6342834	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H]5C[C@H]5[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822641	=	Kd	nM	15.0	CHEMBL2185	Homo sapiens	Kd	nM	15.0
	6342837	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822640	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	6342839	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822640	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd	nM	4.0
	6342842	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822639	=	IC50	nM	91.0	CHEMBL2185	Homo sapiens	IC50	nM	91.0
	6342844	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822639	=	Kd	nM	9.0	CHEMBL2185	Homo sapiens	Kd	nM	9.0
	6342847	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(F)(F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822638	=	IC50	nM	29.0	CHEMBL2185	Homo sapiens	IC50	nM	29.0
	6342849	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(F)(F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822638	=	Kd	nM	5.0	CHEMBL2185	Homo sapiens	Kd	nM	5.0
	6342856	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822637	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
	6342858	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822637	=	Kd	nM	8.0	CHEMBL2185	Homo sapiens	Kd	nM	8.0
	6342861	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822495	=	IC50	nM	146.0	CHEMBL2185	Homo sapiens	IC50	nM	146.0
	6342863	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822495	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd	nM	4.0
	6342866	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN(C)C)cc3)nn3cccc23)n[nH]1		CHEMBL1822494	=	IC50	nM	293.0	CHEMBL2185	Homo sapiens	IC50	nM	293.0
	6342868	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN(C)C)cc3)nn3cccc23)n[nH]1		CHEMBL1822494	=	Kd	nM	8.0	CHEMBL2185	Homo sapiens	Kd	nM	8.0
	6342871	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCOCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822493	=	IC50	nM	1830.0	CHEMBL2185	Homo sapiens	IC50	nM	1830.0
	6342873	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCOCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822493	=	Kd	nM	41.0	CHEMBL2185	Homo sapiens	Kd	nM	41.0
	6342876	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CCCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822492	=	IC50	nM	655.0	CHEMBL2185	Homo sapiens	IC50	nM	655.0
	6342878	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CCCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822492	=	Kd	nM	42.0	CHEMBL2185	Homo sapiens	Kd	nM	42.0
	6342881	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822491	=	IC50	nM	288.0	CHEMBL2185	Homo sapiens	IC50	nM	288.0
	6342883	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822491	=	Kd	nM	41.0	CHEMBL2185	Homo sapiens	Kd	nM	41.0
	6342890	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822485	=	IC50	nM	431.0	CHEMBL2185	Homo sapiens	IC50	nM	431.0
	6342892	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822485	=	Kd	nM	20.0	CHEMBL2185	Homo sapiens	Kd	nM	20.0
	6342894	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)[C@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822661	=	Kd	nM	8.0	CHEMBL2185	Homo sapiens	Kd	nM	8.0
	6342896	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)[C@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822661	=	IC50	nM	84.0	CHEMBL2185	Homo sapiens	IC50	nM	84.0
	6342899	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CCN4CCCCC4)cc23)n[nH]1		CHEMBL1822486	=	Kd	nM	37.0	CHEMBL2185	Homo sapiens	Kd	nM	37.0
	6342901	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CCN4CCCCC4)cc23)n[nH]1		CHEMBL1822486	=	IC50	nM	850.0	CHEMBL2185	Homo sapiens	IC50	nM	850.0
	6342904	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCOCC4)cc23)n[nH]1		CHEMBL1822487	=	Kd	nM	9.0	CHEMBL2185	Homo sapiens	Kd	nM	9.0
	6342906	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCOCC4)cc23)n[nH]1		CHEMBL1822487	=	IC50	nM	420.0	CHEMBL2185	Homo sapiens	IC50	nM	420.0
	6342909	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCCC4)cc23)n[nH]1		CHEMBL1822488	=	Kd	nM	49.0	CHEMBL2185	Homo sapiens	Kd	nM	49.0
	6342911	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCCC4)cc23)n[nH]1		CHEMBL1822488	=	IC50	nM	828.0	CHEMBL2185	Homo sapiens	IC50	nM	828.0
	6342914	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCC[C@@H]4CO)cc23)n[nH]1		CHEMBL1822489	=	Kd	nM	16.0	CHEMBL2185	Homo sapiens	Kd	nM	16.0
	6342916	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCC[C@@H]4CO)cc23)n[nH]1		CHEMBL1822489	=	IC50	nM	6300.0	CHEMBL2185	Homo sapiens	IC50	nM	6300.0
	6342919	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)C(=O)N4CCN(C)CC4)cc23)n[nH]1		CHEMBL1822490	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd	nM	4.0
	6342921	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)C(=O)N4CCN(C)CC4)cc23)n[nH]1		CHEMBL1822490	=	IC50	nM	190.0	CHEMBL2185	Homo sapiens	IC50	nM	190.0
	6342928	CHEMBL1827219	Binding affinity to Aurora B kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	7.0	CHEMBL2185	Homo sapiens	Kd	nM	7.0
	6342930	CHEMBL1827221	Inhibition of Aurora B kinase assessed as reduction in histone H3 phosphorylation in human HCT116 cells	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	55.0	CHEMBL2185	Homo sapiens	IC50	nM	55.0
	6352190	CHEMBL1825645	Inhibition of Aurora B assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	46.0	CHEMBL2185	Homo sapiens	Activity	%	46.0
	6382377	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(NCCN)ncc2C(N)=O)c1		CHEMBL515757	=	IC50	nM	1258.93	CHEMBL2185	Homo sapiens	pIC50		5.9
	6382378	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(OCCN)ncc2C(N)=O)c1		CHEMBL1834756	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	6382379	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3CCCNC3)ncc2C(N)=O)c1		CHEMBL1834757	=	IC50	nM	3162.28	CHEMBL2185	Homo sapiens	pIC50		5.5
	6382380	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@H]3CCCNC3)ncc2C(N)=O)c1		CHEMBL1834758	=	IC50	nM	398.11	CHEMBL2185	Homo sapiens	pIC50		6.4
Not Determined	6382381	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3CCNC3)ncc2C(N)=O)c1		CHEMBL1835057		pIC50			CHEMBL2185	Homo sapiens	pIC50		
	6382382	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@H]3CCNC3)ncc2C(N)=O)c1		CHEMBL1835058	=	IC50	nM	794.33	CHEMBL2185	Homo sapiens	pIC50		6.1
Not Determined	6382383	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(NC3CNC3)ncc2C(N)=O)c1		CHEMBL1835059		pIC50			CHEMBL2185	Homo sapiens	pIC50		
Not Determined	6382384	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(NCC3CCCCN3)ncc2C(N)=O)c1		CHEMBL1835060		pIC50			CHEMBL2185	Homo sapiens	pIC50		
	6382385	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(NC[C@@H]3CCCN3)ncc2C(N)=O)c1		CHEMBL1835061	=	IC50	nM	6309.57	CHEMBL2185	Homo sapiens	pIC50		5.2
Not Determined	6382386	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(NC[C@H]3CCCN3)ncc2C(N)=O)c1		CHEMBL1835062		pIC50			CHEMBL2185	Homo sapiens	pIC50		
	6382387	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL1835063	=	IC50	nM	7943.28	CHEMBL2185	Homo sapiens	pIC50		5.1
	6382388	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)c1		CHEMBL1235110	=	IC50	nM	3981.07	CHEMBL2185	Homo sapiens	pIC50		5.4
	6382389	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@H]3CCCC[C@H]3N)ncc2C(N)=O)c1		CHEMBL1835064	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	6382390	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)c1		CHEMBL1835065	=	IC50	nM	6309.57	CHEMBL2185	Homo sapiens	pIC50		5.2
	6382391	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3COCC[C@@H]3N)ncc2C(N)=O)c1		CHEMBL1835066	=	IC50	nM	3981.07	CHEMBL2185	Homo sapiens	pIC50		5.4
	6382392	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3COC[C@@H]3N)ncc2C(N)=O)c1		CHEMBL1835067	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	6382393	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3CCC(F)(F)C[C@@H]3N)ncc2C(N)=O)c1		CHEMBL1835068	=	IC50	nM	5011.87	CHEMBL2185	Homo sapiens	pIC50		5.3
	6382394	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1cccc(Nc2nc(N[C@@H]3CC(F)(F)CC[C@@H]3N)ncc2C(N)=O)c1		CHEMBL1835069	=	IC50	nM	1258.93	CHEMBL2185	Homo sapiens	pIC50		5.9
	6382395	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1ccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)cc1		CHEMBL1835070	=	IC50	nM	12589.25	CHEMBL2185	Homo sapiens	pIC50		4.9
	6382396	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	Cc1ccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)cc1		CHEMBL1835071	=	IC50	nM	15848.93	CHEMBL2185	Homo sapiens	pIC50		4.8
	6382397	CHEMBL1838852	Inhibition of human recombinant Flag-6His-Thr-tagged Aurora B assessed as phosphorylation of 5FAM-PKA-tide substrate after 150 mins by fuorescence polarisation kinase assay	B	COc1ccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)cc1		CHEMBL1835072	<	IC50	nM	25118.86	CHEMBL2185	Homo sapiens	pIC50		4.6
	6385618	CHEMBL1837983	Inhibition of human AurB in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	6385619	CHEMBL1837983	Inhibition of human AurB in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	6385620	CHEMBL1837983	Inhibition of human AurB in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	6385621	CHEMBL1837983	Inhibition of human AurB in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	6385622	CHEMBL1837983	Inhibition of human AurB in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
Not Determined	6390368	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nccn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC1		CHEMBL1836753		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390369	CHEMBL1839619	Inhibition of AurB	B	CC(C)c1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836756		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390370	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)O)c(Cl)c2)n1		CHEMBL1836757		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390371	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cl)cc(C(=O)N3CCNCC3)c2)n1		CHEMBL1836758		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390372	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(N[C@H]2CC[C@H](C(=O)N3CCNCC3)CC2)n1		CHEMBL1836759		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390373	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(=O)N(C)C)ns2)n1		CHEMBL1836761		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390374	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cncc(N3CCNCC3)c2)n1		CHEMBL1836797		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390375	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(N3CCOCC3)nc2)n1		CHEMBL1836798		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390376	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCN(C)CC3)c(Cl)c2)n1		CHEMBL1836805		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390377	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(=O)C3)c(Cl)c2)n1		CHEMBL1836806		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390378	CHEMBL1839619	Inhibition of AurB	B	CC(=O)N1CCN(C(=O)c2ccc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CC1		CHEMBL1836807		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390379	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCN(CCO)CC3)c(Cl)c2)n1		CHEMBL1836808		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390380	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCCCC3)c(Cl)c2)n1		CHEMBL1836809		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390381	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3(C)C)c(Cl)c2)n1		CHEMBL1836811		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390382	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCC(O)CC3)c(Cl)c2)n1		CHEMBL1836812		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390383	CHEMBL1839619	Inhibition of AurB	B	COC1CCN(C(=O)c2ccc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CC1		CHEMBL1836813		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	6390384	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCCNCC3)c(Cl)c2)n1		CHEMBL1836814		IC50			CHEMBL2185	Homo sapiens	IC50		
	6390385	CHEMBL1839619	Inhibition of AurB	B	CCOc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sc1C(=O)N1CCCC(C)C1		CHEMBL1836760	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	6390386	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL1739550	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	6390387	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(O)CC3)cs2)n1		CHEMBL1836799	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	6390388	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836867	=	IC50	nM	754.0	CHEMBL2185	Homo sapiens	IC50	nM	754.0
	6390389	CHEMBL1839619	Inhibition of AurB	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	6485.0	CHEMBL2185	Homo sapiens	IC50	nM	6485.0
	6390390	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2Cl)n1		CHEMBL1836849	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390391	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(Cl)c1)N1CCNCC1		CHEMBL1836850	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390392	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2Cl)n1		CHEMBL1836851	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390393	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(Cl)c1)N1CCOCC1		CHEMBL1836852	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390394	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2F)n1		CHEMBL1836853	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390395	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1)N1CCNCC1		CHEMBL1836854	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390396	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2F)n1		CHEMBL1836855	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390397	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1)N1CCOCC1		CHEMBL1836861	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390398	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3(C)C)cc2F)n1		CHEMBL1836862	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390399	CHEMBL1839619	Inhibition of AurB	B	CC1(C)CNCCN1C(=O)c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)c(F)c1		CHEMBL1836863	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390400	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(C)(C)C3)cc2F)n1		CHEMBL1836864	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390401	CHEMBL1839619	Inhibition of AurB	B	CC1(C)CN(C(=O)c2ccc(Nc3nc(C4CC4)cn4c(-c5cn[nH]c5)cnc34)c(F)c2)CCN1		CHEMBL1836865	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
	6390402	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCOCC3)c(Cl)c2)n1		CHEMBL1836810	=	IC50	nM	43.0	CHEMBL2185	Homo sapiens	IC50	nM	43.0
	6390403	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(C(F)(F)F)c2)n1		CHEMBL1836802	=	IC50	nM	84.0	CHEMBL2185	Homo sapiens	IC50	nM	84.0
	6390404	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(C3CC3)c2)n1		CHEMBL1836804	=	IC50	nM	128.0	CHEMBL2185	Homo sapiens	IC50	nM	128.0
	6390405	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(F)c2)n1		CHEMBL1836801	=	IC50	nM	143.0	CHEMBL2185	Homo sapiens	IC50	nM	143.0
	6390406	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC34CC4)c(Cl)c2)n1		CHEMBL1836837	=	IC50	nM	194.0	CHEMBL2185	Homo sapiens	IC50	nM	194.0
	6390407	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)cc2)n1		CHEMBL1836800	=	IC50	nM	232.0	CHEMBL2185	Homo sapiens	IC50	nM	232.0
	6390408	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3C[C@@H]4CC[C@H](C3)N4)c(Cl)c2)n1		CHEMBL1836841	=	IC50	nM	242.0	CHEMBL2185	Homo sapiens	IC50	nM	242.0
	6390409	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC(C)(C)C3)c(Cl)c2)n1		CHEMBL1836838	=	IC50	nM	305.0	CHEMBL2185	Homo sapiens	IC50	nM	305.0
	6390410	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3C[C@H]4CC[C@@H]3CN4)c(Cl)c2)n1		CHEMBL1836840	=	IC50	nM	339.0	CHEMBL2185	Homo sapiens	IC50	nM	339.0
	6390411	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccnc(N3CCNCC3)c2)n1		CHEMBL1836796	=	IC50	nM	561.0	CHEMBL2185	Homo sapiens	IC50	nM	561.0
	6390412	CHEMBL1839619	Inhibition of AurB	B	CCc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3)c(Cl)c2)n1		CHEMBL1836754	=	IC50	nM	653.0	CHEMBL2185	Homo sapiens	IC50	nM	653.0
	6390413	CHEMBL1839619	Inhibition of AurB	B	COc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)ccc1C(=O)N1CCNCC1		CHEMBL1836803	=	IC50	nM	837.0	CHEMBL2185	Homo sapiens	IC50	nM	837.0
	6390414	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNCC3(C)C)c(Cl)c2)n1		CHEMBL1836815	=	IC50	nM	1227.0	CHEMBL2185	Homo sapiens	IC50	nM	1227.0
	6390415	CHEMBL1839619	Inhibition of AurB	B	CC1(C)CNCCN1C(=O)c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl		CHEMBL1836842	=	IC50	nM	2252.0	CHEMBL2185	Homo sapiens	IC50	nM	2252.0
	6390416	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNC2(CC2)C1		CHEMBL1836845	=	IC50	nM	2501.0	CHEMBL2185	Homo sapiens	IC50	nM	2501.0
	6390417	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1C[C@@H]2CC[C@H](C1)N2		CHEMBL1836847	=	IC50	nM	2517.0	CHEMBL2185	Homo sapiens	IC50	nM	2517.0
	6390418	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC1		CHEMBL1836755	=	IC50	nM	2541.0	CHEMBL2185	Homo sapiens	IC50	nM	2541.0
	6390419	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1C[C@H]2CC[C@@H]1CN2		CHEMBL1836846	=	IC50	nM	2739.0	CHEMBL2185	Homo sapiens	IC50	nM	2739.0
	6390420	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCNCC12CC2		CHEMBL1836843	=	IC50	nM	2987.0	CHEMBL2185	Homo sapiens	IC50	nM	2987.0
	6390421	CHEMBL1839619	Inhibition of AurB	B	CC1(C)CN(C(=O)c2ccc(Nc3nc(C4CC4)cn4c(-c5cn[nH]c5)cnc34)cc2Cl)CCN1		CHEMBL1836844	=	IC50	nM	4588.0	CHEMBL2185	Homo sapiens	IC50	nM	4588.0
	6390422	CHEMBL1839619	Inhibition of AurB	B	O=C(c1ccc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)cc1Cl)N1CCOCC1		CHEMBL1836848	=	IC50	nM	8484.0	CHEMBL2185	Homo sapiens	IC50	nM	8484.0
	6390423	CHEMBL1839619	Inhibition of AurB	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(C(=O)N3CCNC4(CC4)C3)c(Cl)c2)n1		CHEMBL1836839	=	IC50	nM	11000.0	CHEMBL2185	Homo sapiens	IC50	nM	11000.0
	7567166	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	3200.0	CHEMBL2185	Homo sapiens	Kd	nM	3200.0
	7567625	CHEMBL1908469	Binding constant for AURKB kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7568096	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7568564	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	2000.0	CHEMBL2185	Homo sapiens	Kd	nM	2000.0
	7568996	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	380.0	CHEMBL2185	Homo sapiens	Kd	nM	380.0
	7569139	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7569599	CHEMBL1908469	Binding constant for AURKB kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	76.0	CHEMBL2185	Homo sapiens	Kd	nM	76.0
	7570071	CHEMBL1908469	Binding constant for AURKB kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7570534	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7571115	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7571572	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7572048	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2900.0	CHEMBL2185	Homo sapiens	Kd	nM	2900.0
	7572485	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	150.0	CHEMBL2185	Homo sapiens	Kd	nM	150.0
	7573096	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	420.0	CHEMBL2185	Homo sapiens	Kd	nM	420.0
	7573553	CHEMBL1908469	Binding constant for AURKB kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1400.0	CHEMBL2185	Homo sapiens	Kd	nM	1400.0
	7574056	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	62.0	CHEMBL2185	Homo sapiens	Kd	nM	62.0
	7574464	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7575074	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7575564	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	160.0	CHEMBL2185	Homo sapiens	Kd	nM	160.0
	7576029	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2300.0	CHEMBL2185	Homo sapiens	Kd	nM	2300.0
	7576437	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	490.0	CHEMBL2185	Homo sapiens	Kd	nM	490.0
	7577048	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7577065	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	43.0	CHEMBL2185	Homo sapiens	Kd	nM	43.0
	7577543	CHEMBL1908469	Binding constant for AURKB kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	88.0	CHEMBL2185	Homo sapiens	Kd	nM	88.0
	7578013	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7578418	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7578614	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7579438	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7579912	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7580381	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7580784	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	7.4	CHEMBL2185	Homo sapiens	Kd	nM	7.4
	7580972	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7581357	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7581802	CHEMBL1908469	Binding constant for AURKB kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7582273	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7582737	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	110.0	CHEMBL2185	Homo sapiens	Kd	nM	110.0
	7583137	CHEMBL1908469	Binding constant for AURKB kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7583318	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	390.0	CHEMBL2185	Homo sapiens	Kd	nM	390.0
	7583715	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7584160	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7584631	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7585093	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7585648	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7586056	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7586502	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7586973	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7587609	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	11.0	CHEMBL2185	Homo sapiens	Kd	nM	11.0
	7588028	CHEMBL1908469	Binding constant for AURKB kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	16.0	CHEMBL2185	Homo sapiens	Kd	nM	16.0
	7588481	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7588961	CHEMBL1908469	Binding constant for AURKB kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7589574	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7589998	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	280.0	CHEMBL2185	Homo sapiens	Kd	nM	280.0
	7590465	CHEMBL1908469	Binding constant for AURKB kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7590497	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	1700.0	CHEMBL2185	Homo sapiens	Kd	nM	1700.0
	7590948	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7591547	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	4400.0	CHEMBL2185	Homo sapiens	Kd	nM	4400.0
	7591969	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7592472	CHEMBL1908469	Binding constant for AURKB kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	43.0	CHEMBL2185	Homo sapiens	Kd	nM	43.0
	7592925	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7593514	CHEMBL1908469	Binding constant for AURKB kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7593979	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7594452	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7594904	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	440.0	CHEMBL2185	Homo sapiens	Kd	nM	440.0
	7595484	CHEMBL1908469	Binding constant for AURKB kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4200.0	CHEMBL2185	Homo sapiens	Kd	nM	4200.0
	7595958	CHEMBL1908469	Binding constant for AURKB kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7596429	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7596876	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	19.0	CHEMBL2185	Homo sapiens	Kd	nM	19.0
	7597012	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	4.6	CHEMBL2185	Homo sapiens	Kd	nM	4.6
	7597465	CHEMBL1908469	Binding constant for AURKB kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7597938	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7598408	CHEMBL1908469	Binding constant for AURKB kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	7598850	CHEMBL1908469	Binding constant for AURKB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	340.0	CHEMBL2185	Homo sapiens	Kd	nM	340.0
	7843034	CHEMBL1913270	Inhibition of human recombinant Aurora B at 10 uM after 4 hrs by Kinase-Glo luminescent assay	B	O=C(c1c[nH]c2ccccc12)c1nccc2c1[nH]c1ccc(O)cc12		CHEMBL1910715	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	7951342	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL1922224	=	IC50	nM	38100.0	CHEMBL2185	Homo sapiens	IC50	uM	38.1
	7951343	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL518060	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	7951344	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C		CHEMBL1922225	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	7951345	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456936	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	7951346	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL517956	=	IC50	nM	25100.0	CHEMBL2185	Homo sapiens	IC50	uM	25.1
	7951347	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456294	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	7951348	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C		CHEMBL515982	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	7951349	CHEMBL1926222	Inhibition of recombinant human Aurora-B using tetra(LRRWLSG) as substrate	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL464351	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	7956217	CHEMBL1924836	Inhibition of N-terminus 6XHis-tagged Aurora-B expressed in baculovirus infected insect cells using [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	=	IC50	nM	1700.0	CHEMBL2185	Homo sapiens	IC50	nM	1700.0
	7969694	CHEMBL1930950	Inhibition of aurora-B assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	49.0	CHEMBL2185	Homo sapiens	Activity	%	49.0
	7984058	CHEMBL1936505	Inhibition of Aurora-B	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	7984059	CHEMBL1936505	Inhibition of Aurora-B	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	7989303	CHEMBL1936694	Inhibition of human Aurora B at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	7989304	CHEMBL1936694	Inhibition of human Aurora B at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	>=	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	7989305	CHEMBL1936694	Inhibition of human Aurora B at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	<	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	7989306	CHEMBL1936694	Inhibition of human Aurora B at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	7992175	CHEMBL1935903	Inhibition of AURKB at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	94.0	CHEMBL2185	Homo sapiens	INH	%	94.0
	7996677	CHEMBL1944008	Inhibition of AURKB at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	98.0	CHEMBL2185	Homo sapiens	INH	%	98.0
	7996740	CHEMBL1944008	Inhibition of AURKB at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	98.0	CHEMBL2185	Homo sapiens	INH	%	98.0
	8004487	CHEMBL1943919	Inhibition of Aurora B at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	8004531	CHEMBL1943919	Inhibition of Aurora B at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	8005005	CHEMBL1942923	Inhibition of aurora-B	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4cccc(F)c4)c3)c2cc1OC		CHEMBL1940103	<	IC50	nM	0.2	CHEMBL2185	Homo sapiens	IC50	nM	0.2
	8005006	CHEMBL1942923	Inhibition of aurora-B	B	COc1cccc(NC(=O)Cn2cc(Nc3ncnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940104	>	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	uM	0.01
	8005007	CHEMBL1942923	Inhibition of aurora-B	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4ccc(N(C)C)cc4)c3)c2cc1OC		CHEMBL1940105	>	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	uM	0.01
	8005195	CHEMBL1943919	Inhibition of Aurora B at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	8005238	CHEMBL1943919	Inhibition of Aurora B at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	8060103	CHEMBL1961276	Inhibition of human recombinant aurora-B expressed in Sf9 cells using tetra(LRRWSLG) as substrate after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL2185	Homo sapiens	IC50	uM	35.0
	8060104	CHEMBL1961276	Inhibition of human recombinant aurora-B expressed in Sf9 cells using tetra(LRRWSLG) as substrate after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	2500.0	CHEMBL2185	Homo sapiens	IC50	uM	2.5
	8061332	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.17	CHEMBL2185	Homo sapiens	Inhibition	%	1.17
	8061509	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	34.41	CHEMBL2185	Homo sapiens	Inhibition	%	34.41
	8061840	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.9	CHEMBL2185	Homo sapiens	Inhibition	%	3.9
	8062031	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	7.66	CHEMBL2185	Homo sapiens	Inhibition	%	7.66
	8062371	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.6	CHEMBL2185	Homo sapiens	Inhibition	%	1.6
	8062533	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.6	CHEMBL2185	Homo sapiens	Inhibition	%	4.6
	8062855	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.04	CHEMBL2185	Homo sapiens	Inhibition	%	3.04
	8063211	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	6.56	CHEMBL2185	Homo sapiens	Inhibition	%	6.56
	8063378	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.71	CHEMBL2185	Homo sapiens	Inhibition	%	4.71
	8063710	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.83	CHEMBL2185	Homo sapiens	Inhibition	%	4.83
	8063892	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	55.15	CHEMBL2185	Homo sapiens	Inhibition	%	55.15
	8064231	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.18	CHEMBL2185	Homo sapiens	Inhibition	%	4.18
	8064441	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.09	CHEMBL2185	Homo sapiens	Inhibition	%	2.09
	8064803	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	8.72	CHEMBL2185	Homo sapiens	Inhibition	%	8.72
	8064969	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.65	CHEMBL2185	Homo sapiens	Inhibition	%	2.65
	8065193	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.59	CHEMBL2185	Homo sapiens	Inhibition	%	3.59
	8065309	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.45	CHEMBL2185	Homo sapiens	Inhibition	%	4.45
	8065484	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.28	CHEMBL2185	Homo sapiens	Inhibition	%	4.28
	8065708	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	12.37	CHEMBL2185	Homo sapiens	Inhibition	%	12.37
	8065823	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.58	CHEMBL2185	Homo sapiens	Inhibition	%	3.58
	8066033	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.86	CHEMBL2185	Homo sapiens	Inhibition	%	5.86
	8066257	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.28	CHEMBL2185	Homo sapiens	Inhibition	%	1.28
	8066393	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	51.11	CHEMBL2185	Homo sapiens	Inhibition	%	51.11
	8066783	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.77	CHEMBL2185	Homo sapiens	Inhibition	%	5.77
	8066907	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	8.64	CHEMBL2185	Homo sapiens	Inhibition	%	8.64
	8067131	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	21.03	CHEMBL2185	Homo sapiens	Inhibition	%	21.03
	8067306	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.7	CHEMBL2185	Homo sapiens	Inhibition	%	3.7
	8067427	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	18.12	CHEMBL2185	Homo sapiens	Inhibition	%	18.12
	8067651	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-1.03	CHEMBL2185	Homo sapiens	Inhibition	%	-1.03
	8067861	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	5.03	CHEMBL2185	Homo sapiens	Inhibition	%	5.03
	8067996	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	20.54	CHEMBL2185	Homo sapiens	Inhibition	%	20.54
	8068220	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	71.04	CHEMBL2185	Homo sapiens	Inhibition	%	71.04
	8068384	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	4.81	CHEMBL2185	Homo sapiens	Inhibition	%	4.81
	8068733	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.3	CHEMBL2185	Homo sapiens	Inhibition	%	2.3
	8068907	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	7.15	CHEMBL2185	Homo sapiens	Inhibition	%	7.15
	8069256	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.77	CHEMBL2185	Homo sapiens	Inhibition	%	4.77
	8069551	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	9.93	CHEMBL2185	Homo sapiens	Inhibition	%	9.93
	8069712	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.97	CHEMBL2185	Homo sapiens	Inhibition	%	1.97
	8070062	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.27	CHEMBL2185	Homo sapiens	Inhibition	%	1.27
	8070234	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.15	CHEMBL2185	Homo sapiens	Inhibition	%	4.15
	8070583	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.9	CHEMBL2185	Homo sapiens	Inhibition	%	0.9
	8070881	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	56.46	CHEMBL2185	Homo sapiens	Inhibition	%	56.46
	8071038	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.55	CHEMBL2185	Homo sapiens	Inhibition	%	4.55
	8071262	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	6.64	CHEMBL2185	Homo sapiens	Inhibition	%	6.64
	8071388	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-1.18	CHEMBL2185	Homo sapiens	Inhibition	%	-1.18
	8071561	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	10.99	CHEMBL2185	Homo sapiens	Inhibition	%	10.99
	8071785	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.16	CHEMBL2185	Homo sapiens	Inhibition	%	5.16
	8071910	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.53	CHEMBL2185	Homo sapiens	Inhibition	%	5.53
	8072224	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.59	CHEMBL2185	Homo sapiens	Inhibition	%	-1.59
	8072605	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	11.91	CHEMBL2185	Homo sapiens	Inhibition	%	11.91
	8072730	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.2	CHEMBL2185	Homo sapiens	Inhibition	%	4.2
	8073121	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	14.49	CHEMBL2185	Homo sapiens	Inhibition	%	14.49
	8073246	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	5.4	CHEMBL2185	Homo sapiens	Inhibition	%	5.4
	8073470	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	30.8	CHEMBL2185	Homo sapiens	Inhibition	%	30.8
	8073589	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.05	CHEMBL2185	Homo sapiens	Inhibition	%	1.05
	8073822	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.29	CHEMBL2185	Homo sapiens	Inhibition	%	-0.29
	8074198	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	24.94	CHEMBL2185	Homo sapiens	Inhibition	%	24.94
	8074328	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	5.54	CHEMBL2185	Homo sapiens	Inhibition	%	5.54
	8074552	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	31.08	CHEMBL2185	Homo sapiens	Inhibition	%	31.08
	8074709	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.8	CHEMBL2185	Homo sapiens	Inhibition	%	2.8
	8075060	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.66	CHEMBL2185	Homo sapiens	Inhibition	%	0.66
	8075171	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	7.36	CHEMBL2185	Homo sapiens	Inhibition	%	7.36
	8075395	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.52	CHEMBL2185	Homo sapiens	Inhibition	%	0.52
	8075408	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.07	CHEMBL2185	Homo sapiens	Inhibition	%	0.07
	8075632	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	4.15	CHEMBL2185	Homo sapiens	Inhibition	%	4.15
	8075773	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.94	CHEMBL2185	Homo sapiens	Inhibition	%	0.94
	8076139	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.15	CHEMBL2185	Homo sapiens	Inhibition	%	1.15
	8076287	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.02	CHEMBL2185	Homo sapiens	Inhibition	%	1.02
	8076645	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.9	CHEMBL2185	Homo sapiens	Inhibition	%	4.9
	8076971	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	5.52	CHEMBL2185	Homo sapiens	Inhibition	%	5.52
	8077218	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.38	CHEMBL2185	Homo sapiens	Inhibition	%	0.38
	8077346	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.32	CHEMBL2185	Homo sapiens	Inhibition	%	8.32
	8077721	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	7.77	CHEMBL2185	Homo sapiens	Inhibition	%	7.77
	8077864	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.16	CHEMBL2185	Homo sapiens	Inhibition	%	3.16
	8078088	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	7.8	CHEMBL2185	Homo sapiens	Inhibition	%	7.8
	8078227	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.09	CHEMBL2185	Homo sapiens	Inhibition	%	0.09
	8078553	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.1	CHEMBL2185	Homo sapiens	Inhibition	%	0.1
	8078803	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	6.56	CHEMBL2185	Homo sapiens	Inhibition	%	6.56
	8078919	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.83	CHEMBL2185	Homo sapiens	Inhibition	%	2.83
	8079143	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.74	CHEMBL2185	Homo sapiens	Inhibition	%	4.74
	8079301	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.7	CHEMBL2185	Homo sapiens	Inhibition	%	0.7
	8079667	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.65	CHEMBL2185	Homo sapiens	Inhibition	%	1.65
	8079806	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	19.45	CHEMBL2185	Homo sapiens	Inhibition	%	19.45
	8080135	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	3.15	CHEMBL2185	Homo sapiens	Inhibition	%	3.15
	8080387	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	6.97	CHEMBL2185	Homo sapiens	Inhibition	%	6.97
	8080726	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.34	CHEMBL2185	Homo sapiens	Inhibition	%	2.34
	8080890	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.36	CHEMBL2185	Homo sapiens	Inhibition	%	1.36
	8081249	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.29	CHEMBL2185	Homo sapiens	Inhibition	%	4.29
	8081393	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.95	CHEMBL2185	Homo sapiens	Inhibition	%	1.95
	8081617	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.04	CHEMBL2185	Homo sapiens	Inhibition	%	3.04
	8081720	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.17	CHEMBL2185	Homo sapiens	Inhibition	%	1.17
	8081972	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	47.99	CHEMBL2185	Homo sapiens	Inhibition	%	47.99
	8082309	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	21.97	CHEMBL2185	Homo sapiens	Inhibition	%	21.97
	8082482	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-5.29	CHEMBL2185	Homo sapiens	Inhibition	%	-5.29
	8082706	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.57	CHEMBL2185	Homo sapiens	Inhibition	%	-0.57
	8082829	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.48	CHEMBL2185	Homo sapiens	Inhibition	%	0.48
	8083209	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.38	CHEMBL2185	Homo sapiens	Inhibition	%	1.38
	8083308	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	6.09	CHEMBL2185	Homo sapiens	Inhibition	%	6.09
	8083532	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.84	CHEMBL2185	Homo sapiens	Inhibition	%	1.84
	8083562	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.62	CHEMBL2185	Homo sapiens	Inhibition	%	0.62
	8083786	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	7.52	CHEMBL2185	Homo sapiens	Inhibition	%	7.52
	8083896	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.08	CHEMBL2185	Homo sapiens	Inhibition	%	1.08
	8084305	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	19.99	CHEMBL2185	Homo sapiens	Inhibition	%	19.99
	8084423	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	5.72	CHEMBL2185	Homo sapiens	Inhibition	%	5.72
	8084647	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-0.85	CHEMBL2185	Homo sapiens	Inhibition	%	-0.85
	8084808	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	17.8	CHEMBL2185	Homo sapiens	Inhibition	%	17.8
	8085130	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.58	CHEMBL2185	Homo sapiens	Inhibition	%	3.58
	8085386	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	2.52	CHEMBL2185	Homo sapiens	Inhibition	%	2.52
	8085494	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.37	CHEMBL2185	Homo sapiens	Inhibition	%	7.37
	8085718	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.55	CHEMBL2185	Homo sapiens	Inhibition	%	3.55
	8085907	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	67.88	CHEMBL2185	Homo sapiens	Inhibition	%	67.88
	8086246	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	8.49	CHEMBL2185	Homo sapiens	Inhibition	%	8.49
	8086408	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.01	CHEMBL2185	Homo sapiens	Inhibition	%	-1.01
	8086731	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.79	CHEMBL2185	Homo sapiens	Inhibition	%	0.79
	8086942	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-2.93	CHEMBL2185	Homo sapiens	Inhibition	%	-2.93
	8087324	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.16	CHEMBL2185	Homo sapiens	Inhibition	%	-0.16
	8087438	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	7.33	CHEMBL2185	Homo sapiens	Inhibition	%	7.33
	8087662	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.39	CHEMBL2185	Homo sapiens	Inhibition	%	4.39
	8087800	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	45.62	CHEMBL2185	Homo sapiens	Inhibition	%	45.62
	8088166	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.51	CHEMBL2185	Homo sapiens	Inhibition	%	4.51
	8088314	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.93	CHEMBL2185	Homo sapiens	Inhibition	%	1.93
	8088666	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	8.64	CHEMBL2185	Homo sapiens	Inhibition	%	8.64
	8088983	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.64	CHEMBL2185	Homo sapiens	Inhibition	%	5.64
	8089111	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.16	CHEMBL2185	Homo sapiens	Inhibition	%	3.16
	8089483	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	8.72	CHEMBL2185	Homo sapiens	Inhibition	%	8.72
	8089603	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.01	CHEMBL2185	Homo sapiens	Inhibition	%	2.01
	8089827	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-1.57	CHEMBL2185	Homo sapiens	Inhibition	%	-1.57
	8090007	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.7	CHEMBL2185	Homo sapiens	Inhibition	%	0.7
	8090172	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.62	CHEMBL2185	Homo sapiens	Inhibition	%	1.62
	8090396	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.41	CHEMBL2185	Homo sapiens	Inhibition	%	2.41
	8090563	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.82	CHEMBL2185	Homo sapiens	Inhibition	%	1.82
	8090702	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	9.87	CHEMBL2185	Homo sapiens	Inhibition	%	9.87
	8090926	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	63.93	CHEMBL2185	Homo sapiens	Inhibition	%	63.93
	8091131	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.74	CHEMBL2185	Homo sapiens	Inhibition	%	4.74
	8091268	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.43	CHEMBL2185	Homo sapiens	Inhibition	%	2.43
	8091492	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.03	CHEMBL2185	Homo sapiens	Inhibition	%	5.03
	8091647	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.49	CHEMBL2185	Homo sapiens	Inhibition	%	3.49
	8091987	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	11.07	CHEMBL2185	Homo sapiens	Inhibition	%	11.07
	8092124	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.82	CHEMBL2185	Homo sapiens	Inhibition	%	-0.82
	8092499	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.13	CHEMBL2185	Homo sapiens	Inhibition	%	5.13
	8092647	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	5.23	CHEMBL2185	Homo sapiens	Inhibition	%	5.23
	8092871	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.14	CHEMBL2185	Homo sapiens	Inhibition	%	1.14
	8093000	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	38.77	CHEMBL2185	Homo sapiens	Inhibition	%	38.77
	8093312	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.85	CHEMBL2185	Homo sapiens	Inhibition	%	3.85
	8093452	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	6.47	CHEMBL2185	Homo sapiens	Inhibition	%	6.47
	8093676	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.1	CHEMBL2185	Homo sapiens	Inhibition	%	2.1
	8093815	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	44.95	CHEMBL2185	Homo sapiens	Inhibition	%	44.95
	8094159	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.12	CHEMBL2185	Homo sapiens	Inhibition	%	5.12
	8094339	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	Inhibition	%	0.0
	8094738	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.99	CHEMBL2185	Homo sapiens	Inhibition	%	2.99
	8094894	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	8.37	CHEMBL2185	Homo sapiens	Inhibition	%	8.37
	8095258	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	78.98	CHEMBL2185	Homo sapiens	Inhibition	%	78.98
	8095461	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	10.01	CHEMBL2185	Homo sapiens	Inhibition	%	10.01
	8095826	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	12.78	CHEMBL2185	Homo sapiens	Inhibition	%	12.78
	8095974	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.48	CHEMBL2185	Homo sapiens	Inhibition	%	3.48
	8096315	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.03	CHEMBL2185	Homo sapiens	Inhibition	%	4.03
	8096454	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.75	CHEMBL2185	Homo sapiens	Inhibition	%	1.75
	8096678	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.28	CHEMBL2185	Homo sapiens	Inhibition	%	3.28
	8096834	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	9.34	CHEMBL2185	Homo sapiens	Inhibition	%	9.34
	8097205	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	6.42	CHEMBL2185	Homo sapiens	Inhibition	%	6.42
	8097292	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.24	CHEMBL2185	Homo sapiens	Inhibition	%	1.24
	8097512	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	9.08	CHEMBL2185	Homo sapiens	Inhibition	%	9.08
	8097886	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	7.36	CHEMBL2185	Homo sapiens	Inhibition	%	7.36
	8098019	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.26	CHEMBL2185	Homo sapiens	Inhibition	%	-1.26
	8098363	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.57	CHEMBL2185	Homo sapiens	Inhibition	%	-1.57
	8098543	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.63	CHEMBL2185	Homo sapiens	Inhibition	%	3.63
	8098767	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.9	CHEMBL2185	Homo sapiens	Inhibition	%	1.9
	8098952	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.23	CHEMBL2185	Homo sapiens	Inhibition	%	2.23
	8099096	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.47	CHEMBL2185	Homo sapiens	Inhibition	%	1.47
	8099462	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	7.82	CHEMBL2185	Homo sapiens	Inhibition	%	7.82
	8099656	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.7	CHEMBL2185	Homo sapiens	Inhibition	%	0.7
	8100027	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.27	CHEMBL2185	Homo sapiens	Inhibition	%	4.27
	8100173	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	15.0	CHEMBL2185	Homo sapiens	Inhibition	%	15.0
	8100397	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-2.59	CHEMBL2185	Homo sapiens	Inhibition	%	-2.59
	8100513	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.56	CHEMBL2185	Homo sapiens	Inhibition	%	5.56
	8100877	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	5.05	CHEMBL2185	Homo sapiens	Inhibition	%	5.05
	8101037	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.11	CHEMBL2185	Homo sapiens	Inhibition	%	5.11
	8101403	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	10.14	CHEMBL2185	Homo sapiens	Inhibition	%	10.14
	8101588	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.75	CHEMBL2185	Homo sapiens	Inhibition	%	-0.75
	8101841	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	9.33	CHEMBL2185	Homo sapiens	Inhibition	%	9.33
	8102220	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	24.48	CHEMBL2185	Homo sapiens	Inhibition	%	24.48
	8102351	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	9.37	CHEMBL2185	Homo sapiens	Inhibition	%	9.37
	8102575	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.33	CHEMBL2185	Homo sapiens	Inhibition	%	1.33
	8102695	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.15	CHEMBL2185	Homo sapiens	Inhibition	%	1.15
	8103097	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	4.9	CHEMBL2185	Homo sapiens	Inhibition	%	4.9
	8103293	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.29	CHEMBL2185	Homo sapiens	Inhibition	%	3.29
	8103431	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	9.78	CHEMBL2185	Homo sapiens	Inhibition	%	9.78
	8103655	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	12.62	CHEMBL2185	Homo sapiens	Inhibition	%	12.62
	8103805	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	9.68	CHEMBL2185	Homo sapiens	Inhibition	%	9.68
	8103990	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.38	CHEMBL2185	Homo sapiens	Inhibition	%	-0.38
	8104214	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	16.03	CHEMBL2185	Homo sapiens	Inhibition	%	16.03
	8104362	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.65	CHEMBL2185	Homo sapiens	Inhibition	%	6.65
	8104732	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.73	CHEMBL2185	Homo sapiens	Inhibition	%	1.73
	8104846	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.58	CHEMBL2185	Homo sapiens	Inhibition	%	3.58
	8105070	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.49	CHEMBL2185	Homo sapiens	Inhibition	%	5.49
	8105210	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.57	CHEMBL2185	Homo sapiens	Inhibition	%	0.57
	8105376	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	7.24	CHEMBL2185	Homo sapiens	Inhibition	%	7.24
	8105600	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.58	CHEMBL2185	Homo sapiens	Inhibition	%	-0.58
	8105738	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	49.98	CHEMBL2185	Homo sapiens	Inhibition	%	49.98
	8106018	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.68	CHEMBL2185	Homo sapiens	Inhibition	%	1.68
	8106183	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	55.37	CHEMBL2185	Homo sapiens	Inhibition	%	55.37
	8106407	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.91	CHEMBL2185	Homo sapiens	Inhibition	%	0.91
	8106563	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	73.71	CHEMBL2185	Homo sapiens	Inhibition	%	73.71
	8106916	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.64	CHEMBL2185	Homo sapiens	Inhibition	%	4.64
	8107037	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.62	CHEMBL2185	Homo sapiens	Inhibition	%	2.62
	8107261	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	14.14	CHEMBL2185	Homo sapiens	Inhibition	%	14.14
	8107433	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.8	CHEMBL2185	Homo sapiens	Inhibition	%	-0.8
	8107634	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.24	CHEMBL2185	Homo sapiens	Inhibition	%	5.24
	8107993	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	49.3	CHEMBL2185	Homo sapiens	Inhibition	%	49.3
	8108151	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	6.28	CHEMBL2185	Homo sapiens	Inhibition	%	6.28
	8108550	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	22.7	CHEMBL2185	Homo sapiens	Inhibition	%	22.7
	8108697	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.49	CHEMBL2185	Homo sapiens	Inhibition	%	4.49
	8109063	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.69	CHEMBL2185	Homo sapiens	Inhibition	%	2.69
	8109401	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.65	CHEMBL2185	Homo sapiens	Inhibition	%	3.65
	8109531	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.45	CHEMBL2185	Homo sapiens	Inhibition	%	2.45
	8109926	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.75	CHEMBL2185	Homo sapiens	Inhibition	%	1.75
	8110058	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	Inhibition	%	5.0
	8110337	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.28	CHEMBL2185	Homo sapiens	Inhibition	%	5.28
	8110727	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.92	CHEMBL2185	Homo sapiens	Inhibition	%	6.92
	8110885	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.99	CHEMBL2185	Homo sapiens	Inhibition	%	4.99
	8111232	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	7.89	CHEMBL2185	Homo sapiens	Inhibition	%	7.89
	8111583	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.36	CHEMBL2185	Homo sapiens	Inhibition	%	-1.36
	8111749	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.44	CHEMBL2185	Homo sapiens	Inhibition	%	2.44
	8111954	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.4	CHEMBL2185	Homo sapiens	Inhibition	%	3.4
	8112178	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.88	CHEMBL2185	Homo sapiens	Inhibition	%	7.88
	8112315	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.73	CHEMBL2185	Homo sapiens	Inhibition	%	2.73
	8112483	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	16.57	CHEMBL2185	Homo sapiens	Inhibition	%	16.57
	8112707	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.25	CHEMBL2185	Homo sapiens	Inhibition	%	2.25
	8112879	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.11	CHEMBL2185	Homo sapiens	Inhibition	%	0.11
	8113031	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.33	CHEMBL2185	Homo sapiens	Inhibition	%	5.33
	8113255	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.66	CHEMBL2185	Homo sapiens	Inhibition	%	2.66
	8113391	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	7.69	CHEMBL2185	Homo sapiens	Inhibition	%	7.69
	8113739	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.08	CHEMBL2185	Homo sapiens	Inhibition	%	2.08
	8113855	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.43	CHEMBL2185	Homo sapiens	Inhibition	%	-1.43
	8114079	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	5.06	CHEMBL2185	Homo sapiens	Inhibition	%	5.06
	8114255	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.65	CHEMBL2185	Homo sapiens	Inhibition	%	5.65
	8114387	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	19.66	CHEMBL2185	Homo sapiens	Inhibition	%	19.66
	8114611	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.38	CHEMBL2185	Homo sapiens	Inhibition	%	3.38
	8114663	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.05	CHEMBL2185	Homo sapiens	Inhibition	%	3.05
	8114887	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	7.57	CHEMBL2185	Homo sapiens	Inhibition	%	7.57
	8115053	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	24.38	CHEMBL2185	Homo sapiens	Inhibition	%	24.38
	8115218	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.36	CHEMBL2185	Homo sapiens	Inhibition	%	6.36
	8115442	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.23	CHEMBL2185	Homo sapiens	Inhibition	%	3.23
	8115562	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	15.58	CHEMBL2185	Homo sapiens	Inhibition	%	15.58
	8115919	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.87	CHEMBL2185	Homo sapiens	Inhibition	%	0.87
	8116078	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.26	CHEMBL2185	Homo sapiens	Inhibition	%	0.26
	8116505	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.65	CHEMBL2185	Homo sapiens	Inhibition	%	2.65
	8116639	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.95	CHEMBL2185	Homo sapiens	Inhibition	%	3.95
	8117035	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	14.69	CHEMBL2185	Homo sapiens	Inhibition	%	14.69
	8117206	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	8.33	CHEMBL2185	Homo sapiens	Inhibition	%	8.33
	8117588	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.49	CHEMBL2185	Homo sapiens	Inhibition	%	5.49
	8117718	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.22	CHEMBL2185	Homo sapiens	Inhibition	%	2.22
	8117942	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	10.36	CHEMBL2185	Homo sapiens	Inhibition	%	10.36
	8118080	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-1.34	CHEMBL2185	Homo sapiens	Inhibition	%	-1.34
	8118420	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.21	CHEMBL2185	Homo sapiens	Inhibition	%	2.21
	8118592	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.87	CHEMBL2185	Homo sapiens	Inhibition	%	4.87
	8118952	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.89	CHEMBL2185	Homo sapiens	Inhibition	%	6.89
	8119223	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-2.09	CHEMBL2185	Homo sapiens	Inhibition	%	-2.09
	8119382	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	69.86	CHEMBL2185	Homo sapiens	Inhibition	%	69.86
	8119773	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.96	CHEMBL2185	Homo sapiens	Inhibition	%	1.96
	8119892	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.41	CHEMBL2185	Homo sapiens	Inhibition	%	3.41
	8120116	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	6.36	CHEMBL2185	Homo sapiens	Inhibition	%	6.36
	8120255	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.46	CHEMBL2185	Homo sapiens	Inhibition	%	-0.46
	8120415	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	21.01	CHEMBL2185	Homo sapiens	Inhibition	%	21.01
	8120639	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.76	CHEMBL2185	Homo sapiens	Inhibition	%	0.76
	8120840	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.85	CHEMBL2185	Homo sapiens	Inhibition	%	1.85
	8120968	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.3	CHEMBL2185	Homo sapiens	Inhibition	%	1.3
	8121192	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	Inhibition	%	7.0
	8121364	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.27	CHEMBL2185	Homo sapiens	Inhibition	%	1.27
	8121531	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.64	CHEMBL2185	Homo sapiens	Inhibition	%	3.64
	8121755	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	7.9	CHEMBL2185	Homo sapiens	Inhibition	%	7.9
	8121918	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.16	CHEMBL2185	Homo sapiens	Inhibition	%	4.16
	8122263	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	17.27	CHEMBL2185	Homo sapiens	Inhibition	%	17.27
	8122401	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.81	CHEMBL2185	Homo sapiens	Inhibition	%	1.81
	8122745	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.28	CHEMBL2185	Homo sapiens	Inhibition	%	3.28
	8122912	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.46	CHEMBL2185	Homo sapiens	Inhibition	%	4.46
	8123136	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.6	CHEMBL2185	Homo sapiens	Inhibition	%	4.6
	8123278	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.06	CHEMBL2185	Homo sapiens	Inhibition	%	3.06
	8123556	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	6.07	CHEMBL2185	Homo sapiens	Inhibition	%	6.07
	8123706	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	11.53	CHEMBL2185	Homo sapiens	Inhibition	%	11.53
	8123930	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	56.77	CHEMBL2185	Homo sapiens	Inhibition	%	56.77
	8124097	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.64	CHEMBL2185	Homo sapiens	Inhibition	%	0.64
	8124440	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	26.7	CHEMBL2185	Homo sapiens	Inhibition	%	26.7
	8124579	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-2.36	CHEMBL2185	Homo sapiens	Inhibition	%	-2.36
	8124968	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	11.13	CHEMBL2185	Homo sapiens	Inhibition	%	11.13
	8125169	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.48	CHEMBL2185	Homo sapiens	Inhibition	%	3.48
	8125523	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.12	CHEMBL2185	Homo sapiens	Inhibition	%	0.12
	8125691	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.04	CHEMBL2185	Homo sapiens	Inhibition	%	2.04
	8126079	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.39	CHEMBL2185	Homo sapiens	Inhibition	%	-0.39
	8126243	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	9.94	CHEMBL2185	Homo sapiens	Inhibition	%	9.94
	8126582	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	55.89	CHEMBL2185	Homo sapiens	Inhibition	%	55.89
	8126718	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	19.61	CHEMBL2185	Homo sapiens	Inhibition	%	19.61
	8126942	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	55.23	CHEMBL2185	Homo sapiens	Inhibition	%	55.23
	8127064	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.04	CHEMBL2185	Homo sapiens	Inhibition	%	4.04
	8127455	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.7	CHEMBL2185	Homo sapiens	Inhibition	%	4.7
	8127597	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	26.55	CHEMBL2185	Homo sapiens	Inhibition	%	26.55
	8127885	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.0	CHEMBL2185	Homo sapiens	Inhibition	%	2.0
	8128261	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	7.28	CHEMBL2185	Homo sapiens	Inhibition	%	7.28
	8128428	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	7.54	CHEMBL2185	Homo sapiens	Inhibition	%	7.54
	8128771	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	72.31	CHEMBL2185	Homo sapiens	Inhibition	%	72.31
	8128908	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.21	CHEMBL2185	Homo sapiens	Inhibition	%	2.21
	8129132	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.34	CHEMBL2185	Homo sapiens	Inhibition	%	3.34
	8129303	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.06	CHEMBL2185	Homo sapiens	Inhibition	%	-1.06
	8129492	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.75	CHEMBL2185	Homo sapiens	Inhibition	%	2.75
	8129855	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.67	CHEMBL2185	Homo sapiens	Inhibition	%	3.67
	8130016	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.65	CHEMBL2185	Homo sapiens	Inhibition	%	1.65
	8130240	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.22	CHEMBL2185	Homo sapiens	Inhibition	%	4.22
	8130412	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.97	CHEMBL2185	Homo sapiens	Inhibition	%	3.97
	8130572	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	27.53	CHEMBL2185	Homo sapiens	Inhibition	%	27.53
	8130912	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.11	CHEMBL2185	Homo sapiens	Inhibition	%	1.11
	8131275	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.64	CHEMBL2185	Homo sapiens	Inhibition	%	5.64
	8131395	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.66	CHEMBL2185	Homo sapiens	Inhibition	%	3.66
	8131786	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.78	CHEMBL2185	Homo sapiens	Inhibition	%	3.78
	8131927	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	30.73	CHEMBL2185	Homo sapiens	Inhibition	%	30.73
	8132151	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	66.66	CHEMBL2185	Homo sapiens	Inhibition	%	66.66
	8132213	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	15.79	CHEMBL2185	Homo sapiens	Inhibition	%	15.79
	8132437	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.04	CHEMBL2185	Homo sapiens	Inhibition	%	-3.04
	8132584	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	14.67	CHEMBL2185	Homo sapiens	Inhibition	%	14.67
	8132752	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.57	CHEMBL2185	Homo sapiens	Inhibition	%	2.57
	8132976	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	7.3	CHEMBL2185	Homo sapiens	Inhibition	%	7.3
	8133097	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.06	CHEMBL2185	Homo sapiens	Inhibition	%	-0.06
	8133459	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.22	CHEMBL2185	Homo sapiens	Inhibition	%	0.22
	8133631	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.93	CHEMBL2185	Homo sapiens	Inhibition	%	1.93
	8133811	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	68.5	CHEMBL2185	Homo sapiens	Inhibition	%	68.5
	8134035	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	72.81	CHEMBL2185	Homo sapiens	Inhibition	%	72.81
	8134183	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.85	CHEMBL2185	Homo sapiens	Inhibition	%	-0.85
	8134567	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.19	CHEMBL2185	Homo sapiens	Inhibition	%	1.19
	8134751	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	7.77	CHEMBL2185	Homo sapiens	Inhibition	%	7.77
	8134911	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	63.66	CHEMBL2185	Homo sapiens	Inhibition	%	63.66
	8135135	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.09	CHEMBL2185	Homo sapiens	Inhibition	%	2.09
	8135250	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.21	CHEMBL2185	Homo sapiens	Inhibition	%	4.21
	8135615	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.08	CHEMBL2185	Homo sapiens	Inhibition	%	7.08
	8135736	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.42	CHEMBL2185	Homo sapiens	Inhibition	%	-2.42
	8135960	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.44	CHEMBL2185	Homo sapiens	Inhibition	%	-1.44
	8136128	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.75	CHEMBL2185	Homo sapiens	Inhibition	%	2.75
	8136496	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.39	CHEMBL2185	Homo sapiens	Inhibition	%	5.39
	8136786	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.55	CHEMBL2185	Homo sapiens	Inhibition	%	-0.55
	8136921	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.32	CHEMBL2185	Homo sapiens	Inhibition	%	1.32
	8137308	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	14.26	CHEMBL2185	Homo sapiens	Inhibition	%	14.26
	8137428	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	8.64	CHEMBL2185	Homo sapiens	Inhibition	%	8.64
	8137800	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.4	CHEMBL2185	Homo sapiens	Inhibition	%	4.4
	8137966	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.47	CHEMBL2185	Homo sapiens	Inhibition	%	-1.47
	8138369	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.85	CHEMBL2185	Homo sapiens	Inhibition	%	4.85
	8138517	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	11.66	CHEMBL2185	Homo sapiens	Inhibition	%	11.66
	8138899	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.85	CHEMBL2185	Homo sapiens	Inhibition	%	4.85
	8139084	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	43.0	CHEMBL2185	Homo sapiens	Inhibition	%	43.0
	8139467	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.42	CHEMBL2185	Homo sapiens	Inhibition	%	7.42
	8139581	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.73	CHEMBL2185	Homo sapiens	Inhibition	%	1.73
	8139805	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.4	CHEMBL2185	Homo sapiens	Inhibition	%	3.4
	8139946	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.97	CHEMBL2185	Homo sapiens	Inhibition	%	4.97
	8140293	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.6	CHEMBL2185	Homo sapiens	Inhibition	%	2.6
	8140452	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.96	CHEMBL2185	Homo sapiens	Inhibition	%	5.96
	8140819	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.86	CHEMBL2185	Homo sapiens	Inhibition	%	7.86
	8141121	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.77	CHEMBL2185	Homo sapiens	Inhibition	%	0.77
	8141251	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	19.48	CHEMBL2185	Homo sapiens	Inhibition	%	19.48
	8141475	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.7	CHEMBL2185	Homo sapiens	Inhibition	%	1.7
	8141635	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	43.75	CHEMBL2185	Homo sapiens	Inhibition	%	43.75
	8141754	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.36	CHEMBL2185	Homo sapiens	Inhibition	%	-3.36
	8141978	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.06	CHEMBL2185	Homo sapiens	Inhibition	%	-3.06
	8142139	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.61	CHEMBL2185	Homo sapiens	Inhibition	%	3.61
	8142307	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.26	CHEMBL2185	Homo sapiens	Inhibition	%	0.26
	8142531	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.46	CHEMBL2185	Homo sapiens	Inhibition	%	-2.46
	8142707	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.3	CHEMBL2185	Homo sapiens	Inhibition	%	6.3
	8142856	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.47	CHEMBL2185	Homo sapiens	Inhibition	%	-0.47
	8143080	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.24	CHEMBL2185	Homo sapiens	Inhibition	%	2.24
	8143235	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.38	CHEMBL2185	Homo sapiens	Inhibition	%	3.38
	8143422	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.83	CHEMBL2185	Homo sapiens	Inhibition	%	1.83
	8143646	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.08	CHEMBL2185	Homo sapiens	Inhibition	%	3.08
	8143805	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.03	CHEMBL2185	Homo sapiens	Inhibition	%	5.03
	8144143	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.52	CHEMBL2185	Homo sapiens	Inhibition	%	-1.52
	8144282	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	9.46	CHEMBL2185	Homo sapiens	Inhibition	%	9.46
	8144506	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.11	CHEMBL2185	Homo sapiens	Inhibition	%	5.11
	8144636	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.72	CHEMBL2185	Homo sapiens	Inhibition	%	4.72
	8144789	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.91	CHEMBL2185	Homo sapiens	Inhibition	%	2.91
	8145013	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.09	CHEMBL2185	Homo sapiens	Inhibition	%	3.09
	8145150	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.41	CHEMBL2185	Homo sapiens	Inhibition	%	5.41
	8145463	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.08	CHEMBL2185	Homo sapiens	Inhibition	%	3.08
	8145811	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	8.39	CHEMBL2185	Homo sapiens	Inhibition	%	8.39
	8145972	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	76.41	CHEMBL2185	Homo sapiens	Inhibition	%	76.41
	8146316	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.96	CHEMBL2185	Homo sapiens	Inhibition	%	0.96
	8146476	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	17.37	CHEMBL2185	Homo sapiens	Inhibition	%	17.37
	8146867	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.14	CHEMBL2185	Homo sapiens	Inhibition	%	2.14
	8147036	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.45	CHEMBL2185	Homo sapiens	Inhibition	%	4.45
	8147402	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.71	CHEMBL2185	Homo sapiens	Inhibition	%	2.71
	8147555	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.27	CHEMBL2185	Homo sapiens	Inhibition	%	1.27
	8147966	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.96	CHEMBL2185	Homo sapiens	Inhibition	%	2.96
	8148124	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	7.6	CHEMBL2185	Homo sapiens	Inhibition	%	7.6
	8148462	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.89	CHEMBL2185	Homo sapiens	Inhibition	%	3.89
	8148825	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	6.89	CHEMBL2185	Homo sapiens	Inhibition	%	6.89
	8148963	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.63	CHEMBL2185	Homo sapiens	Inhibition	%	2.63
	8149346	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.61	CHEMBL2185	Homo sapiens	Inhibition	%	-3.61
	8149480	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	11.85	CHEMBL2185	Homo sapiens	Inhibition	%	11.85
	8149704	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.77	CHEMBL2185	Homo sapiens	Inhibition	%	2.77
	8149802	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.2	CHEMBL2185	Homo sapiens	Inhibition	%	0.2
	8150151	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	5.43	CHEMBL2185	Homo sapiens	Inhibition	%	5.43
	8150311	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	84.19	CHEMBL2185	Homo sapiens	Inhibition	%	84.19
	8150655	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	8.08	CHEMBL2185	Homo sapiens	Inhibition	%	8.08
	8150820	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.75	CHEMBL2185	Homo sapiens	Inhibition	%	0.75
	8151044	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.92	CHEMBL2185	Homo sapiens	Inhibition	%	2.92
	8151207	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.69	CHEMBL2185	Homo sapiens	Inhibition	%	-2.69
	8151384	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.84	CHEMBL2185	Homo sapiens	Inhibition	%	6.84
	8151608	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.59	CHEMBL2185	Homo sapiens	Inhibition	%	2.59
	8151746	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	8.1	CHEMBL2185	Homo sapiens	Inhibition	%	8.1
	8151900	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.05	CHEMBL2185	Homo sapiens	Inhibition	%	1.05
	8152124	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.57	CHEMBL2185	Homo sapiens	Inhibition	%	5.57
	8152312	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.43	CHEMBL2185	Homo sapiens	Inhibition	%	8.43
	8152470	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.84	CHEMBL2185	Homo sapiens	Inhibition	%	3.84
	8152694	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	10.27	CHEMBL2185	Homo sapiens	Inhibition	%	10.27
	8152808	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.25	CHEMBL2185	Homo sapiens	Inhibition	%	3.25
	8153171	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	15.96	CHEMBL2185	Homo sapiens	Inhibition	%	15.96
	8153308	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.74	CHEMBL2185	Homo sapiens	Inhibition	%	3.74
	8153532	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.66	CHEMBL2185	Homo sapiens	Inhibition	%	3.66
	8153689	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.96	CHEMBL2185	Homo sapiens	Inhibition	%	0.96
	8154046	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.83	CHEMBL2185	Homo sapiens	Inhibition	%	1.83
	8154143	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.25	CHEMBL2185	Homo sapiens	Inhibition	%	1.25
	8154367	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.55	CHEMBL2185	Homo sapiens	Inhibition	%	0.55
	8154493	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	38.83	CHEMBL2185	Homo sapiens	Inhibition	%	38.83
	8154652	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.67	CHEMBL2185	Homo sapiens	Inhibition	%	-0.67
	8154876	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.77	CHEMBL2185	Homo sapiens	Inhibition	%	4.77
	8154996	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.72	CHEMBL2185	Homo sapiens	Inhibition	%	0.72
	8155396	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.38	CHEMBL2185	Homo sapiens	Inhibition	%	1.38
	8155557	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.44	CHEMBL2185	Homo sapiens	Inhibition	%	-0.44
	8155959	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	17.36	CHEMBL2185	Homo sapiens	Inhibition	%	17.36
	8156097	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	6.17	CHEMBL2185	Homo sapiens	Inhibition	%	6.17
	8156309	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	13.23	CHEMBL2185	Homo sapiens	Inhibition	%	13.23
	8156533	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.78	CHEMBL2185	Homo sapiens	Inhibition	%	5.78
	8156683	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.28	CHEMBL2185	Homo sapiens	Inhibition	%	6.28
	8157050	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	24.67	CHEMBL2185	Homo sapiens	Inhibition	%	24.67
	8157170	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	7.45	CHEMBL2185	Homo sapiens	Inhibition	%	7.45
	8157394	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	45.74	CHEMBL2185	Homo sapiens	Inhibition	%	45.74
	8157535	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.06	CHEMBL2185	Homo sapiens	Inhibition	%	4.06
	8157889	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.06	CHEMBL2185	Homo sapiens	Inhibition	%	4.06
	8158050	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.95	CHEMBL2185	Homo sapiens	Inhibition	%	4.95
	8158300	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	16.21	CHEMBL2185	Homo sapiens	Inhibition	%	16.21
	8158682	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.5	CHEMBL2185	Homo sapiens	Inhibition	%	6.5
	8158851	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.4	CHEMBL2185	Homo sapiens	Inhibition	%	2.4
	8159210	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.72	CHEMBL2185	Homo sapiens	Inhibition	%	3.72
	8159330	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	10.01	CHEMBL2185	Homo sapiens	Inhibition	%	10.01
	8159554	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.21	CHEMBL2185	Homo sapiens	Inhibition	%	-0.21
	8159685	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	19.44	CHEMBL2185	Homo sapiens	Inhibition	%	19.44
	8160050	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.28	CHEMBL2185	Homo sapiens	Inhibition	%	2.28
	8160187	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.66	CHEMBL2185	Homo sapiens	Inhibition	%	4.66
	8160561	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-3.41	CHEMBL2185	Homo sapiens	Inhibition	%	-3.41
	8160855	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	17.54	CHEMBL2185	Homo sapiens	Inhibition	%	17.54
	8161005	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	29.66	CHEMBL2185	Homo sapiens	Inhibition	%	29.66
	8161372	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	14.45	CHEMBL2185	Homo sapiens	Inhibition	%	14.45
	8161721	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.88	CHEMBL2185	Homo sapiens	Inhibition	%	2.88
	8161859	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	14.45	CHEMBL2185	Homo sapiens	Inhibition	%	14.45
	8162213	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.05	CHEMBL2185	Homo sapiens	Inhibition	%	5.05
	8162373	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.75	CHEMBL2185	Homo sapiens	Inhibition	%	-0.75
	8162597	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	4.51	CHEMBL2185	Homo sapiens	Inhibition	%	4.51
	8162626	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.84	CHEMBL2185	Homo sapiens	Inhibition	%	2.84
	8162850	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.38	CHEMBL2185	Homo sapiens	Inhibition	%	6.38
	8162998	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	29.95	CHEMBL2185	Homo sapiens	Inhibition	%	29.95
	8163167	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	6.93	CHEMBL2185	Homo sapiens	Inhibition	%	6.93
	8163391	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.03	CHEMBL2185	Homo sapiens	Inhibition	%	1.03
	8163525	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	9.81	CHEMBL2185	Homo sapiens	Inhibition	%	9.81
	8163872	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.83	CHEMBL2185	Homo sapiens	Inhibition	%	1.83
	8164006	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-0.78	CHEMBL2185	Homo sapiens	Inhibition	%	-0.78
	8164230	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.45	CHEMBL2185	Homo sapiens	Inhibition	%	3.45
	8164370	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.04	CHEMBL2185	Homo sapiens	Inhibition	%	3.04
	8164525	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	10.72	CHEMBL2185	Homo sapiens	Inhibition	%	10.72
	8164749	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	19.27	CHEMBL2185	Homo sapiens	Inhibition	%	19.27
	8164893	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	4.15	CHEMBL2185	Homo sapiens	Inhibition	%	4.15
	8165187	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.79	CHEMBL2185	Homo sapiens	Inhibition	%	3.79
	8165328	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	76.92	CHEMBL2185	Homo sapiens	Inhibition	%	76.92
	8165552	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.77	CHEMBL2185	Homo sapiens	Inhibition	%	4.77
	8165695	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	65.24	CHEMBL2185	Homo sapiens	Inhibition	%	65.24
	8166045	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	7.74	CHEMBL2185	Homo sapiens	Inhibition	%	7.74
	8166183	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.89	CHEMBL2185	Homo sapiens	Inhibition	%	3.89
	8166407	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.74	CHEMBL2185	Homo sapiens	Inhibition	%	3.74
	8166537	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.38	CHEMBL2185	Homo sapiens	Inhibition	%	3.38
	8166862	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	24.21	CHEMBL2185	Homo sapiens	Inhibition	%	24.21
	8167174	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.17	CHEMBL2185	Homo sapiens	Inhibition	%	2.17
	8167315	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	69.62	CHEMBL2185	Homo sapiens	Inhibition	%	69.62
	8167703	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.57	CHEMBL2185	Homo sapiens	Inhibition	%	3.57
	8167836	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.24	CHEMBL2185	Homo sapiens	Inhibition	%	1.24
	8168060	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.81	CHEMBL2185	Homo sapiens	Inhibition	%	7.81
	8168184	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.96	CHEMBL2185	Homo sapiens	Inhibition	%	3.96
	8168549	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.54	CHEMBL2185	Homo sapiens	Inhibition	%	2.54
	8168685	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.43	CHEMBL2185	Homo sapiens	Inhibition	%	-0.43
	8169073	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	64.02	CHEMBL2185	Homo sapiens	Inhibition	%	64.02
	8169215	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.33	CHEMBL2185	Homo sapiens	Inhibition	%	4.33
	8169519	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.73	CHEMBL2185	Homo sapiens	Inhibition	%	8.73
	8169877	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	9.34	CHEMBL2185	Homo sapiens	Inhibition	%	9.34
	8170022	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	10.63	CHEMBL2185	Homo sapiens	Inhibition	%	10.63
	8170246	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	44.51	CHEMBL2185	Homo sapiens	Inhibition	%	44.51
	8170371	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.31	CHEMBL2185	Homo sapiens	Inhibition	%	3.31
	8170735	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.07	CHEMBL2185	Homo sapiens	Inhibition	%	-0.07
	8170870	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	8.4	CHEMBL2185	Homo sapiens	Inhibition	%	8.4
	8171291	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	5.08	CHEMBL2185	Homo sapiens	Inhibition	%	5.08
	8171508	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	8.22	CHEMBL2185	Homo sapiens	Inhibition	%	8.22
	8171649	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.17	CHEMBL2185	Homo sapiens	Inhibition	%	6.17
	8171873	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	11.69	CHEMBL2185	Homo sapiens	Inhibition	%	11.69
	8172026	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.0	CHEMBL2185	Homo sapiens	Inhibition	%	-1.0
	8172382	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	10.79	CHEMBL2185	Homo sapiens	Inhibition	%	10.79
	8172510	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	18.48	CHEMBL2185	Homo sapiens	Inhibition	%	18.48
	8172876	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.26	CHEMBL2185	Homo sapiens	Inhibition	%	0.26
	8173012	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.82	CHEMBL2185	Homo sapiens	Inhibition	%	1.82
	8173236	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.24	CHEMBL2185	Homo sapiens	Inhibition	%	1.24
	8173401	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.94	CHEMBL2185	Homo sapiens	Inhibition	%	7.94
	8173542	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	8.21	CHEMBL2185	Homo sapiens	Inhibition	%	8.21
	8173766	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.87	CHEMBL2185	Homo sapiens	Inhibition	%	4.87
	8173853	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.0	CHEMBL2185	Homo sapiens	Inhibition	%	6.0
	8174077	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	26.78	CHEMBL2185	Homo sapiens	Inhibition	%	26.78
	8174209	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.38	CHEMBL2185	Homo sapiens	Inhibition	%	2.38
	8174581	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.04	CHEMBL2185	Homo sapiens	Inhibition	%	2.04
	8174703	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.09	CHEMBL2185	Homo sapiens	Inhibition	%	7.09
	8175070	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	0.45	CHEMBL2185	Homo sapiens	Inhibition	%	0.45
	8175206	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	7.65	CHEMBL2185	Homo sapiens	Inhibition	%	7.65
	8175430	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	43.13	CHEMBL2185	Homo sapiens	Inhibition	%	43.13
	8175462	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.72	CHEMBL2185	Homo sapiens	Inhibition	%	6.72
	8175686	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	27.74	CHEMBL2185	Homo sapiens	Inhibition	%	27.74
	8175849	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	7.86	CHEMBL2185	Homo sapiens	Inhibition	%	7.86
	8176226	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.64	CHEMBL2185	Homo sapiens	Inhibition	%	3.64
	8176375	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	7.83	CHEMBL2185	Homo sapiens	Inhibition	%	7.83
	8176731	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	44.73	CHEMBL2185	Homo sapiens	Inhibition	%	44.73
	8176861	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.69	CHEMBL2185	Homo sapiens	Inhibition	%	1.69
	8177085	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	15.05	CHEMBL2185	Homo sapiens	Inhibition	%	15.05
	8177227	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-2.87	CHEMBL2185	Homo sapiens	Inhibition	%	-2.87
	8177589	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	20.66	CHEMBL2185	Homo sapiens	Inhibition	%	20.66
	8177753	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	43.09	CHEMBL2185	Homo sapiens	Inhibition	%	43.09
	8178117	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	15.97	CHEMBL2185	Homo sapiens	Inhibition	%	15.97
	8178429	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.92	CHEMBL2185	Homo sapiens	Inhibition	%	3.92
	8178556	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	9.6	CHEMBL2185	Homo sapiens	Inhibition	%	9.6
	8178929	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	5.76	CHEMBL2185	Homo sapiens	Inhibition	%	5.76
	8179052	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.34	CHEMBL2185	Homo sapiens	Inhibition	%	0.34
	8179276	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	8.23	CHEMBL2185	Homo sapiens	Inhibition	%	8.23
	8179420	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.41	CHEMBL2185	Homo sapiens	Inhibition	%	3.41
	8179781	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.11	CHEMBL2185	Homo sapiens	Inhibition	%	3.11
	8180038	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.81	CHEMBL2185	Homo sapiens	Inhibition	%	3.81
	8180192	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	47.45	CHEMBL2185	Homo sapiens	Inhibition	%	47.45
	8180572	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	12.36	CHEMBL2185	Homo sapiens	Inhibition	%	12.36
	8180720	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.95	CHEMBL2185	Homo sapiens	Inhibition	%	4.95
	8180944	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	30.35	CHEMBL2185	Homo sapiens	Inhibition	%	30.35
	8181077	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.16	CHEMBL2185	Homo sapiens	Inhibition	%	2.16
	8181432	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	8.07	CHEMBL2185	Homo sapiens	Inhibition	%	8.07
	8181572	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.12	CHEMBL2185	Homo sapiens	Inhibition	%	1.12
	8181935	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	66.87	CHEMBL2185	Homo sapiens	Inhibition	%	66.87
	8182098	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.06	CHEMBL2185	Homo sapiens	Inhibition	%	6.06
	8182322	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.91	CHEMBL2185	Homo sapiens	Inhibition	%	7.91
	8182462	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.71	CHEMBL2185	Homo sapiens	Inhibition	%	4.71
	8182778	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	7.39	CHEMBL2185	Homo sapiens	Inhibition	%	7.39
	8182900	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.02	CHEMBL2185	Homo sapiens	Inhibition	%	4.02
	8183124	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	12.92	CHEMBL2185	Homo sapiens	Inhibition	%	12.92
	8183273	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.15	CHEMBL2185	Homo sapiens	Inhibition	%	2.15
	8183626	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	7.15	CHEMBL2185	Homo sapiens	Inhibition	%	7.15
	8183768	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	11.03	CHEMBL2185	Homo sapiens	Inhibition	%	11.03
	8184128	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	8.39	CHEMBL2185	Homo sapiens	Inhibition	%	8.39
	8184394	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	9.47	CHEMBL2185	Homo sapiens	Inhibition	%	9.47
	8184541	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.54	CHEMBL2185	Homo sapiens	Inhibition	%	0.54
	8184765	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	13.15	CHEMBL2185	Homo sapiens	Inhibition	%	13.15
	8184922	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.26	CHEMBL2185	Homo sapiens	Inhibition	%	4.26
	8185295	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.99	CHEMBL2185	Homo sapiens	Inhibition	%	1.99
	8185426	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.99	CHEMBL2185	Homo sapiens	Inhibition	%	5.99
	8185781	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	47.98	CHEMBL2185	Homo sapiens	Inhibition	%	47.98
	8185920	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.05	CHEMBL2185	Homo sapiens	Inhibition	%	4.05
	8186144	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.92	CHEMBL2185	Homo sapiens	Inhibition	%	3.92
	8186285	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.36	CHEMBL2185	Homo sapiens	Inhibition	%	4.36
	8186673	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.57	CHEMBL2185	Homo sapiens	Inhibition	%	0.57
	8186812	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.62	CHEMBL2185	Homo sapiens	Inhibition	%	4.62
	8187134	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.21	CHEMBL2185	Homo sapiens	Inhibition	%	2.21
	8187482	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.14	CHEMBL2185	Homo sapiens	Inhibition	%	5.14
	8187630	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	5.4	CHEMBL2185	Homo sapiens	Inhibition	%	5.4
	8187983	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	11.16	CHEMBL2185	Homo sapiens	Inhibition	%	11.16
	8188126	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.68	CHEMBL2185	Homo sapiens	Inhibition	%	3.68
	8188350	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.25	CHEMBL2185	Homo sapiens	Inhibition	%	6.25
	8188485	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	9.58	CHEMBL2185	Homo sapiens	Inhibition	%	9.58
	8188759	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	Inhibition	%	13.0
	8189131	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.34	CHEMBL2185	Homo sapiens	Inhibition	%	3.34
	8189287	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	12.22	CHEMBL2185	Homo sapiens	Inhibition	%	12.22
	8189660	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	6.3	CHEMBL2185	Homo sapiens	Inhibition	%	6.3
	8189792	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-2.61	CHEMBL2185	Homo sapiens	Inhibition	%	-2.61
	8190016	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.47	CHEMBL2185	Homo sapiens	Inhibition	%	2.47
	8190148	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	12.39	CHEMBL2185	Homo sapiens	Inhibition	%	12.39
	8190512	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.91	CHEMBL2185	Homo sapiens	Inhibition	%	3.91
	8190649	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	14.31	CHEMBL2185	Homo sapiens	Inhibition	%	14.31
	8190873	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.23	CHEMBL2185	Homo sapiens	Inhibition	%	4.23
	8191037	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.83	CHEMBL2185	Homo sapiens	Inhibition	%	5.83
	8191175	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	21.62	CHEMBL2185	Homo sapiens	Inhibition	%	21.62
	8191399	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	69.11	CHEMBL2185	Homo sapiens	Inhibition	%	69.11
	8191495	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	7.09	CHEMBL2185	Homo sapiens	Inhibition	%	7.09
	8191841	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	28.79	CHEMBL2185	Homo sapiens	Inhibition	%	28.79
	8191990	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.55	CHEMBL2185	Homo sapiens	Inhibition	%	-0.55
	8192214	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.73	CHEMBL2185	Homo sapiens	Inhibition	%	6.73
	8192343	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.79	CHEMBL2185	Homo sapiens	Inhibition	%	5.79
	8192711	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.77	CHEMBL2185	Homo sapiens	Inhibition	%	3.77
	8192847	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	42.41	CHEMBL2185	Homo sapiens	Inhibition	%	42.41
	8193071	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.18	CHEMBL2185	Homo sapiens	Inhibition	%	2.18
	8193119	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	53.03	CHEMBL2185	Homo sapiens	Inhibition	%	53.03
	8193343	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.72	CHEMBL2185	Homo sapiens	Inhibition	%	2.72
	8193488	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	15.5	CHEMBL2185	Homo sapiens	Inhibition	%	15.5
	8193645	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	6.68	CHEMBL2185	Homo sapiens	Inhibition	%	6.68
	8193869	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	40.46	CHEMBL2185	Homo sapiens	Inhibition	%	40.46
	8194018	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.12	CHEMBL2185	Homo sapiens	Inhibition	%	-1.12
	8194373	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.5	CHEMBL2185	Homo sapiens	Inhibition	%	4.5
	8194504	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	57.24	CHEMBL2185	Homo sapiens	Inhibition	%	57.24
	8194728	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.02	CHEMBL2185	Homo sapiens	Inhibition	%	5.02
	8194871	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.94	CHEMBL2185	Homo sapiens	Inhibition	%	4.94
	8195228	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.96	CHEMBL2185	Homo sapiens	Inhibition	%	4.96
	8195392	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.22	CHEMBL2185	Homo sapiens	Inhibition	%	3.22
	8195755	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.24	CHEMBL2185	Homo sapiens	Inhibition	%	6.24
	8195853	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.38	CHEMBL2185	Homo sapiens	Inhibition	%	3.38
	8196077	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	16.92	CHEMBL2185	Homo sapiens	Inhibition	%	16.92
	8196194	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.89	CHEMBL2185	Homo sapiens	Inhibition	%	5.89
	8196568	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-4.16	CHEMBL2185	Homo sapiens	Inhibition	%	-4.16
	8196696	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.54	CHEMBL2185	Homo sapiens	Inhibition	%	6.54
	8196920	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.98	CHEMBL2185	Homo sapiens	Inhibition	%	2.98
	8197061	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-0.01	CHEMBL2185	Homo sapiens	Inhibition	%	-0.01
	8197422	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	8.92	CHEMBL2185	Homo sapiens	Inhibition	%	8.92
	8197697	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.54	CHEMBL2185	Homo sapiens	Inhibition	%	3.54
	8197837	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.78	CHEMBL2185	Homo sapiens	Inhibition	%	4.78
	8198218	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.42	CHEMBL2185	Homo sapiens	Inhibition	%	-0.42
	8198356	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	5.43	CHEMBL2185	Homo sapiens	Inhibition	%	5.43
	8198710	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	8.54	CHEMBL2185	Homo sapiens	Inhibition	%	8.54
	8199065	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	13.75	CHEMBL2185	Homo sapiens	Inhibition	%	13.75
	8199213	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.09	CHEMBL2185	Homo sapiens	Inhibition	%	6.09
	8199571	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-1.58	CHEMBL2185	Homo sapiens	Inhibition	%	-1.58
	8199734	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	13.3	CHEMBL2185	Homo sapiens	Inhibition	%	13.3
	8200096	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	11.67	CHEMBL2185	Homo sapiens	Inhibition	%	11.67
	8200424	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.6	CHEMBL2185	Homo sapiens	Inhibition	%	3.6
	8200539	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	10.96	CHEMBL2185	Homo sapiens	Inhibition	%	10.96
	8200763	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	9.45	CHEMBL2185	Homo sapiens	Inhibition	%	9.45
	8200913	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	12.91	CHEMBL2185	Homo sapiens	Inhibition	%	12.91
	8201267	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	19.96	CHEMBL2185	Homo sapiens	Inhibition	%	19.96
	8201402	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.9	CHEMBL2185	Homo sapiens	Inhibition	%	2.9
	8201759	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.96	CHEMBL2185	Homo sapiens	Inhibition	%	2.96
	8202038	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.77	CHEMBL2185	Homo sapiens	Inhibition	%	2.77
	8202178	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	29.9	CHEMBL2185	Homo sapiens	Inhibition	%	29.9
	8202402	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.57	CHEMBL2185	Homo sapiens	Inhibition	%	1.57
	8202569	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.92	CHEMBL2185	Homo sapiens	Inhibition	%	2.92
	8202694	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.48	CHEMBL2185	Homo sapiens	Inhibition	%	2.48
	8202918	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.17	CHEMBL2185	Homo sapiens	Inhibition	%	5.17
	8203048	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.6	CHEMBL2185	Homo sapiens	Inhibition	%	1.6
	8203403	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	12.54	CHEMBL2185	Homo sapiens	Inhibition	%	12.54
	8203549	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	27.44	CHEMBL2185	Homo sapiens	Inhibition	%	27.44
	8203773	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.38	CHEMBL2185	Homo sapiens	Inhibition	%	2.38
	8203907	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.0	CHEMBL2185	Homo sapiens	Inhibition	%	6.0
	8204073	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.41	CHEMBL2185	Homo sapiens	Inhibition	%	3.41
	8204297	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	6.42	CHEMBL2185	Homo sapiens	Inhibition	%	6.42
	8204434	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	9.57	CHEMBL2185	Homo sapiens	Inhibition	%	9.57
	8204763	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	20.16	CHEMBL2185	Homo sapiens	Inhibition	%	20.16
	8205102	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	42.07	CHEMBL2185	Homo sapiens	Inhibition	%	42.07
	8205251	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.41	CHEMBL2185	Homo sapiens	Inhibition	%	7.41
	8205611	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.61	CHEMBL2185	Homo sapiens	Inhibition	%	5.61
	8205750	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.42	CHEMBL2185	Homo sapiens	Inhibition	%	4.42
	8205974	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.07	CHEMBL2185	Homo sapiens	Inhibition	%	0.07
	8206106	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	6.06	CHEMBL2185	Homo sapiens	Inhibition	%	6.06
	8206382	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-1.87	CHEMBL2185	Homo sapiens	Inhibition	%	-1.87
	8206749	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	6.47	CHEMBL2185	Homo sapiens	Inhibition	%	6.47
	8206929	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.93	CHEMBL2185	Homo sapiens	Inhibition	%	3.93
	8207279	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.18	CHEMBL2185	Homo sapiens	Inhibition	%	3.18
	8207409	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.65	CHEMBL2185	Homo sapiens	Inhibition	%	3.65
	8207633	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.29	CHEMBL2185	Homo sapiens	Inhibition	%	4.29
	8207765	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	54.21	CHEMBL2185	Homo sapiens	Inhibition	%	54.21
	8208134	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.43	CHEMBL2185	Homo sapiens	Inhibition	%	5.43
	8208266	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.41	CHEMBL2185	Homo sapiens	Inhibition	%	4.41
	8208656	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.02	CHEMBL2185	Homo sapiens	Inhibition	%	4.02
	8208789	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	43.89	CHEMBL2185	Homo sapiens	Inhibition	%	43.89
	8209013	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.82	CHEMBL2185	Homo sapiens	Inhibition	%	5.82
	8209118	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.23	CHEMBL2185	Homo sapiens	Inhibition	%	3.23
	8209458	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.61	CHEMBL2185	Homo sapiens	Inhibition	%	1.61
	8209608	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	46.82	CHEMBL2185	Homo sapiens	Inhibition	%	46.82
	8209832	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.22	CHEMBL2185	Homo sapiens	Inhibition	%	3.22
	8209968	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	8.46	CHEMBL2185	Homo sapiens	Inhibition	%	8.46
	8210333	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.1	CHEMBL2185	Homo sapiens	Inhibition	%	6.1
	8210469	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.51	CHEMBL2185	Homo sapiens	Inhibition	%	-0.51
	8210728	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.69	CHEMBL2185	Homo sapiens	Inhibition	%	-0.69
	8211096	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	13.9	CHEMBL2185	Homo sapiens	Inhibition	%	13.9
	8211266	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.46	CHEMBL2185	Homo sapiens	Inhibition	%	4.46
	8211613	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.58	CHEMBL2185	Homo sapiens	Inhibition	%	5.58
	8211966	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.72	CHEMBL2185	Homo sapiens	Inhibition	%	12.72
	8212098	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.33	CHEMBL2185	Homo sapiens	Inhibition	%	7.33
	8212463	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.7	CHEMBL2185	Homo sapiens	Inhibition	%	2.7
	8212596	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.71	CHEMBL2185	Homo sapiens	Inhibition	%	5.71
	8212820	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.21	CHEMBL2185	Homo sapiens	Inhibition	%	3.21
	8212990	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	22.01	CHEMBL2185	Homo sapiens	Inhibition	%	22.01
	8213343	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	11.35	CHEMBL2185	Homo sapiens	Inhibition	%	11.35
	8213447	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.48	CHEMBL2185	Homo sapiens	Inhibition	%	3.48
	8213671	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.14	CHEMBL2185	Homo sapiens	Inhibition	%	-0.14
	8213784	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	8.29	CHEMBL2185	Homo sapiens	Inhibition	%	8.29
	8214155	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.63	CHEMBL2185	Homo sapiens	Inhibition	%	0.63
	8214292	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	8.7	CHEMBL2185	Homo sapiens	Inhibition	%	8.7
	8214650	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.44	CHEMBL2185	Homo sapiens	Inhibition	%	6.44
	8214802	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	3.7	CHEMBL2185	Homo sapiens	Inhibition	%	3.7
	8215026	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.03	CHEMBL2185	Homo sapiens	Inhibition	%	7.03
	8215053	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-2.09	CHEMBL2185	Homo sapiens	Inhibition	%	-2.09
	8215277	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.68	CHEMBL2185	Homo sapiens	Inhibition	%	2.68
	8215430	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	54.51	CHEMBL2185	Homo sapiens	Inhibition	%	54.51
	8215594	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.02	CHEMBL2185	Homo sapiens	Inhibition	%	5.02
	8215818	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	8.88	CHEMBL2185	Homo sapiens	Inhibition	%	8.88
	8215937	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-2.39	CHEMBL2185	Homo sapiens	Inhibition	%	-2.39
	8216280	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.77	CHEMBL2185	Homo sapiens	Inhibition	%	2.77
	8216416	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	17.91	CHEMBL2185	Homo sapiens	Inhibition	%	17.91
	8216640	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	44.83	CHEMBL2185	Homo sapiens	Inhibition	%	44.83
	8216778	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.25	CHEMBL2185	Homo sapiens	Inhibition	%	6.25
	8217136	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.09	CHEMBL2185	Homo sapiens	Inhibition	%	3.09
	8217310	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.17	CHEMBL2185	Homo sapiens	Inhibition	%	2.17
	8217665	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	28.2	CHEMBL2185	Homo sapiens	Inhibition	%	28.2
	8217990	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.81	CHEMBL2185	Homo sapiens	Inhibition	%	2.81
	8218105	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.63	CHEMBL2185	Homo sapiens	Inhibition	%	1.63
	8218456	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	7.23	CHEMBL2185	Homo sapiens	Inhibition	%	7.23
	8218599	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	37.85	CHEMBL2185	Homo sapiens	Inhibition	%	37.85
	8218823	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	8.53	CHEMBL2185	Homo sapiens	Inhibition	%	8.53
	8218954	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	42.65	CHEMBL2185	Homo sapiens	Inhibition	%	42.65
	8219338	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	11.92	CHEMBL2185	Homo sapiens	Inhibition	%	11.92
	8219588	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.99	CHEMBL2185	Homo sapiens	Inhibition	%	4.99
	8219749	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.4	CHEMBL2185	Homo sapiens	Inhibition	%	3.4
	8220142	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.11	CHEMBL2185	Homo sapiens	Inhibition	%	3.11
	8220271	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.15	CHEMBL2185	Homo sapiens	Inhibition	%	3.15
	8220495	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.12	CHEMBL2185	Homo sapiens	Inhibition	%	5.12
	8220609	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.43	CHEMBL2185	Homo sapiens	Inhibition	%	5.43
	8220971	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	80.54	CHEMBL2185	Homo sapiens	Inhibition	%	80.54
	8221107	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.78	CHEMBL2185	Homo sapiens	Inhibition	%	-0.78
	8221331	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.86	CHEMBL2185	Homo sapiens	Inhibition	%	1.86
	8221464	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.82	CHEMBL2185	Homo sapiens	Inhibition	%	4.82
	8221629	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	7.16	CHEMBL2185	Homo sapiens	Inhibition	%	7.16
	8221853	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.13	CHEMBL2185	Homo sapiens	Inhibition	%	2.13
	8221984	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	73.62	CHEMBL2185	Homo sapiens	Inhibition	%	73.62
	8222306	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.08	CHEMBL2185	Homo sapiens	Inhibition	%	3.08
	8222440	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.16	CHEMBL2185	Homo sapiens	Inhibition	%	6.16
	8222664	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.18	CHEMBL2185	Homo sapiens	Inhibition	%	5.18
	8222782	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	38.63	CHEMBL2185	Homo sapiens	Inhibition	%	38.63
	8223150	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	46.23	CHEMBL2185	Homo sapiens	Inhibition	%	46.23
	8223279	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.59	CHEMBL2185	Homo sapiens	Inhibition	%	0.59
	8223503	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	13.86	CHEMBL2185	Homo sapiens	Inhibition	%	13.86
	8223664	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.53	CHEMBL2185	Homo sapiens	Inhibition	%	3.53
	8223914	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.05	CHEMBL2185	Homo sapiens	Inhibition	%	4.05
	8224076	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	8.81	CHEMBL2185	Homo sapiens	Inhibition	%	8.81
	8224300	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.95	CHEMBL2185	Homo sapiens	Inhibition	%	1.95
	8224470	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.03	CHEMBL2185	Homo sapiens	Inhibition	%	6.03
	8224829	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.23	CHEMBL2185	Homo sapiens	Inhibition	%	5.23
	8224943	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.95	CHEMBL2185	Homo sapiens	Inhibition	%	2.95
	8225301	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	9.52	CHEMBL2185	Homo sapiens	Inhibition	%	9.52
	8225663	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.52	CHEMBL2185	Homo sapiens	Inhibition	%	1.52
	8225798	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.02	CHEMBL2185	Homo sapiens	Inhibition	%	5.02
	8226180	CHEMBL1962197	GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.55	CHEMBL2185	Homo sapiens	Inhibition	%	3.55
	8226305	CHEMBL1962196	GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.2	CHEMBL2185	Homo sapiens	Inhibition	%	5.2
active	9577709	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9577710	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577711	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9577712	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577713	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577714	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577715	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577716	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577717	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9577718	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9577719	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9577720	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9577721	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(S(=O)(=O)Nc2ccc3c(c2)C(=NO)c2ccccc2-3)c1		CHEMBL1971271	=	Ki	nM	6.31	CHEMBL2185	Homo sapiens	pKi		8.2
inactive	9577722	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577723	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	15848.93	CHEMBL2185	Homo sapiens	pKi		4.8
active	9577724	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9577725	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
inactive	9577726	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577727	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577728	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577729	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577730	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9577731	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577732	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577733	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577734	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577735	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577736	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9577737	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577738	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9577739	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
inactive	9577740	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577741	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9577742	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2nc3ccc(Br)cc3c(C(=O)O)c2CC(=O)O)cc1C		CHEMBL1974408	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9577743	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Ki	nM	5.012	CHEMBL2185	Homo sapiens	pKi		8.3
inactive	9577744	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577745	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9577746	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577747	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577748	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9577749	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9577750	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
inactive	9577751	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577752	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
inactive	9577753	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577754	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577755	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9577756	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9577757	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	7.943	CHEMBL2185	Homo sapiens	pKi		8.1
inactive	9577758	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577759	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9577760	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9577761	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9577762	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
inactive	9577763	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577764	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9577765	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9577766	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577767	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
inactive	9577768	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577769	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
active	9577770	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(CCCCCCC(=NO)c1ncco1)Nc1cccc(-c2ccccc2)c1		CHEMBL1992935	=	Ki	nM	25.12	CHEMBL2185	Homo sapiens	pKi		7.6
active	9577771	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9577772	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9577773	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2c1c(=O)n(C)c1ccccc21		CHEMBL1981183	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
inactive	9577774	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577775	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9577776	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577777	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9577778	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577779	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
inactive	9577780	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577781	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577782	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9577783	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
inactive	9577784	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577785	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9577786	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	25.12	CHEMBL2185	Homo sapiens	pKi		7.6
active	9577787	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc(-n2cnc3ccccc32)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1993510	=	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
active	9577788	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577789	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCCN4)cc3F)nc12		CHEMBL1089101	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9577790	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9577791	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9577792	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9577793	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577794	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1985433	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9577795	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9577796	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577797	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
inactive	9577798	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577799	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577800	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577801	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9577802	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C(=O)NCCOCCOCCN)ccc1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1976396	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577803	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577804	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	3.162	CHEMBL2185	Homo sapiens	pKi		8.5
active	9577805	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9577806	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9577807	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9577808	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9577809	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577810	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9577811	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577812	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577813	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577814	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577815	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577816	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577817	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577818	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
inactive	9577819	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577820	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9577821	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
inactive	9577822	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577823	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9577824	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577825	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577826	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577827	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577828	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577829	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
inactive	9577830	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577831	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	12.59	CHEMBL2185	Homo sapiens	pKi		7.9
active	9577832	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577833	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577834	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
inactive	9577835	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577836	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577837	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577838	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9577839	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
inactive	9577840	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577841	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9577842	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCN1CCN(c2ccc(-c3nc4c(C(N)=O)cccc4[nH]3)cc2)CC1		CHEMBL1970534	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
inactive	9577843	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577844	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9577845	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
inactive	9577846	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9577847	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577848	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9577849	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	7.943	CHEMBL2185	Homo sapiens	pKi		8.1
active	9577850	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577851	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	3.162	CHEMBL2185	Homo sapiens	pKi		8.5
active	9577852	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
active	9577853	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9577854	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1C(=O)NCCN2		CHEMBL1992607	=	Ki	nM	31622.78	CHEMBL2185	Homo sapiens	pKi		4.5
inactive	9577855	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577856	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577857	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577858	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577859	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577860	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)CC(CO)NC(=O)C=Cc1cnc(N)c2ccccc12		CHEMBL1969284	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9577861	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577862	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577863	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
active	9577864	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9577865	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577866	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577867	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577868	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577869	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	3.162	CHEMBL2185	Homo sapiens	pKi		8.5
inactive	9577870	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577871	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9577872	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9577873	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577874	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(c1ccccc1CNc1nc(N)nc2[nH]ccc12)S(C)(=O)=O		CHEMBL1970006	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9577875	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577876	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577877	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9577878	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577879	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9577880	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
inactive	9577881	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577882	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9577883	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9577884	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9577885	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9577886	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9577887	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
inactive	9577888	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577889	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9577890	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577891	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9577892	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCCc4ccccc4)cc[nH]c3=O)nc12		CHEMBL2005714	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
active	9577893	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9577894	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
active	9577895	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2ncnc(Nc3cc[nH]n3)n2)cc(OC)c1OC		CHEMBL1965303	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9577896	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9577897	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577898	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9577899	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2[nH]c(-c3ccc(-n4ccc(CN5CCCCC5)c4)cc3)nc12		CHEMBL2006873	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
inactive	9577900	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577901	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577902	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	12.59	CHEMBL2185	Homo sapiens	pKi		7.9
active	9577903	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9577904	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9577905	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9577906	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9577907	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Nc1nccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL2002432	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577908	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577909	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577910	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	31622.78	CHEMBL2185	Homo sapiens	pKi		4.5
active	9577911	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
inactive	9577912	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577913	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577914	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9577915	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9577916	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9577917	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9577918	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577919	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9577920	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	12.59	CHEMBL2185	Homo sapiens	pKi		7.9
active	9577921	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9577922	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1977652	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9577923	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1cncc(-n2cnc3ccccc32)n1)c1ccc(F)cc1		CHEMBL1976530	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9577924	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1ccccc1Nc1nc(Nc2cccc(O)c2)ncc1F		CHEMBL243749	=	Ki	nM	1.995	CHEMBL2185	Homo sapiens	pKi		8.7
active	9577925	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9577926	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9577927	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9577928	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	25118.86	CHEMBL2185	Homo sapiens	pKi		4.6
active	9577929	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
inactive	9577930	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577931	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9577932	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9577933	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577934	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9577935	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9577936	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9577937	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9577938	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	=	Ki	nM	63095.73	CHEMBL2185	Homo sapiens	pKi		4.2
active	9577939	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9577940	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577941	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9577942	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9577943	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577944	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9577945	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9577946	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9577947	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9577948	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9581517	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
inactive	9581518	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581519	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9581520	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9581521	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9581522	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9581523	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9581524	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9581525	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581526	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9581527	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(N=Cc2ccc(O)c(O)c2)c2ccccc2n1		CHEMBL1991915	=	Ki	nM	6.31	CHEMBL2185	Homo sapiens	pKi		8.2
inactive	9581528	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581529	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581530	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(Cl)cc(C)c5o4)c(F)c3)c3c(N)ncnc32)CC1		CHEMBL1988769	=	Ki	nM	7.943	CHEMBL2185	Homo sapiens	pKi		8.1
active	9581531	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9581532	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	5.012	CHEMBL2185	Homo sapiens	pKi		8.3
inactive	9581533	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581534	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9581535	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581536	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9581537	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9581538	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9581539	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Cl)c1		CHEMBL1999910	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
active	9581540	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9581541	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
inactive	9581542	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581543	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9581544	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9581545	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9581546	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9581547	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581548	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9581549	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
active	9581550	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	10000.0	CHEMBL2185	Homo sapiens	pKi		5.0
active	9581551	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2ncc(C(F)(F)F)c(OC)n2)cc(OC)c1OC		CHEMBL1993966	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
inactive	9581552	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9581553	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9581554	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9581555	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9581556	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581557	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9581558	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581559	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581560	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9581561	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581562	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9581563	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581564	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581565	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9581566	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581567	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581568	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9581569	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581570	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581571	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N=C(N)Cc1cccc(-c2nc3ccccc3[nH]2)c1		CHEMBL2003622	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9581572	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	7.943	CHEMBL2185	Homo sapiens	pKi		8.1
inactive	9581573	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581574	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9581575	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	12.59	CHEMBL2185	Homo sapiens	pKi		7.9
inactive	9581576	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581577	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9581578	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9581579	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9581580	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9581581	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9581582	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	6.31	CHEMBL2185	Homo sapiens	pKi		8.2
active	9581583	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	12.59	CHEMBL2185	Homo sapiens	pKi		7.9
active	9581584	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9581585	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1O		CHEMBL487402	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9581586	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	0.7943	CHEMBL2185	Homo sapiens	pKi		9.1
active	9581587	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9581588	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9581589	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9581590	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9581591	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9581592	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9581593	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCOc1ccc(C(C)(C)CC)cc1S(=O)(=O)Nc1ccc(-c2csc3ncnc(N)c23)cc1		CHEMBL1985690	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581594	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
inactive	9581595	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9581596	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1		CHEMBL1968606	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9581597	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9581598	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581599	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9581600	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9581601	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9589171	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9589172	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589173	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9589174	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9589175	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589176	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1ccccc1F		CHEMBL1988038	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
inactive	9589177	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9589178	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9589179	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	3.162	CHEMBL2185	Homo sapiens	pKi		8.5
inactive	9589180	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589181	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9589182	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9589183	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9589184	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9589185	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9589186	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)c1		CHEMBL2007009	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9589187	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9589188	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589189	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9589190	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9589191	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9589192	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)C(=O)C=Cc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)n[nH]c12		CHEMBL1972472	=	Ki	nM	3.162	CHEMBL2185	Homo sapiens	pKi		8.5
inactive	9589193	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589194	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9589195	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2c(C#N)c(N)nc3cc(C)nn23)cc1		CHEMBL1968565	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
inactive	9589196	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589197	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589198	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589199	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589200	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589201	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589202	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589203	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9589204	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	=	Ki	nM	25118.86	CHEMBL2185	Homo sapiens	pKi		4.6
active	9589205	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9589206	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccccc1-c1cccc2c1c(Nc1ccccc1)c(C(=O)O)n2CCCOc1cccc2ccccc12		CHEMBL2001646	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589207	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589208	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9589209	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
inactive	9589210	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589211	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589212	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9589213	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589214	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589215	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9589216	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9589217	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9589218	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9589219	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9589220	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL2185	Homo sapiens	pKi		4.1
active	9589221	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9589222	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9589223	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
inactive	9589224	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589225	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
active	9589226	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9589227	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589228	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9589229	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589230	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589231	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589232	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589233	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9589234	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9589235	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9589236	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589237	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9589238	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9589239	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
inactive	9589240	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589241	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9589242	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9589243	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9589244	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
active	9589245	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9589246	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9589247	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
inactive	9589248	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589249	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	79432.82	CHEMBL2185	Homo sapiens	pKi		4.1
active	9589250	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9589251	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9589252	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9589253	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589254	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589255	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589256	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589257	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589258	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589259	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589260	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9589261	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL2005800	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9589262	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9589263	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9589264	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589265	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
inactive	9589266	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589267	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589268	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589269	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9589270	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9589271	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(Br)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1972851	=	Ki	nM	3.162	CHEMBL2185	Homo sapiens	pKi		8.5
inactive	9589272	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589273	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589274	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9589275	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9589276	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9589277	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589278	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589279	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9589280	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9589281	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9589282	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589283	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9589284	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9589285	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9589286	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9589287	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9589288	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
inactive	9589289	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589290	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9589291	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589292	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9589293	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589294	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9589295	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589296	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1CC3		CHEMBL1985523	=	Ki	nM	1.259	CHEMBL2185	Homo sapiens	pKi		8.9
inactive	9589297	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589298	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589299	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589300	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(CNC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1C		CHEMBL1994968	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9589301	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1c(SC(C(=O)O)c2ccccc2)nc2ccccc2c1=O		CHEMBL1981556	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9589302	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589303	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589304	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9589305	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9589306	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(F)c(N2CCC(N)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1968103	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589307	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9589308	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC1CCN(C(=O)c2ccc3c(c2)[nH]c(=O)c2cccn23)CC1		CHEMBL1967620	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
inactive	9589309	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	79432.82	CHEMBL2185	Homo sapiens	pKi		4.1
active	9589310	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9589311	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9589312	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9589313	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589314	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9589315	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9589316	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9589317	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9589318	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9589319	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9589320	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589321	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589322	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2cc(-c3ccccc3)nc3ncnc(NC(=O)COCC(=O)O)c23)cc1		CHEMBL1980521	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9589323	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9589324	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589325	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589326	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589327	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589328	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9589329	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589330	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	=	Ki	nM	50118.72	CHEMBL2185	Homo sapiens	pKi		4.3
inactive	9589331	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589332	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9589333	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589334	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1oc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL2003604	=	Ki	nM	7.943	CHEMBL2185	Homo sapiens	pKi		8.1
inactive	9589335	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589336	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589337	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9589338	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	63095.73	CHEMBL2185	Homo sapiens	pKi		4.2
active	9589339	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9589340	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
inactive	9589341	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589342	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9589343	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589344	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9589345	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9589346	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
inactive	9589347	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589348	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589349	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589350	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589351	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589352	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589353	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589354	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589355	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9589356	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589357	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9589358	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9589359	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
inactive	9589360	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9589361	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9589362	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1F		CHEMBL243518	=	Ki	nM	5.012	CHEMBL2185	Homo sapiens	pKi		8.3
active	9592929	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9592930	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9592931	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CC(=O)Nc1n[nH]c2cc(-c3cn(Cc4ccccc4)nn3)ccc12		CHEMBL1972795	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9592932	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592933	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9592934	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9592935	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9592936	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9592937	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592938	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1(C)CC(C=Cc2ccc(Cl)cc2)=Cc2c1sc1ncnc(N)c21		CHEMBL1987334	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9592939	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9592940	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
inactive	9592941	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592942	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9592943	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9592944	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nc(SCC(=O)Nc2ncccn2)nc2nc[nH]c12		CHEMBL1982388	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9592945	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ccc(-c2csc3ccnc(N)c23)cc1		CHEMBL231153	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9592946	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
inactive	9592947	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592948	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	25.12	CHEMBL2185	Homo sapiens	pKi		7.6
active	9592949	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9592950	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9592951	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9592952	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9592953	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9592954	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9592955	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592956	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
inactive	9592957	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592958	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9592959	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9592960	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9592961	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1966411	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9592962	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9592963	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9592964	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9592965	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592966	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9592967	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9592968	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9592969	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4ccccc4)cc[nH]c3=O)nc12		CHEMBL1992527	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9592970	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9592971	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592972	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	31622.78	CHEMBL2185	Homo sapiens	pKi		4.5
inactive	9592973	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592974	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9592975	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
active	9592976	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2nc3ccc(Br)cc3c(C(=O)O)c2CC(=O)O)cc1		CHEMBL1978973	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9592977	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
inactive	9592978	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2nc3ccccc3n12		CHEMBL1983884	<	Ki	nM	79432.82	CHEMBL2185	Homo sapiens	pKi		4.1
active	9592979	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9592980	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9592981	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9592982	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592983	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(S(=O)(=O)Nc2ccc3c(c2)C(=NO)c2ccccc2-3)c1		CHEMBL1971271	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9592984	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9592985	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2cc(OCCCCO)c(OC)cc2NC3=O)ccc1O		CHEMBL2000746	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9592986	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9592987	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9592988	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592989	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9592990	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9592991	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9592992	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9592993	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9592994	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	1.995	CHEMBL2185	Homo sapiens	pKi		8.7
inactive	9592995	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9592996	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592997	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	25.12	CHEMBL2185	Homo sapiens	pKi		7.6
inactive	9592998	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9592999	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
active	9593000	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9593001	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9593002	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2[nH]c(-c3cccc(NCCN4CCCC4)n3)nc12		CHEMBL1985309	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9593003	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9593004	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9593005	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2ncc(C(F)(F)F)c(N)n2)cc(OC)c1OC		CHEMBL1998724	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9593006	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9593007	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593008	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
active	9593009	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
inactive	9593010	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593011	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593012	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593013	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593014	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2cc(-c3ccccc3)c3cc(Cl)ccc3n2)cc1		CHEMBL1979749	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
inactive	9593015	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593016	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	1.995	CHEMBL2185	Homo sapiens	pKi		8.7
active	9593017	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(-c2nn3ccccc3c2-c2ccnc(Nc3ccc4c(c3)CNCC4)n2)c1)c1c(F)cccc1F		CHEMBL1969834	=	Ki	nM	5.012	CHEMBL2185	Homo sapiens	pKi		8.3
active	9593018	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593019	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9593020	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9593021	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593022	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593023	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9593024	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593025	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593026	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9593027	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9593028	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9593029	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9593030	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9593031	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593032	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9593033	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9593034	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9593035	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9593036	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CCNc1ccc(O)c2ccccc12		CHEMBL576113	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593037	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=NO)c1ccccc1S(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1996539	=	Ki	nM	25.12	CHEMBL2185	Homo sapiens	pKi		7.6
inactive	9593038	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593039	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593040	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593041	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593042	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
inactive	9593043	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593044	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9593045	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9593046	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9593047	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593048	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593049	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9593050	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9593051	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)c1		CHEMBL243517	=	Ki	nM	1.259	CHEMBL2185	Homo sapiens	pKi		8.9
active	9593052	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9593053	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593054	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593055	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593056	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9593057	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1		CHEMBL1971463	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9593058	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(F)c1		CHEMBL1987658	=	Ki	nM	6.31	CHEMBL2185	Homo sapiens	pKi		8.2
active	9593059	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9593060	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9593061	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
inactive	9593062	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593063	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9593064	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9593065	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9593066	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9593067	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593068	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9593069	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9593070	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	12.59	CHEMBL2185	Homo sapiens	pKi		7.9
active	9593071	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9593072	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9593073	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9593074	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
active	9593075	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2c(-c3ccccc3)cccc12		CHEMBL1991008	=	Ki	nM	79432.82	CHEMBL2185	Homo sapiens	pKi		4.1
active	9593076	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9593077	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9593078	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
inactive	9593079	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9593080	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9593081	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9593082	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9593083	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593084	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593085	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9593086	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9593087	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593088	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593089	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9593090	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9593091	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593092	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9593093	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593094	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593095	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9593096	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9593097	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593098	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9593099	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	=	Ki	nM	15848.93	CHEMBL2185	Homo sapiens	pKi		4.8
active	9593100	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
inactive	9593101	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593102	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9593103	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9593104	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9593105	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9593106	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593107	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
inactive	9593108	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593109	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593110	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9593111	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593112	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9593113	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9593114	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9593115	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9593116	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
active	9593117	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
inactive	9593118	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593119	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9593120	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	7.943	CHEMBL2185	Homo sapiens	pKi		8.1
inactive	9593121	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593122	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9593123	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9593124	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9593125	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593126	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9593127	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593128	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9593129	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593130	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9593131	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9593132	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
inactive	9593133	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593134	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)CCOc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)c1		CHEMBL1989569	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9593135	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9593136	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(C(=O)O)c(O)c2)o1		CHEMBL496412	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
inactive	9593137	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593138	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	<	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
active	9593139	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9593140	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9593141	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1cncc(Nc2ncc(-c3ccncn3)c(-c3ccco3)n2)c1		CHEMBL375293	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9593142	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9593143	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
inactive	9593144	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593145	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2Nc2cc(-c3ccccc3O)ccc21		CHEMBL1974365	<	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9593146	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9593147	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3nn(C)c4ncnc(N)c34)cc2)c1		CHEMBL1982837	=	Ki	nM	1.585	CHEMBL2185	Homo sapiens	pKi		8.8
active	9593148	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9593149	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
inactive	9593150	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9593151	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9593152	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9593153	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593154	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593155	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9593156	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
inactive	9593157	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593158	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9593159	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9593160	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9593161	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9593162	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9593163	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9593164	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9593165	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
inactive	9593166	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9593167	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9593168	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9593169	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596731	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596732	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596733	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
inactive	9596734	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596735	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9596736	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596737	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596738	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	15848.93	CHEMBL2185	Homo sapiens	pKi		4.8
active	9596739	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9596740	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9596741	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9596742	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596743	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	15848.93	CHEMBL2185	Homo sapiens	pKi		4.8
active	9596744	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9596745	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9596746	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9596747	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9596748	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596749	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596750	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596751	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596752	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9596753	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9596754	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596755	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596756	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9596757	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596758	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
inactive	9596759	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596760	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9596761	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9596762	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
inactive	9596763	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596764	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596765	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9596766	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596767	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596768	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
active	9596769	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9596770	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9596771	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ccc(S(=O)(=O)O)c2cccc(O)c12		CHEMBL1618860	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9596772	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9596773	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596774	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596775	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596776	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9596777	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	6.31	CHEMBL2185	Homo sapiens	pKi		8.2
active	9596778	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
inactive	9596779	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596780	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
active	9596781	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596782	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596783	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9596784	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	2.512	CHEMBL2185	Homo sapiens	pKi		8.6
active	9596785	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9596786	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9596787	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	=	Ki	nM	79432.82	CHEMBL2185	Homo sapiens	pKi		4.1
active	9596788	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9596789	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	7.943	CHEMBL2185	Homo sapiens	pKi		8.1
active	9596790	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9596791	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9596792	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9596793	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596794	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9596795	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
inactive	9596796	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596797	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596798	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	63095.73	CHEMBL2185	Homo sapiens	pKi		4.2
active	9596799	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
active	9596800	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
inactive	9596801	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9596802	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
active	9596803	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccccc1)Nc1ccccn1		CHEMBL143703	=	Ki	nM	79432.82	CHEMBL2185	Homo sapiens	pKi		4.1
active	9596804	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1cccc(NC(=O)Nc2ccc(-c3c(C)oc4ncnc(N)c34)cc2)c1		CHEMBL1979528	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
inactive	9596805	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596806	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596807	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596808	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596809	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9596810	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(Cl)ccc5o4)c(F)c3)c3c(N)ncnc32)CC1		CHEMBL2001535	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9596811	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9596812	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9596813	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9596814	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9596815	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9596816	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596817	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596818	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc(CO)c(F)c4[nH]nc(N)c34)cc2)c1		CHEMBL1993073	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9596819	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	15.85	CHEMBL2185	Homo sapiens	pKi		7.8
active	9596820	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9596821	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9596822	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596823	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9596824	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596825	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	50118.72	CHEMBL2185	Homo sapiens	pKi		4.3
active	9596826	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	158.49	CHEMBL2185	Homo sapiens	pKi		6.8
inactive	9596827	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596828	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	6.31	CHEMBL2185	Homo sapiens	pKi		8.2
inactive	9596829	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
inactive	9596830	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596831	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9596832	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9596833	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
active	9596834	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	pKi		8.0
active	9596835	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=NO)c1cccc(S(=O)(=O)Nc2ccc3c(c2)C(=NO)c2ccccc2-3)c1		CHEMBL1968271	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9596836	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9596837	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596838	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596839	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596840	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
inactive	9596841	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596842	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9596843	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
active	9596844	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1O		CHEMBL1964519	=	Ki	nM	5.012	CHEMBL2185	Homo sapiens	pKi		8.3
inactive	9596845	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596846	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596847	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1cccc2c1n(CC)c(=N)n2CC(=O)c1ccc(Br)cc1		CHEMBL2003871	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9596848	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596849	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596850	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596851	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9596852	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9596853	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9596854	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	199.53	CHEMBL2185	Homo sapiens	pKi		6.7
active	9596855	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9596856	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9596857	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596858	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596859	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596860	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9596861	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9596862	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596863	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596864	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9596865	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596866	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596867	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596868	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9596869	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9596870	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9596871	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9596872	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9596873	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2[nH]c(-c3ccc(N4CCN(Cc5ccccc5)CC4)nc3)nc12		CHEMBL2001099	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9596874	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9596875	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596876	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596877	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
inactive	9596878	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596879	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	=	Ki	nM	1258.93	CHEMBL2185	Homo sapiens	pKi		5.9
active	9596880	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
active	9596881	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
active	9596882	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9596883	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9596884	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9596885	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596886	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9596887	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	=	Ki	nM	63095.73	CHEMBL2185	Homo sapiens	pKi		4.2
inactive	9596888	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596889	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
active	9596890	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	5.012	CHEMBL2185	Homo sapiens	pKi		8.3
inactive	9596891	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596892	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9596893	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596894	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1oc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1995068	=	Ki	nM	12.59	CHEMBL2185	Homo sapiens	pKi		7.9
inactive	9596895	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596896	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
active	9596897	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9596898	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	3.162	CHEMBL2185	Homo sapiens	pKi		8.5
active	9596899	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
active	9596900	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9596901	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
active	9596902	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9596903	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
inactive	9596904	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596905	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9596906	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9596907	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
active	9596908	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1cc(S(=O)(=O)NC(=O)c2ccc(-c3ccc(F)cc3)cc2)ccc1NC1CCCCC1		CHEMBL1996795	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9596909	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9596910	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
active	9596911	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	pKi		6.0
inactive	9596912	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596913	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596914	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9596915	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	19.95	CHEMBL2185	Homo sapiens	pKi		7.7
active	9596916	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	6.31	CHEMBL2185	Homo sapiens	pKi		8.2
active	9596917	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
inactive	9596918	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596919	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9596920	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596921	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596922	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	1.0	CHEMBL2185	Homo sapiens	pKi		9.0
inactive	9596923	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596924	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9596925	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
inactive	9596926	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596927	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596928	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	=	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596929	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	50118.72	CHEMBL2185	Homo sapiens	pKi		4.3
inactive	9596930	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
inactive	9596931	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596932	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9596933	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596934	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	31622.78	CHEMBL2185	Homo sapiens	pKi		4.5
active	9596935	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
inactive	9596936	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596937	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL2185	Homo sapiens	pKi		5.4
active	9596938	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	39.81	CHEMBL2185	Homo sapiens	pKi		7.4
inactive	9596939	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596940	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9596941	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCCCN1CCN(c2ccc(-c3nc4c(C(N)=O)cccc4[nH]3)cn2)CC1		CHEMBL2003948	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
active	9596942	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
active	9596943	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	31.62	CHEMBL2185	Homo sapiens	pKi		7.5
inactive	9596944	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596945	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Clc1cc2nnc(-c3ccccc3)n2cn1		CHEMBL1998228	=	Ki	nM	25118.86	CHEMBL2185	Homo sapiens	pKi		4.6
active	9596946	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	25.12	CHEMBL2185	Homo sapiens	pKi		7.6
inactive	9596947	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596948	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
active	9596949	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	3.981	CHEMBL2185	Homo sapiens	pKi		8.4
active	9596950	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9596951	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	1995.26	CHEMBL2185	Homo sapiens	pKi		5.7
inactive	9596952	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596953	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596954	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	50.12	CHEMBL2185	Homo sapiens	pKi		7.3
inactive	9596955	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596956	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
active	9596957	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9596958	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	=	Ki	nM	125.89	CHEMBL2185	Homo sapiens	pKi		6.9
active	9596959	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
inactive	9596960	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596961	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CCS(=O)(=O)c1ccc(-c2ccc(-c3n[nH]c4c3Cc3cc(O)c(OC)cc3-4)cc2)cc1		CHEMBL1992195	=	Ki	nM	0.7943	CHEMBL2185	Homo sapiens	pKi		9.1
inactive	9596962	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596963	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
inactive	9596964	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
inactive	9596965	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	6309.57	CHEMBL2185	Homo sapiens	pKi		5.2
active	9596966	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
active	9596967	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	1584.89	CHEMBL2185	Homo sapiens	pKi		5.8
active	9596968	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
active	9596969	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc(O)cc2)n1		CHEMBL243297	=	Ki	nM	1.995	CHEMBL2185	Homo sapiens	pKi		8.7
active	9596970	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
active	9596971	CHEMBL1963807	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	794.33	CHEMBL2185	Homo sapiens	pKi		6.1
	10834728	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCC4CCNCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011926	=	IC50	nM	43.0	CHEMBL2185	Homo sapiens	IC50	uM	0.043
	10834729	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(OCC4CCNCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011927	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	uM	0.031
	10834730	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(C)=O)c(Br)cnc3[nH]2)cc1		CHEMBL2011928	=	IC50	nM	24.0	CHEMBL2185	Homo sapiens	IC50	uM	0.024
	10834731	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C(C)C)c(Br)cnc3[nH]2)cc1		CHEMBL2011929	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	uM	0.03
	10834732	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C(C)(C)C)c(Br)cnc3[nH]2)cc1		CHEMBL2011930	=	IC50	nM	81.0	CHEMBL2185	Homo sapiens	IC50	uM	0.081
	10834733	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011931	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	uM	0.025
	10834734	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4(CN)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011932	=	IC50	nM	29.0	CHEMBL2185	Homo sapiens	IC50	uM	0.029
	10834735	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011933	=	IC50	nM	38.0	CHEMBL2185	Homo sapiens	IC50	uM	0.038
	10834736	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCN(C)C(=O)C4CCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011934	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	uM	0.007
	10834737	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CC(O)C4)c(Br)cnc3[nH]2)cc1		CHEMBL2011935	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	uM	0.016
	10834738	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011936	=	IC50	nM	93.0	CHEMBL2185	Homo sapiens	IC50	uM	0.093
	10834739	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)c4ccccc4)c(Br)cnc3[nH]2)cc1		CHEMBL2011937	=	IC50	nM	733.0	CHEMBL2185	Homo sapiens	IC50	uM	0.733
Not Determined	10834740	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)c4cccnc4)c(Br)cnc3[nH]2)cc1		CHEMBL2011938		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	10834741	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)c4cccs4)c(Br)cnc3[nH]2)cc1		CHEMBL2011939		IC50			CHEMBL2185	Homo sapiens	IC50		
	10834742	CHEMBL2013352	Inhibition of Aurora B kinase	B	Nc1cccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)c1		CHEMBL2011940	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10834743	CHEMBL2013352	Inhibition of Aurora B kinase	B	O=C(NCCCNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12)C1CCC1		CHEMBL2011941	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	uM	0.013
	10834744	CHEMBL2013352	Inhibition of Aurora B kinase	B	NC(=O)c1cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1NCCCNC(=O)C1CCC1		CHEMBL2011942	=	IC50	nM	478.0	CHEMBL2185	Homo sapiens	IC50	uM	0.478
	10834745	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(C(N)=O)cnc3[nH]2)cc1		CHEMBL2011943	=	IC50	nM	1580.0	CHEMBL2185	Homo sapiens	IC50	uM	1.58
	10834746	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccccc1-c1nc2c(NCC(O)CNC(=O)C3CCC3)c(Br)cnc2[nH]1		CHEMBL2011944	=	IC50	nM	872.0	CHEMBL2185	Homo sapiens	IC50	uM	0.872
	10834747	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1ccc(F)cc1-c1nc2c(NCCCNC(=O)C3CCC3)c(Br)cnc2[nH]1		CHEMBL2011945	=	IC50	nM	370.0	CHEMBL2185	Homo sapiens	IC50	uM	0.37
	10834748	CHEMBL2013352	Inhibition of Aurora B kinase	B	COc1cc(F)ccc1-c1nc2c(NCCCNC(=O)C3CCC3)c(Br)cnc2[nH]1		CHEMBL2010815	=	IC50	nM	664.0	CHEMBL2185	Homo sapiens	IC50	uM	0.664
	10837503	CHEMBL2013812	Inhibition of aurora B kinase	B	CC(C)n1ncc2cnc(Nc3cc(C(N)=O)n(C)c3)nc21		CHEMBL2012308	=	IC50	nM	38.0	CHEMBL2185	Homo sapiens	IC50	uM	0.038
	10837504	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn(C4CCC5(CC5)C4)c3n2)cc1C(N)=O		CHEMBL2012309	=	IC50	nM	19.0	CHEMBL2185	Homo sapiens	IC50	uM	0.019
	10837505	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn(C4C5CC6CC(C5)CC4C6)c3n2)cc1C(N)=O		CHEMBL2012397	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	uM	0.018
	10837506	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4CC[C@H]5CCC[C@@H]45)c3n2)cc1C(N)=O		CHEMBL2012398	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	uM	0.012
	10837507	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1C(N)=O		CHEMBL2012399	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	uM	0.023
	10837508	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn(C4CCC5(CC4)CC5)c3n2)cc1C(N)=O		CHEMBL2012400	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	uM	0.005
	10837509	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn(C4CCC(C)(C)CC4)c3n2)cc1C(N)=O		CHEMBL2012401	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	uM	0.005
	10837510	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(N)=O		CHEMBL2012402	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10837511	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@@H]4CC[C@H]5CCC[C@H]54)c3n2)cc1C(N)=O		CHEMBL2012403	=	IC50	nM	22.0	CHEMBL2185	Homo sapiens	IC50	uM	0.022
	10837512	CHEMBL2013812	Inhibition of aurora B kinase	B	CN(C)C(=O)[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012404	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10837513	CHEMBL2013812	Inhibition of aurora B kinase	B	CNC[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012405	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	uM	0.05
	10837514	CHEMBL2013812	Inhibition of aurora B kinase	B	C[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012406	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10837515	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCCC1		CHEMBL2012407	=	IC50	nM	40.0	CHEMBL2185	Homo sapiens	IC50	uM	0.04
	10837516	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1C(N)=O		CHEMBL2012408	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10837517	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1CO		CHEMBL2012409	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	uM	0.003
	10837518	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1CN1CCCC1		CHEMBL2012410	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	uM	0.005
	10837519	CHEMBL2013812	Inhibition of aurora B kinase	B	COC[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012411	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	uM	0.005
	10837520	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1CN1CCOCC1		CHEMBL2012412	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10837521	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@@H]1CO		CHEMBL2012413	=	IC50	nM	36.0	CHEMBL2185	Homo sapiens	IC50	uM	0.036
	10837522	CHEMBL2013812	Inhibition of aurora B kinase	B	COC[C@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012414	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	uM	0.006
	10837523	CHEMBL2013812	Inhibition of aurora B kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@@H]1CN1CCOCC1		CHEMBL2012415	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
Active	10837574	CHEMBL2013817	Inhibition of aurora B kinase phosphorylation in human K562 cells at 0.003 to 1 uM by Western blot analysis	B	COC[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012411		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10839657	CHEMBL2015924	Inhibition of Aurora B assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	76.0	CHEMBL2185	Homo sapiens	Activity	%	76.0
	10840426	CHEMBL2015832	Inhibition of Aurora B assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	114.0	CHEMBL2185	Homo sapiens	Activity	%	114.0
	10853972	CHEMBL2020363	Inhibition of AURKB at 10 uM relative to control	B	Cc1ccc(S(=O)(=O)n2c(N)nc3ccccc32)cc1		CHEMBL1412853	=	Inhibition	%	21.0	CHEMBL2185	Homo sapiens	INH	%	21.0
	10862685	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	IC50	nM	487.0	CHEMBL2185	Homo sapiens	IC50	nM	487.0
	10862686	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	CNC(=O)/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2023220	=	IC50	nM	80.0	CHEMBL2185	Homo sapiens	IC50	nM	80.0
	10862687	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
	10862688	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2023221	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10862689	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccccc5)cnc(N)c34)cc2)c1		CHEMBL231511	=	IC50	nM	3280.0	CHEMBL2185	Homo sapiens	IC50	nM	3280.0
	10862690	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccoc5)cnc(N)c34)cc2)c1		CHEMBL2023222	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	IC50	nM	100.0
	10862691	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccsc5)cnc(N)c34)cc2)c1		CHEMBL2023223	=	IC50	nM	179.0	CHEMBL2185	Homo sapiens	IC50	nM	179.0
	10862692	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cc[nH]c5)cnc(N)c34)cc2)c1		CHEMBL2021941	=	IC50	nM	68.0	CHEMBL2185	Homo sapiens	IC50	nM	68.0
	10862693	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cc[nH]n5)cnc(N)c34)cc2)c1		CHEMBL2023224	=	IC50	nM	66.0	CHEMBL2185	Homo sapiens	IC50	nM	66.0
	10862694	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	10862695	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
	10862696	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1ccccc1NC(=O)Nc1ccc(-c2csc3c(-c4cnn(C)c4)cnc(N)c23)cc1		CHEMBL2023225	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	10862697	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
	10862698	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccccc5)cc4)csc23)cn1		CHEMBL2023226	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	nM	6.0
	10862699	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccccc5F)cc4)csc23)cn1		CHEMBL2023227	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	10862700	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	IC50	nM	9.0	CHEMBL2185	Homo sapiens	IC50	nM	9.0
	10862701	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(Cl)c5)cc4)csc23)cn1		CHEMBL2023228	=	IC50	nM	70.0	CHEMBL2185	Homo sapiens	IC50	nM	70.0
	10862702	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(Cl)cc5)cc4)csc23)cn1		CHEMBL2023229	=	IC50	nM	48.0	CHEMBL2185	Homo sapiens	IC50	nM	48.0
	10862703	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	COc1ccccc1NC(=O)Nc1ccc(-c2csc3c(-c4cnn(C)c4)cnc(N)c23)cc1		CHEMBL2023230	=	IC50	nM	52.0	CHEMBL2185	Homo sapiens	IC50	nM	52.0
	10862704	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL2023231	=	IC50	nM	114.0	CHEMBL2185	Homo sapiens	IC50	nM	114.0
	10862705	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)(F)F)cc5)cc4)csc23)cn1		CHEMBL2023232	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	nM	17.0
	10862706	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(C(N)=O)c5)cc4)csc23)cn1		CHEMBL2022850	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	nM	23.0
	10862707	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	10862708	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	CC(C)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022851	=	IC50	nM	177.0	CHEMBL2185	Homo sapiens	IC50	nM	177.0
	10862709	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	CC(C)CCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022852	=	IC50	nM	529.0	CHEMBL2185	Homo sapiens	IC50	nM	529.0
	10862710	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	CS(=O)(=O)CCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022853	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
	10862711	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Nc1ncc(-c2cnn(CCN3CCCCC3)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL2022854	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	10862712	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	CN1CCC(n2cc(-c3cnc(N)c4c(-c5ccc(NC(=O)Nc6cccc(F)c6)cc5)csc34)cn2)C1=O		CHEMBL2022855	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	10862713	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	10862714	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	C[C@@H](O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022856	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	10862715	CHEMBL2024777	Inhibition of Aurora B using 1 mM ATP by HTRF assay	B	Nc1ncc(-c2cnn(CCCN3CC[C@@H](O)C3)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL2022857	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	10862727	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	EC15	nM	4140.0	CHEMBL2185	Homo sapiens	EC15	nM	4140.0
	10862728	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	CNC(=O)/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2023220	=	EC15	nM	87.0	CHEMBL2185	Homo sapiens	EC15	nM	87.0
	10862729	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	EC15	nM	141.0	CHEMBL2185	Homo sapiens	EC15	nM	141.0
	10862730	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2023221	=	EC15	nM	46.0	CHEMBL2185	Homo sapiens	EC15	nM	46.0
Not Determined	10862731	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccccc5)cnc(N)c34)cc2)c1		CHEMBL231511		EC15			CHEMBL2185	Homo sapiens	EC15		
	10862732	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccoc5)cnc(N)c34)cc2)c1		CHEMBL2023222	>	EC15	nM	300.0	CHEMBL2185	Homo sapiens	EC15	nM	300.0
	10862733	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccsc5)cnc(N)c34)cc2)c1		CHEMBL2023223	>	EC15	nM	300.0	CHEMBL2185	Homo sapiens	EC15	nM	300.0
	10862734	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cc[nH]c5)cnc(N)c34)cc2)c1		CHEMBL2021941	=	EC15	nM	389.0	CHEMBL2185	Homo sapiens	EC15	nM	389.0
	10862735	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cc[nH]n5)cnc(N)c34)cc2)c1		CHEMBL2023224	=	EC15	nM	161.0	CHEMBL2185	Homo sapiens	EC15	nM	161.0
	10862736	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	EC15	nM	31.0	CHEMBL2185	Homo sapiens	EC15	nM	31.0
	10862737	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	EC15	nM	55.0	CHEMBL2185	Homo sapiens	EC15	nM	55.0
	10862738	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1ccccc1NC(=O)Nc1ccc(-c2csc3c(-c4cnn(C)c4)cnc(N)c23)cc1		CHEMBL2023225	=	EC15	nM	2.0	CHEMBL2185	Homo sapiens	EC15	nM	2.0
	10862739	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	EC15	nM	64.0	CHEMBL2185	Homo sapiens	EC15	nM	64.0
	10862740	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccccc5)cc4)csc23)cn1		CHEMBL2023226	=	EC15	nM	9.0	CHEMBL2185	Homo sapiens	EC15	nM	9.0
	10862741	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccccc5F)cc4)csc23)cn1		CHEMBL2023227	<	EC15	nM	30.0	CHEMBL2185	Homo sapiens	EC15	nM	30.0
	10862742	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	EC15	nM	6.0	CHEMBL2185	Homo sapiens	EC15	nM	6.0
	10862743	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(Cl)c5)cc4)csc23)cn1		CHEMBL2023228	=	EC15	nM	18.0	CHEMBL2185	Homo sapiens	EC15	nM	18.0
	10862744	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(Cl)cc5)cc4)csc23)cn1		CHEMBL2023229	=	EC15	nM	27.0	CHEMBL2185	Homo sapiens	EC15	nM	27.0
	10862745	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	COc1ccccc1NC(=O)Nc1ccc(-c2csc3c(-c4cnn(C)c4)cnc(N)c23)cc1		CHEMBL2023230	>	EC15	nM	100.0	CHEMBL2185	Homo sapiens	EC15	nM	100.0
	10862746	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL2023231	=	EC15	nM	57.0	CHEMBL2185	Homo sapiens	EC15	nM	57.0
	10862747	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)(F)F)cc5)cc4)csc23)cn1		CHEMBL2023232	=	EC15	nM	12.0	CHEMBL2185	Homo sapiens	EC15	nM	12.0
	10862748	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(C(N)=O)c5)cc4)csc23)cn1		CHEMBL2022850	=	EC15	nM	413.0	CHEMBL2185	Homo sapiens	EC15	nM	413.0
	10862749	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	EC15	nM	4.0	CHEMBL2185	Homo sapiens	EC15	nM	4.0
	10862750	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	CC(C)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022851	=	EC15	nM	355.0	CHEMBL2185	Homo sapiens	EC15	nM	355.0
Not Determined	10862751	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	CC(C)CCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022852		EC15			CHEMBL2185	Homo sapiens	EC15		
	10862752	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	CS(=O)(=O)CCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022853	=	EC15	nM	4.0	CHEMBL2185	Homo sapiens	EC15	nM	4.0
	10862753	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Nc1ncc(-c2cnn(CCN3CCCCC3)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL2022854	<	EC15	nM	3.0	CHEMBL2185	Homo sapiens	EC15	nM	3.0
	10862754	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	CN1CCC(n2cc(-c3cnc(N)c4c(-c5ccc(NC(=O)Nc6cccc(F)c6)cc5)csc34)cn2)C1=O		CHEMBL2022855	=	EC15	nM	1.0	CHEMBL2185	Homo sapiens	EC15	nM	1.0
	10862755	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	EC15	nM	12.0	CHEMBL2185	Homo sapiens	EC15	nM	12.0
	10862756	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	C[C@@H](O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022856	=	EC15	nM	2.0	CHEMBL2185	Homo sapiens	EC15	nM	2.0
	10862757	CHEMBL2024779	Inhibition of Aurora B in human NCI-H1229 cells assessed as induction of polyploidy formation after 48 hrs by Hoechst staining-based fluorescence analysis	B	Nc1ncc(-c2cnn(CCCN3CC[C@@H](O)C3)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL2022857	<	EC15	nM	1.0	CHEMBL2185	Homo sapiens	EC15	nM	1.0
	10863760	CHEMBL2024915	Inhibition of Aurora B by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	10870060	CHEMBL2027241	Inhibition of Aurora B at 200 nM	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	=	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	10870071	CHEMBL2025259	Inhibition of Aurora B	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	=	IC50	nM	12.4	CHEMBL2185	Homo sapiens	IC50	nM	12.4
Active	10870073	CHEMBL2025261	Inhibition of Aurora-B in human PSN1 cells assessed as accumulation of >/= 4N DNA cells at 30 nM after 24 hrs by flow cytometry	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10870823	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL1739550	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870824	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)O)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022112	=	IC50	nM	363.0	CHEMBL2185	Homo sapiens	IC50	nM	363.0
	10870825	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)O)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022113	=	IC50	nM	146.0	CHEMBL2185	Homo sapiens	IC50	nM	146.0
	10870826	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(N)=O)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022114	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	10870827	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CNC(=O)Cn1cc(-c2cnc3c(Nc4cc(CN5CCCCC5)ns4)nc(C)cn23)cn1		CHEMBL2022115	=	IC50	nM	193.0	CHEMBL2185	Homo sapiens	IC50	nM	193.0
	10870828	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCCC(C)C)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022116	=	IC50	nM	44.0	CHEMBL2185	Homo sapiens	IC50	nM	44.0
	10870829	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)N(C)C)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022117	>	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	nM	3000.0
	10870830	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCCN(C)C)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022118	=	IC50	nM	761.0	CHEMBL2185	Homo sapiens	IC50	nM	761.0
	10870831	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)N4CCOCC4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022119	>	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	nM	3000.0
	10870832	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022120	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870833	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022121	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	10870834	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)N(C)Cc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022122	=	IC50	nM	261.0	CHEMBL2185	Homo sapiens	IC50	nM	261.0
	10870835	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4nc5ccccc5[nH]4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022123	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870836	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4nc(-c5ccccc5)no4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022124	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870837	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4noc(-c5ccccc5)n4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023291	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870838	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4nc(-c5ccccc5)c[nH]4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023292	=	IC50	nM	21.0	CHEMBL2185	Homo sapiens	IC50	nM	21.0
	10870839	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccccc4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023293	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870840	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023294	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870841	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccc(F)cc4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023295	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870842	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023296	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870843	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cc(F)cc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023297	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870844	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(C(F)(F)F)c4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023298	=	IC50	nM	35.0	CHEMBL2185	Homo sapiens	IC50	nM	35.0
	10870845	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccc(C(F)(F)F)cc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023299	=	IC50	nM	175.0	CHEMBL2185	Homo sapiens	IC50	nM	175.0
	10870846	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(N(C)C)c4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023300	=	IC50	nM	155.0	CHEMBL2185	Homo sapiens	IC50	nM	155.0
	10870847	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	COc1cccc(CNC(=O)Cn2cc(-c3cnc4c(Nc5cc(CN6CCCC(C)C6)ns5)nc(C)cn34)cn2)c1		CHEMBL2023301	=	IC50	nM	41.0	CHEMBL2185	Homo sapiens	IC50	nM	41.0
	10870848	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	COc1ccc(CNC(=O)Cn2cc(-c3cnc4c(Nc5cc(CN6CCCC(C)C6)ns5)nc(C)cn34)cn2)cc1		CHEMBL2023302	=	IC50	nM	161.0	CHEMBL2185	Homo sapiens	IC50	nM	161.0
	10870849	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccnc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023303	=	IC50	nM	439.0	CHEMBL2185	Homo sapiens	IC50	nM	439.0
	10870850	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022366	=	IC50	nM	1107.0	CHEMBL2185	Homo sapiens	IC50	nM	1107.0
	10870851	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ncco4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022367	=	IC50	nM	178.0	CHEMBL2185	Homo sapiens	IC50	nM	178.0
	10870852	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccco4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022368	=	IC50	nM	70.0	CHEMBL2185	Homo sapiens	IC50	nM	70.0
	10870853	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022369	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870854	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccc4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022370	=	IC50	nM	35.0	CHEMBL2185	Homo sapiens	IC50	nM	35.0
	10870855	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022371	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870856	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccc(F)cc4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022372	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	nM	30.0
	10870857	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022373	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870858	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cc(F)cc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022374	=	IC50	nM	94.0	CHEMBL2185	Homo sapiens	IC50	nM	94.0
	10870859	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4nccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022375	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870860	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NN4CC=CC=N4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022376	=	IC50	nM	45.0	CHEMBL2185	Homo sapiens	IC50	nM	45.0
	10870861	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccn4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022377	=	IC50	nM	32.0	CHEMBL2185	Homo sapiens	IC50	nM	32.0
	10870862	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccnc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022378	=	IC50	nM	118.0	CHEMBL2185	Homo sapiens	IC50	nM	118.0
	10870863	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022379	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870864	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cc[n+]([O-])cc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022709	=	IC50	nM	91.0	CHEMBL2185	Homo sapiens	IC50	nM	91.0
	10870865	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4O)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022710	=	IC50	nM	282.0	CHEMBL2185	Homo sapiens	IC50	nM	282.0
	10870866	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022711	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	10870867	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)n4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022712	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	10870868	CHEMBL2024835	Inhibition of aurora B kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccnc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022713	=	IC50	nM	81.0	CHEMBL2185	Homo sapiens	IC50	nM	81.0
	10870869	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL1739550	=	EC50	nM	50.0	CHEMBL2185	Homo sapiens	EC50	nM	50.0
Not Determined	10870870	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)O)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022112		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870871	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)O)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022113		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870872	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(N)=O)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022114	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
Not Determined	10870873	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	CNC(=O)Cn1cc(-c2cnc3c(Nc4cc(CN5CCCCC5)ns4)nc(C)cn23)cn1		CHEMBL2022115		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870874	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCCC(C)C)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022116	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
Not Determined	10870875	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)N(C)C)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022117		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870876	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCCN(C)C)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022118		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870877	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)N4CCOCC4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022119		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870878	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022120	=	EC50	nM	129.0	CHEMBL2185	Homo sapiens	EC50	nM	129.0
	10870879	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022121	=	EC50	nM	327.0	CHEMBL2185	Homo sapiens	EC50	nM	327.0
Not Determined	10870880	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)N(C)Cc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022122		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870881	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(Cc4nc5ccccc5[nH]4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022123	=	EC50	nM	534.0	CHEMBL2185	Homo sapiens	EC50	nM	534.0
	10870882	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(Cc4nc(-c5ccccc5)no4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022124	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
	10870883	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(Cc4noc(-c5ccccc5)n4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023291	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
	10870884	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(Cc4nc(-c5ccccc5)c[nH]4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023292	=	EC50	nM	887.0	CHEMBL2185	Homo sapiens	EC50	nM	887.0
	10870885	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccccc4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023293	=	EC50	nM	469.0	CHEMBL2185	Homo sapiens	EC50	nM	469.0
	10870886	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023294	=	EC50	nM	234.0	CHEMBL2185	Homo sapiens	EC50	nM	234.0
	10870887	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccc(F)cc4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023295	=	EC50	nM	416.0	CHEMBL2185	Homo sapiens	EC50	nM	416.0
	10870888	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023296	=	EC50	nM	870.0	CHEMBL2185	Homo sapiens	EC50	nM	870.0
	10870889	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cc(F)cc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023297	=	EC50	nM	389.0	CHEMBL2185	Homo sapiens	EC50	nM	389.0
	10870890	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(C(F)(F)F)c4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023298	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
Not Determined	10870891	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccc(C(F)(F)F)cc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023299		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870892	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(N(C)C)c4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023300		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870893	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	COc1cccc(CNC(=O)Cn2cc(-c3cnc4c(Nc5cc(CN6CCCC(C)C6)ns5)nc(C)cn34)cn2)c1		CHEMBL2023301	=	EC50	nM	442.0	CHEMBL2185	Homo sapiens	EC50	nM	442.0
Not Determined	10870894	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	COc1ccc(CNC(=O)Cn2cc(-c3cnc4c(Nc5cc(CN6CCCC(C)C6)ns5)nc(C)cn34)cn2)cc1		CHEMBL2023302		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870895	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccnc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023303		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870896	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022366		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870897	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ncco4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022367		EC50			CHEMBL2185	Homo sapiens	EC50		
Not Determined	10870898	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccco4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022368		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870899	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022369	=	EC50	nM	193.0	CHEMBL2185	Homo sapiens	EC50	nM	193.0
	10870900	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccc4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022370	=	EC50	nM	388.0	CHEMBL2185	Homo sapiens	EC50	nM	388.0
	10870901	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022371	=	EC50	nM	892.0	CHEMBL2185	Homo sapiens	EC50	nM	892.0
	10870902	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccc(F)cc4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022372	=	EC50	nM	412.0	CHEMBL2185	Homo sapiens	EC50	nM	412.0
	10870903	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022373	=	EC50	nM	58.0	CHEMBL2185	Homo sapiens	EC50	nM	58.0
	10870904	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cc(F)cc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022374	=	EC50	nM	2378.0	CHEMBL2185	Homo sapiens	EC50	nM	2378.0
	10870905	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4nccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022375	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
	10870906	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)NN4CC=CC=N4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022376	=	EC50	nM	951.0	CHEMBL2185	Homo sapiens	EC50	nM	951.0
	10870907	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccn4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022377	=	EC50	nM	285.0	CHEMBL2185	Homo sapiens	EC50	nM	285.0
Not Determined	10870908	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccnc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022378		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870909	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022379	=	EC50	nM	83.0	CHEMBL2185	Homo sapiens	EC50	nM	83.0
	10870910	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cc[n+]([O-])cc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022709	=	EC50	nM	402.0	CHEMBL2185	Homo sapiens	EC50	nM	402.0
Not Determined	10870911	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4O)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022710		EC50			CHEMBL2185	Homo sapiens	EC50		
	10870912	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022711	=	EC50	nM	62.0	CHEMBL2185	Homo sapiens	EC50	nM	62.0
	10870913	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)n4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022712	=	EC50	nM	164.0	CHEMBL2185	Homo sapiens	EC50	nM	164.0
	10870914	CHEMBL2024836	Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of histone H3 phosphorylation incubated for 1 hr by Hoechst 33342 staining based microscopic analysis	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccnc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022713	=	EC50	nM	110.0	CHEMBL2185	Homo sapiens	EC50	nM	110.0
	10886023	CHEMBL2033407	Inhibition of Aurora B in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
	10889049	CHEMBL2032466	Inhibition of aurora-2	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	10889076	CHEMBL2032466	Inhibition of aurora-2	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	10890712	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(/C=N/O)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029900	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	uM	0.03
	10890713	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(C#N)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029901	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10890714	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4ccn(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029902	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	uM	0.018
	10890715	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(C(N)=O)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029903	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	uM	0.011
	10890716	CHEMBL2032822	Inhibition of aurora B kinase	B	CNCc1cc2cnc(Nc3cc(C(=O)N4CCN(C)CC4)n(C)c3)nc2n1C1CCCC1		CHEMBL2029904	=	IC50	nM	60.0	CHEMBL2185	Homo sapiens	IC50	uM	0.06
	10890717	CHEMBL2032822	Inhibition of aurora B kinase	B	CC(O)c1cc2cnc(Nc3cc(C(=O)N4CCN(C)CC4)n(C)c3)nc2n1C1CCCC1		CHEMBL2029905	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	uM	0.03
	10890718	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(CO)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029906	=	IC50	nM	40.0	CHEMBL2185	Homo sapiens	IC50	uM	0.04
	10890719	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(C(=O)O)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029907	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	10890720	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cnco5)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029908	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10890721	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cnn(C)c5)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029909	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10890722	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cncn5C)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029910	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	uM	0.005
	10890723	CHEMBL2032822	Inhibition of aurora B kinase	B	Cc1c(-c2cc3cnc(Nc4cc(C(=O)N5CCN(C)CC5)n(C)c4)nc3n2C2CCCC2)cnn1C		CHEMBL2029911	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10890724	CHEMBL2032822	Inhibition of aurora B kinase	B	CC(C)CCn1cc(-c2cc3cnc(Nc4cc(C(=O)N5CCN(C)CC5)n(C)c4)nc3n2C2CCCC2)cn1		CHEMBL2029912	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10890725	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5ccnn5C)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029913	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10890726	CHEMBL2032822	Inhibition of aurora B kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cnn(Cc6ccccc6)c5)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029914	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	uM	0.004
	10912550	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O		CHEMBL2036871	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
Not Active	10912555	CHEMBL2038038	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate at <10 uM after 80 mins by scintillation counting	B	Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O		CHEMBL2036871		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10912566	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2NC(=O)C3)cc1O		CHEMBL603463	=	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	uM	3.0
	10913460	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccccc3)n2)nc2ccccc21		CHEMBL2036725	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
Not Active	10913465	CHEMBL2038038	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate at <10 uM after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccccc3)n2)nc2ccccc21		CHEMBL2036725		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10913476	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036726	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
Not Active	10913481	CHEMBL2038038	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate at <10 uM after 80 mins by scintillation counting	B	Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036726		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10913492	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21		CHEMBL2036727	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
Not Active	10913497	CHEMBL2038038	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate at <10 uM after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21		CHEMBL2036727		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10913508	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21		CHEMBL2036728	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
Not Active	10913513	CHEMBL2038038	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate at <10 uM after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21		CHEMBL2036728		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10913524	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036867	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
Not Active	10913529	CHEMBL2038038	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate at <10 uM after 80 mins by scintillation counting	B	CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036867		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10913540	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036868	=	IC50	nM	62000.0	CHEMBL2185	Homo sapiens	IC50	uM	62.0
Not Active	10913545	CHEMBL2038038	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate at <10 uM after 80 mins by scintillation counting	B	COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036868		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	10913556	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccc(O)cc3)n2)nc2ccccc21		CHEMBL2036869	=	IC50	nM	11100.0	CHEMBL2185	Homo sapiens	IC50	uM	11.1
	10913561	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21		CHEMBL2036870	=	IC50	nM	5500.0	CHEMBL2185	Homo sapiens	IC50	uM	5.5
	10913566	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	Cn1c(-c2ccnc(Nc3ccc(O)c(Cl)c3)n2)nc2ccccc21		CHEMBL2036865	=	IC50	nM	7000.0	CHEMBL2185	Homo sapiens	IC50	uM	7.0
	10913571	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1O		CHEMBL2036866	=	IC50	nM	6000.0	CHEMBL2185	Homo sapiens	IC50	uM	6.0
	10913586	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL1200485	=	IC50	nM	1800.0	CHEMBL2185	Homo sapiens	IC50	uM	1.8
	10913601	CHEMBL2038023	Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	1500.0	CHEMBL2185	Homo sapiens	IC50	uM	1.5
	10945428	CHEMBL2049895	Inhibition of Aur B	B	Cc1cc(N2CCOCC2)ccc1Nc1nc(NC2CCCCC2)c2nc[nH]c2n1		CHEMBL2047943	>	IC50	nM	5000.0	CHEMBL2185	Homo sapiens	IC50	uM	5.0
	10945429	CHEMBL2049895	Inhibition of Aur B	B	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1		CHEMBL188343	=	IC50	nM	75.0	CHEMBL2185	Homo sapiens	IC50	uM	0.075
	10949777	CHEMBL2049401	Inhibition of N-terminal 6xHis tagged Aurora B kinase expressed using baculovirus expression system using [gamma-33P]ATP	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	10975647	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Cc4cccc(F)c4)c3)c12		CHEMBL2063452	>	IC50	nM	12500.0	CHEMBL2185	Homo sapiens	IC50	nM	12500.0
	10975648	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNS(=O)(=O)c4ccccc4)c3)c12		CHEMBL2063450	>	IC50	nM	12500.0	CHEMBL2185	Homo sapiens	IC50	nM	12500.0
	10975668	CHEMBL2064925	Inhibition of Aurora B kinase in presence of 10 uM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	10975688	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1nc(N)c2c(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)cccc21		CHEMBL2063457	=	IC50	nM	938.0	CHEMBL2185	Homo sapiens	IC50	nM	938.0
	10975692	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NCc1cccc(NC(=O)c2cccc3onc(N)c23)c1		CHEMBL2063449	=	IC50	nM	525.0	CHEMBL2185	Homo sapiens	IC50	nM	525.0
	10975693	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c12		CHEMBL2063438	=	IC50	nM	480.0	CHEMBL2185	Homo sapiens	IC50	nM	480.0
	10975694	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063451	=	IC50	nM	450.0	CHEMBL2185	Homo sapiens	IC50	nM	450.0
	10975698	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1nc(N)c2c(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)cccc21		CHEMBL2063458	=	IC50	nM	172.0	CHEMBL2185	Homo sapiens	IC50	nM	172.0
	10975702	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)c12		CHEMBL2063440	=	IC50	nM	140.0	CHEMBL2185	Homo sapiens	IC50	nM	140.0
	10975703	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL2063437	=	IC50	nM	127.0	CHEMBL2185	Homo sapiens	IC50	nM	127.0
	10975707	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3cccc4onc(N)c34)cc2)cc1		CHEMBL2063439	=	IC50	nM	82.0	CHEMBL2185	Homo sapiens	IC50	nM	82.0
	10975709	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063446	=	IC50	nM	59.0	CHEMBL2185	Homo sapiens	IC50	nM	59.0
	10975710	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccccc4F)c3)c12		CHEMBL2063445	=	IC50	nM	55.0	CHEMBL2185	Homo sapiens	IC50	nM	55.0
	10975711	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1nsc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL1986658	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
	10975715	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)cc4)c3)c12		CHEMBL2063442	=	IC50	nM	41.0	CHEMBL2185	Homo sapiens	IC50	nM	41.0
	10975716	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3ccn4ncnc(N)c34)cc2)c1		CHEMBL2063464	=	IC50	nM	38.0	CHEMBL2185	Homo sapiens	IC50	nM	38.0
	10975718	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c12		CHEMBL2063465	=	IC50	nM	36.0	CHEMBL2185	Homo sapiens	IC50	nM	36.0
	10975719	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1nsc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)c(F)c4)c3)c12		CHEMBL2063454	=	IC50	nM	36.0	CHEMBL2185	Homo sapiens	IC50	nM	36.0
	10975720	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)NC4CCCC4)cc3)c12		CHEMBL2063466	=	IC50	nM	33.0	CHEMBL2185	Homo sapiens	IC50	nM	33.0
	10975722	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1n[nH]c2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)c(F)c4)c3)c12		CHEMBL2063456	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	10975723	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c12		CHEMBL2063460	=	IC50	nM	24.0	CHEMBL2185	Homo sapiens	IC50	nM	24.0
	10975727	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1n[nH]c2cccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063455	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	10975728	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccccc4)c3)c12		CHEMBL2063441	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	10975729	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4ccsc4)cc3)c12		CHEMBL2063467	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	nM	17.0
	10975735	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1nsc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c12		CHEMBL2063453	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	10975736	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c12		CHEMBL2063447	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	10975737	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(Cl)c4)c3)c12		CHEMBL2063463	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	10975739	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	IC50	nM	9.0	CHEMBL2185	Homo sapiens	IC50	nM	9.0
	10975741	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)c(F)c4)c3)c12		CHEMBL2063448	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	10975744	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063462	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	nM	4.0
	10975745	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1ccc(NC(=O)NCc2cccc(NC(=O)c3cccc4onc(N)c34)c2)cc1		CHEMBL2063443	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	nM	4.0
	10975748	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(Cl)cc4)c3)c12		CHEMBL2063444	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	10975754	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1ccc(NC(=O)NCc2cccc(NC(=O)c3ccn4ncnc(N)c34)c2)cc1		CHEMBL2063461	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	10975755	CHEMBL2064921	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(Cl)cc4)c3)c12		CHEMBL2063459	=	IC50	nM	0.9	CHEMBL2185	Homo sapiens	IC50	nM	0.9
	10986051	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	10986052	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1cc(Nc2ncc(F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc1N1CCN(C)CC1		CHEMBL1614709	=	IC50	nM	54.0	CHEMBL2185	Homo sapiens	IC50	nM	54.0
	10986053	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071194	=	IC50	nM	29.0	CHEMBL2185	Homo sapiens	IC50	nM	29.0
	10986054	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2nccc(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071195	=	IC50	nM	294.0	CHEMBL2185	Homo sapiens	IC50	nM	294.0
	10986055	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1cnc(Nc2cnn(C)c2)nc1N[C@H]1[C@@H](C(N)=O)[C@@H]2C=C[C@H]1C2		CHEMBL2071196	=	IC50	nM	252.0	CHEMBL2185	Homo sapiens	IC50	nM	252.0
	10986056	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	COc1cnc(Nc2cnn(C)c2)nc1N[C@H]1[C@@H](C(N)=O)[C@@H]2C=C[C@H]1C2		CHEMBL2071197	=	IC50	nM	145.0	CHEMBL2185	Homo sapiens	IC50	nM	145.0
	10986057	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(N)=O)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071198	=	IC50	nM	197.0	CHEMBL2185	Homo sapiens	IC50	nM	197.0
	10986058	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc([N+](=O)[O-])c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071199	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
	10986059	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(F)(F)F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071200	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	10986060	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Br)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071201	=	IC50	nM	42.0	CHEMBL2185	Homo sapiens	IC50	nM	42.0
	10986061	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071202	=	IC50	nM	29.0	CHEMBL2185	Homo sapiens	IC50	nM	29.0
	10986062	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(F)(F)F)c(N[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C(N)=O)n2)cn1		CHEMBL2071203	=	IC50	nM	66.0	CHEMBL2185	Homo sapiens	IC50	nM	66.0
	10986063	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(F)(F)F)c(N[C@H]3C[C@@H]4CC[C@H]3C4)n2)cn1		CHEMBL2071204	=	IC50	nM	61.0	CHEMBL2185	Homo sapiens	IC50	nM	61.0
	10986064	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(F)(F)F)c(N[C@H]3[C@@H](C(N)=O)C[C@H]4C[C@@H]3C4(C)C)n2)cn1		CHEMBL2071205	=	IC50	nM	43.0	CHEMBL2185	Homo sapiens	IC50	nM	43.0
	10986065	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	CNC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn(C)c2)ncc1C(F)(F)F		CHEMBL2071206	=	IC50	nM	45.0	CHEMBL2185	Homo sapiens	IC50	nM	45.0
	10986066	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(F)(F)F)c(N[C@H]3[C@@H](C(=O)NC4CC4)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071207	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	10986067	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(F)(F)F)c(N[C@H]3[C@@H](C(=O)NCCO)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071208	=	IC50	nM	99.0	CHEMBL2185	Homo sapiens	IC50	nM	99.0
	10986068	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(C(F)(F)F)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL2071209	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
	10986069	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Cl)c(N[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C(N)=O)n2)cn1		CHEMBL2071210	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	10986070	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Cl)c(N[C@H]3[C@H]4CC[C@H](C4)[C@H]3C(N)=O)n2)cn1		CHEMBL2071211	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	10986071	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Cl)c(N[C@@H]3[C@H]4CC[C@H](O4)[C@@H]3C(N)=O)n2)cn1		CHEMBL2071212	=	IC50	nM	118.0	CHEMBL2185	Homo sapiens	IC50	nM	118.0
	10986072	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Cl)c(N[C@@H]3CCCC[C@@H]3C(N)=O)n2)cn1		CHEMBL2071213	=	IC50	nM	135.0	CHEMBL2185	Homo sapiens	IC50	nM	135.0
	10986073	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Cl)c(N[C@@H]3CCC[C@@H]3C(N)=O)n2)cn1		CHEMBL2071214	=	IC50	nM	32.0	CHEMBL2185	Homo sapiens	IC50	nM	32.0
	10986074	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1cc(Nc2ncc(Cl)c(N[C@@H]3CC[C@@H]3C(N)=O)n2)cn1		CHEMBL2071215	=	IC50	nM	44.0	CHEMBL2185	Homo sapiens	IC50	nM	44.0
	10986075	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	CCn1cc(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071216	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	10986076	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn(Cc3ccccc3)c2)ncc1Cl		CHEMBL2071217	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	10986077	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn(CCO)c2)ncc1Cl		CHEMBL2071270	=	IC50	nM	19.0	CHEMBL2185	Homo sapiens	IC50	nM	19.0
	10986078	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn(CC(=O)O)c2)ncc1Cl		CHEMBL2071271	=	IC50	nM	32.0	CHEMBL2185	Homo sapiens	IC50	nM	32.0
	10986079	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)Cn1cc(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071272	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
	10986080	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	CNC(=O)Cn1cc(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071273	=	IC50	nM	26.0	CHEMBL2185	Homo sapiens	IC50	nM	26.0
	10986081	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn(CCN3CCOCC3)c2)ncc1Cl		CHEMBL2071274	=	IC50	nM	27.0	CHEMBL2185	Homo sapiens	IC50	nM	27.0
	10986082	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn(C3CCNCC3)c2)ncc1Cl		CHEMBL2071275	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	10986083	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn([C@@H]3CCCNC3)c2)ncc1Cl		CHEMBL2071276	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	10986084	CHEMBL2073499	Inhibition of Aurora B kinase by HTRF analysis in presence of 1 mM ATP	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cnn(C[C@H]3CCCN3)c2)ncc1Cl		CHEMBL2071277	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
	11011603	CHEMBL2091234	Inhibition of Aurora kinase B at 10 uM by luciferase assay	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	>	Inhibition	%	25.0	CHEMBL2185	Homo sapiens	INH	%	25.0
	11011605	CHEMBL2091234	Inhibition of Aurora kinase B at 10 uM by luciferase assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Inhibition	%	25.0	CHEMBL2185	Homo sapiens	INH	%	25.0
	11011608	CHEMBL2091234	Inhibition of Aurora kinase B at 10 uM by luciferase assay	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	>	Inhibition	%	25.0	CHEMBL2185	Homo sapiens	INH	%	25.0
	11011616	CHEMBL2091234	Inhibition of Aurora kinase B at 10 uM by luciferase assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	11011623	CHEMBL2091234	Inhibition of Aurora kinase B at 10 uM by luciferase assay	B	O=C(c1ccc(Nc2nccc(-c3cc4ccccc4s3)n2)cc1)N1CCC(N2CCCC2)CC1		CHEMBL200027	>	Inhibition	%	29.0	CHEMBL2185	Homo sapiens	INH	%	29.0
	12036414	CHEMBL2150621	Inhibition of N-terminal His6-tagged Aurora B expressed in baculovirus after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	nM	500.0
	12046242	CHEMBL2157262	Inhibition of Aurora B at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-7.4	CHEMBL2185	Homo sapiens	INH	%	-7.4
Not Active	12047545	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3Cl)cc1CC2		CHEMBL2152781		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048336	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3C(F)(F)F)cc1CC2		CHEMBL2152782		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048351	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3Cl)cc1CC2		CHEMBL2152785		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048366	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3C)cc1CC2		CHEMBL2152786		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048381	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C(F)(F)F)cc3N)cc1CC2		CHEMBL2152787		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048396	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C)c3)cc1CC2		CHEMBL2152788		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048411	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)cc(F)c3F)cc1CC2		CHEMBL2152789		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048426	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2		CHEMBL2152791		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048441	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1ccc2ccc3cc(Nc4ccc(F)cc4F)ccc3c(=O)c2c1		CHEMBL2152792		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048456	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152798		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048471	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL2152936		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048486	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	Nc1ccccc1Nc1ccc2c(=O)c3cc(OCCN4CCOCC4)ccc3ccc2c1		CHEMBL2152939		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048501	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048516	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048531	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC3CCOCC3)cc21		CHEMBL2152942		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048546	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152943		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048561	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048576	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152947		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048591	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCN3CCOCC3)cc21		CHEMBL2152950		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048606	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152957		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048621	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@H](O)CO)ccc21		CHEMBL2152958		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048636	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	CC1(C)OC[C@@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152959		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048651	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@@H](O)CO)ccc21		CHEMBL2152960		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12048666	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152965		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049610	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(O)cccc21		CHEMBL2152966		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049625	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c1cccc2C1CCOCC1		CHEMBL2152967		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049640	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152968		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049655	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OC[C@H](O)CO)cccc21		CHEMBL2152969		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049670	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21		CHEMBL2152970		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049685	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152971		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049700	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152972		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	12049715	CHEMBL2155539	Inhibition of AuroraB at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1c(OC[C@H](O)CO)cccc1C2=O		CHEMBL2152973		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	12060758	CHEMBL2156892	Inhibition of Aurora kinase B	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	>	IC50	nM	3600.0	CHEMBL2185	Homo sapiens	IC50	nM	3600.0
	12060759	CHEMBL2156892	Inhibition of Aurora kinase B	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	>	IC50	nM	3600.0	CHEMBL2185	Homo sapiens	IC50	nM	3600.0
	12060919	CHEMBL2157048	Binding affinity to AURKB at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	85.0	CHEMBL2185	Homo sapiens	Activity	%	85.0
	12070716	CHEMBL2161899	Inhibition of human Aurora B kinase at 10 uM	B	CC(=O)n1nc(NC(=O)c2ccccc2)c2c1CN(C(=O)c1ccccc1)C2		CHEMBL2160091	=	Inhibition	%	32.0	CHEMBL2185	Homo sapiens	INH	%	32.0
Dose-dependent effect	12086155	CHEMBL2168171	Inhibition of Aurora kinase B in human HCT116 cells assessed as induction of 8N polyploidy	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163404		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	12086156	CHEMBL2168171	Inhibition of Aurora kinase B in human HCT116 cells assessed as induction of 8N polyploidy	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163404	=	EC50	nM	3.0	CHEMBL2185	Homo sapiens	EC50	nM	3.0
Dose-dependent effect	12086160	CHEMBL2168171	Inhibition of Aurora kinase B in human HCT116 cells assessed as induction of 8N polyploidy	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163394		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	12086187	CHEMBL2168171	Inhibition of Aurora kinase B in human HCT116 cells assessed as induction of 8N polyploidy	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163394	=	EC50	nM	3.0	CHEMBL2185	Homo sapiens	EC50	nM	3.0
	12086250	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCC(F)(F)F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163388	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	12086251	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163387	=	IC50	nM	6.2	CHEMBL2185	Homo sapiens	IC50	nM	6.2
	12086252	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163395	=	IC50	nM	9.3	CHEMBL2185	Homo sapiens	IC50	nM	9.3
	12086253	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163394	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	12086254	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)Nc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163393	=	IC50	nM	42.2	CHEMBL2185	Homo sapiens	IC50	nM	42.2
	12086255	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163392	=	IC50	nM	63.2	CHEMBL2185	Homo sapiens	IC50	nM	63.2
	12086256	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(O)CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163391	=	IC50	nM	293.0	CHEMBL2185	Homo sapiens	IC50	nM	293.0
	12086257	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163390	=	IC50	nM	14.6	CHEMBL2185	Homo sapiens	IC50	nM	14.6
	12086258	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163389	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	12086259	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163404	=	IC50	nM	6.1	CHEMBL2185	Homo sapiens	IC50	nM	6.1
	12086260	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163403	=	IC50	nM	6.3	CHEMBL2185	Homo sapiens	IC50	nM	6.3
	12086261	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163402	=	IC50	nM	37.6	CHEMBL2185	Homo sapiens	IC50	nM	37.6
	12086262	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](S(=O)(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163401	=	IC50	nM	28.6	CHEMBL2185	Homo sapiens	IC50	nM	28.6
	12086263	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H]([S+]([O-])C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163400	=	IC50	nM	11.9	CHEMBL2185	Homo sapiens	IC50	nM	11.9
	12086264	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](SC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163399	=	IC50	nM	94.5	CHEMBL2185	Homo sapiens	IC50	nM	94.5
	12086265	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC(C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163398	=	IC50	nM	9.0	CHEMBL2185	Homo sapiens	IC50	nM	9.0
	12086266	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC(C(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163397	=	IC50	nM	44.8	CHEMBL2185	Homo sapiens	IC50	nM	44.8
	12086267	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NS(C)(=O)=O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163396	=	IC50	nM	362.0	CHEMBL2185	Homo sapiens	IC50	nM	362.0
	12086268	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NC(=O)C(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163413	=	IC50	nM	114.0	CHEMBL2185	Homo sapiens	IC50	nM	114.0
	12086269	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163412	=	IC50	nM	8.9	CHEMBL2185	Homo sapiens	IC50	nM	8.9
	12086270	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163411	=	IC50	nM	27.1	CHEMBL2185	Homo sapiens	IC50	nM	27.1
	12086271	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCN(C)CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163410	=	IC50	nM	169.0	CHEMBL2185	Homo sapiens	IC50	nM	169.0
	12086272	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163409	=	IC50	nM	43.4	CHEMBL2185	Homo sapiens	IC50	nM	43.4
	12086273	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	COCCO[C@@H]1CCN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C1		CHEMBL2163408	=	IC50	nM	6.2	CHEMBL2185	Homo sapiens	IC50	nM	6.2
	12086274	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCO)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163407	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	12086275	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163406	=	IC50	nM	103.0	CHEMBL2185	Homo sapiens	IC50	nM	103.0
	12086276	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163405	=	IC50	nM	420.0	CHEMBL2185	Homo sapiens	IC50	nM	420.0
	12086277	CHEMBL2167307	Inhibition of Aurora kinase B-mediated histone H3 Ser10 phosphorylation in human HCT116 cells after 2 hrs by sandwich ELISA	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822658	=	IC50	nM	44.0	CHEMBL2185	Homo sapiens	IC50	nM	44.0
	12086278	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCC(F)(F)F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163388	=	Kd	nM	2.2	CHEMBL2185	Homo sapiens	Kd	nM	2.2
	12086279	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163387	=	Kd	nM	3.1	CHEMBL2185	Homo sapiens	Kd	nM	3.1
	12086280	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163395	=	Kd	nM	3.3	CHEMBL2185	Homo sapiens	Kd	nM	3.3
	12086281	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163394	=	Kd	nM	1.9	CHEMBL2185	Homo sapiens	Kd	nM	1.9
	12086282	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)Nc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163393	=	Kd	nM	6.9	CHEMBL2185	Homo sapiens	Kd	nM	6.9
	12086283	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163392	=	Kd	nM	2.9	CHEMBL2185	Homo sapiens	Kd	nM	2.9
	12086866	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(O)CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163391	=	Kd	nM	3.7	CHEMBL2185	Homo sapiens	Kd	nM	3.7
	12086867	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163390	=	Kd	nM	2.6	CHEMBL2185	Homo sapiens	Kd	nM	2.6
	12086868	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163389	=	Kd	nM	2.9	CHEMBL2185	Homo sapiens	Kd	nM	2.9
	12086869	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163404	=	Kd	nM	1.7	CHEMBL2185	Homo sapiens	Kd	nM	1.7
	12086870	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163403	=	Kd	nM	2.5	CHEMBL2185	Homo sapiens	Kd	nM	2.5
	12086871	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163402	=	Kd	nM	1.9	CHEMBL2185	Homo sapiens	Kd	nM	1.9
	12086872	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](S(=O)(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163401	=	Kd	nM	4.3	CHEMBL2185	Homo sapiens	Kd	nM	4.3
	12086873	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H]([S+]([O-])C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163400	=	Kd	nM	3.1	CHEMBL2185	Homo sapiens	Kd	nM	3.1
	12086874	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](SC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163399	=	Kd	nM	14.2	CHEMBL2185	Homo sapiens	Kd	nM	14.2
	12086875	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC(C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163398	=	Kd	nM	2.4	CHEMBL2185	Homo sapiens	Kd	nM	2.4
	12086876	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC(C(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163397	=	Kd	nM	6.1	CHEMBL2185	Homo sapiens	Kd	nM	6.1
	12086877	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NS(C)(=O)=O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163396	=	Kd	nM	3.2	CHEMBL2185	Homo sapiens	Kd	nM	3.2
	12086878	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NC(=O)C(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163413	=	Kd	nM	5.7	CHEMBL2185	Homo sapiens	Kd	nM	5.7
	12086879	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163412	=	Kd	nM	3.6	CHEMBL2185	Homo sapiens	Kd	nM	3.6
	12086880	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163411	=	Kd	nM	3.7	CHEMBL2185	Homo sapiens	Kd	nM	3.7
	12086881	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCN(C)CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163410	=	Kd	nM	2.9	CHEMBL2185	Homo sapiens	Kd	nM	2.9
	12086882	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163409	=	Kd	nM	6.6	CHEMBL2185	Homo sapiens	Kd	nM	6.6
	12086883	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	COCCO[C@@H]1CCN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C1		CHEMBL2163408	=	Kd	nM	3.1	CHEMBL2185	Homo sapiens	Kd	nM	3.1
	12086884	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCO)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163407	=	Kd	nM	1.7	CHEMBL2185	Homo sapiens	Kd	nM	1.7
	12086885	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163406	=	Kd	nM	6.6	CHEMBL2185	Homo sapiens	Kd	nM	6.6
	12086886	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163405	=	Kd	nM	14.8	CHEMBL2185	Homo sapiens	Kd	nM	14.8
	12086887	CHEMBL2167306	Binding affinity to Aurora kinase B catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822658	=	Kd	nM	8.0	CHEMBL2185	Homo sapiens	Kd	nM	8.0
	12112545	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170442	<	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112546	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	NC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170442	=	IC50	nM	50.2	CHEMBL2185	Homo sapiens	IC50	nM	50.2
	12112555	CHEMBL2174325	Inhibition of Aurora B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	12112559	CHEMBL2174329	Inhibition of recombinant Aurora B by radioactive flash plate assay	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	396.0	CHEMBL2185	Homo sapiens	IC50	nM	396.0
	12112566	CHEMBL2174336	Inhibition of Aurora B kinase using [33P]ATP at 0.5 uM by filter-binding assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	>	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	12112600	CHEMBL2174421	Inhibition of Aurora B kinase at 1 uM by 33P kinase hotspot assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	Inhibition	%	93.0	CHEMBL2185	Homo sapiens	INH	%	93.0
	12112601	CHEMBL2174421	Inhibition of Aurora B kinase at 1 uM by 33P kinase hotspot assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	98.0	CHEMBL2185	Homo sapiens	INH	%	98.0
	12112620	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Clc1ccccc1Nc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl		CHEMBL2170418	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112621	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Oc1cc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)ccc1-c1nnn[nH]1		CHEMBL2170417	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12112622	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Fc1cnc(Nc2ccc(-c3nnn[nH]3)cc2)nc1Nc1ccccc1Cl		CHEMBL2169893	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12112623	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12112624	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NS(=O)(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170415	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12112625	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	<	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112626	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=C(NCCO)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170413	<	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112627	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Fc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170412	<	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112628	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Fc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170411	<	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112629	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170410	<	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112630	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL2170409	<	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112631	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	COc1cc(Nc2nccc(Nc3ccccc3Cl)n2)ccc1C(=O)O		CHEMBL2170408	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12112632	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=c1[nH]c2ccc(Nc3nccc(Nc4ccccc4Cl)n3)cc2[nH]1		CHEMBL2170407	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112633	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	CC(=O)Nc1cccc(Nc2nccc(Nc3ccccc3Cl)n2)c1		CHEMBL2170406	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12112634	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	CS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170405	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12112635	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	COCCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170404	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112636	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	CN(C)CCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170591	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	12112637	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=C(NCCN1CCOCC1)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170590	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
Not Active	12112638	CHEMBL2173308	Inhibition of Aurora B kinase-mediated histone H3 phosphorylation at Ser10 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	12112639	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	Clc1ccccc1Nc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl		CHEMBL2170418	=	IC50	nM	106.0	CHEMBL2185	Homo sapiens	IC50	nM	106.0
Not Determined	12112640	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	Oc1cc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)ccc1-c1nnn[nH]1		CHEMBL2170417		IC50			CHEMBL2185	Homo sapiens	IC50		
	12112641	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	Fc1cnc(Nc2ccc(-c3nnn[nH]3)cc2)nc1Nc1ccccc1Cl		CHEMBL2169893	=	IC50	nM	83.7	CHEMBL2185	Homo sapiens	IC50	nM	83.7
	12112642	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	=	IC50	nM	226.0	CHEMBL2185	Homo sapiens	IC50	nM	226.0
	12112643	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	NS(=O)(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170415	=	IC50	nM	56.6	CHEMBL2185	Homo sapiens	IC50	nM	56.6
	12112644	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	IC50	nM	10.7	CHEMBL2185	Homo sapiens	IC50	nM	10.7
	12112645	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	O=C(NCCO)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170413	=	IC50	nM	40.4	CHEMBL2185	Homo sapiens	IC50	nM	40.4
	12112646	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	Fc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170412	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	nM	30.0
	12112647	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	Fc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170411	=	IC50	nM	25.6	CHEMBL2185	Homo sapiens	IC50	nM	25.6
	12112648	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	NS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170410	=	IC50	nM	43.3	CHEMBL2185	Homo sapiens	IC50	nM	43.3
	12112649	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL2170409	=	IC50	nM	194.0	CHEMBL2185	Homo sapiens	IC50	nM	194.0
	12112650	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	COc1cc(Nc2nccc(Nc3ccccc3Cl)n2)ccc1C(=O)O		CHEMBL2170408	=	IC50	nM	1510.0	CHEMBL2185	Homo sapiens	IC50	nM	1510.0
	12112651	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	O=c1[nH]c2ccc(Nc3nccc(Nc4ccccc4Cl)n3)cc2[nH]1		CHEMBL2170407	=	IC50	nM	361.0	CHEMBL2185	Homo sapiens	IC50	nM	361.0
	12112652	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	CC(=O)Nc1cccc(Nc2nccc(Nc3ccccc3Cl)n2)c1		CHEMBL2170406	=	IC50	nM	174.0	CHEMBL2185	Homo sapiens	IC50	nM	174.0
	12112653	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	CS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170405	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	nM	180.0
	12112654	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	COCCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170404	=	IC50	nM	123.0	CHEMBL2185	Homo sapiens	IC50	nM	123.0
	12112655	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	CN(C)CCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170591	=	IC50	nM	93.9	CHEMBL2185	Homo sapiens	IC50	nM	93.9
	12112656	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	O=C(NCCN1CCOCC1)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170590	=	IC50	nM	232.0	CHEMBL2185	Homo sapiens	IC50	nM	232.0
	12112657	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	=	IC50	nM	42.9	CHEMBL2185	Homo sapiens	IC50	nM	42.9
	12112658	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	IC50	nM	193.0	CHEMBL2185	Homo sapiens	IC50	nM	193.0
	12112659	CHEMBL2173309	Inhibition of Aurora B by 33P minase hotspot assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	12113653	CHEMBL2173312	Inhibition of Aurora B kinase using LRRASLG as substrate by Z-LYTE assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	5400.0	CHEMBL2185	Homo sapiens	IC50	uM	5.4
	12116243	CHEMBL2172949	Inhibition of Aurora B	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL2171124	=	IC50	nM	407.0	CHEMBL2185	Homo sapiens	IC50	nM	407.0
	12116244	CHEMBL2172949	Inhibition of Aurora B	B	Nc1ncc(-c2cccnc2)c2scc(-c3ccc4c(c3)CCN4C(=O)Cc3ccccc3)c12		CHEMBL2171128	=	IC50	nM	457.0	CHEMBL2185	Homo sapiens	IC50	nM	457.0
	12116245	CHEMBL2172949	Inhibition of Aurora B	B	Nc1ncnc2scc(-c3ccc(NC(=O)Cc4cc(F)ccc4F)cc3)c12		CHEMBL2171127	=	IC50	nM	58.0	CHEMBL2185	Homo sapiens	IC50	nM	58.0
	12139731	CHEMBL2184772	Inhibition of human Aurora kinase B/INCEP complex expressed in Escherichia coli BL21 (DE3) using gamma-[32P]ATP incubated for 1 hr by autoradiography	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	12139734	CHEMBL2184772	Inhibition of human Aurora kinase B/INCEP complex expressed in Escherichia coli BL21 (DE3) using gamma-[32P]ATP incubated for 1 hr by autoradiography	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	12139737	CHEMBL2184772	Inhibition of human Aurora kinase B/INCEP complex expressed in Escherichia coli BL21 (DE3) using gamma-[32P]ATP incubated for 1 hr by autoradiography	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	12170841	CHEMBL2212708	Inhibition of Aurora B assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL2185	Homo sapiens	Activity	%	86.0
	12172142	CHEMBL2209220	Inhibition of Aurora B assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL2185	Homo sapiens	Activity	%	86.0
	12173732	CHEMBL2212070	Inhibition of AURKB assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	12174096	CHEMBL2214091	Binding affinity to Aurora B kinase	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	Kd	nM	48.0	CHEMBL2185	Homo sapiens	Kd	nM	48.0
	12175182	CHEMBL2210708	Inhibition of aurora B	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	4000.0	CHEMBL2185	Homo sapiens	IC50	nM	4000.0
	12175371	CHEMBL2211567	Inhibition of Aurora B kinase-mediated Histone H3 phosphorylation at S10 in human HeLa cells	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	IC50	nM	148.0	CHEMBL2185	Homo sapiens	IC50	uM	0.148
	12185158	CHEMBL2216373	Inhibition of AURKB	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	12190844	CHEMBL2213798	Inhibition of Aurora B	B	Cn1cc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cn1		CHEMBL2207208	=	IC50	nM	190.0	CHEMBL2185	Homo sapiens	IC50	uM	0.19
	12190845	CHEMBL2213798	Inhibition of Aurora B	B	O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C1CC1)C1CCC1		CHEMBL2207198	=	IC50	nM	700.0	CHEMBL2185	Homo sapiens	IC50	uM	0.7
	12213592	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	108.0	CHEMBL2185	Homo sapiens	Residual Activity	%	108.0
	12213593	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	76.0	CHEMBL2185	Homo sapiens	Residual Activity	%	76.0
	12213594	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	68.0	CHEMBL2185	Homo sapiens	Residual Activity	%	68.0
	12213595	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	114.0	CHEMBL2185	Homo sapiens	Residual Activity	%	114.0
	12213596	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	43.0	CHEMBL2185	Homo sapiens	Residual Activity	%	43.0
	12213597	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	105.0	CHEMBL2185	Homo sapiens	Residual Activity	%	105.0
	12213598	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12213599	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	64.0	CHEMBL2185	Homo sapiens	Residual Activity	%	64.0
	12213600	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	80.0	CHEMBL2185	Homo sapiens	Residual Activity	%	80.0
	12213601	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	45.0	CHEMBL2185	Homo sapiens	Residual Activity	%	45.0
	12213602	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	114.0	CHEMBL2185	Homo sapiens	Residual Activity	%	114.0
	12213603	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	100.0	CHEMBL2185	Homo sapiens	Residual Activity	%	100.0
	12213604	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	101.0	CHEMBL2185	Homo sapiens	Residual Activity	%	101.0
	12213605	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	130.0	CHEMBL2185	Homo sapiens	Residual Activity	%	130.0
	12213606	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	104.0	CHEMBL2185	Homo sapiens	Residual Activity	%	104.0
	12213607	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	74.0	CHEMBL2185	Homo sapiens	Residual Activity	%	74.0
	12213608	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	139.0	CHEMBL2185	Homo sapiens	Residual Activity	%	139.0
	12213609	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	130.0	CHEMBL2185	Homo sapiens	Residual Activity	%	130.0
	12213610	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	69.0	CHEMBL2185	Homo sapiens	Residual Activity	%	69.0
	12213611	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213612	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	124.0	CHEMBL2185	Homo sapiens	Residual Activity	%	124.0
	12213613	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	124.0	CHEMBL2185	Homo sapiens	Residual Activity	%	124.0
	12213614	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	108.0	CHEMBL2185	Homo sapiens	Residual Activity	%	108.0
	12213615	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	100.0	CHEMBL2185	Homo sapiens	Residual Activity	%	100.0
	12213616	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	112.0	CHEMBL2185	Homo sapiens	Residual Activity	%	112.0
	12213617	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	56.0	CHEMBL2185	Homo sapiens	Residual Activity	%	56.0
	12213618	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	9.0	CHEMBL2185	Homo sapiens	Residual Activity	%	9.0
	12213619	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	43.0	CHEMBL2185	Homo sapiens	Residual Activity	%	43.0
	12213620	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	15.0	CHEMBL2185	Homo sapiens	Residual Activity	%	15.0
	12213621	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	99.0	CHEMBL2185	Homo sapiens	Residual Activity	%	99.0
	12213622	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	75.0	CHEMBL2185	Homo sapiens	Residual Activity	%	75.0
	12213623	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12213624	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	116.0	CHEMBL2185	Homo sapiens	Residual Activity	%	116.0
	12213625	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	110.0	CHEMBL2185	Homo sapiens	Residual Activity	%	110.0
	12213626	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	110.0	CHEMBL2185	Homo sapiens	Residual Activity	%	110.0
	12213627	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	109.0	CHEMBL2185	Homo sapiens	Residual Activity	%	109.0
	12213628	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	43.0	CHEMBL2185	Homo sapiens	Residual Activity	%	43.0
	12213629	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	92.0	CHEMBL2185	Homo sapiens	Residual Activity	%	92.0
	12213630	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	106.0	CHEMBL2185	Homo sapiens	Residual Activity	%	106.0
	12213631	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	18.0	CHEMBL2185	Homo sapiens	Residual Activity	%	18.0
	12213632	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	141.0	CHEMBL2185	Homo sapiens	Residual Activity	%	141.0
	12213633	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	100.0	CHEMBL2185	Homo sapiens	Residual Activity	%	100.0
	12213634	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12213635	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL2185	Homo sapiens	Residual Activity	%	4.0
	12213636	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12213637	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	92.0	CHEMBL2185	Homo sapiens	Residual Activity	%	92.0
	12213638	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	105.0	CHEMBL2185	Homo sapiens	Residual Activity	%	105.0
	12213639	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12213640	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	89.0	CHEMBL2185	Homo sapiens	Residual Activity	%	89.0
	12213641	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL2185	Homo sapiens	Residual Activity	%	98.0
	12213642	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	39.0	CHEMBL2185	Homo sapiens	Residual Activity	%	39.0
	12213643	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	43.0	CHEMBL2185	Homo sapiens	Residual Activity	%	43.0
	12213644	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12213645	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12213646	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	108.0	CHEMBL2185	Homo sapiens	Residual Activity	%	108.0
	12213647	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	103.0	CHEMBL2185	Homo sapiens	Residual Activity	%	103.0
	12213648	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12213649	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	95.0	CHEMBL2185	Homo sapiens	Residual Activity	%	95.0
	12213650	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	39.0	CHEMBL2185	Homo sapiens	Residual Activity	%	39.0
	12213651	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	89.0	CHEMBL2185	Homo sapiens	Residual Activity	%	89.0
	12213652	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	51.0	CHEMBL2185	Homo sapiens	Residual Activity	%	51.0
	12213653	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213654	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	81.0	CHEMBL2185	Homo sapiens	Residual Activity	%	81.0
	12213655	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	86.0	CHEMBL2185	Homo sapiens	Residual Activity	%	86.0
	12213656	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	76.0	CHEMBL2185	Homo sapiens	Residual Activity	%	76.0
	12213657	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	13.0	CHEMBL2185	Homo sapiens	Residual Activity	%	13.0
	12213658	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	72.0	CHEMBL2185	Homo sapiens	Residual Activity	%	72.0
	12213659	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	79.0	CHEMBL2185	Homo sapiens	Residual Activity	%	79.0
	12213660	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	71.0	CHEMBL2185	Homo sapiens	Residual Activity	%	71.0
	12213661	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	28.0	CHEMBL2185	Homo sapiens	Residual Activity	%	28.0
	12213662	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	87.0	CHEMBL2185	Homo sapiens	Residual Activity	%	87.0
	12213663	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213664	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	31.0	CHEMBL2185	Homo sapiens	Residual Activity	%	31.0
	12213665	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12213666	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	67.0	CHEMBL2185	Homo sapiens	Residual Activity	%	67.0
	12213667	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12213668	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	74.0	CHEMBL2185	Homo sapiens	Residual Activity	%	74.0
	12213669	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	7.0	CHEMBL2185	Homo sapiens	Residual Activity	%	7.0
	12213670	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	83.0	CHEMBL2185	Homo sapiens	Residual Activity	%	83.0
	12213671	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213672	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL2185	Homo sapiens	Residual Activity	%	101.0
	12213673	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	-2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-2.0
	12213674	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	5.0	CHEMBL2185	Homo sapiens	Residual Activity	%	5.0
	12213675	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	73.0	CHEMBL2185	Homo sapiens	Residual Activity	%	73.0
	12213676	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12213677	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL2185	Homo sapiens	Residual Activity	%	107.0
	12213678	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	46.0	CHEMBL2185	Homo sapiens	Residual Activity	%	46.0
	12213679	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	102.0	CHEMBL2185	Homo sapiens	Residual Activity	%	102.0
	12213680	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	105.0	CHEMBL2185	Homo sapiens	Residual Activity	%	105.0
	12213681	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213682	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	93.0	CHEMBL2185	Homo sapiens	Residual Activity	%	93.0
	12213683	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	91.0	CHEMBL2185	Homo sapiens	Residual Activity	%	91.0
	12213684	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	-2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-2.0
	12213685	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	104.0	CHEMBL2185	Homo sapiens	Residual Activity	%	104.0
	12213686	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	112.0	CHEMBL2185	Homo sapiens	Residual Activity	%	112.0
	12213687	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	115.0	CHEMBL2185	Homo sapiens	Residual Activity	%	115.0
	12213688	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	110.0	CHEMBL2185	Homo sapiens	Residual Activity	%	110.0
	12213689	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL2185	Homo sapiens	Residual Activity	%	105.0
	12213690	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	104.0	CHEMBL2185	Homo sapiens	Residual Activity	%	104.0
	12213691	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	5.0	CHEMBL2185	Homo sapiens	Residual Activity	%	5.0
	12213692	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12213693	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12213694	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	113.0	CHEMBL2185	Homo sapiens	Residual Activity	%	113.0
	12213695	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12213696	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	48.0	CHEMBL2185	Homo sapiens	Residual Activity	%	48.0
	12213697	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	99.0	CHEMBL2185	Homo sapiens	Residual Activity	%	99.0
	12213698	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	111.0	CHEMBL2185	Homo sapiens	Residual Activity	%	111.0
	12213699	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	93.0	CHEMBL2185	Homo sapiens	Residual Activity	%	93.0
	12213700	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	59.0	CHEMBL2185	Homo sapiens	Residual Activity	%	59.0
	12213701	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	69.0	CHEMBL2185	Homo sapiens	Residual Activity	%	69.0
	12213702	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	114.0	CHEMBL2185	Homo sapiens	Residual Activity	%	114.0
	12213703	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	44.0	CHEMBL2185	Homo sapiens	Residual Activity	%	44.0
	12213704	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	8.0	CHEMBL2185	Homo sapiens	Residual Activity	%	8.0
	12213705	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	94.0	CHEMBL2185	Homo sapiens	Residual Activity	%	94.0
	12213706	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	68.0	CHEMBL2185	Homo sapiens	Residual Activity	%	68.0
	12213707	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	88.0	CHEMBL2185	Homo sapiens	Residual Activity	%	88.0
	12213708	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213709	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	90.0	CHEMBL2185	Homo sapiens	Residual Activity	%	90.0
	12213710	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	111.0	CHEMBL2185	Homo sapiens	Residual Activity	%	111.0
	12213711	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	115.0	CHEMBL2185	Homo sapiens	Residual Activity	%	115.0
	12213712	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12213713	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	21.0	CHEMBL2185	Homo sapiens	Residual Activity	%	21.0
	12213714	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	13.0	CHEMBL2185	Homo sapiens	Residual Activity	%	13.0
	12213715	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	77.0	CHEMBL2185	Homo sapiens	Residual Activity	%	77.0
	12213716	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12213717	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	106.0	CHEMBL2185	Homo sapiens	Residual Activity	%	106.0
	12213718	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	72.0	CHEMBL2185	Homo sapiens	Residual Activity	%	72.0
	12213719	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	124.0	CHEMBL2185	Homo sapiens	Residual Activity	%	124.0
	12213720	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213721	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12213722	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	95.0	CHEMBL2185	Homo sapiens	Residual Activity	%	95.0
	12213723	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	91.0	CHEMBL2185	Homo sapiens	Residual Activity	%	91.0
	12213724	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213725	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	73.0	CHEMBL2185	Homo sapiens	Residual Activity	%	73.0
	12213726	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	9.0	CHEMBL2185	Homo sapiens	Residual Activity	%	9.0
	12213727	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	14.0	CHEMBL2185	Homo sapiens	Residual Activity	%	14.0
	12213728	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	77.0	CHEMBL2185	Homo sapiens	Residual Activity	%	77.0
	12213729	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12213730	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12213731	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	75.0	CHEMBL2185	Homo sapiens	Residual Activity	%	75.0
	12213732	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	26.0	CHEMBL2185	Homo sapiens	Residual Activity	%	26.0
	12213733	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	43.0	CHEMBL2185	Homo sapiens	Residual Activity	%	43.0
	12213734	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	64.0	CHEMBL2185	Homo sapiens	Residual Activity	%	64.0
	12213735	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	18.0	CHEMBL2185	Homo sapiens	Residual Activity	%	18.0
	12213736	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	89.0	CHEMBL2185	Homo sapiens	Residual Activity	%	89.0
	12213737	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	69.0	CHEMBL2185	Homo sapiens	Residual Activity	%	69.0
	12213738	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	19.0	CHEMBL2185	Homo sapiens	Residual Activity	%	19.0
	12213739	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	51.0	CHEMBL2185	Homo sapiens	Residual Activity	%	51.0
	12213740	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	55.0	CHEMBL2185	Homo sapiens	Residual Activity	%	55.0
	12213741	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	67.0	CHEMBL2185	Homo sapiens	Residual Activity	%	67.0
	12213742	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	21.0	CHEMBL2185	Homo sapiens	Residual Activity	%	21.0
	12213743	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	60.0	CHEMBL2185	Homo sapiens	Residual Activity	%	60.0
	12213744	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	80.0	CHEMBL2185	Homo sapiens	Residual Activity	%	80.0
	12213745	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	14.0	CHEMBL2185	Homo sapiens	Residual Activity	%	14.0
	12213746	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	69.0	CHEMBL2185	Homo sapiens	Residual Activity	%	69.0
	12213747	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	41.0	CHEMBL2185	Homo sapiens	Residual Activity	%	41.0
	12213748	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	69.0	CHEMBL2185	Homo sapiens	Residual Activity	%	69.0
	12213749	CHEMBL2218950	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12213750	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	45.0	CHEMBL2185	Homo sapiens	Residual Activity	%	45.0
	12213751	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	20.0	CHEMBL2185	Homo sapiens	Residual Activity	%	20.0
	12213752	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	30.0	CHEMBL2185	Homo sapiens	Residual Activity	%	30.0
	12213753	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	127.0	CHEMBL2185	Homo sapiens	Residual Activity	%	127.0
	12213754	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	10.0	CHEMBL2185	Homo sapiens	Residual Activity	%	10.0
	12213755	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	68.0	CHEMBL2185	Homo sapiens	Residual Activity	%	68.0
	12213756	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12213757	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	8.0	CHEMBL2185	Homo sapiens	Residual Activity	%	8.0
	12213758	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	16.0	CHEMBL2185	Homo sapiens	Residual Activity	%	16.0
	12213759	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12213760	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	85.0	CHEMBL2185	Homo sapiens	Residual Activity	%	85.0
	12213761	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	40.0	CHEMBL2185	Homo sapiens	Residual Activity	%	40.0
	12213762	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	67.0	CHEMBL2185	Homo sapiens	Residual Activity	%	67.0
	12213763	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	87.0	CHEMBL2185	Homo sapiens	Residual Activity	%	87.0
	12213764	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	46.0	CHEMBL2185	Homo sapiens	Residual Activity	%	46.0
	12213765	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	61.0	CHEMBL2185	Homo sapiens	Residual Activity	%	61.0
	12213766	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	91.0	CHEMBL2185	Homo sapiens	Residual Activity	%	91.0
	12213767	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	60.0	CHEMBL2185	Homo sapiens	Residual Activity	%	60.0
	12213768	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	46.0	CHEMBL2185	Homo sapiens	Residual Activity	%	46.0
	12213769	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12213770	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	47.0	CHEMBL2185	Homo sapiens	Residual Activity	%	47.0
	12213771	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	120.0	CHEMBL2185	Homo sapiens	Residual Activity	%	120.0
	12213772	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL2185	Homo sapiens	Residual Activity	%	90.0
	12213773	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	37.0	CHEMBL2185	Homo sapiens	Residual Activity	%	37.0
	12213774	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	106.0	CHEMBL2185	Homo sapiens	Residual Activity	%	106.0
	12213775	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	7.0	CHEMBL2185	Homo sapiens	Residual Activity	%	7.0
	12213776	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12213777	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12213778	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	7.0	CHEMBL2185	Homo sapiens	Residual Activity	%	7.0
	12213779	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	79.0	CHEMBL2185	Homo sapiens	Residual Activity	%	79.0
	12213780	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	51.0	CHEMBL2185	Homo sapiens	Residual Activity	%	51.0
	12213781	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213782	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	77.0	CHEMBL2185	Homo sapiens	Residual Activity	%	77.0
	12213783	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	90.0	CHEMBL2185	Homo sapiens	Residual Activity	%	90.0
	12213784	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	76.0	CHEMBL2185	Homo sapiens	Residual Activity	%	76.0
	12213785	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	83.0	CHEMBL2185	Homo sapiens	Residual Activity	%	83.0
	12213786	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12213787	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	73.0	CHEMBL2185	Homo sapiens	Residual Activity	%	73.0
	12213788	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	95.0	CHEMBL2185	Homo sapiens	Residual Activity	%	95.0
	12213789	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	8.0	CHEMBL2185	Homo sapiens	Residual Activity	%	8.0
	12213790	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	103.0	CHEMBL2185	Homo sapiens	Residual Activity	%	103.0
	12213791	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	95.0	CHEMBL2185	Homo sapiens	Residual Activity	%	95.0
	12213792	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12213793	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL2185	Homo sapiens	Residual Activity	%	4.0
	12213794	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12213795	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	70.0	CHEMBL2185	Homo sapiens	Residual Activity	%	70.0
	12213796	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	88.0	CHEMBL2185	Homo sapiens	Residual Activity	%	88.0
	12213797	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12213798	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	34.0	CHEMBL2185	Homo sapiens	Residual Activity	%	34.0
	12213799	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	92.0	CHEMBL2185	Homo sapiens	Residual Activity	%	92.0
	12213800	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	7.0	CHEMBL2185	Homo sapiens	Residual Activity	%	7.0
	12216632	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12216633	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216634	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12216635	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	97.0	CHEMBL2185	Homo sapiens	Residual Activity	%	97.0
	12216636	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	98.0	CHEMBL2185	Homo sapiens	Residual Activity	%	98.0
	12216637	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216638	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	115.0	CHEMBL2185	Homo sapiens	Residual Activity	%	115.0
	12216639	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	4.0	CHEMBL2185	Homo sapiens	Residual Activity	%	4.0
	12216640	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	83.0	CHEMBL2185	Homo sapiens	Residual Activity	%	83.0
	12216641	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12216642	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12216643	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	62.0	CHEMBL2185	Homo sapiens	Residual Activity	%	62.0
	12216644	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	65.0	CHEMBL2185	Homo sapiens	Residual Activity	%	65.0
	12216645	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	63.0	CHEMBL2185	Homo sapiens	Residual Activity	%	63.0
	12216646	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	4.0	CHEMBL2185	Homo sapiens	Residual Activity	%	4.0
	12216647	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	68.0	CHEMBL2185	Homo sapiens	Residual Activity	%	68.0
	12216648	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	63.0	CHEMBL2185	Homo sapiens	Residual Activity	%	63.0
	12216649	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	39.0	CHEMBL2185	Homo sapiens	Residual Activity	%	39.0
	12216650	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	9.0	CHEMBL2185	Homo sapiens	Residual Activity	%	9.0
	12216651	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	75.0	CHEMBL2185	Homo sapiens	Residual Activity	%	75.0
	12216652	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12216653	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	7.0	CHEMBL2185	Homo sapiens	Residual Activity	%	7.0
	12216654	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12216655	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	18.0	CHEMBL2185	Homo sapiens	Residual Activity	%	18.0
	12216656	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12216657	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	64.0	CHEMBL2185	Homo sapiens	Residual Activity	%	64.0
	12216658	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12216659	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	50.0	CHEMBL2185	Homo sapiens	Residual Activity	%	50.0
	12216660	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12216661	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	87.0	CHEMBL2185	Homo sapiens	Residual Activity	%	87.0
	12216662	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12216663	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	4.0	CHEMBL2185	Homo sapiens	Residual Activity	%	4.0
	12216664	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	82.0	CHEMBL2185	Homo sapiens	Residual Activity	%	82.0
	12216665	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12216666	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	91.0	CHEMBL2185	Homo sapiens	Residual Activity	%	91.0
	12216667	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	13.0	CHEMBL2185	Homo sapiens	Residual Activity	%	13.0
	12216668	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	80.0	CHEMBL2185	Homo sapiens	Residual Activity	%	80.0
	12216669	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL2185	Homo sapiens	Residual Activity	%	92.0
	12216670	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	-2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-2.0
	12216671	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	52.0	CHEMBL2185	Homo sapiens	Residual Activity	%	52.0
	12216672	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	41.0	CHEMBL2185	Homo sapiens	Residual Activity	%	41.0
	12216673	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216674	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	90.0	CHEMBL2185	Homo sapiens	Residual Activity	%	90.0
	12216675	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	94.0	CHEMBL2185	Homo sapiens	Residual Activity	%	94.0
	12216676	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	76.0	CHEMBL2185	Homo sapiens	Residual Activity	%	76.0
	12216677	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	69.0	CHEMBL2185	Homo sapiens	Residual Activity	%	69.0
	12216678	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	88.0	CHEMBL2185	Homo sapiens	Residual Activity	%	88.0
	12216679	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	68.0	CHEMBL2185	Homo sapiens	Residual Activity	%	68.0
	12216680	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12216681	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216682	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216683	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	103.0	CHEMBL2185	Homo sapiens	Residual Activity	%	103.0
	12216684	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	4.0	CHEMBL2185	Homo sapiens	Residual Activity	%	4.0
	12216685	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	22.0	CHEMBL2185	Homo sapiens	Residual Activity	%	22.0
	12216686	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	85.0	CHEMBL2185	Homo sapiens	Residual Activity	%	85.0
	12216687	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	122.0	CHEMBL2185	Homo sapiens	Residual Activity	%	122.0
	12216688	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	52.0	CHEMBL2185	Homo sapiens	Residual Activity	%	52.0
	12216689	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	48.0	CHEMBL2185	Homo sapiens	Residual Activity	%	48.0
	12216690	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	15.0	CHEMBL2185	Homo sapiens	Residual Activity	%	15.0
	12216691	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	90.0	CHEMBL2185	Homo sapiens	Residual Activity	%	90.0
	12216692	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	25.0	CHEMBL2185	Homo sapiens	Residual Activity	%	25.0
	12216693	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12216694	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	59.0	CHEMBL2185	Homo sapiens	Residual Activity	%	59.0
	12216695	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	34.0	CHEMBL2185	Homo sapiens	Residual Activity	%	34.0
	12216696	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	66.0	CHEMBL2185	Homo sapiens	Residual Activity	%	66.0
	12216697	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12216698	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	95.0	CHEMBL2185	Homo sapiens	Residual Activity	%	95.0
	12216699	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	72.0	CHEMBL2185	Homo sapiens	Residual Activity	%	72.0
	12216700	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	88.0	CHEMBL2185	Homo sapiens	Residual Activity	%	88.0
	12216701	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216702	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12216703	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	3.0	CHEMBL2185	Homo sapiens	Residual Activity	%	3.0
	12216704	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	42.0	CHEMBL2185	Homo sapiens	Residual Activity	%	42.0
	12216705	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12216706	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	75.0	CHEMBL2185	Homo sapiens	Residual Activity	%	75.0
	12216707	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	17.0	CHEMBL2185	Homo sapiens	Residual Activity	%	17.0
	12216708	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	71.0	CHEMBL2185	Homo sapiens	Residual Activity	%	71.0
	12216709	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12216710	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216711	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	73.0	CHEMBL2185	Homo sapiens	Residual Activity	%	73.0
	12216712	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	50.0	CHEMBL2185	Homo sapiens	Residual Activity	%	50.0
	12216713	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216714	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	36.0	CHEMBL2185	Homo sapiens	Residual Activity	%	36.0
	12216715	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216716	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12216717	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	26.0	CHEMBL2185	Homo sapiens	Residual Activity	%	26.0
	12216718	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216719	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	-1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	-1.0
	12216720	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12216721	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	15.0	CHEMBL2185	Homo sapiens	Residual Activity	%	15.0
	12216722	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	8.0	CHEMBL2185	Homo sapiens	Residual Activity	%	8.0
	12216723	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	18.0	CHEMBL2185	Homo sapiens	Residual Activity	%	18.0
	12216724	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	2.0	CHEMBL2185	Homo sapiens	Residual Activity	%	2.0
	12216725	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	70.0	CHEMBL2185	Homo sapiens	Residual Activity	%	70.0
	12216726	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	58.0	CHEMBL2185	Homo sapiens	Residual Activity	%	58.0
	12216727	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	6.0	CHEMBL2185	Homo sapiens	Residual Activity	%	6.0
	12216728	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	15.0	CHEMBL2185	Homo sapiens	Residual Activity	%	15.0
	12216729	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	22.0	CHEMBL2185	Homo sapiens	Residual Activity	%	22.0
	12216730	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	62.0	CHEMBL2185	Homo sapiens	Residual Activity	%	62.0
	12216731	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	0.0	CHEMBL2185	Homo sapiens	Residual Activity	%	0.0
	12216732	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	16.0	CHEMBL2185	Homo sapiens	Residual Activity	%	16.0
	12216733	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	53.0	CHEMBL2185	Homo sapiens	Residual Activity	%	53.0
	12216734	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	9.0	CHEMBL2185	Homo sapiens	Residual Activity	%	9.0
	12216735	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	69.0	CHEMBL2185	Homo sapiens	Residual Activity	%	69.0
	12216736	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	11.0	CHEMBL2185	Homo sapiens	Residual Activity	%	11.0
	12216737	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	58.0	CHEMBL2185	Homo sapiens	Residual Activity	%	58.0
	12216738	CHEMBL2218951	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	1.0	CHEMBL2185	Homo sapiens	Residual Activity	%	1.0
	12626716	CHEMBL2316990	Inhibition of aurora B (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	12671326	CHEMBL2344167	Inhibition of aurora-B (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	2300.0	CHEMBL2185	Homo sapiens	IC50	uM	2.3
	12671327	CHEMBL2344167	Inhibition of aurora-B (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	uM	0.5
	12671328	CHEMBL2344167	Inhibition of aurora-B (unknown origin)	B	O=C1NCCc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)CCNC(=O)/C(=N/O)Cc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)C/C1=N\O		CHEMBL510730	=	IC50	nM	2900.0	CHEMBL2185	Homo sapiens	IC50	uM	2.9
	12671329	CHEMBL2344167	Inhibition of aurora-B (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	2600.0	CHEMBL2185	Homo sapiens	IC50	uM	2.6
	12671330	CHEMBL2344167	Inhibition of aurora-B (unknown origin)	B	O=C1NCCc2ccc(O)c(c2)Oc2c(Br)cc(cc2Br)CCNC(=O)/C(=N/O)Cc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)C/C1=N\O		CHEMBL2333164	=	IC50	nM	1600.0	CHEMBL2185	Homo sapiens	IC50	uM	1.6
	12673095	CHEMBL2345633	Inhibition of recombinant AURB (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	70.0	CHEMBL2185	Homo sapiens	Activity	%	70.0
	12673096	CHEMBL2345633	Inhibition of recombinant AURB (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	47.0	CHEMBL2185	Homo sapiens	Activity	%	47.0
	12675477	CHEMBL2344399	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12705258	CHEMBL2345796	Inhibition of aurora-B (unknown origin)	B	CN1c2ccc(NCc3ccc(C(C)(C)C)cc3)cc2-c2c(cnn2C)S1(=O)=O		CHEMBL2333444	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12705259	CHEMBL2345796	Inhibition of aurora-B (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2c(cnn2C)S(=O)(=O)N3C)cc1		CHEMBL2333435	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	12705260	CHEMBL2345796	Inhibition of aurora-B (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	IC50	nM	5100.0	CHEMBL2185	Homo sapiens	IC50	uM	5.1
	12718782	CHEMBL2350668	Inhibition of Aurora B (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
	12718806	CHEMBL2350691	Inhibition of Aurora B (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	25.0	CHEMBL2185	Homo sapiens	INH	%	25.0
	12718829	CHEMBL2350981	Inhibition of Aurora B (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	34.0	CHEMBL2185	Homo sapiens	INH	%	34.0
	12721825	CHEMBL2353810	Inhibition of AURKB (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	12728087	CHEMBL2351302	Inhibition of N-terminal His6x-tagged aurora-B (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-33P]ATP addition measured after 60 mins by scintillation counting analysis	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	12728895	CHEMBL2350228	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	89.0	CHEMBL2185	Homo sapiens	Activity	%	89.0
	12730037	CHEMBL2353912	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	102.0	CHEMBL2185	Homo sapiens	Activity	%	102.0
	12730931	CHEMBL2350104	Inhibition of Aurora B (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	86.0	CHEMBL2185	Homo sapiens	Activity	%	86.0
	12731174	CHEMBL2350228	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL2185	Homo sapiens	Activity	%	98.0
Active	13300200	CHEMBL2384447	Inhibition of human Aurora B at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13301271	CHEMBL2384612	Inhibition of aurora-B in human MIAPaCa2 cells assessed as reduction of phosphorylation of histone H3	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1C(F)(F)F		CHEMBL2380834	=	IC50	nM	52.0	CHEMBL2185	Homo sapiens	IC50	nM	52.0
	13301272	CHEMBL2384612	Inhibition of aurora-B in human MIAPaCa2 cells assessed as reduction of phosphorylation of histone H3	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	208.0	CHEMBL2185	Homo sapiens	IC50	nM	208.0
	13301307	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	COc1cccc(F)c1C(=O)Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380838	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
Not Determined	13301308	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cc(F)cc(C(F)(F)F)c1		CHEMBL2380837		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	13301309	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(C(F)(F)F)cc1F		CHEMBL2380836		IC50			CHEMBL2185	Homo sapiens	IC50		
	13301310	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cccc(C(F)(F)F)c1F		CHEMBL2380835	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	13301311	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1C(F)(F)F		CHEMBL2380834	=	IC50	nM	0.4	CHEMBL2185	Homo sapiens	IC50	nM	0.4
	13301312	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cc(F)cc(F)c1		CHEMBL2380833	=	IC50	nM	0.7	CHEMBL2185	Homo sapiens	IC50	nM	0.7
	13301313	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)c(F)c1		CHEMBL2380832	=	IC50	nM	0.8	CHEMBL2185	Homo sapiens	IC50	nM	0.8
	13301314	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1c(F)cccc1F		CHEMBL2380831	=	IC50	nM	0.6	CHEMBL2185	Homo sapiens	IC50	nM	0.6
	13301315	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1F		CHEMBL2380830	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	13301316	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cccc(F)c1F		CHEMBL2380829	=	IC50	nM	0.5	CHEMBL2185	Homo sapiens	IC50	nM	0.5
	13301317	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(C(F)(F)F)cc1		CHEMBL2380828	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	nM	6.0
	13301318	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1		CHEMBL2380827	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	13301319	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(Nc3ccnc4[nH]c(=O)c5ccccc5c34)cc2)cc1		CHEMBL2380826	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	13301320	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cccc(F)c1		CHEMBL2380825	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	13301321	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1C(F)(F)F		CHEMBL2380824	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	13301322	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1F		CHEMBL2380823	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	13301323	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	COc1ccccc1C(=O)Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380839	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	13301324	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ncc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cn1)c1ccccc1		CHEMBL2380848	=	IC50	nM	21.0	CHEMBL2185	Homo sapiens	IC50	nM	21.0
	13301325	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)nc1)c1ccccc1		CHEMBL2380847	=	IC50	nM	79.0	CHEMBL2185	Homo sapiens	IC50	nM	79.0
	13301326	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cn1)c1ccccc1		CHEMBL2380846	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	13301327	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
Not Determined	13301328	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	CNc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380844		IC50			CHEMBL2185	Homo sapiens	IC50		
	13301329	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380843	=	IC50	nM	174.0	CHEMBL2185	Homo sapiens	IC50	nM	174.0
Not Determined	13301330	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=c1[nH]c2nccc(Nc3ccccc3)c2c2ccccc12		CHEMBL2380842		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	13301331	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	Nc1ccnc2[nH]c(=O)c3ccccc3c12		CHEMBL2380841		IC50			CHEMBL2185	Homo sapiens	IC50		
	13301332	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	O=c1[nH]c2nccc(Cl)c2c2ccccc12		CHEMBL2380840	=	IC50	nM	1440.0	CHEMBL2185	Homo sapiens	IC50	nM	1440.0
Not Determined	13301333	CHEMBL2382840	Inhibition of aurora-B (unknown origin)	B	Oc1nc2ncccc2c2ccccc12		CHEMBL110381		IC50			CHEMBL2185	Homo sapiens	IC50		
Active	13301920	CHEMBL2383379	Inhibition of human AURKB at 1 uM relative to control	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13301921	CHEMBL2383379	Inhibition of human AURKB at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2n[nH]c3cc(-c4cnn(C)c4)c(NC4CCCCC4)cc23)c1		CHEMBL2380587	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	13301922	CHEMBL2383379	Inhibition of human AURKB at 1 uM relative to control	B	Cn1cc(-c2cc3[nH]nc(-c4cccc(S(N)(=O)=O)c4)c3cc2NC2CCCCC2)cn1		CHEMBL2380586	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	13327704	CHEMBL2390010	Inhibition of AURKB (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	79.0	CHEMBL2185	Homo sapiens	INH	%	79.0
	13327705	CHEMBL2390010	Inhibition of AURKB (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	79.0	CHEMBL2185	Homo sapiens	INH	%	79.0
	13343475	CHEMBL2396194	Inhibition of aurora B (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	13343476	CHEMBL2396194	Inhibition of aurora B (unknown origin)	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Ki	nM	0.37	CHEMBL2185	Homo sapiens	Ki	nM	0.37
Dose-dependent effect	13343481	CHEMBL2396198	Inhibition of aurora B-mediated histone H3 phosphorylation at ser 10 residue in human A549 cells after 24 hrs by immunofluorescence method	B	CS(=O)(=O)c1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(CN4CCOCC4)ccc3[nH]2)n1		CHEMBL2392111		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13343482	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	2.7	CHEMBL2185	Homo sapiens	IC50	nM	2.7
	13343483	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(S(C)(=O)=O)n3)nc2c1		CHEMBL2392113	=	IC50	nM	392.3	CHEMBL2185	Homo sapiens	IC50	nM	392.3
	13343484	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(S(C)(=O)=O)n3)nc2c1		CHEMBL2392112	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
	13343485	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	CS(=O)(=O)c1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(CN4CCOCC4)ccc3[nH]2)n1		CHEMBL2392111	=	IC50	nM	2.2	CHEMBL2185	Homo sapiens	IC50	nM	2.2
	13343486	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(Sc4ccc(NC(=O)C5CC5)cc4)n3)nc2c1		CHEMBL2392110	=	IC50	nM	424.1	CHEMBL2185	Homo sapiens	IC50	nM	424.1
	13343487	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(SC)n3)nc2c1		CHEMBL2392109	=	IC50	nM	98.8	CHEMBL2185	Homo sapiens	IC50	nM	98.8
	13343488	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(C)n3)nc2c1		CHEMBL2392108	=	IC50	nM	1201.0	CHEMBL2185	Homo sapiens	IC50	nM	1201.0
Not Determined	13343489	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(Sc4ccc(NC(=O)C5CC5)cc4)n3)nc2c1		CHEMBL2392107		IC50			CHEMBL2185	Homo sapiens	IC50		
	13343490	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	CSc1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(C)ccc3[nH]2)n1		CHEMBL2392106	=	IC50	nM	231.3	CHEMBL2185	Homo sapiens	IC50	nM	231.3
	13343491	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(C)n3)nc2c1		CHEMBL2392105	=	IC50	nM	138.6	CHEMBL2185	Homo sapiens	IC50	nM	138.6
	13343492	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	O=C(Nc1ccc(Sc2nc(Cl)cc(Nc3c[nH]nc3-c3nc4cc(CN5CCCCC5)ccc4[nH]3)n2)cc1)C1CC1		CHEMBL2392104	=	IC50	nM	191.0	CHEMBL2185	Homo sapiens	IC50	nM	191.0
	13343493	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	O=C(Nc1ccc(Sc2nc(Cl)cc(Nc3c[nH]nc3-c3nc4cc(CN5CCOCC5)ccc4[nH]3)n2)cc1)C1CC1		CHEMBL2392103	=	IC50	nM	412.3	CHEMBL2185	Homo sapiens	IC50	nM	412.3
	13343494	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	CSc1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(CN4CCOCC4)ccc3[nH]2)n1		CHEMBL2392102	=	IC50	nM	143.9	CHEMBL2185	Homo sapiens	IC50	nM	143.9
	13343495	CHEMBL2396199	Inhibition of aurora B (unknown origin) by HTRF assay	B	Cc1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(CN4CCOCC4)ccc3[nH]2)n1		CHEMBL2392101	=	IC50	nM	91.8	CHEMBL2185	Homo sapiens	IC50	nM	91.8
Active	13358542	CHEMBL2400274	Inhibition of Aurora kinase B in human HeLa cells assessed as delay in mitotic arrest by accumulation of multinucleated cells with 4N/8N DNA content at 10 to 1000 nM after 48 hrs by propidium iodide staining-based FACS flow cytometric analysis	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	13358543	CHEMBL2400274	Inhibition of Aurora kinase B in human HeLa cells assessed as delay in mitotic arrest by accumulation of multinucleated cells with 4N/8N DNA content at 10 to 1000 nM after 48 hrs by propidium iodide staining-based FACS flow cytometric analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2185	Homo sapiens	Activity		
Not Active	13358548	CHEMBL2400279	Inhibition of Aurora kinase B-mediated histone H3 phosphorylation at Ser10 in human HCT116 cells at 50 nM after 2 hrs by Western blotting analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	13358551	CHEMBL2400282	Inhibition of Aurora kinase B-mediated histone H3 phosphorylation at Ser10 in human HCT116 cells at 4 to 1000 nM after 2 hrs by Western blotting analysis	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	13358552	CHEMBL2400283	Inhibition of Aurora kinase B-mediated histone H3 phosphorylation at Ser10 in human HCT116 cells after 2 hrs by Western blotting analysis	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13358592	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CCN(CCO)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398641	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	13358593	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CCN(CCO)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398641	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	13358594	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCOCC5)cc4)cc23)cc1		CHEMBL2398640	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	13358595	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN1CCN(CCOc2ccc(-c3cc4c(NCCc5ccc(NC(=O)Nc6ccccc6)cc5)ncnc4o3)cc2)CC1		CHEMBL2398639	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	13358596	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	13358598	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCCC5)cc4)cc23)cc1		CHEMBL2398660	=	Inhibition	%	85.1	CHEMBL2185	Homo sapiens	INH	%	85.1
	13358601	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCC(O)CC5)cc4)cc23)cc1		CHEMBL2398642	=	Inhibition	%	76.6	CHEMBL2185	Homo sapiens	INH	%	76.6
	13358602	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN1CCN(CCOc2ccc(-c3cc4c(NCCc5ccc(NC(=O)Nc6ccccc6)cc5)ncnc4o3)cc2)CC1		CHEMBL2398639	=	Inhibition	%	76.4	CHEMBL2185	Homo sapiens	INH	%	76.4
	13358603	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657	=	Inhibition	%	76.4	CHEMBL2185	Homo sapiens	INH	%	76.4
	13358604	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CCCCN(CCCC)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398659	=	Inhibition	%	75.3	CHEMBL2185	Homo sapiens	INH	%	75.3
	13358605	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)cc23)cc1		CHEMBL2398655	=	Inhibition	%	73.6	CHEMBL2185	Homo sapiens	INH	%	73.6
	13358606	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657	=	Inhibition	%	70.4	CHEMBL2185	Homo sapiens	INH	%	70.4
	13359777	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCC(O)CC5)cc4)cc23)cc1		CHEMBL2398642	=	Inhibition	%	70.4	CHEMBL2185	Homo sapiens	INH	%	70.4
	13359778	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN(C)CCCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398643	=	Inhibition	%	64.8	CHEMBL2185	Homo sapiens	INH	%	64.8
	13359780	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCCC5)cc4)cc23)cc1		CHEMBL2398660	=	Inhibition	%	59.2	CHEMBL2185	Homo sapiens	INH	%	59.2
	13359783	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN(C)CCCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398643	=	Inhibition	%	56.4	CHEMBL2185	Homo sapiens	INH	%	56.4
	13359784	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCOCC5)cc4)cc23)cc1		CHEMBL2398640	=	Inhibition	%	54.7	CHEMBL2185	Homo sapiens	INH	%	54.7
	13359785	CHEMBL2400290	Inhibition of Aurora kinase B (unknown origin)	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657	=	IC50	nM	53.0	CHEMBL2185	Homo sapiens	IC50	nM	53.0
	13359786	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)cc23)cc1		CHEMBL2398655	=	Inhibition	%	52.4	CHEMBL2185	Homo sapiens	INH	%	52.4
	13359789	CHEMBL2400110	Inhibition of Aurora kinase B (unknown origin) at 1 uM relative to control	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	13359796	CHEMBL2400290	Inhibition of Aurora kinase B (unknown origin)	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCC(O)CC5)cc4)cc23)cc1		CHEMBL2398642	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	nM	17.0
	13359797	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCCCC5)cc4)cc23)cc1		CHEMBL2398638	=	Inhibition	%	38.4	CHEMBL2185	Homo sapiens	INH	%	38.4
	13359799	CHEMBL2400290	Inhibition of Aurora kinase B (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	nM	30.0
	13359800	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN(C)CCOc1cccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)c1		CHEMBL2398644	=	Inhibition	%	29.2	CHEMBL2185	Homo sapiens	INH	%	29.2
	13359806	CHEMBL2400286	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CCN(CC)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398658	=	Inhibition	%	17.7	CHEMBL2185	Homo sapiens	INH	%	17.7
	13359807	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCCCC5)cc4)cc23)cc1		CHEMBL2398638	=	Inhibition	%	17.6	CHEMBL2185	Homo sapiens	INH	%	17.6
	13359808	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CCCCN(CCCC)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398659	=	Inhibition	%	10.8	CHEMBL2185	Homo sapiens	INH	%	10.8
	13359809	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CN(C)CCOc1cccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)c1		CHEMBL2398644	=	Inhibition	%	15.9	CHEMBL2185	Homo sapiens	INH	%	15.9
	13359810	CHEMBL2400285	Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 100 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	CCN(CC)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398658	=	Inhibition	%	16.3	CHEMBL2185	Homo sapiens	INH	%	16.3
	13360655	CHEMBL2400321	Inhibition of human aurora-B	B	COc1ccc2c(c1)C=C(C(=O)/C=C/c1c(OC)cc(OC)cc1OC)CO2		CHEMBL2396883	=	Inhibition	%	65.0	CHEMBL2185	Homo sapiens	INH	%	65.0
Active	13371337	CHEMBL2403983	Inhibition of Aurora B kinase in human HeLa cells assessed as inhibition of Histone H3 phosphorylation after 48 hrs by immuno-fluorescence analysis relative to control	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	13371338	CHEMBL2403984	Inhibition of Aurora B kinase in human SW620 cells assessed as inhibition of Histone H3 phosphorylation after 48 hrs by Western blotting analysis	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	13371339	CHEMBL2403985	Inhibition of Aurora B kinase phosphorylation in human SW620 cells after 48 hrs by Western blotting analysis	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	13371340	CHEMBL2403987	Inhibition of Aurora B kinase in human HepG2 cells assessed as inhibition of Histone H3 phosphorylation after 48 hrs by Western blotting analysis	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	13371341	CHEMBL2403986	Inhibition of Aurora B kinase phosphorylation in human HepG2 cells after 48 hrs by Western blotting analysis	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	13371342	CHEMBL2403989	Inhibition of Aurora B kinase in human HeLa cells assessed as inhibition of Histone H3 phosphorylation after 48 hrs by Western blotting analysis	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	13371343	CHEMBL2403988	Inhibition of Aurora B kinase phosphorylation in human HeLa cells after 48 hrs by Western blotting analysis	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13371344	CHEMBL2403990	Inhibition of Aurora B kinase (unknown origin) by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	IC50	nM	7.665	CHEMBL2185	Homo sapiens	IC50	nM	7.665
	13371359	CHEMBL2404112	Inhibition of Aurora B kinase (unknown origin) at 10 uM by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	Inhibition	%	74.39	CHEMBL2185	Homo sapiens	INH	%	74.39
Active	13371361	CHEMBL2404114	Competitive inhibition of recombinant Aurora B kinase (unknown origin) expressed in Escherichia coli by Z'-LYTE kinase assay in presence of ATP	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13371362	CHEMBL2404115	Inhibition of recombinant Aurora B kinase (unknown origin) expressed in Escherichia coli	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	IC50	nM	141.1	CHEMBL2185	Homo sapiens	IC50	nM	141.1
	13372366	CHEMBL2406469	Inhibition of aurora-B in human HT-29 cells assessed as phosphorylation of histone H3 at Ser10	B	C[C@@H](Oc1c(N)ncc2c(C3=CCN(C(N)=O)CC3)coc12)c1c(Cl)ccc(F)c1Cl		CHEMBL2401832	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	13372428	CHEMBL2406471	Inhibition of aurora-B (unknown origin) autophosphorylation	B	C[C@@H](Oc1c(N)ncc2c(C3=CCN(C(N)=O)CC3)coc12)c1c(Cl)ccc(F)c1Cl		CHEMBL2401832	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	uM	0.011
	13372447	CHEMBL2406468	Inhibition of aurora-B in human HT-29 cells assessed as phosphorylation of histone H3 at Ser10 in presence of mouse plasma	B	C[C@@H](Oc1c(N)ncc2c(C3=CCN(C(N)=O)CC3)coc12)c1c(Cl)ccc(F)c1Cl		CHEMBL2401832	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	13375943	CHEMBL2405954	Inhibition of AURKB (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL2185	Homo sapiens	INH	%	6.0
	13395047	CHEMBL2410113	Inhibition of aurora B (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL2407900	=	IC50	nM	210.0	CHEMBL2185	Homo sapiens	IC50	uM	0.21
Not Determined	13396468	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Cn1cc(-c2cnc(N)c3oc(-c4csc5cnccc45)cc23)c(C#N)n1		CHEMBL2408735		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	13396469	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Cc1nn(C)c(C)c1-c1cnc(N)c2oc(-c3csc4cnccc34)cc12		CHEMBL2408733		IC50			CHEMBL2185	Homo sapiens	IC50		
	13396478	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	COc1nn(C)cc1-c1cnc(N)c2oc(-c3csc4cnccc34)cc12		CHEMBL2408734	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	uM	20.0
	13396479	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Cc1nn(C)cc1-c1cnc(N)c2oc(-c3csc4cnccc34)cc12		CHEMBL2408731	>	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	uM	20.0
	13396480	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	N#Cc1c(-c2cccc3nnsc23)oc2c(N)ncc(-c3cnn([C@H]4CC[C@H](O)CC4)c3)c12		CHEMBL2408612	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	13396520	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Cc1c(-c2cnc(N)c3oc(-c4csc5cnccc45)cc23)cnn1C		CHEMBL2408732	=	IC50	nM	17400.0	CHEMBL2185	Homo sapiens	IC50	uM	17.4
	13396529	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(-c3cccnc3)c(-c3cccc4nnsc34)oc12		CHEMBL2408613	=	IC50	nM	6900.0	CHEMBL2185	Homo sapiens	IC50	uM	6.9
	13396530	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(Cl)c(-c3cccc4nnsc34)oc12		CHEMBL2408611	=	IC50	nM	6500.0	CHEMBL2185	Homo sapiens	IC50	uM	6.5
	13396542	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Cn1cc(-c2cnc(N)c3oc(-c4csc5cnccc45)cc23)cn1		CHEMBL2408617	=	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	uM	3.0
	13396552	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(C(F)F)c(-c3cccc4nnsc34)oc12		CHEMBL2408616	=	IC50	nM	1700.0	CHEMBL2185	Homo sapiens	IC50	uM	1.7
	13396553	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(-c3cncs3)c(-c3cccc4nnsc34)oc12		CHEMBL2408614	=	IC50	nM	1700.0	CHEMBL2185	Homo sapiens	IC50	uM	1.7
	13396557	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(CF)c(-c3cccc4nnsc34)oc12		CHEMBL2408615	=	IC50	nM	1500.0	CHEMBL2185	Homo sapiens	IC50	uM	1.5
	13396584	CHEMBL2410823	Inhibition of aurora B kinase in human HT-29 cells assessed as inhibition of histone H3 S10 phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2cc(-c3cccc4nnsc34)oc12		CHEMBL2408610	=	IC50	nM	160.0	CHEMBL2185	Homo sapiens	IC50	uM	0.16
	13419562	CHEMBL2423809	Inhibition of AURB (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	73.0	CHEMBL2185	Homo sapiens	INH	%	73.0
	13419563	CHEMBL2423809	Inhibition of AURB (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	66.0	CHEMBL2185	Homo sapiens	INH	%	66.0
	13419564	CHEMBL2423809	Inhibition of AURB (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	64.0	CHEMBL2185	Homo sapiens	INH	%	64.0
	13424292	CHEMBL2423435	Inhibition of Aurora kinase B (unknown origin)	B	CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1		CHEMBL1086377	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	13439895	CHEMBL2428324	Competitive binding affinity to AURKB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	13440870	CHEMBL2429612	Inhibition of Aurora B kinase (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-94.0	CHEMBL2185	Homo sapiens	INH	%	-94.0
	13445403	CHEMBL2428324	Competitive binding affinity to AURKB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	91.0	CHEMBL2185	Homo sapiens	INH	%	91.0
	13448460	CHEMBL2428324	Competitive binding affinity to AURKB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	13451715	CHEMBL2428324	Competitive binding affinity to AURKB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	68.0	CHEMBL2185	Homo sapiens	INH	%	68.0
	13453048	CHEMBL2429612	Inhibition of Aurora B kinase (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	13453096	CHEMBL2429612	Inhibition of Aurora B kinase (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1		CHEMBL2425145	=	Inhibition	%	1.0	CHEMBL2185	Homo sapiens	INH	%	1.0
	13464338	CHEMBL2433471	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	102.0	CHEMBL2185	Homo sapiens	Activity	%	102.0
	13465283	CHEMBL2434029	Inhibition of human Aurora-B assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	71.0	CHEMBL2185	Homo sapiens	Activity	%	71.0
	13465306	CHEMBL2433278	Inhibition of human Aurora-B assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	13465330	CHEMBL2434029	Inhibition of human Aurora-B assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	88.0	CHEMBL2185	Homo sapiens	Activity	%	88.0
	13465361	CHEMBL2433471	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	93.46	CHEMBL2185	Homo sapiens	Activity	%	93.46
	13465392	CHEMBL2434029	Inhibition of human Aurora-B assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	93.03	CHEMBL2185	Homo sapiens	Activity	%	93.03
	13465423	CHEMBL2433471	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	77.16	CHEMBL2185	Homo sapiens	Activity	%	77.16
	13465454	CHEMBL2434029	Inhibition of human Aurora-B assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	85.13	CHEMBL2185	Homo sapiens	Activity	%	85.13
Active	13466844	CHEMBL2432703	Induction of Aurora B-mediated histone H3 phosphorylation at Ser10 in human PC3 cells after 12 to 48 hrs by Western blotting analysis	B	CC1=C(CO)C(=O)O[C@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@@]32C)C1		CHEMBL1221986		Activity			CHEMBL2185	Homo sapiens	Activity		
	13476371	CHEMBL2439770	Inhibition of wild type human Aurora kinase B by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	123.0	CHEMBL2185	Homo sapiens	IC50	nM	123.0
Active	13488451	CHEMBL2439439	Inhibition of human Aurora kinase B at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13490909	CHEMBL2446688	Inhibition of Aurora-B (unknown origin)	B	CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441273	=	IC50	nM	398.11	CHEMBL2185	Homo sapiens	pIC50		6.4
	13490921	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2n1		CHEMBL2441277	=	Ki	nM	63.1	CHEMBL2185	Homo sapiens	pKi		7.2
	13490922	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Cc3ccccc3)cc(Nc3nc4cccnc4s3)n2)CC1		CHEMBL2441276	=	Ki	nM	100.0	CHEMBL2185	Homo sapiens	pKi		7.0
	13490923	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	COc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2n1		CHEMBL2441275	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
	13490924	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	N#Cc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441274	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
	13490925	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441273	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
	13490926	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Cc3ccccc3)cc(Nc3nc4ccc(C(F)(F)F)cc4s3)n2)CC1		CHEMBL2441272	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
	13490927	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Cc3ccccc3)cc(Nc3nc4ccc(Cl)cc4s3)n2)CC1		CHEMBL2441271	=	Ki	nM	251.19	CHEMBL2185	Homo sapiens	pKi		6.6
	13490928	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	Cc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441270	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
	13490929	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Cc3ccccc3)cc(Nc3nc4ccccc4s3)n2)CC1		CHEMBL2441269	=	Ki	nM	398.11	CHEMBL2185	Homo sapiens	pKi		6.4
	13490930	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	Cc1cc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2cc1C		CHEMBL2441268	=	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
	13490931	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	Cc1cnc(Nc2cc(Cc3ccccc3)nc(N[C@H]3CC[C@H](O)CC3)n2)s1		CHEMBL2441267	=	Ki	nM	0.5012	CHEMBL2185	Homo sapiens	pKi		9.3
	13490932	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	COc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441112	=	Ki	nM	501.19	CHEMBL2185	Homo sapiens	pKi		6.3
	13490933	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	COc1ccc2nc(Nc3cc(C(F)(F)c4ccc(F)cc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441286	=	Ki	nM	2511.89	CHEMBL2185	Homo sapiens	pKi		5.6
	13490934	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	NC(=O)[C@@H]1CCCN1c1nc(Nc2ncc(Cc3ccccc3)s2)cc(C(F)(F)c2ccc(F)cc2)n1		CHEMBL2441284	=	Ki	nM	3162.28	CHEMBL2185	Homo sapiens	pKi		5.5
	13490935	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Nc3ncc(Cc4ccccc4)s3)cc(C(F)(F)c3ccc(F)cc3)n2)CC1		CHEMBL2441283	=	Ki	nM	5.012	CHEMBL2185	Homo sapiens	pKi		8.3
	13490936	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Nc3ccc(Oc4ccc(F)cc4)cn3)cc(C(F)(F)c3ccc(F)cc3)n2)CC1		CHEMBL2441282	=	Ki	nM	5011.87	CHEMBL2185	Homo sapiens	pKi		5.3
	13490937	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Nc3cc4ccccc4cn3)cc(C(F)(F)c3ccc(F)cc3)n2)CC1		CHEMBL2441281	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
	13490938	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	O[C@H]1CC[C@H](Nc2nc(Nc3n[nH]c4ccccc34)cc(C(F)(F)c3ccc(F)cc3)n2)CC1		CHEMBL2441280	=	Ki	nM	630.96	CHEMBL2185	Homo sapiens	pKi		6.2
	13490980	CHEMBL2446688	Inhibition of Aurora-B (unknown origin)	B	CS(=O)(=O)N1CCOC(CNc2nc(Cc3ccccc3)cc(Nc3cc(-c4ccco4)[nH]n3)n2)C1		CHEMBL2441279	=	Ki	nM	316.23	CHEMBL2185	Homo sapiens	pKi		6.5
	13490981	CHEMBL2446688	Inhibition of Aurora-B (unknown origin)	B	NC(=O)C1CCN1c1nc(Cc2ccccc2)cc(Nc2cc(C3CCC3)[nH]n2)n1		CHEMBL2441278	=	Ki	nM	79.43	CHEMBL2185	Homo sapiens	pKi		7.1
	13490986	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	Cc1csc(Nc2cc(Cc3ccccc3)nc(N[C@H]3CC[C@H](O)CC3)n2)n1		CHEMBL2441113	<	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
	13490987	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	COc1ccc2nc(Nc3cc(C(F)(F)c4ccc(F)cc4)nc(N4CCC[C@H]4C(N)=O)n3)sc2c1		CHEMBL2441111	<	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
	13490989	CHEMBL2446685	Inhibition of Aurora-B (unknown origin) using 5FAM-PKAtide as substrate after 120 mins	B	COc1ccc2nc(Nc3cc(C(F)(F)c4ccc(F)cc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2n1		CHEMBL2441285	<	Ki	nM	19952.62	CHEMBL2185	Homo sapiens	pKi		4.7
	13502858	CHEMBL2446252	Inhibition of human aurora-B kinase	B	COc1ccc(C2CC(c3c(O)ccc4ccccc34)=NN2)c(OC)c1	Non standard unit for type	CHEMBL2442816	=	INH	uM	13.2	CHEMBL2185	Homo sapiens	INH	uM	13.2
	13507651	CHEMBL2444018	Inhibition of Aurora kinase-1 (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	13507652	CHEMBL2444018	Inhibition of Aurora kinase-1 (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	13507653	CHEMBL2444018	Inhibition of Aurora kinase-1 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	13507654	CHEMBL2444018	Inhibition of Aurora kinase-1 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
Not Active	13825956	CHEMBL3088423	Activity at Aurora kinase B (unknown origin)	B	c1ccc2[nH]c(Nc3ccc(Oc4nccnc4N4CCOCC4)cc3)nc2c1		CHEMBL2180803		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	13826013	CHEMBL3088423	Activity at Aurora kinase B (unknown origin)	B	CNc1cc(-c2cccnc2Oc2ccc(Nc3nc4ccc(F)c(F)c4[nH]3)cc2)ccn1		CHEMBL3086086		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	13835418	CHEMBL3090487	Inhibition of N-terminal Myc tagged aurora-B-mediated histone H3 phosphorylation at S10 in human HCT116 cells at 25 to 50 uM after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	13835446	CHEMBL3090773	Inhibition of N-terminal Myc tagged aurora-B-mediated histone H3 phosphorylation at S10 in human HCT116 cells after 2 hrs	B	Cc1cc(NC(=O)c2ccc(Oc3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)cc2)on1		CHEMBL3085798	=	IC50	nM	4930.0	CHEMBL2185	Homo sapiens	IC50	uM	4.93
	13835447	CHEMBL3090773	Inhibition of N-terminal Myc tagged aurora-B-mediated histone H3 phosphorylation at S10 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	24650.0	CHEMBL2185	Homo sapiens	IC50	uM	24.65
	13835454	CHEMBL3090776	Inhibition of N-terminal Myc tagged aurora-B-mediated histone H3 phosphorylation at S10 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	24240.0	CHEMBL2185	Homo sapiens	IC50	uM	24.24
	13835455	CHEMBL3090776	Inhibition of N-terminal Myc tagged aurora-B-mediated histone H3 phosphorylation at S10 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4cccnc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087820	=	IC50	nM	19720.0	CHEMBL2185	Homo sapiens	IC50	uM	19.72
	13835456	CHEMBL3090776	Inhibition of N-terminal Myc tagged aurora-B-mediated histone H3 phosphorylation at S10 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccncc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087819	=	IC50	nM	19740.0	CHEMBL2185	Homo sapiens	IC50	uM	19.74
	13835457	CHEMBL3090776	Inhibition of N-terminal Myc tagged aurora-B-mediated histone H3 phosphorylation at S10 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	76840.0	CHEMBL2185	Homo sapiens	IC50	uM	76.84
	13835463	CHEMBL3090779	Inhibition of N-terminal Myc tagged aurora-B (unknown origin)-mediated histone H3 phosphorylation at S10 after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087783	=	IC50	nM	18600.0	CHEMBL2185	Homo sapiens	IC50	uM	18.6
	13835465	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	3045.0	CHEMBL2185	Homo sapiens	IC50	uM	3.045
	13835466	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)N4CCCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087822	=	IC50	nM	1817.0	CHEMBL2185	Homo sapiens	IC50	uM	1.817
	13835467	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NCc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087821	=	IC50	nM	3910.0	CHEMBL2185	Homo sapiens	IC50	uM	3.91
	13835468	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4cccnc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087820	=	IC50	nM	1676.0	CHEMBL2185	Homo sapiens	IC50	uM	1.676
	13835469	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccncc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087819	=	IC50	nM	3447.0	CHEMBL2185	Homo sapiens	IC50	uM	3.447
	13835470	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1cc(NC(=O)c2ccc(Oc3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)cc2)on1		CHEMBL3085798	=	IC50	nM	693.0	CHEMBL2185	Homo sapiens	IC50	uM	0.693
	13835471	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	12710.0	CHEMBL2185	Homo sapiens	IC50	uM	12.71
	13835472	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087783	=	IC50	nM	4123.0	CHEMBL2185	Homo sapiens	IC50	uM	4.123
	13835473	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N(C)Cc3ccccc3)c(Cl)cnc2[nH]1		CHEMBL3087782	=	IC50	nM	169.0	CHEMBL2185	Homo sapiens	IC50	uM	0.169
	13835474	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N3CCC[C@H](CN(C)S(C)(=O)=O)C3)c(Cl)cnc2[nH]1		CHEMBL3087781	=	IC50	nM	9.0	CHEMBL2185	Homo sapiens	IC50	uM	0.009
	13835475	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N3CCC[C@@H](CNS(C)(=O)=O)C3)c(Cl)cnc2[nH]1		CHEMBL3087780	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	uM	0.017
	13835476	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N3CCC[C@H](CNS(C)(=O)=O)C3)c(Cl)cnc2[nH]1		CHEMBL3087779	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	uM	0.008
	13835477	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)NC[C@@H]1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1		CHEMBL3087778	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	uM	0.007
	13835478	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)N[C@@H]1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1		CHEMBL3087777	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	uM	0.002
	13835479	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)N[C@H]1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1		CHEMBL3087776	=	IC50	nM	80.0	CHEMBL2185	Homo sapiens	IC50	uM	0.08
	13835480	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	COc1ccc(-c2[nH]c3ncc(Cl)cc3c2-c2cccc(CNC(C)=O)c2)cc1		CHEMBL3087775	=	IC50	nM	1087.0	CHEMBL2185	Homo sapiens	IC50	uM	1.087
	13835481	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)NCc1cccc(-c2c(-c3cnn(C)c3)[nH]c3ncc(Cl)cc23)c1		CHEMBL3087774	=	IC50	nM	97.0	CHEMBL2185	Homo sapiens	IC50	uM	0.097
	13835482	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	COc1ccc(-c2[nH]c3ncc(Cl)cc3c2-c2cccc(CNS(C)(=O)=O)c2)cc1		CHEMBL3087773	=	IC50	nM	7095.0	CHEMBL2185	Homo sapiens	IC50	uM	7.095
	13835483	CHEMBL3090781	Inhibition of full-length aurora-B (unknown origin) using 5FAMLRRASLG-CONH2 as substrate after 60 mins	B	Cn1cc(-c2[nH]c3ncc(Cl)cc3c2-c2cccc(CNS(C)(=O)=O)c2)cn1		CHEMBL3087772	=	IC50	nM	441.0	CHEMBL2185	Homo sapiens	IC50	uM	0.441
	13872240	CHEMBL3102546	Inhibition of Aurora-B (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	88.0	CHEMBL2185	Homo sapiens	Activity	%	88.0
	13872270	CHEMBL3100472	Inhibition of Aurora-B (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	108.0	CHEMBL2185	Homo sapiens	Activity	%	108.0
	13878428	CHEMBL3108326	Inhibition of aurora-B (unknown origin)	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	910.0	CHEMBL2185	Homo sapiens	IC50	uM	0.91
	13878429	CHEMBL3108326	Inhibition of aurora-B (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	uM	0.008
	13878430	CHEMBL3108326	Inhibition of aurora-B (unknown origin)	B	Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1		CHEMBL3104855	=	IC50	nM	7290.0	CHEMBL2185	Homo sapiens	IC50	uM	7.29
	13878431	CHEMBL3108326	Inhibition of aurora-B (unknown origin)	B	Cc1c(O)c(O)c(O)c2c1COC2=O		CHEMBL3104854	=	IC50	nM	8690.0	CHEMBL2185	Homo sapiens	IC50	uM	8.69
	13878432	CHEMBL3108326	Inhibition of aurora-B (unknown origin)	B	COCc1c(C)c(O)c(O)c(O)c1C=O		CHEMBL3104853	=	IC50	nM	20600.0	CHEMBL2185	Homo sapiens	IC50	uM	20.6
	13878433	CHEMBL3108326	Inhibition of aurora-B (unknown origin)	B	COC1OC(=O)c2c(O)c(O)c(O)c(C)c21		CHEMBL3104852	=	IC50	nM	22600.0	CHEMBL2185	Homo sapiens	IC50	uM	22.6
	13878434	CHEMBL3108326	Inhibition of aurora-B (unknown origin)	B	Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O		CHEMBL3104851	=	IC50	nM	2510.0	CHEMBL2185	Homo sapiens	IC50	uM	2.51
	13895878	CHEMBL3111603	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate at 1 uM after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1OC		CHEMBL3109932	=	Inhibition	%	61.0	CHEMBL2185	Homo sapiens	INH	%	61.0
	13895891	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cncn3C)cc2cn1		CHEMBL3109964	=	IC50	nM	47000.0	CHEMBL2185	Homo sapiens	IC50	uM	47.0
	13895900	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)C1CCN(C(=O)c2ccc(Nc3cc4[nH]c(-c5cnn(C)c5)cc4cn3)c(Cl)c2)CC1		CHEMBL3109971	=	IC50	nM	34000.0	CHEMBL2185	Homo sapiens	IC50	uM	34.0
	13895915	CHEMBL3111603	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate at 1 uM after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1		CHEMBL3109949	=	Inhibition	%	22.0	CHEMBL2185	Homo sapiens	INH	%	22.0
	13895925	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3c(C)noc3C)cc2cn1		CHEMBL3109963	=	IC50	nM	16000.0	CHEMBL2185	Homo sapiens	IC50	uM	16.0
	13895943	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	c1cc(OCCN2CCOCC2)ccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109952	=	IC50	nM	4500.0	CHEMBL2185	Homo sapiens	IC50	uM	4.5
	13895956	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	c1cnn(Cc2ccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)cc2)c1		CHEMBL3109951	=	IC50	nM	2300.0	CHEMBL2185	Homo sapiens	IC50	uM	2.3
	13895962	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)S(=O)(=O)c1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1		CHEMBL3109950	=	IC50	nM	1700.0	CHEMBL2185	Homo sapiens	IC50	uM	1.7
	13896025	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(C(=O)N5CCS(=O)(=O)CC5)cc4Cl)cc3[nH]2)cn1		CHEMBL3109972	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896026	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COC1CCN(C(=O)c2ccc(Nc3cc4[nH]c(-c5cnn(C)c5)cc4cn3)c(Cl)c2)CC1		CHEMBL3109970	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896027	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)S(=O)(=O)c1ccc(Nc2cc3[nH]c(-c4cnn(C)c4)cc3cn2)c(Cl)c1		CHEMBL3109969	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896028	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1cc(C(=O)N(C)C)ccc1Nc1cc2[nH]c(-c3cnn(C)c3)cc2cn1		CHEMBL3109968	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896029	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)C(=O)c1ccc(Nc2cc3[nH]c(-c4cnn(C)c4)cc3cn2)c(Cl)c1		CHEMBL3109967	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896030	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccccc4Cl)cc3[nH]2)cn1		CHEMBL3109966	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896031	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(C(F)(F)F)cc1Nc1cc2[nH]c(-c3cnn(C)c3)cc2cn1		CHEMBL3109965	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896032	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnco3)cc2cn1		CHEMBL3109962	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896033	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(C)c3C)cc2cn1		CHEMBL3109961	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896034	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn(C)nc4C(F)(F)F)cc3cn2)c(OC)c1		CHEMBL3109960	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896035	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(C(F)F)c3)cc2cn1		CHEMBL3109959	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896036	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(CC(F)(F)F)c3)cc2cn1		CHEMBL3109958	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896314	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(C)c3)cc2cn1		CHEMBL3109957	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896315	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)c(Cl)c1		CHEMBL3109956	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896316	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Clc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109955	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896317	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CCOc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109954	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13896318	CHEMBL3111605	Inhibition of full length Aurora B (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109953	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13897469	CHEMBL3111646	Inhibition of recombinant aurora kinase B (unknown origin) using tetra(LRRWSLG) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1		CHEMBL3109404	=	IC50	nM	3890.0	CHEMBL2185	Homo sapiens	IC50	uM	3.89
	13897470	CHEMBL3111646	Inhibition of recombinant aurora kinase B (unknown origin) using tetra(LRRWSLG) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O		CHEMBL3109402	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	13897471	CHEMBL3111646	Inhibition of recombinant aurora kinase B (unknown origin) using tetra(LRRWSLG) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O		CHEMBL3109401	=	IC50	nM	61000.0	CHEMBL2185	Homo sapiens	IC50	uM	61.0
	13928582	CHEMBL3124207	Inhibition of aurora-B (unknown origin) at 0.1 uM relative to control	B	CNc1nc(Nc2cn(C(C)(C)C#N)nc2C)ncc1C(F)(F)F		CHEMBL3122113	=	Inhibition	%	51.0	CHEMBL2185	Homo sapiens	INH	%	51.0
	13948195	CHEMBL3132602	Inhibition of N-terminal His-6-tagged Aurora kinase B (unknown origin) expressed in baculovirus system after 60 mins	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	IC50	nM	66.0	CHEMBL2185	Homo sapiens	IC50	nmol/L	66.0
	13953187	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	>	IC50	nM	5320.0	CHEMBL2185	Homo sapiens	IC50	uM	5.32
	13954575	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	IC50	nM	18800.0	CHEMBL2185	Homo sapiens	IC50	uM	18.8
	13954596	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)NCC(C)C)cs4)cnc3[nH]2)cc1		CHEMBL3125720	=	IC50	nM	2470.0	CHEMBL2185	Homo sapiens	IC50	uM	2.47
	13954603	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	IC50	nM	1440.0	CHEMBL2185	Homo sapiens	IC50	uM	1.44
	13954604	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(OCCCNC(=O)C4CCCC4)c(-c4csc(C(=O)O)c4)cnc3[nH]2)cc1		CHEMBL3125724	=	IC50	nM	1300.0	CHEMBL2185	Homo sapiens	IC50	uM	1.3
	13954612	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(C(N)=S)cnc3[nH]2)cc1		CHEMBL3125723	=	IC50	nM	889.0	CHEMBL2185	Homo sapiens	IC50	uM	0.889
	13954630	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)O)cs4)cnc3[nH]2)cc1		CHEMBL3125722	=	IC50	nM	299.0	CHEMBL2185	Homo sapiens	IC50	uM	0.299
	13954631	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(N)=O)cs4)cnc3[nH]2)cc1		CHEMBL3125721	=	IC50	nM	284.0	CHEMBL2185	Homo sapiens	IC50	uM	0.284
	13954642	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(OCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1		CHEMBL3125725	=	IC50	nM	156.0	CHEMBL2185	Homo sapiens	IC50	uM	0.156
	13954650	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011936	=	IC50	nM	93.0	CHEMBL2185	Homo sapiens	IC50	uM	0.093
	13954664	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011933	=	IC50	nM	38.0	CHEMBL2185	Homo sapiens	IC50	uM	0.038
	13954733	CHEMBL3130943	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	78.0	CHEMBL2185	Homo sapiens	Activity	%	78.0
	13954742	CHEMBL3130943	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	13954777	CHEMBL3130943	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	43.0	CHEMBL2185	Homo sapiens	Activity	%	43.0
	13954805	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(C)=O)c4)cnc3[nH]2)cc1		CHEMBL3125734	=	IC50	nM	12100.0	CHEMBL2185	Homo sapiens	IC50	uM	12.1
	13954816	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	IC50	nM	5920.0	CHEMBL2185	Homo sapiens	IC50	uM	5.92
	13954821	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	CCC(C)CNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1		CHEMBL3125729	=	IC50	nM	2820.0	CHEMBL2185	Homo sapiens	IC50	uM	2.82
	13954823	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(N)=O)c4)cnc3[nH]2)cc1		CHEMBL3125732	=	IC50	nM	2300.0	CHEMBL2185	Homo sapiens	IC50	uM	2.3
	13954825	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)CO)c4)cnc3[nH]2)cc1		CHEMBL3125730	=	IC50	nM	1680.0	CHEMBL2185	Homo sapiens	IC50	uM	1.68
	13954826	CHEMBL3132511	Inhibition of aurora B (unknown origin)	B	COCCNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1		CHEMBL3125731	=	IC50	nM	1380.0	CHEMBL2185	Homo sapiens	IC50	uM	1.38
	13966015	CHEMBL3136066	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	95.0	CHEMBL2185	Homo sapiens	INH	%	95.0
	13973290	CHEMBL3136764	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	13974008	CHEMBL3135908	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	4.0	CHEMBL2185	Homo sapiens	INH	%	4.0
	13974099	CHEMBL3135610	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	13974190	CHEMBL3137130	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	98.5	CHEMBL2185	Homo sapiens	INH	%	98.5
	13974281	CHEMBL3136259	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	96.0	CHEMBL2185	Homo sapiens	INH	%	96.0
	13975019	CHEMBL3135979	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	15.0	CHEMBL2185	Homo sapiens	INH	%	15.0
	13975110	CHEMBL3135706	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	13975201	CHEMBL3135790	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	34.0	CHEMBL2185	Homo sapiens	INH	%	34.0
	13975844	CHEMBL3134767	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	76.0	CHEMBL2185	Homo sapiens	INH	%	76.0
	13975937	CHEMBL3136874	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	87.5	CHEMBL2185	Homo sapiens	INH	%	87.5
	13976028	CHEMBL3135228	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	97.0	CHEMBL2185	Homo sapiens	INH	%	97.0
	13976119	CHEMBL3136909	Inhibition of human full length AurB expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	85.0	CHEMBL2185	Homo sapiens	INH	%	85.0
	14600183	CHEMBL3243850	Inhibition of N-terminal His-6-tagged recombinant Aurora 2 (1 to 403) (unknown origin) expressed in baculovirus expression system by radiometric assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	14600185	CHEMBL3243853	Inhibition of recombinant human Aurora B using peptide substrate PanVera Z'-Lyte kinase assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1.O=C(O)C(O)C(O)C(=O)O		CHEMBL3237191	=	IC50	nM	290.0	CHEMBL2185	Homo sapiens	IC50	nM	290.0
	14648106	CHEMBL3267011	Inhibition of human aurora B kinase at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	=	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	14648107	CHEMBL3267011	Inhibition of human aurora B kinase at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	14666343	CHEMBL3270462	Inhibition of aurora B (unknown origin) assessed as [33P] incorporation in substrate by TopCount microplate scintillation counting analysis	B	COc1ccc(Oc2cc(C)c(-c3csc(NC(=O)c4ccnc(F)c4)n3)c(C)c2)cc1		CHEMBL3263869	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	14751169	CHEMBL3301288	Inhibition of aurora kinase 2 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	14751170	CHEMBL3301288	Inhibition of aurora kinase 2 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	14983214	CHEMBL3383539	Inhibition of recombinant Aur B (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	Inhibition	%	93.5	CHEMBL2185	Homo sapiens	INH	%	93.5
	14983220	CHEMBL3383545	Inhibition of recombinant Aur B (unknown origin) at 1 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	Inhibition	%	41.6	CHEMBL2185	Homo sapiens	INH	%	41.6
	14983226	CHEMBL3383551	Inhibition of recombinant Aur B (unknown origin) at 0.1 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	Inhibition	%	4.5	CHEMBL2185	Homo sapiens	INH	%	4.5
	14983230	CHEMBL3383555	Inhibition of recombinant Aur B (unknown origin) after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	IC50	nM	2205.0	CHEMBL2185	Homo sapiens	IC50	nM	2205.0
	14983255	CHEMBL3383539	Inhibition of recombinant Aur B (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	Inhibition	%	88.3	CHEMBL2185	Homo sapiens	INH	%	88.3
	14983261	CHEMBL3383545	Inhibition of recombinant Aur B (unknown origin) at 1 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	Inhibition	%	53.5	CHEMBL2185	Homo sapiens	INH	%	53.5
	14983267	CHEMBL3383551	Inhibition of recombinant Aur B (unknown origin) at 0.1 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	Inhibition	%	14.4	CHEMBL2185	Homo sapiens	INH	%	14.4
	14983271	CHEMBL3383555	Inhibition of recombinant Aur B (unknown origin) after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	IC50	nM	587.0	CHEMBL2185	Homo sapiens	IC50	nM	587.0
	14984398	CHEMBL3384393	Inhibition of AURKB (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	12.0	CHEMBL2185	Homo sapiens	INH	%	12.0
	14984464	CHEMBL3381883	Inhibition of AURKB (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	14992866	CHEMBL3372223	Inhibition of recombinant AURKB (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	735.0	CHEMBL2185	Homo sapiens	IC50	uM	0.735
Active	14992877	CHEMBL3375941	Inhibition of AURKB in human HepG cells assessed as reduction in histone H3 phosphorylation at 5 to 20 uM after 48 hrs by hematoxylin and eosin staining-based microscopic analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992878	CHEMBL3375940	Inhibition of AURKB in human HepG2 cells assessed as reduction in Aurora B expression expression at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992879	CHEMBL3375939	Inhibition of AURKB in human SW620 cells assessed as reduction in Aurora B expression expression at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992880	CHEMBL3375938	Inhibition of AURKB in human HeLa cells assessed as reduction in Aurora B expression at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992881	CHEMBL3375937	Inhibition of AURKB in human HepG2 cells assessed as reduction in histone H3 expression at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992882	CHEMBL3375936	Inhibition of AURKB in human SW620 cells assessed as reduction in histone H3 expression at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992883	CHEMBL3375935	Inhibition of AURKB in human HeLa cells assessed as reduction in histone H3 expression at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992884	CHEMBL3375934	Inhibition of AURKB in human HepG2 cells assessed as reduction in histone H3 phosphorylation at 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992885	CHEMBL3375933	Inhibition of AURKB in human SW620 cells assessed as reduction in histone H3 phosphorylation at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	14992886	CHEMBL3375932	Inhibition of AURKB in human HeLa cells assessed as reduction in histone H3 phosphorylation at 5 to 20 uM after 48 hrs by Western blotting analysis	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	14992920	CHEMBL3372797	Binding affinity to AURKB (unknown origin)	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	Kd	nM	3060.0	CHEMBL2185	Homo sapiens	Kd	10'-6M	3.06
	14996600	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1		CHEMBL2407749	=	IC50	nM	24.0	CHEMBL2185	Homo sapiens	IC50	nM	24.0
	14996601	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2[C@]12C[C@H]2c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1		CHEMBL3353340	=	IC50	nM	7.4	CHEMBL2185	Homo sapiens	IC50	nM	7.4
	14996602	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccccc45)ccc23)c(C)n1		CHEMBL3353344	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	14996603	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	CN(C)Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccccc45)ccc23)cc1		CHEMBL3353347	=	IC50	nM	6.4	CHEMBL2185	Homo sapiens	IC50	nM	6.4
	14996604	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN(C)C)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3353348	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
	14996605	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	CN(C)Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccc(OC(F)F)cc45)ccc23)cc1		CHEMBL3353349	=	IC50	nM	33.0	CHEMBL2185	Homo sapiens	IC50	nM	33.0
	14996606	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2[C@]12C[C@H]2c1ccc2c(/C=C/c3ccc(CN4CCOCC4)cc3)n[nH]c2c1		CHEMBL3353354	=	IC50	nM	49.0	CHEMBL2185	Homo sapiens	IC50	nM	49.0
	14996607	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5CCOCC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3353355	=	IC50	nM	29.0	CHEMBL2185	Homo sapiens	IC50	nM	29.0
	14996608	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4cc(F)c(CN5CCOCC5)c(F)c4)n[nH]c3c1)C(=O)N2		CHEMBL3353358	=	IC50	nM	51.0	CHEMBL2185	Homo sapiens	IC50	nM	51.0
	14996609	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	CN1CCN(Cc2ccc(/C=C/c3n[nH]c4cc([C@@H]5C[C@@]56C(=O)Nc5ccccc56)ccc34)cc2)CC1		CHEMBL3353359	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	nM	180.0
	14996610	CHEMBL3364631	Inhibition of AURKB (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2[C@]12C[C@H]2c1ccc2c(/C=C/c3ccc(CN4CCCCC4)cc3)n[nH]c2c1		CHEMBL3353362	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
	15003470	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3cccc(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3322930	=	Inhibition	%	4.4	CHEMBL2185	Homo sapiens	INH	%	4.4
	15003471	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4ccccc4)c3)nn2)c1		CHEMBL3322931	=	Inhibition	%	65.9	CHEMBL2185	Homo sapiens	INH	%	65.9
	15003472	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C)c4)c3)nn2)c1		CHEMBL3321769	=	Inhibition	%	11.8	CHEMBL2185	Homo sapiens	INH	%	11.8
	15003473	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322932	=	Inhibition	%	50.3	CHEMBL2185	Homo sapiens	INH	%	50.3
	15003474	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(Cl)c4)c3)nn2)c1		CHEMBL3322933	=	Inhibition	%	56.3	CHEMBL2185	Homo sapiens	INH	%	56.3
	15003475	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4ccccc4C(F)(F)F)c3)nn2)c1		CHEMBL3322934	=	Inhibition	%	21.3	CHEMBL2185	Homo sapiens	INH	%	21.3
	15003476	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	Inhibition	%	71.3	CHEMBL2185	Homo sapiens	INH	%	71.3
	15003477	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(=O)O)c4)c3)nn2)c1		CHEMBL3322936	=	Inhibition	%	34.8	CHEMBL2185	Homo sapiens	INH	%	34.8
	15003478	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)nn2)ccc1O		CHEMBL3322937	=	Inhibition	%	80.4	CHEMBL2185	Homo sapiens	INH	%	80.4
	15003479	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cc(F)cc(F)c3)nn2)ccc1O		CHEMBL3322938	=	Inhibition	%	39.5	CHEMBL2185	Homo sapiens	INH	%	39.5
	15003480	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	CN(C)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3322939	=	Inhibition	%	16.2	CHEMBL2185	Homo sapiens	INH	%	16.2
	15003481	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	N#Cc1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3322940	=	Inhibition	%	36.2	CHEMBL2185	Homo sapiens	INH	%	36.2
	15003482	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)c(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1Cl		CHEMBL3323022	=	Inhibition	%	76.7	CHEMBL2185	Homo sapiens	INH	%	76.7
	15003483	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cccc(Cl)c3)nn2)ccc1O		CHEMBL3323023	=	Inhibition	%	41.7	CHEMBL2185	Homo sapiens	INH	%	41.7
	15003484	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323024	=	Inhibition	%	23.0	CHEMBL2185	Homo sapiens	INH	%	23.0
	15003485	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323025	=	Inhibition	%	30.6	CHEMBL2185	Homo sapiens	INH	%	30.6
	15003486	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cc1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323026	=	Inhibition	%	20.0	CHEMBL2185	Homo sapiens	INH	%	20.0
	15003487	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccc(F)cc3)nn2)ccc1O		CHEMBL3323027	=	Inhibition	%	21.7	CHEMBL2185	Homo sapiens	INH	%	21.7
	15003488	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cccnc3)nn2)ccc1O		CHEMBL3323028	=	Inhibition	%	53.6	CHEMBL2185	Homo sapiens	INH	%	53.6
	15003489	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccsc3)nn2)ccc1O		CHEMBL3323029	=	Inhibition	%	25.3	CHEMBL2185	Homo sapiens	INH	%	25.3
	15003490	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	CC(=O)Nc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323030	=	Inhibition	%	71.4	CHEMBL2185	Homo sapiens	INH	%	71.4
	15003491	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3321770	=	Inhibition	%	57.3	CHEMBL2185	Homo sapiens	INH	%	57.3
	15003492	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccccn3)nn2)ccc1O		CHEMBL3323031	=	Inhibition	%	44.9	CHEMBL2185	Homo sapiens	INH	%	44.9
	15003493	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cn1cncc1-c1cn(-c2ccc(O)c(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1		CHEMBL3323032	=	Inhibition	%	42.3	CHEMBL2185	Homo sapiens	INH	%	42.3
	15003494	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(O)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323033	=	Inhibition	%	27.4	CHEMBL2185	Homo sapiens	INH	%	27.4
	15003495	CHEMBL3370369	Inhibition of Aurora B (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(O)c1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323034	=	Inhibition	%	39.6	CHEMBL2185	Homo sapiens	INH	%	39.6
	15003508	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(Cl)c4)c3)nn2)c1		CHEMBL3322933	=	IC50	nM	47500.0	CHEMBL2185	Homo sapiens	IC50	uM	47.5
	15003509	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	IC50	nM	3580.0	CHEMBL2185	Homo sapiens	IC50	uM	3.58
	15003510	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)nn2)ccc1O		CHEMBL3322937	=	IC50	nM	13800.0	CHEMBL2185	Homo sapiens	IC50	uM	13.8
Not Determined	15003511	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	N#Cc1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3322940		IC50			CHEMBL2185	Homo sapiens	IC50		
	15003512	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)c(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1Cl		CHEMBL3323022	=	IC50	nM	31900.0	CHEMBL2185	Homo sapiens	IC50	uM	31.9
Not Determined	15003513	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cccc(Cl)c3)nn2)ccc1O		CHEMBL3323023		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	15003514	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323024		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	15003515	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323025		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	15003516	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccsc3)nn2)ccc1O		CHEMBL3323029		IC50			CHEMBL2185	Homo sapiens	IC50		
	15003517	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	CC(=O)Nc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323030	=	IC50	nM	21800.0	CHEMBL2185	Homo sapiens	IC50	uM	21.8
	15003518	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3321770	=	IC50	nM	63200.0	CHEMBL2185	Homo sapiens	IC50	uM	63.2
	15003519	CHEMBL3370371	Inhibition of Aurora B (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	15007935	CHEMBL3367528	Inhibition of Aurora B (unknown origin) by FRET-based homogenous assay	B	CCc1cccc(CC)c1NC(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1		CHEMBL3330260	=	IC50	nM	2400.0	CHEMBL2185	Homo sapiens	IC50	uM	2.4
	15007936	CHEMBL3367528	Inhibition of Aurora B (unknown origin) by FRET-based homogenous assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	IC50	nM	720.0	CHEMBL2185	Homo sapiens	IC50	uM	0.72
	15007937	CHEMBL3367528	Inhibition of Aurora B (unknown origin) by FRET-based homogenous assay	B	CCc1ccccc1C(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)N(C)C		CHEMBL3330409	=	IC50	nM	480.0	CHEMBL2185	Homo sapiens	IC50	uM	0.48
	15014104	CHEMBL3361859	Inhibition of Aurora-B (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	8.8	CHEMBL2185	Homo sapiens	INH	%	8.8
	15022245	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2cc3c(cc2F)/C(=C/c2[nH]c(C)c(CCC(=O)O)c2C)C(=O)N3)c(F)c1		CHEMBL3329675	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
	15022246	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2cc3c(cc2F)/C(=C/c2[nH]c(C)c(C(=O)O)c2C)C(=O)N3)c(F)c1		CHEMBL3329674	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	15022247	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c(F)c1		CHEMBL3329673	=	IC50	nM	1.3	CHEMBL2185	Homo sapiens	IC50	nM	1.3
	15022248	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)c(F)c1		CHEMBL3329672	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
	15022249	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2cc3c(cc2F)/C(=C/c2[nH]c(C)c(CCC(=O)O)c2C)C(=O)N3)cc1		CHEMBL3329671	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	15022250	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2cc3c(cc2F)/C(=C/c2[nH]c(C)c(C(=O)O)c2C)C(=O)N3)cc1		CHEMBL3329670	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
	15022251	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1		CHEMBL3329669	=	IC50	nM	1.2	CHEMBL2185	Homo sapiens	IC50	nM	1.2
	15022252	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CC(=O)O)c2C)cc1		CHEMBL3329668	=	IC50	nM	1.8	CHEMBL2185	Homo sapiens	IC50	nM	1.8
	15022253	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc(C(=O)O)[nH]2)cc1		CHEMBL3329667	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	15022254	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(-c3ccccc3)c2C)cc1		CHEMBL3329666	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	15022255	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)cc2C)cc1		CHEMBL3329665	=	IC50	nM	55.5	CHEMBL2185	Homo sapiens	IC50	nM	55.5
	15022256	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL3329664	=	IC50	nM	1.9	CHEMBL2185	Homo sapiens	IC50	nM	1.9
	15022257	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	CN(C)c1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329663	=	IC50	nM	158.7	CHEMBL2185	Homo sapiens	IC50	nM	158.7
	15022258	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1cc(OC)cc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)c1		CHEMBL3329662	=	IC50	nM	29.8	CHEMBL2185	Homo sapiens	IC50	nM	29.8
	15022259	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	Cc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329661	=	IC50	nM	18.4	CHEMBL2185	Homo sapiens	IC50	nM	18.4
	15022260	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	O=C(NC(=O)c1ccc(Cl)c(C(F)(F)F)c1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3329660	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
	15022261	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	O=C(NC(=O)c1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3329659	=	IC50	nM	40.9	CHEMBL2185	Homo sapiens	IC50	nM	40.9
	15022262	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	O=C(NC(=O)c1ccccc1F)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3329658	=	IC50	nM	6.5	CHEMBL2185	Homo sapiens	IC50	nM	6.5
	15022263	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	O=C(NC(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3329657	=	IC50	nM	7.7	CHEMBL2185	Homo sapiens	IC50	nM	7.7
	15022264	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	O=C(NC(=O)c1ccc(Cl)cc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3329656	=	IC50	nM	6.5	CHEMBL2185	Homo sapiens	IC50	nM	6.5
	15022265	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	O=C(NC(=O)c1ccccc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3329655	=	IC50	nM	5.3	CHEMBL2185	Homo sapiens	IC50	nM	5.3
	15022266	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	0.3	CHEMBL2185	Homo sapiens	IC50	nM	0.3
	15022267	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.8	CHEMBL2185	Homo sapiens	IC50	nM	1.8
	15022268	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329652	=	IC50	nM	14.9	CHEMBL2185	Homo sapiens	IC50	nM	14.9
	15022269	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)NC(=O)c4ccc(OC)cc4F)ccc32)c1C		CHEMBL3329676	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	15022270	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	CCOC(=O)CCc1c(C)[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)NC(=O)c4ccc(OC)cc4F)ccc32)c1C		CHEMBL3329677	=	IC50	nM	217.9	CHEMBL2185	Homo sapiens	IC50	nM	217.9
	15022271	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)N3CCN(C)CC3)c2C)c(F)c1		CHEMBL3329678	=	IC50	nM	30.6	CHEMBL2185	Homo sapiens	IC50	nM	30.6
	15022272	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)N3CCN(C)CC3)c2C)c(F)c1		CHEMBL3329679	=	IC50	nM	18.4	CHEMBL2185	Homo sapiens	IC50	nM	18.4
	15022273	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)N3CCOCC3)c2C)c(F)c1		CHEMBL3329680	=	IC50	nM	16.8	CHEMBL2185	Homo sapiens	IC50	nM	16.8
	15022274	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)N3CCOCC3)c2C)c(F)c1		CHEMBL3329681	=	IC50	nM	16.4	CHEMBL2185	Homo sapiens	IC50	nM	16.4
	15022275	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN(C)C)c2C)c(F)c1		CHEMBL3329682	=	IC50	nM	10.5	CHEMBL2185	Homo sapiens	IC50	nM	10.5
	15022276	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)NC(=O)c4ccc(OC)cc4F)ccc32)c1C		CHEMBL3329683	=	IC50	nM	7.6	CHEMBL2185	Homo sapiens	IC50	nM	7.6
	15022277	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	IC50	nM	0.4	CHEMBL2185	Homo sapiens	IC50	nM	0.4
	15022457	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2cccc3c2/C(=C/c2ccc[nH]2)C(=O)N3)cc1		CHEMBL3329650	=	Inhibition	%	11.0	CHEMBL2185	Homo sapiens	INH	%	11.0
	15022458	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)/C(=C/c2ccc[nH]2)C(=O)N3)cc1		CHEMBL3329651	=	Inhibition	%	39.0	CHEMBL2185	Homo sapiens	INH	%	39.0
	15022459	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329652	=	Inhibition	%	94.0	CHEMBL2185	Homo sapiens	INH	%	94.0
	15022460	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2cccc3c2NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329653	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	15025229	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C(CC(=O)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1)Nc1ccc(F)cc1		CHEMBL3322563	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
	15025230	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3322564	=	IC50	nM	29.6	CHEMBL2185	Homo sapiens	IC50	nM	29.6
	15025231	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL3322565	=	IC50	nM	5.9	CHEMBL2185	Homo sapiens	IC50	nM	5.9
	15025232	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)cc1		CHEMBL3322566	=	IC50	nM	93.0	CHEMBL2185	Homo sapiens	IC50	nM	93.0
	15025233	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322567	=	IC50	nM	252.6	CHEMBL2185	Homo sapiens	IC50	nM	252.6
	15025234	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)C2(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)CC2)cc1		CHEMBL3322568	=	IC50	nM	347.0	CHEMBL2185	Homo sapiens	IC50	nM	347.0
	15025235	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322572	=	IC50	nM	791.1	CHEMBL2185	Homo sapiens	IC50	nM	791.1
	15025236	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(-n2cccc(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)c2=O)cc1		CHEMBL3322573	=	IC50	nM	209.3	CHEMBL2185	Homo sapiens	IC50	nM	209.3
	15025237	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3cccn(-c4ccccc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322574	=	IC50	nM	87.4	CHEMBL2185	Homo sapiens	IC50	nM	87.4
	15025238	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1ccc(-n2cccc(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)c2=O)cc1		CHEMBL3322575	=	IC50	nM	209.4	CHEMBL2185	Homo sapiens	IC50	nM	209.4
	15025239	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3cccn(-c4cccc(Cl)c4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322578	=	IC50	nM	250.6	CHEMBL2185	Homo sapiens	IC50	nM	250.6
	15025240	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cn1cccc(C(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)c1=O		CHEMBL3322579	=	IC50	nM	102.2	CHEMBL2185	Homo sapiens	IC50	nM	102.2
	15025241	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3cccn(CCO)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322580	=	IC50	nM	32.5	CHEMBL2185	Homo sapiens	IC50	nM	32.5
	15025242	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)ccc32)c(C)c1C(=O)O		CHEMBL3322581	=	IC50	nM	10.7	CHEMBL2185	Homo sapiens	IC50	nM	10.7
	15025243	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)c4cccn(C)c4=O)ccc32)c(C)c1C(=O)O		CHEMBL3322582	=	IC50	nM	14.3	CHEMBL2185	Homo sapiens	IC50	nM	14.3
	15025244	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322583	=	IC50	nM	127.6	CHEMBL2185	Homo sapiens	IC50	nM	127.6
	15025245	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(-c2c[nH]cc(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)c2=O)cc1		CHEMBL3322584	=	IC50	nM	10.2	CHEMBL2185	Homo sapiens	IC50	nM	10.2
	15025246	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322585	=	IC50	nM	33.1	CHEMBL2185	Homo sapiens	IC50	nM	33.1
	15025247	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1ccc(-c2c[nH]cc(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)c2=O)cc1		CHEMBL3322586	=	IC50	nM	63.2	CHEMBL2185	Homo sapiens	IC50	nM	63.2
	15025248	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccc(Cl)cc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322587	=	IC50	nM	53.8	CHEMBL2185	Homo sapiens	IC50	nM	53.8
	15025249	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccc(C(F)(F)F)cc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322588	=	IC50	nM	348.0	CHEMBL2185	Homo sapiens	IC50	nM	348.0
	15025250	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4cccc(Cl)c4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322589	=	IC50	nM	161.4	CHEMBL2185	Homo sapiens	IC50	nM	161.4
	15025251	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	IC50	nM	25.5	CHEMBL2185	Homo sapiens	IC50	nM	25.5
	15025252	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1c[nH]cc(C(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)c1=O		CHEMBL3322591	=	IC50	nM	29.2	CHEMBL2185	Homo sapiens	IC50	nM	29.2
	15025253	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(-c2c[nH]cc(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3[nH]c(C)c(C(=O)O)c3C)c2=O)cc1		CHEMBL3322592	=	IC50	nM	4.5	CHEMBL2185	Homo sapiens	IC50	nM	4.5
	15025254	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)c4c[nH]cc(-c5ccc(F)cc5)c4=O)ccc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL3322593	=	IC50	nM	70.5	CHEMBL2185	Homo sapiens	IC50	nM	70.5
	15025255	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)c4c[nH]cc(-c5ccc(F)cc5)c4=O)ccc32)c(C)c1CC(=O)N1CCN(C)CC1		CHEMBL3322594	=	IC50	nM	91.6	CHEMBL2185	Homo sapiens	IC50	nM	91.6
	15025256	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)c4c[nH]cc(-c5ccc(F)cc5)c4=O)ccc32)c(C)c1C(=O)N1CCOCC1		CHEMBL3322595	=	IC50	nM	2.9	CHEMBL2185	Homo sapiens	IC50	nM	2.9
	15025257	CHEMBL3362102	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)c4c[nH]cc(-c5ccc(F)cc5)c4=O)ccc32)c(C)c1CC(=O)N1CCOCC1		CHEMBL3322596	=	IC50	nM	73.9	CHEMBL2185	Homo sapiens	IC50	nM	73.9
	15025294	CHEMBL3362114	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)c2/C1=C/c1ccc[nH]1		CHEMBL3322569	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	15025295	CHEMBL3362114	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2/C1=C/c1ccc[nH]1		CHEMBL3322570	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	15025296	CHEMBL3362114	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2c(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cccc2/C1=C/c1ccc[nH]1		CHEMBL3322571	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	15025297	CHEMBL3362114	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3cccn(-c4ccc(Cl)cc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322576	=	Inhibition	%	49.0	CHEMBL2185	Homo sapiens	INH	%	49.0
	15025298	CHEMBL3362114	Inhibition of Aurora B (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3cccn(-c4ccc(C(F)(F)F)cc4)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322577	=	Inhibition	%	29.0	CHEMBL2185	Homo sapiens	INH	%	29.0
Active	15025369	CHEMBL3362117	Inhibition of Aurora B in human A549 cells assessed as decrease in pHH3 level at 10 uM after 4 hrs by high-throughput dot-blot system	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	15025370	CHEMBL3362118	Inhibition of Aurora B in human HepG2 cells assessed as decrease in pHH3 level at 10 uM after 4 hrs by high-throughput dot-blot system	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	15025426	CHEMBL3362117	Inhibition of Aurora B in human A549 cells assessed as decrease in pHH3 level at 10 uM after 4 hrs by high-throughput dot-blot system	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	15025427	CHEMBL3362118	Inhibition of Aurora B in human HepG2 cells assessed as decrease in pHH3 level at 10 uM after 4 hrs by high-throughput dot-blot system	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	15026408	CHEMBL3380433	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2cccs2)cc1		CHEMBL3361346	=	IC50	nM	21.5	CHEMBL2185	Homo sapiens	IC50	nM	21.5
	15026432	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccccc2)cc1		CHEMBL3329686	=	Inhibition	%	61.0	CHEMBL2185	Homo sapiens	INH	%	61.0
	15026433	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(Cl)cc2)cc1		CHEMBL3329687	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	INH	%	13.0
	15026434	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(Cl)c(Cl)c2)cc1		CHEMBL3330968	=	Inhibition	%	9.0	CHEMBL2185	Homo sapiens	INH	%	9.0
	15026435	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(O)cc2)cc1		CHEMBL3330969	=	Inhibition	%	63.0	CHEMBL2185	Homo sapiens	INH	%	63.0
	15026436	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(/C=C2/C(=O)Nc3cc(NC(=O)NC(=O)c4ccc(OC)cc4)ccc32)cc1		CHEMBL3330970	=	Inhibition	%	56.0	CHEMBL2185	Homo sapiens	INH	%	56.0
	15026437	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(N(C)C)cc2)cc1		CHEMBL3330971	=	Inhibition	%	59.0	CHEMBL2185	Homo sapiens	INH	%	59.0
	15026438	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2cccc(C(=O)O)c2)cc1		CHEMBL3330972	=	Inhibition	%	73.0	CHEMBL2185	Homo sapiens	INH	%	73.0
	15026439	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccco2)cc1		CHEMBL3361347	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	15026440	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccccn2)cc1		CHEMBL3330975	=	Inhibition	%	29.0	CHEMBL2185	Homo sapiens	INH	%	29.0
	15026441	CHEMBL3380439	Inhibition of Aurora B (unknown origin) using HLRRASLG substrate at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccncc2)cc1		CHEMBL3330976	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	15036728	CHEMBL3381061	Inhibition of Aurora 2 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15036729	CHEMBL3381061	Inhibition of Aurora 2 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15036730	CHEMBL3381061	Inhibition of Aurora 2 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15036731	CHEMBL3381061	Inhibition of Aurora 2 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15036732	CHEMBL3381061	Inhibition of Aurora 2 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15037158	CHEMBL3368327	Inhibition of AURKB (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	82.0	CHEMBL2185	Homo sapiens	INH	%	82.0
	15037159	CHEMBL3368327	Inhibition of AURKB (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	15037160	CHEMBL3368327	Inhibition of AURKB (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	15037161	CHEMBL3368327	Inhibition of AURKB (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	92.0	CHEMBL2185	Homo sapiens	INH	%	92.0
	15037162	CHEMBL3368327	Inhibition of AURKB (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	85.0	CHEMBL2185	Homo sapiens	INH	%	85.0
	15055291	CHEMBL3380463	Inhibition of human recombinant Aurora B using Tetra(LRRWSLG) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	15055376	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3ccc(NC(=O)NCCc4ccccc4)nc3c2)cn1		CHEMBL3318030	=	IC50	nM	171.0	CHEMBL2185	Homo sapiens	IC50	uM	0.171
	15055377	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3ccc(NC(=O)NCc4ccccc4)nc3c2)cn1		CHEMBL3318029	=	IC50	nM	579.0	CHEMBL2185	Homo sapiens	IC50	uM	0.579
	15055378	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3ccc(NC(=O)Nc4ccccc4)nc3c2)cn1		CHEMBL3318028	=	IC50	nM	1140.0	CHEMBL2185	Homo sapiens	IC50	uM	1.14
	15055379	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3ccc(NC(=O)NC(C)(C)C)nc3c2)cn1		CHEMBL3318027	=	IC50	nM	260.0	CHEMBL2185	Homo sapiens	IC50	uM	0.26
	15055380	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	COc1cc(-c2cnc3ccc(NC(=O)NC(C)(C)C)nc3c2)ccc1O		CHEMBL3318026	=	IC50	nM	227.0	CHEMBL2185	Homo sapiens	IC50	uM	0.227
	15055381	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	COc1ccc(-c2cnc3ccc(NC(=O)NC(C)(C)C)nc3c2)cc1OC		CHEMBL3318025	=	IC50	nM	805.0	CHEMBL2185	Homo sapiens	IC50	uM	0.805
	15055382	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(OC)c(OC)c3)cc2n1		CHEMBL3318024	=	IC50	nM	624.0	CHEMBL2185	Homo sapiens	IC50	uM	0.624
	15055383	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(OC)cc3)cc2n1		CHEMBL3318023	=	IC50	nM	2230.0	CHEMBL2185	Homo sapiens	IC50	uM	2.23
	15055510	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	CCNC(=O)Nc1ccnc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3318008	=	IC50	nM	136.0	CHEMBL2185	Homo sapiens	IC50	uM	0.136
	15055511	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	COc1ccc(-c2cnc3c(NC(=O)NC(C)(C)C)ccnc3c2)cc1OC		CHEMBL3318009	=	IC50	nM	714.0	CHEMBL2185	Homo sapiens	IC50	uM	0.714
	15055512	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	COc1cc(-c2cnc3c(NC(=O)NC(C)(C)C)ccnc3c2)ccc1O		CHEMBL3318031	=	IC50	nM	1580.0	CHEMBL2185	Homo sapiens	IC50	uM	1.58
	15055513	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3c(NC(=O)NC(C)(C)C)ccnc3c2)cn1		CHEMBL3318032	=	IC50	nM	112.0	CHEMBL2185	Homo sapiens	IC50	uM	0.112
	15055514	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3c(NC(=O)Nc4ccccc4)ccnc3c2)cn1		CHEMBL3318033	=	IC50	nM	1260.0	CHEMBL2185	Homo sapiens	IC50	uM	1.26
	15055515	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3c(NC(=O)NCc4ccccc4)ccnc3c2)cn1		CHEMBL3318034	=	IC50	nM	66.0	CHEMBL2185	Homo sapiens	IC50	uM	0.066
	15055516	CHEMBL3367496	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cnc3c(NC(=O)NCCc4ccccc4)ccnc3c2)cn1		CHEMBL3318035	=	IC50	nM	86.0	CHEMBL2185	Homo sapiens	IC50	uM	0.086
	15068308	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)ccc23)cc1		CHEMBL3343308	=	IC50	nM	367.0	CHEMBL2185	Homo sapiens	IC50	nM	367.0
	15068309	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CN1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NCc5ccccc5)cc4)ncnc3c2)CC1		CHEMBL3343309	=	IC50	nM	289.0	CHEMBL2185	Homo sapiens	IC50	nM	289.0
	15068310	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCCCC4)ccc23)cc1		CHEMBL3343310	=	IC50	nM	193.0	CHEMBL2185	Homo sapiens	IC50	nM	193.0
	15068311	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCCCN1CCCOc1ccc2c(Nc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL3343311	=	IC50	nM	172.0	CHEMBL2185	Homo sapiens	IC50	nM	172.0
	15068312	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NCc5ccccc5)cc4)ncnc3c2)CC1		CHEMBL3343312	=	IC50	nM	292.0	CHEMBL2185	Homo sapiens	IC50	nM	292.0
	15068313	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCCC4)ccc23)cc1		CHEMBL3706674	=	IC50	nM	278.0	CHEMBL2185	Homo sapiens	IC50	nM	278.0
	15068314	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CC)CCCOc1ccc2c(Nc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL3706673	=	IC50	nM	196.0	CHEMBL2185	Homo sapiens	IC50	nM	196.0
	15068315	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CCO)CCCOc1ccc2c(Nc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL3706675	=	IC50	nM	573.0	CHEMBL2185	Homo sapiens	IC50	nM	573.0
	15068316	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCN(CCO)CC4)ccc23)cc1		CHEMBL3706676	=	IC50	nM	621.0	CHEMBL2185	Homo sapiens	IC50	nM	621.0
	15068317	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCC(CO)CC4)ccc23)cc1		CHEMBL3706677	=	IC50	nM	783.0	CHEMBL2185	Homo sapiens	IC50	nM	783.0
	15068318	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706678	=	IC50	nM	264.0	CHEMBL2185	Homo sapiens	IC50	nM	264.0
	15068319	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CN1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NC5CCCCC5)cc4)ncnc3c2)CC1		CHEMBL3706679	=	IC50	nM	318.0	CHEMBL2185	Homo sapiens	IC50	nM	318.0
	15068320	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCCCC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706680	=	IC50	nM	221.0	CHEMBL2185	Homo sapiens	IC50	nM	221.0
	15068321	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCCCN1CCCOc1ccc2c(Nc3ccc(NC(=O)NC4CCCCC4)cc3)ncnc2c1		CHEMBL3706681	=	IC50	nM	197.0	CHEMBL2185	Homo sapiens	IC50	nM	197.0
	15068322	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NC5CCCCC5)cc4)ncnc3c2)CC1		CHEMBL3706682	=	IC50	nM	232.0	CHEMBL2185	Homo sapiens	IC50	nM	232.0
	15068323	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCCC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706683	=	IC50	nM	181.0	CHEMBL2185	Homo sapiens	IC50	nM	181.0
	15068324	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CC)CCCOc1ccc2c(Nc3ccc(NC(=O)NC4CCCCC4)cc3)ncnc2c1		CHEMBL3706684	=	IC50	nM	176.0	CHEMBL2185	Homo sapiens	IC50	nM	176.0
	15068325	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CCO)CCCOc1ccc2c(Nc3ccc(NC(=O)NC4CCCCC4)cc3)ncnc2c1		CHEMBL3706685	=	IC50	nM	387.0	CHEMBL2185	Homo sapiens	IC50	nM	387.0
	15068326	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCN(CCO)CC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706686	=	IC50	nM	589.0	CHEMBL2185	Homo sapiens	IC50	nM	589.0
	15068327	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCC(CO)CC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706687	=	IC50	nM	845.0	CHEMBL2185	Homo sapiens	IC50	nM	845.0
	15068328	CHEMBL3388439	Inhibition of Aurora-B (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	156.0	CHEMBL2185	Homo sapiens	IC50	nM	156.0
	15068352	CHEMBL3388442	Inhibition of Aurora-B (unknown origin)	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
	15072450	CHEMBL3380124	Inhibition of Aurora B (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	104.0	CHEMBL2185	Homo sapiens	Activity	%	104.0
	15096811	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1O		CHEMBL3343033	=	IC50	nM	275.0	CHEMBL2185	Homo sapiens	IC50	uM	0.275
	15096812	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(C)nc2cc1O		CHEMBL3343034	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096813	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCO		CHEMBL3343037	=	IC50	nM	27.3	CHEMBL2185	Homo sapiens	IC50	uM	0.0273
	15096814	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(=O)O		CHEMBL3343038	=	IC50	nM	689.0	CHEMBL2185	Homo sapiens	IC50	uM	0.689
	15096815	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(N)=O		CHEMBL3343039	=	IC50	nM	155.0	CHEMBL2185	Homo sapiens	IC50	uM	0.155
	15096816	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(N)nc2cc1O		CHEMBL3343040	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096817	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(NCCc3ccccn3)nc2cc1O		CHEMBL3343042	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096818	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)ccc1O		CHEMBL3343044	=	IC50	nM	5910.0	CHEMBL2185	Homo sapiens	IC50	uM	5.91
	15096819	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1ccc(O)c([N+](=O)[O-])c1		CHEMBL3343045	=	IC50	nM	23100.0	CHEMBL2185	Homo sapiens	IC50	uM	23.1
	15096820	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1O		CHEMBL3343046	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096821	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)c(N)cc1O		CHEMBL3343047	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096822	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1OCC(=O)O		CHEMBL3343048	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096823	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3341771	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096824	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1cccc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3343051	=	IC50	nM	7510.0	CHEMBL2185	Homo sapiens	IC50	uM	7.51
	15096825	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1ccc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc1-c1c[nH]c(=O)[nH]c1=O		CHEMBL3343052	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096826	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(N2CCC(=O)NC2=O)c1		CHEMBL3343055	=	IC50	nM	14300.0	CHEMBL2185	Homo sapiens	IC50	uM	14.3
	15096827	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)C3CCCCN3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3343057	>	IC50	nM	30000.0	CHEMBL2185	Homo sapiens	IC50	uM	30.0
	15096828	CHEMBL3380800	Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	CCNC(=O)Nc1ccc(NC(=O)c2cc(OC)cc(-c3c[nH]c(=O)[nH]c3=O)c2)cc1		CHEMBL3343058	=	IC50	nM	18100.0	CHEMBL2185	Homo sapiens	IC50	uM	18.1
Active	15100339	CHEMBL3389102	Inhibition of Aurora B kinase phosphorylation in human HT-29 cells at 10 uM incubated for 15 to 120 mins by Western blotting method	B	COc1c2c(cc3oc(C)cc(=O)c13)OC(C(C)(C)O[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O)C2		CHEMBL2059296		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	15104937	CHEMBL3386796	Inhibition of AURKB (unknown origin) assessed as residual enzyme activity at 10 uM	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	Activity	%	29.0	CHEMBL2185	Homo sapiens	Activity	%	29.0
	15135622	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc(NC(=O)c4c(Cl)cccc4Cl)ccn3)n2)CC1		CHEMBL3352835	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	15135623	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)nc4cn3)n2)CC1		CHEMBL3354185	=	IC50	nM	3260.0	CHEMBL2185	Homo sapiens	IC50	nM	3260.0
	15135624	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)n2)CC1		CHEMBL3354186	=	IC50	nM	1770.0	CHEMBL2185	Homo sapiens	IC50	nM	1770.0
	15135625	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(cn3)cc(-c3cn[nH]c3)n4C(C)C)n2)CC1		CHEMBL3354187	=	IC50	nM	107.0	CHEMBL2185	Homo sapiens	IC50	nM	107.0
	15135626	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(ccn4C(C)C)cn3)n2)CC1		CHEMBL3354188	=	IC50	nM	6190.0	CHEMBL2185	Homo sapiens	IC50	nM	6190.0
	15135627	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(ccn4C4CCCC4)cn3)n2)CC1		CHEMBL3354189	=	IC50	nM	4030.0	CHEMBL2185	Homo sapiens	IC50	nM	4030.0
	15135628	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C(C)C)n2)CC1		CHEMBL3354190	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	15135629	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(cn3)c(N)nn4C(C)C)n2)CC1		CHEMBL3354191	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	15135630	CHEMBL3375804	Inhibition of Aurora B (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(C(C)C)n[nH]c4cn3)n2)CC1		CHEMBL3354192	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	15151642	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1ccc(Sc2nc3c(F)cccc3[nH]2)o1		CHEMBL3393488	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	15151643	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1ccc(Sc2nc3cccc(Cl)c3[nH]2)o1		CHEMBL3393487	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	15151644	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(C(=O)CN)C1)[C@H]2c1ccc(Sc2nc3c(F)cccc3[nH]2)o1.Cl		CHEMBL3393486	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	15151645	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(C(=O)CN)C1)[C@H]2c1ccc(Sc2nc3ccccc3[nH]2)o1.Cl		CHEMBL3393485	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	nM	4.0
	15152239	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(CC)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393484	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	nM	6.0
	15152240	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(N)cccc3[nH]2)o1		CHEMBL3393483	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
	15152241	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(O)cccc3[nH]2)o1		CHEMBL3393482	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	15152242	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cccnc3[nH]2)o1		CHEMBL3393481	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	15152243	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cc(Cl)ccc3[nH]2)o1		CHEMBL3393480	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	15152244	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cccc(Cl)c3[nH]2)o1		CHEMBL3393479	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	15152245	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(F)c(F)c(F)cc3[nH]2)o1		CHEMBL3393478	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	15152246	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccc(F)c(F)c3[nH]2)o1		CHEMBL3393477	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	15152247	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cc(F)c(F)cc3[nH]2)o1		CHEMBL3393476	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	nM	6.0
	15152248	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(F)cc(F)cc3[nH]2)o1		CHEMBL3393475	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	nM	4.0
	15152249	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cccc(F)c3[nH]2)o1		CHEMBL3393474	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	nM	6.0
	15152250	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cc(F)ccc3[nH]2)o1		CHEMBL3393473	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
	15152251	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1.Cl.O		CHEMBL3393472	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	15152252	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1c[nH]c(C(=O)O)c1N2		CHEMBL3393471	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
	15152253	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	COC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393470	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	15152254	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393469	>	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	nM	500.0
	15152255	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393469	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	15152256	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393469	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	15152257	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1c[nH]cc1N2		CHEMBL3393468	=	IC50	nM	127.0	CHEMBL2185	Homo sapiens	IC50	nM	127.0
	15152258	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	COC(=O)c1csc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393467	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	15152259	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	Nc1nc(O)c2c(n1)NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393466	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	15152260	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	NC(=O)c1[nH]nc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393465	=	IC50	nM	19.0	CHEMBL2185	Homo sapiens	IC50	nM	19.0
	15152261	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]nc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393464	=	IC50	nM	33.0	CHEMBL2185	Homo sapiens	IC50	nM	33.0
	15152262	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1n[nH]cc1N2		CHEMBL3393463	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	nM	500.0
	15152263	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1cn[nH]c1N2		CHEMBL3393462	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	15152325	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
	15152326	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393497	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	15152327	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccnc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3393496	=	IC50	nM	1100.0	CHEMBL2185	Homo sapiens	IC50	nM	1100.0
	15152328	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Sc2nc3ccccc3[nH]2)n1		CHEMBL3393495	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	15152329	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3393494	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	nM	7.0
	15152330	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cc(Sc2nc3ccccc3[nH]2)cs1		CHEMBL3393065	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
	15152331	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cnc(Sc2nc3ccccc3[nH]2)s1		CHEMBL3393493	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	15152332	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)s1		CHEMBL3393492	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	nM	180.0
	15152333	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(Cc3ccccc3)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393491	=	IC50	nM	8.0	CHEMBL2185	Homo sapiens	IC50	nM	8.0
	15152334	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(C(=O)OC(C)(C)C)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393490	=	IC50	nM	26.0	CHEMBL2185	Homo sapiens	IC50	nM	26.0
	15152335	CHEMBL3396726	Inhibition of poly-histidine tagged full length recombinant aurora B (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CC(C)(C)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393489	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	15152434	CHEMBL3395868	Inhibition of aurora B (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	350.0	CHEMBL2185	Homo sapiens	IC50	nM	350.0
	15152436	CHEMBL3395868	Inhibition of aurora B (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	15152437	CHEMBL3395868	Inhibition of aurora B (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	IC50	nM	200.0	CHEMBL2185	Homo sapiens	IC50	nM	200.0
	15152445	CHEMBL3395868	Inhibition of aurora B (unknown origin)	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	79.0	CHEMBL2185	Homo sapiens	IC50	nM	79.0
	15183844	CHEMBL3406102	Inhibition of AurB (unknown origin)	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCNCCCCCC(=O)N3CCN(c4nc(N5CCOCC5)nc(-n5c(C(F)F)nc6ccccc65)n4)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400291	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15211854	CHEMBL3420206	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	EC50	nM	102.0	CHEMBL2185	Homo sapiens	EC50	nM	102.0
Dose-dependent effect	15220464	CHEMBL3418595	Inhibition of Aurora B in human HeLa cells after 12 hrs by Western blot method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	15220465	CHEMBL3418595	Inhibition of Aurora B in human HeLa cells after 12 hrs by Western blot method	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc(F)c(NC2CCCC2)n1		CHEMBL3417327		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	15220467	CHEMBL3418774	Inhibition of Aurora B in human HeLa cells at	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	15220471	CHEMBL3418776	Inhibition of Aurora B in human HeLa cells after 12 hrs by ELISA method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325	=	IC50	nM	430.0	CHEMBL2185	Homo sapiens	IC50	uM	0.43
	15220472	CHEMBL3418776	Inhibition of Aurora B in human HeLa cells after 12 hrs by ELISA method	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc(F)c(NC2CCCC2)n1		CHEMBL3417327	=	IC50	nM	395.0	CHEMBL2185	Homo sapiens	IC50	uM	0.395
	15220473	CHEMBL3418776	Inhibition of Aurora B in human HeLa cells after 12 hrs by ELISA method	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	453.0	CHEMBL2185	Homo sapiens	IC50	uM	0.453
Active	15220475	CHEMBL3418778	Inhibition of Aurora B in human HeLa cells at >10 nM after 12 hrs by ELISA method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	15251868	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	6.0	CHEMBL2185	Homo sapiens	Activity	%	6.0
	15251929	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	15252031	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	91.0	CHEMBL2185	Homo sapiens	Activity	%	91.0
	15252676	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	84.0	CHEMBL2185	Homo sapiens	Activity	%	84.0
	15252778	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	82.0	CHEMBL2185	Homo sapiens	Activity	%	82.0
	15252880	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	106.0	CHEMBL2185	Homo sapiens	Activity	%	106.0
	15253554	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	83.0	CHEMBL2185	Homo sapiens	Activity	%	83.0
	15253656	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	85.0	CHEMBL2185	Homo sapiens	Activity	%	85.0
	15253758	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	109.0	CHEMBL2185	Homo sapiens	Activity	%	109.0
	15254424	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	99.0	CHEMBL2185	Homo sapiens	Activity	%	99.0
	15254526	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	77.0	CHEMBL2185	Homo sapiens	Activity	%	77.0
	15254628	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	88.0	CHEMBL2185	Homo sapiens	Activity	%	88.0
	15255319	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	7.0	CHEMBL2185	Homo sapiens	Activity	%	7.0
	15255421	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	21.0	CHEMBL2185	Homo sapiens	Activity	%	21.0
	15255524	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	5.0	CHEMBL2185	Homo sapiens	Activity	%	5.0
	15256255	CHEMBL3427940	Inhibition of Aurora B (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	6.0	CHEMBL2185	Homo sapiens	Activity	%	6.0
	15622929	CHEMBL3586966	Inhibition of aurora kinase B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence analysis	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O	Potential transcription error	CHEMBL483158	=	IC50	nM	1500.0	CHEMBL2185	Homo sapiens	IC50	uM	1.5
	15622930	CHEMBL3586966	Inhibition of aurora kinase B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence analysis	B	COc1cccc(F)c1C1=NCc2cnc(Nc3ccc(C(=O)O)cc3)nc2-c2ccc(Cl)cc21		CHEMBL3586473	=	IC50	nM	2500.0	CHEMBL2185	Homo sapiens	IC50	uM	2.5
	15622931	CHEMBL3586966	Inhibition of aurora kinase B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence analysis	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	5200.0	CHEMBL2185	Homo sapiens	IC50	uM	5.2
	15622932	CHEMBL3586966	Inhibition of aurora kinase B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence analysis	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2ccccc2F)=NC3)cc1		CHEMBL3586468	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15622933	CHEMBL3586966	Inhibition of aurora kinase B in human HCT116 cells assessed as inhibition of histone H3 phosphorylation by immunofluorescence analysis	B	Nc1ncc2c(n1)-c1ccc(Cl)cc1C(c1ccccc1F)=NC2		CHEMBL41816	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15650130	CHEMBL3595396	Inhibition of human AURKB at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	85.0	CHEMBL2185	Homo sapiens	INH	%	85.0
	15654958	CHEMBL3599526	Inhibition of Aurora B (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	Inhibition	%	4.1	CHEMBL2185	Homo sapiens	INH	%	4.1
	15654959	CHEMBL3599526	Inhibition of Aurora B (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2cn(C(=O)N3CCOCC3)c3ccc(Br)cc23)n1		CHEMBL3133762	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	15654960	CHEMBL3599526	Inhibition of Aurora B (unknown origin) at 0.5 uM relative to control	B	Cc1noc(C)c1Cn1cc(-c2ccnc(N)n2)c2ccccc21		CHEMBL3133770	=	Inhibition	%	10.1	CHEMBL2185	Homo sapiens	INH	%	10.1
	15656760	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cc2c(cc1N1CCCC1)/C(=C/c1cccs1)C(=O)N2		CHEMBL3598139	=	Inhibition	%	47.0	CHEMBL2185	Homo sapiens	INH	%	47.0
	15656761	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cc2c(cc1N1CCCC1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3598138	=	Inhibition	%	97.0	CHEMBL2185	Homo sapiens	INH	%	97.0
	15656762	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCN(CC)c1cc2c(cc1NC(C)=O)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3598137	=	Inhibition	%	83.0	CHEMBL2185	Homo sapiens	INH	%	83.0
	15656763	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCN(CC)c1cc2c(cc1NC(C)=O)NC(=O)/C2=C\c1ccccn1		CHEMBL3598136	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656764	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCN(CC)c1cc2c(cc1NC(C)=O)NC(=O)/C2=C\c1cccs1		CHEMBL3598135	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656765	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	O=C(Nc1ccc(F)cc1)Nc1cc2c(cc1N1CCOCC1)/C(=C/c1ccc(F)cc1)C(=O)N2		CHEMBL3598134	=	Inhibition	%	65.0	CHEMBL2185	Homo sapiens	INH	%	65.0
	15656766	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CC(=O)Nc1cc2c(cc1N1CCOCC1)/C(=C/c1ccco1)C(=O)N2		CHEMBL3598133	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656767	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	COc1ccc(/C=C2\C(=O)Nc3cc(NC(C)=O)c(N4CCOCC4)cc32)cc1		CHEMBL3598132	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656768	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	C=CCNC(=S)Nc1cc2c(cc1N(CCC)CCC)/C(=C/c1ccc3c(c1)OCO3)C(=O)N2		CHEMBL3598131	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	15656769	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCCCCCCNC(=O)Nc1cc2c(cc1N1CCN(C(=O)OCC)CC1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3598130	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656770	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCCC1(C(=O)OCC)C(=O)Nc2cc(NC(=O)Nc3ccc(F)cc3)c(N3CCN(c4cccc(C)c4C)CC3)cc21		CHEMBL3598129	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656771	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCCC1(C(=O)OCC)C(=O)Nc2cc(NC(C)=O)c(N3CCN(c4cccc(C)c4C)CC3)cc21		CHEMBL3598128	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656772	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	C=CCC1C(=O)Nc2cc(NC(=S)Nc3ccccc3OC)c(N(CCC)CCC)cc21		CHEMBL3598127	=	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	15656773	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCCCC1C(=O)Nc2cc(NC(=O)Nc3ccc(F)cc3)c(N3CCOCC3)cc21		CHEMBL3598126	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656774	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	O=C1Cc2cc(N3CCOCC3)c(NC(=O)Nc3ccc(F)cc3)cc2N1		CHEMBL3598125	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656775	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	C=CCC1C(=O)Nc2cc(NC(=O)Nc3ccc(F)cc3)c(N(CCC)CCC)cc21		CHEMBL3598124	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656776	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	C=CCNC(=S)Nc1cc2c(cc1Oc1cc(C)cc(C)c1)C(Cc1ccccc1)C(=O)N2		CHEMBL3598123	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656777	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	Cc1cc(C)cc(Oc2cc3c(cc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)NC(=O)C3Cc2ccccc2)c1		CHEMBL3598122	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656778	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	Cc1cc(C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(F)cc2)NC(=O)C3Cc2ccccc2)c1		CHEMBL3598121	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656779	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCc1ccc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(C)cc2)NC(=O)C3)cc1		CHEMBL3598120	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15656780	CHEMBL3599860	Inhibition of aurora B kinase (unknown origin) using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cc2c(cc1N1CCCC1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3598138	=	IC50	nM	1800.0	CHEMBL2185	Homo sapiens	IC50	uM	1.8
	15656781	CHEMBL3599860	Inhibition of aurora B kinase (unknown origin) using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCN(CC)c1cc2c(cc1NC(C)=O)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL3598137	=	IC50	nM	2500.0	CHEMBL2185	Homo sapiens	IC50	uM	2.5
	15656782	CHEMBL3599860	Inhibition of aurora B kinase (unknown origin) using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	O=C(Nc1ccc(F)cc1)Nc1cc2c(cc1N1CCOCC1)/C(=C/c1ccc3c(c1)OCO3)C(=O)N2		CHEMBL3598119	=	IC50	nM	8200.0	CHEMBL2185	Homo sapiens	IC50	uM	8.2
	15656783	CHEMBL3599860	Inhibition of aurora B kinase (unknown origin) using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	O=C(Nc1ccc(F)cc1)Nc1cc2c(cc1N1CCOCC1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3598118	=	IC50	nM	3300.0	CHEMBL2185	Homo sapiens	IC50	uM	3.3
	15656784	CHEMBL3599861	Inhibition of aurora B kinase (unknown origin) at 10 uM using ATP and SB2 substrate incubated at 37 degC for 2 hrs by kinase-Glo reagent based luminescent kinase assay	B	CCC/C=C1\C(=O)Nc2cc(NC(C)=O)c(N(CC)CC)cc21		CHEMBL3596217	<	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	15685872	CHEMBL3607948	Inhibition of human AUR1	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15732773	CHEMBL3626659	Inhibition of aurora B kinase (unknown origin) by cell based assay	B	C[C@@H](Oc1nc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1		CHEMBL3622203	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	nM	110.0
Not Determined	15735705	CHEMBL3627023	Inhibition of Aurora B kinase (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1cc(C)cc(Nc2nccc(-n3cc(C)c(CN4CC[C@@H](O)C4)c3)n2)c1		CHEMBL3622924		IC50			CHEMBL2185	Homo sapiens	IC50		
	15735706	CHEMBL3627023	Inhibition of Aurora B kinase (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	=	IC50	nM	1711.0	CHEMBL2185	Homo sapiens	IC50	nM	1711.0
Not Determined	15735707	CHEMBL3627023	Inhibition of Aurora B kinase (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC[C@@H](O)C1		CHEMBL3622957		IC50			CHEMBL2185	Homo sapiens	IC50		
	15736007	CHEMBL3627023	Inhibition of Aurora B kinase (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(C)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622958	=	IC50	nM	985.2	CHEMBL2185	Homo sapiens	IC50	nM	985.2
	15736626	CHEMBL3625825	Inhibition of human recombinant Aurora-B	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	15755843	CHEMBL3630633	Inhibition of AURKB (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	66.0	CHEMBL2185	Homo sapiens	Activity	%	66.0
	15756105	CHEMBL3632161	Inhibition of Aurora B (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	82.07	CHEMBL2185	Homo sapiens	INH	%	82.07
	15757700	CHEMBL3632161	Inhibition of Aurora B (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	49.16	CHEMBL2185	Homo sapiens	INH	%	49.16
	15757994	CHEMBL3632161	Inhibition of Aurora B (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	6.36	CHEMBL2185	Homo sapiens	INH	%	6.36
243028	16258310	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#CCc1ccc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)nc1		CHEMBL3680577	=	IC50	nM	0.76	CHEMBL2185	Homo sapiens	IC50	nM	0.76
242962	16258897	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(O)c4cc(C(F)(F)F)ccc4F)c3)ncnc12		CHEMBL3675525	=	IC50	nM	0.17	CHEMBL2185	Homo sapiens	IC50	nM	0.17
242968	16259431	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)NC2=CC(C(CCN(C)C)Nc3ncnc4c(C(N)=O)cccc34)=CCC2)c(F)c1		CHEMBL3680391	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
242940	16259595	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(F)cc4F)c3)ncnc12		CHEMBL3675441	=	IC50	nM	0.25	CHEMBL2185	Homo sapiens	IC50	nM	0.25
298018	16259844	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	COc1ccc(CC2(C(=O)O)CCN(C(=O)c3cccc(Cl)c3F)CC2)nc1Nc1cc(C)[nH]n1		CHEMBL3692208	=	IC50	nM	930.0	CHEMBL2185	Homo sapiens	IC50	nM	930.0
242895	16259964	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3670468	=	IC50	nM	0.71	CHEMBL2185	Homo sapiens	IC50	nM	0.71
242941	16260265	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675442	=	IC50	nM	2.4	CHEMBL2185	Homo sapiens	IC50	nM	2.4
242906	16260354	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(OCCN(CCO)CCO)c3)ncnc12		CHEMBL3670491	=	IC50	nM	88.0	CHEMBL2185	Homo sapiens	IC50	nM	88.0
243087	16260422	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CN(C)c3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685253	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
242942	16261436	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(O)c2)c1		CHEMBL3675444	=	IC50	nM	0.4	CHEMBL2185	Homo sapiens	IC50	nM	0.4
242924	16261465	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc4ccccc34)ncnc12		CHEMBL3675341	=	IC50	nM	388.0	CHEMBL2185	Homo sapiens	IC50	nM	388.0
243044	16261567	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ccc(C(F)(F)F)cn4)c3)ncnc12		CHEMBL3680604	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
243094	16261947	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#Cc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685261	=	IC50	nM	2.4	CHEMBL2185	Homo sapiens	IC50	nM	2.4
242938	16262760	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CN(C)C)Nc3ncnc4c3=CCCC=4C(N)=O)c2)cc1F		CHEMBL3675431	=	IC50	nM	1.9	CHEMBL2185	Homo sapiens	IC50	nM	1.9
242988	16263139	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cn1cnc2c(Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)nccc21		CHEMBL3680457	=	IC50	nM	43.0	CHEMBL2185	Homo sapiens	IC50	nM	43.0
243076	16263422	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3685243	=	IC50	nM	0.061	CHEMBL2185	Homo sapiens	IC50	nM	0.061
242979	16263715	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(O)/N=C2\C=CCC(CNc3ncnc4c(C(N)=O)cccc34)C2)cc1C		CHEMBL3680429	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
243077	16263783	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(OC)cc4)c3)c2c1		CHEMBL3685244	=	IC50	nM	2.7	CHEMBL2185	Homo sapiens	IC50	nM	2.7
242926	16264379	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccccc3C(F)(F)F)ncnc12		CHEMBL3675352	=	IC50	nM	7.6	CHEMBL2185	Homo sapiens	IC50	nM	7.6
243007	16264537	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(CN5CCCC5)cc4)c3)ncnc12		CHEMBL3680518	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
243011	16264632	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)C1=c2ncnc(NC(CCN3CCCC3)c3cccc(NC(=O)c4ccccc4)c3)c2=CCC1		CHEMBL3680531	=	IC50	nM	2.5	CHEMBL2185	Homo sapiens	IC50	nM	2.5
243010	16265004	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCNc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680523	=	IC50	nM	20.0	CHEMBL2185	Homo sapiens	IC50	nM	20.0
242925	16265135	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)cc3F)ncnc12		CHEMBL3639742	=	IC50	nM	0.59	CHEMBL2185	Homo sapiens	IC50	nM	0.59
243097	16265244	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccccc4OCCO)c3)ncnc12		CHEMBL3685264	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
298021	16265339	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	CNC(=O)C1(Cc2ccc(F)c(Nc3cc(C)[nH]n3)n2)CCN(C(=O)c2cccc(Cl)c2F)CC1		CHEMBL3692211	=	IC50	nM	460.0	CHEMBL2185	Homo sapiens	IC50	nM	460.0
243101	16265490	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(CN(C)C)cc2)c1		CHEMBL3685268	=	IC50	nM	0.62	CHEMBL2185	Homo sapiens	IC50	nM	0.62
242949	16265682	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2=CCC(Br)C=C2)c1		CHEMBL3675466	=	IC50	nM	0.66	CHEMBL2185	Homo sapiens	IC50	nM	0.66
243025	16266307	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(CO)cc4)c3)ncnc12		CHEMBL3680571	=	IC50	nM	0.73	CHEMBL2185	Homo sapiens	IC50	nM	0.73
243070	16266691	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)c1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1		CHEMBL3685237	=	IC50	nM	0.33	CHEMBL2185	Homo sapiens	IC50	nM	0.33
242914	16266784	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCN(CCO)CC2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670505	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	nM	4.0
242902	16267155	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Cc4ccc(Cl)cc4)c3)ncnc12		CHEMBL3670478	=	IC50	nM	1.6	CHEMBL2185	Homo sapiens	IC50	nM	1.6
242964	16267585	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(F)c2)c1		CHEMBL3675538	=	IC50	nM	3.1	CHEMBL2185	Homo sapiens	IC50	nM	3.1
298016	16268207	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4Cl)CC3)ccc2F)n[nH]1		CHEMBL3692206	=	IC50	nM	140.0	CHEMBL2185	Homo sapiens	IC50	nM	140.0
243040	16268384	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4nc5ccccc5s4)c3)ncnc12		CHEMBL3680597	=	IC50	nM	2.5	CHEMBL2185	Homo sapiens	IC50	nM	2.5
243090	16268439	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4=CCC(N5CCOCC5)C=C4)c3)ncnc12		CHEMBL3685256	=	IC50	nM	6.9	CHEMBL2185	Homo sapiens	IC50	nM	6.9
243008	16268483	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H](CN3CCCC3)c3ccccc3)ncnc12		CHEMBL3680521	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
242961	16268503	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc3c(c2)OCCO3)c1		CHEMBL3675520	=	IC50	nM	0.89	CHEMBL2185	Homo sapiens	IC50	nM	0.89
243051	16269184	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cnn5c4CNCC5)c3)ncnc12		CHEMBL3685210	=	IC50	nM	1.6	CHEMBL2185	Homo sapiens	IC50	nM	1.6
242987	16269509	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cc(C(F)(F)F)n[nH]4)c3)ncnc12		CHEMBL3680455	=	IC50	nM	0.51	CHEMBL2185	Homo sapiens	IC50	nM	0.51
243083	16270043	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5c(c4)OC(F)(F)O5)c3)ncnc12		CHEMBL3639841	=	IC50	nM	0.2	CHEMBL2185	Homo sapiens	IC50	nM	0.2
243081	16271298	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4CCCCC4)c3)ncnc12		CHEMBL3685248	=	IC50	nM	1.1	CHEMBL2185	Homo sapiens	IC50	nM	1.1
242955	16271452	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3675501	=	IC50	nM	0.32	CHEMBL2185	Homo sapiens	IC50	nM	0.32
243012	16272758	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1C(F)(F)F		CHEMBL3680532	=	IC50	nM	1.8	CHEMBL2185	Homo sapiens	IC50	nM	1.8
243105	16272788	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(c2ccc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)cc2)CC1		CHEMBL3685273	=	IC50	nM	34.0	CHEMBL2185	Homo sapiens	IC50	nM	34.0
242937	16273087	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccnc(N3CCCC3)c2)c1		CHEMBL3675406	=	IC50	nM	1.4	CHEMBL2185	Homo sapiens	IC50	nM	1.4
242975	16273263	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5c(c4)CCO5)c3)ncnc12		CHEMBL3680417	=	IC50	nM	0.46	CHEMBL2185	Homo sapiens	IC50	nM	0.46
242890	16273531	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cccc(NC(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3670454	=	IC50	nM	4.3	CHEMBL2185	Homo sapiens	IC50	nM	4.3
242956	16273705	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2cccc(F)c2F)=C1		CHEMBL3675504	=	IC50	nM	2.5	CHEMBL2185	Homo sapiens	IC50	nM	2.5
242923	16273794	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(F)c3)ncnc12		CHEMBL3675337	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
242936	16274307	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)c2ccncc2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675385	=	IC50	nM	680.0	CHEMBL2185	Homo sapiens	IC50	nM	680.0
242958	16274417	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4=CC(F)C(Cl)C=C4)c3)ncnc12		CHEMBL3675510	=	IC50	nM	0.47	CHEMBL2185	Homo sapiens	IC50	nM	0.47
300523	16274766	CHEMBL3708028	Biochemical Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.A specific substrate was incubated with the kinase in appropriate buffer conditions in the presence of ATP traced with .sup.33P-.gamma.-ATP (gamma phosphate-labeled, Redivue.TM. Code Number AH9968, 1000-3000 Ci/mmole, Amersham Biosciences Piscataway, N.J., USA), optimal cofactors and test compound.At the end of the phosphorylation reaction, more than 98% cold and radioactive ATP were captured by an excess of Dowex ion exchange resin. The resin was allowed to settle to the bottom of reaction wells by gravity. Supernatant, containing substrate peptide, was subsequently withdrawn and transferred into a counting plate, and radioactivity (corresponding to phosphate incorporated into peptide) was evaluated by .beta.-counting. Assay Conditions:The kinase assay was run with a final enzyme concentration of 6 nM, in the presence of 6 microM ATP, 1 nM .	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	338.0	CHEMBL2185	Homo sapiens	IC50	nM	338.0
242976	16274869	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2c(F)cccc2F)=C1		CHEMBL3680418	=	IC50	nM	5.9	CHEMBL2185	Homo sapiens	IC50	nM	5.9
243079	16275061	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(CCCCO)cc34)c2)cc1		CHEMBL3685246	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
242957	16275149	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)c(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3675506	=	IC50	nM	0.69	CHEMBL2185	Homo sapiens	IC50	nM	0.69
243032	16275538	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(N5CCCCC5=O)cc4)c3)ncnc12		CHEMBL3680584	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	nM	17.0
242917	16275702	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCC[C@H]2CO)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675321	=	IC50	nM	27.0	CHEMBL2185	Homo sapiens	IC50	nM	27.0
243021	16275863	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4[nH]nc5c4CCCC5)c3)ncnc12		CHEMBL3680554	=	IC50	nM	0.3	CHEMBL2185	Homo sapiens	IC50	nM	0.3
243116	16275929	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN3CCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685289	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	nM	6.0
242886	16276086	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670445	=	IC50	nM	4.1	CHEMBL2185	Homo sapiens	IC50	nM	4.1
243001	16276188	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(NCCO)c4)c3)ncnc12		CHEMBL3680497	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
242905	16276214	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(Cl)n4)c3)ncnc12		CHEMBL3670487	=	IC50	nM	2.9	CHEMBL2185	Homo sapiens	IC50	nM	2.9
242982	16276659	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680444	=	IC50	nM	0.042	CHEMBL2185	Homo sapiens	IC50	nM	0.042
243103	16276717	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(Cc2ccc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)cc2)CC1		CHEMBL3685270	=	IC50	nM	33.0	CHEMBL2185	Homo sapiens	IC50	nM	33.0
243117	16277361	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(N5CCCCC5)nc4)c3)ncnc12		CHEMBL3685293	=	IC50	nM	0.81	CHEMBL2185	Homo sapiens	IC50	nM	0.81
243115	16279528	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN3CCCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685288	=	IC50	nM	2.8	CHEMBL2185	Homo sapiens	IC50	nM	2.8
242904	16279621	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)nc4)c3)ncnc12		CHEMBL3670485	=	IC50	nM	0.46	CHEMBL2185	Homo sapiens	IC50	nM	0.46
243029	16280020	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5nc[nH]c5c4)c3)ncnc12		CHEMBL3680578	=	IC50	nM	4.7	CHEMBL2185	Homo sapiens	IC50	nM	4.7
300526	16280248	CHEMBL3708028	Biochemical Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.A specific substrate was incubated with the kinase in appropriate buffer conditions in the presence of ATP traced with .sup.33P-.gamma.-ATP (gamma phosphate-labeled, Redivue.TM. Code Number AH9968, 1000-3000 Ci/mmole, Amersham Biosciences Piscataway, N.J., USA), optimal cofactors and test compound.At the end of the phosphorylation reaction, more than 98% cold and radioactive ATP were captured by an excess of Dowex ion exchange resin. The resin was allowed to settle to the bottom of reaction wells by gravity. Supernatant, containing substrate peptide, was subsequently withdrawn and transferred into a counting plate, and radioactivity (corresponding to phosphate incorporated into peptide) was evaluated by .beta.-counting. Assay Conditions:The kinase assay was run with a final enzyme concentration of 6 nM, in the presence of 6 microM ATP, 1 nM .	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCCCC3)c2)CC1		CHEMBL3672896	=	IC50	nM	3234.0	CHEMBL2185	Homo sapiens	IC50	nM	3234.0
242995	16280643	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680476	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
243017	16280717	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cn[nH]c4N)c3)ncnc12		CHEMBL3680549	=	IC50	nM	1.2	CHEMBL2185	Homo sapiens	IC50	nM	1.2
242983	16280819	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680446	=	IC50	nM	0.57	CHEMBL2185	Homo sapiens	IC50	nM	0.57
243066	16281822	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)CCOC1C=CC(C(O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)=CC1		CHEMBL3685229	=	IC50	nM	59.0	CHEMBL2185	Homo sapiens	IC50	nM	59.0
242973	16281863	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(OCCCO)c4)c3)ncnc12		CHEMBL3680410	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
242951	16282821	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL3675480	=	IC50	nM	1.3	CHEMBL2185	Homo sapiens	IC50	nM	1.3
243039	16282962	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc2nc(Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)sc2c1		CHEMBL3639794	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
243124	16283678	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccccc4C(F)(F)F)c3)ncnc12		CHEMBL3685309	=	IC50	nM	3.8	CHEMBL2185	Homo sapiens	IC50	nM	3.8
298025	16283824	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(c4ncon4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692215	=	IC50	nM	190.0	CHEMBL2185	Homo sapiens	IC50	nM	190.0
243049	16284280	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCCOC1C=CC(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)=CC1		CHEMBL3685203	=	IC50	nM	27.0	CHEMBL2185	Homo sapiens	IC50	nM	27.0
243082	16285146	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(=O)Nc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685249	=	IC50	nM	0.5	CHEMBL2185	Homo sapiens	IC50	nM	0.5
243042	16286668	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(=O)[nH]c2)c1		CHEMBL3680601	=	IC50	nM	6.8	CHEMBL2185	Homo sapiens	IC50	nM	6.8
242943	16286681	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)cc2F)c1		CHEMBL3675445	=	IC50	nM	4.3	CHEMBL2185	Homo sapiens	IC50	nM	4.3
243106	16286717	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCC[C@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3685274	=	IC50	nM	7.6	CHEMBL2185	Homo sapiens	IC50	nM	7.6
242899	16286770	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(F)c(F)c4)c3)ncnc12		CHEMBL3670473	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
243102	16287585	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#Cc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685269	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
242977	16287783	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)c1cc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1		CHEMBL3680420	=	IC50	nM	0.27	CHEMBL2185	Homo sapiens	IC50	nM	0.27
242994	16288702	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)c(C(F)(F)F)o1		CHEMBL3680474	=	IC50	nM	0.94	CHEMBL2185	Homo sapiens	IC50	nM	0.94
242891	16289302	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670464	=	IC50	nM	1.4	CHEMBL2185	Homo sapiens	IC50	nM	1.4
242892	16290101	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)N4CCCCC4)c3)ncnc12		CHEMBL3670465	=	IC50	nM	2.2	CHEMBL2185	Homo sapiens	IC50	nM	2.2
243074	16291289	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685241	=	IC50	nM	1.2	CHEMBL2185	Homo sapiens	IC50	nM	1.2
242919	16291461	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCNCCO)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675325	=	IC50	nM	1.6	CHEMBL2185	Homo sapiens	IC50	nM	1.6
243095	16291695	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)cc4)c3)ncnc12		CHEMBL3685262	=	IC50	nM	0.18	CHEMBL2185	Homo sapiens	IC50	nM	0.18
243126	16291908	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(C2=CCC(C(N)=O)C=C2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685318	=	IC50	nM	160.0	CHEMBL2185	Homo sapiens	IC50	nM	160.0
242950	16291926	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675478	=	IC50	nM	9.6	CHEMBL2185	Homo sapiens	IC50	nM	9.6
243063	16292177	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CNC(=O)C2)c1		CHEMBL3685224	=	IC50	nM	38.0	CHEMBL2185	Homo sapiens	IC50	nM	38.0
243009	16292212	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ccnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680522	=	IC50	nM	0.5	CHEMBL2185	Homo sapiens	IC50	nM	0.5
243120	16293100	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCc2ccccc2)cc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCC5)c4)c3)ncnc12		CHEMBL3685302	=	IC50	nM	400.0	CHEMBL2185	Homo sapiens	IC50	nM	400.0
298017	16293215	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(C(F)(F)F)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692207	=	IC50	nM	340.0	CHEMBL2185	Homo sapiens	IC50	nM	340.0
243084	16293261	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(C(F)(F)F)nc4)c3)ncnc12		CHEMBL3685250	=	IC50	nM	0.38	CHEMBL2185	Homo sapiens	IC50	nM	0.38
242920	16293453	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3675328	=	IC50	nM	170.0	CHEMBL2185	Homo sapiens	IC50	nM	170.0
242896	16294131	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3670470	=	IC50	nM	0.52	CHEMBL2185	Homo sapiens	IC50	nM	0.52
243026	16294371	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680572	=	IC50	nM	0.39	CHEMBL2185	Homo sapiens	IC50	nM	0.39
242960	16294397	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCC3)c3cccc(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3675518	=	IC50	nM	4.5	CHEMBL2185	Homo sapiens	IC50	nM	4.5
298019	16294670	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2Cl)n[nH]1		CHEMBL3692209	=	IC50	nM	260.0	CHEMBL2185	Homo sapiens	IC50	nM	260.0
243099	16295266	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4c(F)cccc4F)c3)ncnc12		CHEMBL3685266	=	IC50	nM	0.88	CHEMBL2185	Homo sapiens	IC50	nM	0.88
243093	16295420	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685259	=	IC50	nM	4.6	CHEMBL2185	Homo sapiens	IC50	nM	4.6
243088	16296092	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4CCCNC4)c3)ncnc12		CHEMBL3685254	=	IC50	nM	1.6	CHEMBL2185	Homo sapiens	IC50	nM	1.6
242999	16296145	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCOc1ccc(NC(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680483	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	nM	180.0
243111	16296314	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccccc4F)c3)ncnc12		CHEMBL3685280	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
242947	16296578	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3675459	=	IC50	nM	0.35	CHEMBL2185	Homo sapiens	IC50	nM	0.35
242963	16296671	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cncc(N5CCOCC5)c4)c3)ncnc12		CHEMBL3675533	=	IC50	nM	21.0	CHEMBL2185	Homo sapiens	IC50	nM	21.0
198776	16296687	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	COc1cc(Nc2ncc3c(n2)-c2cccc(Cl)c2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL3692218	=	IC50	nM	90.0	CHEMBL2185	Homo sapiens	IC50	nM	90.0
243121	16296718	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(F)c(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c(F)c1		CHEMBL3685306	=	IC50	nM	0.22	CHEMBL2185	Homo sapiens	IC50	nM	0.22
242910	16296763	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)n1		CHEMBL3670498	=	IC50	nM	0.73	CHEMBL2185	Homo sapiens	IC50	nM	0.73
242959	16296901	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C=CCN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3675516	=	IC50	nM	1.8	CHEMBL2185	Homo sapiens	IC50	nM	1.8
243069	16297278	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)NCc2cccc(Nc3ncnc4c(C(N)=O)cc(O)cc34)c2)cc1		CHEMBL3685232	=	IC50	nM	8.7	CHEMBL2185	Homo sapiens	IC50	nM	8.7
243109	16297370	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cc(C5CC5)n[nH]4)c3)ncnc12		CHEMBL3685277	=	IC50	nM	0.089	CHEMBL2185	Homo sapiens	IC50	nM	0.089
243056	16297571	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(F)(F)F)nn1CC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685215	=	IC50	nM	4.4	CHEMBL2185	Homo sapiens	IC50	nM	4.4
242998	16297620	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CS(=O)(=O)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680481	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
243061	16298006	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCC3)c3cccc(Nc4ccccn4)c3)ncnc12		CHEMBL3685221	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
242985	16298077	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCCOC1C=C(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)C=CC1		CHEMBL3680450	=	IC50	nM	72.0	CHEMBL2185	Homo sapiens	IC50	nM	72.0
243035	16298126	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC(F)(F)C2)c1		CHEMBL3680588	=	IC50	nM	0.5	CHEMBL2185	Homo sapiens	IC50	nM	0.5
243016	16299873	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4nccs4)c3)ncnc12		CHEMBL3680548	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
242934	16300393	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675380	=	IC50	nM	0.82	CHEMBL2185	Homo sapiens	IC50	nM	0.82
243125	16300574	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)n1cc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)cn1		CHEMBL3685317	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
243052	16301435	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2ccc(C)c(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685211	=	IC50	nM	32.0	CHEMBL2185	Homo sapiens	IC50	nM	32.0
243005	16302122	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(NC(=O)c4cc(C(F)(F)F)n[nH]4)cc3)ncnc12		CHEMBL3680508	=	IC50	nM	0.045	CHEMBL2185	Homo sapiens	IC50	nM	0.045
243080	16302298	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685247	=	IC50	nM	1.8	CHEMBL2185	Homo sapiens	IC50	nM	1.8
243023	16303014	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccc1N1CCOCC1		CHEMBL3680557	=	IC50	nM	2.2	CHEMBL2185	Homo sapiens	IC50	nM	2.2
243006	16303136	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c(OC)c1		CHEMBL3680509	=	IC50	nM	3.6	CHEMBL2185	Homo sapiens	IC50	nM	3.6
242915	16303415	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCOCC2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670506	=	IC50	nM	600.0	CHEMBL2185	Homo sapiens	IC50	nM	600.0
242970	16303461	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2ccccc2F)=C1		CHEMBL3680393	=	IC50	nM	7.8	CHEMBL2185	Homo sapiens	IC50	nM	7.8
243113	16303589	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(O)c4ccccc4)c3)ncnc12		CHEMBL3685286	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
243091	16303590	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1OC		CHEMBL3685257	=	IC50	nM	0.31	CHEMBL2185	Homo sapiens	IC50	nM	0.31
242965	16303974	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CCO)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680387	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
243127	16304060	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)c1		CHEMBL3685320	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	nM	110.0
243022	16304548	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(-c5ncc[nH]5)cc4)c3)ncnc12		CHEMBL3680556	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
242928	16304811	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675355	=	IC50	nM	700.0	CHEMBL2185	Homo sapiens	IC50	nM	700.0
243107	16305038	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4nc5ccc(C(F)(F)F)cc5[nH]4)c3)ncnc12		CHEMBL3685275	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
243104	16305447	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)c3)ncnc12		CHEMBL3685272	=	IC50	nM	0.52	CHEMBL2185	Homo sapiens	IC50	nM	0.52
243057	16305872	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2ccc3c(c2)CN(c2ncnc4c(C(N)=O)cccc24)CC3)cc1		CHEMBL3685216	=	IC50	nM	20.0	CHEMBL2185	Homo sapiens	IC50	nM	20.0
242993	16305957	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(O)c2cc(C3CC3)n[nH]2)c1		CHEMBL3680470	=	IC50	nM	1.1	CHEMBL2185	Homo sapiens	IC50	nM	1.1
242991	16306375	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCCC5)c4)c3)ncnc12		CHEMBL3680464	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
243037	16307484	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(N5CCOCC5)c4)c3)ncnc12		CHEMBL3680590	=	IC50	nM	5.5	CHEMBL2185	Homo sapiens	IC50	nM	5.5
242954	16307717	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2=CCC(Cl)N=C2)c1		CHEMBL3675493	=	IC50	nM	0.4	CHEMBL2185	Homo sapiens	IC50	nM	0.4
243004	16307836	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3680507	=	IC50	nM	0.82	CHEMBL2185	Homo sapiens	IC50	nM	0.82
243020	16307838	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#Cc1ccnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680552	=	IC50	nM	0.06	CHEMBL2185	Homo sapiens	IC50	nM	0.06
242980	16308200	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(=O)NC2=CCCC(C(C)Nc3ncnc4c(C(N)=O)cccc34)=C2)ccn1		CHEMBL3680436	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
243071	16308855	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3685238	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
243024	16309253	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(CO)cc34)c2)cc1		CHEMBL3680567	=	IC50	nM	0.96	CHEMBL2185	Homo sapiens	IC50	nM	0.96
242989	16309292	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(F)ccc2F)c1		CHEMBL3680458	=	IC50	nM	9.2	CHEMBL2185	Homo sapiens	IC50	nM	9.2
242882	16310137	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4cccc(F)c4)c3)ncnc12		CHEMBL3670425	=	IC50	nM	5.6	CHEMBL2185	Homo sapiens	IC50	nM	5.6
298020	16310471	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692210	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	nM	180.0
243078	16310893	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(C(F)(F)F)cc4F)c3)ncnc12		CHEMBL3685245	=	IC50	nM	0.21	CHEMBL2185	Homo sapiens	IC50	nM	0.21
242930	16310960	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675365	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	nM	500.0
243112	16310966	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(CN3CCCC3)cc2)c1		CHEMBL3685285	=	IC50	nM	3.3	CHEMBL2185	Homo sapiens	IC50	nM	3.3
242966	16311578	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3680388	=	IC50	nM	2.4	CHEMBL2185	Homo sapiens	IC50	nM	2.4
242909	16311791	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3670497	=	IC50	nM	0.94	CHEMBL2185	Homo sapiens	IC50	nM	0.94
243003	16311907	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680500	=	IC50	nM	0.26	CHEMBL2185	Homo sapiens	IC50	nM	0.26
243019	16312941	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCc1cnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)s1		CHEMBL3680551	=	IC50	nM	0.74	CHEMBL2185	Homo sapiens	IC50	nM	0.74
243123	16313192	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)C1=c2ncnc(NCc3cccc(NC(=O)c4ccc(C(F)(F)F)cc4)c3)c2=CCC1		CHEMBL3685308	=	IC50	nM	0.68	CHEMBL2185	Homo sapiens	IC50	nM	0.68
243086	16313429	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(Cl)c4)c3)ncnc12		CHEMBL3685252	=	IC50	nM	0.38	CHEMBL2185	Homo sapiens	IC50	nM	0.38
242885	16313635	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc2ccccc12		CHEMBL3670439	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
243002	16313687	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3680499	=	IC50	nM	0.94	CHEMBL2185	Homo sapiens	IC50	nM	0.94
298026	16314081	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(c4nnc(C)o4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692216	=	IC50	nM	450.0	CHEMBL2185	Homo sapiens	IC50	nM	450.0
242897	16314635	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5c(c4)OCO5)c3)ncnc12		CHEMBL3670471	=	IC50	nM	1.2	CHEMBL2185	Homo sapiens	IC50	nM	1.2
242911	16314873	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3639693	=	IC50	nM	2.6	CHEMBL2185	Homo sapiens	IC50	nM	2.6
242992	16314972	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3C=CC=C(NC=O)C3)ncnc12		CHEMBL3680467	=	IC50	nM	0.58	CHEMBL2185	Homo sapiens	IC50	nM	0.58
243073	16315094	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1		CHEMBL3685240	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
242984	16315391	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)c1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680447	=	IC50	nM	0.046	CHEMBL2185	Homo sapiens	IC50	nM	0.046
242908	16315625	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCc2ccccc2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670496	=	IC50	nM	2500.0	CHEMBL2185	Homo sapiens	IC50	nM	2500.0
243036	16315788	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C(F)(F)C(F)(F)F)c1		CHEMBL3680589	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
300525	16316421	CHEMBL3708028	Biochemical Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.A specific substrate was incubated with the kinase in appropriate buffer conditions in the presence of ATP traced with .sup.33P-.gamma.-ATP (gamma phosphate-labeled, Redivue.TM. Code Number AH9968, 1000-3000 Ci/mmole, Amersham Biosciences Piscataway, N.J., USA), optimal cofactors and test compound.At the end of the phosphorylation reaction, more than 98% cold and radioactive ATP were captured by an excess of Dowex ion exchange resin. The resin was allowed to settle to the bottom of reaction wells by gravity. Supernatant, containing substrate peptide, was subsequently withdrawn and transferred into a counting plate, and radioactivity (corresponding to phosphate incorporated into peptide) was evaluated by .beta.-counting. Assay Conditions:The kinase assay was run with a final enzyme concentration of 6 nM, in the presence of 6 microM ATP, 1 nM .	B	COCCNc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3672895	=	IC50	nM	568.0	CHEMBL2185	Homo sapiens	IC50	nM	568.0
243033	16316496	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)C1=CC(NC(=O)C2(C(F)(F)F)CCC2)=CCC1		CHEMBL3680586	=	IC50	nM	9.4	CHEMBL2185	Homo sapiens	IC50	nM	9.4
243031	16317223	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)ncnc12		CHEMBL3680582	=	IC50	nM	2.3	CHEMBL2185	Homo sapiens	IC50	nM	2.3
242903	16317242	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(F)cc4)c3)c2c1		CHEMBL3670479	=	IC50	nM	7.8	CHEMBL2185	Homo sapiens	IC50	nM	7.8
242880	16317612	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4Cl)c3)ncnc12		CHEMBL3670422	=	IC50	nM	91.0	CHEMBL2185	Homo sapiens	IC50	nM	91.0
242990	16317863	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680460	=	IC50	nM	0.41	CHEMBL2185	Homo sapiens	IC50	nM	0.41
242935	16317990	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(N)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675381	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
242893	16318082	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCCNCc3ccccc3)ncnc12		CHEMBL3670466	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	nM	23.0
243068	16318105	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COC1C=CC(C(=O)Nc2cccc(CNc3ncnc4c3=CC(CN3CCN(C)CC3)CC=4C(N)=O)c2)=CC1		CHEMBL3685231	=	IC50	nM	22.0	CHEMBL2185	Homo sapiens	IC50	nM	22.0
243054	16318436	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3cccc(CNC(=O)c4cccnc4)c3)ncnc12		CHEMBL3685213	=	IC50	nM	170.0	CHEMBL2185	Homo sapiens	IC50	nM	170.0
243015	16318938	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOC(=O)c1cnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)s1		CHEMBL3680544	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
243034	16319383	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1nc(-c2cccc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)c2)no1		CHEMBL3680587	=	IC50	nM	0.5	CHEMBL2185	Homo sapiens	IC50	nM	0.5
242901	16319931	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(F)cc4)c3)c2c1		CHEMBL3670476	=	IC50	nM	1.7	CHEMBL2185	Homo sapiens	IC50	nM	1.7
243064	16320456	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3c(C(N)=O)cnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685225	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
243053	16320482	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ncccn4)c3)ncnc12		CHEMBL3685212	=	IC50	nM	3.3	CHEMBL2185	Homo sapiens	IC50	nM	3.3
243114	16320560	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)c(NC(=O)c4ccc(OC(F)(F)F)cc4)c3)ncnc12		CHEMBL3685287	=	IC50	nM	1.8	CHEMBL2185	Homo sapiens	IC50	nM	1.8
242898	16321540	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Cc4ccccc4)c3)ncnc12		CHEMBL3670472	=	IC50	nM	2.1	CHEMBL2185	Homo sapiens	IC50	nM	2.1
243059	16321560	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(N)c1cccc(NC(=O)c2ccoc2CN2CCOCC2)c1		CHEMBL3685218	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
243014	16323439	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ccccn4)c3)ncnc12		CHEMBL3680542	=	IC50	nM	0.94	CHEMBL2185	Homo sapiens	IC50	nM	0.94
242953	16323488	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Cl)c(F)c2)c1		CHEMBL3675491	=	IC50	nM	1.2	CHEMBL2185	Homo sapiens	IC50	nM	1.2
300524	16323945	CHEMBL3708028	Biochemical Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.A specific substrate was incubated with the kinase in appropriate buffer conditions in the presence of ATP traced with .sup.33P-.gamma.-ATP (gamma phosphate-labeled, Redivue.TM. Code Number AH9968, 1000-3000 Ci/mmole, Amersham Biosciences Piscataway, N.J., USA), optimal cofactors and test compound.At the end of the phosphorylation reaction, more than 98% cold and radioactive ATP were captured by an excess of Dowex ion exchange resin. The resin was allowed to settle to the bottom of reaction wells by gravity. Supernatant, containing substrate peptide, was subsequently withdrawn and transferred into a counting plate, and radioactivity (corresponding to phosphate incorporated into peptide) was evaluated by .beta.-counting. Assay Conditions:The kinase assay was run with a final enzyme concentration of 6 nM, in the presence of 6 microM ATP, 1 nM .	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)cc2)CC1		CHEMBL3672894	=	IC50	nM	484.0	CHEMBL2185	Homo sapiens	IC50	nM	484.0
243096	16324147	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(O)c(F)c2)c1		CHEMBL3685263	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
243043	16324580	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)CC(F)(F)F)c1		CHEMBL3680602	=	IC50	nM	4.2	CHEMBL2185	Homo sapiens	IC50	nM	4.2
243048	16324706	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3685202	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
243119	16325724	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(OCCCN(C)C)cc34)c2)cc1		CHEMBL3685297	=	IC50	nM	5.3	CHEMBL2185	Homo sapiens	IC50	nM	5.3
242997	16325869	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOc1cc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680480	=	IC50	nM	2.1	CHEMBL2185	Homo sapiens	IC50	nM	2.1
243055	16327135	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(Nc4ccccn4)c3)ncnc12		CHEMBL3685214	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
242944	16327593	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)cc4Cl)c3)ncnc12		CHEMBL3675446	=	IC50	nM	0.35	CHEMBL2185	Homo sapiens	IC50	nM	0.35
242889	16327726	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4C(F)(F)F)c3)ncnc12		CHEMBL3670453	=	IC50	nM	22.0	CHEMBL2185	Homo sapiens	IC50	nM	22.0
242967	16328002	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)C1=c2ncnc(NC(CCN3CCCC3)c3cccc(NC(=O)c4ccc(Br)cc4)c3)c2=CCC1		CHEMBL3680390	=	IC50	nM	1.4	CHEMBL2185	Homo sapiens	IC50	nM	1.4
242986	16328013	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCCOc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680451	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
242945	16328410	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL3675449	=	IC50	nM	1.6	CHEMBL2185	Homo sapiens	IC50	nM	1.6
243046	16329392	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3CC=C/C(=N/C(O)c4c[nH]c5ncccc45)C3)ncnc12		CHEMBL4114812	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
242933	16329748	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(C(F)(F)F)c3)ccnc12		CHEMBL3675379	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
243038	16330707	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#CCc1ccnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680596	=	IC50	nM	0.18	CHEMBL2185	Homo sapiens	IC50	nM	0.18
242916	16330736	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCC(O)C2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675320	=	IC50	nM	1060.0	CHEMBL2185	Homo sapiens	IC50	nM	1060.0
243118	16331365	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN3CCCCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685294	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
242883	16331461	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cc(F)cc(F)c3)ncnc12		CHEMBL3670427	=	IC50	nM	3.9	CHEMBL2185	Homo sapiens	IC50	nM	3.9
243062	16331652	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)N1CCC(C(=O)Nc2cccc(CNC3=NC=NC4C(C(N)=O)=CCC=C34)c2)CC1		CHEMBL3685222	=	IC50	nM	1.9	CHEMBL2185	Homo sapiens	IC50	nM	1.9
243075	16331864	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1cccc(C(=O)Nc2cccc(CNc3ncnc4c3=CCCC=4C(N)=O)c2)c1		CHEMBL3685242	=	IC50	nM	1.7	CHEMBL2185	Homo sapiens	IC50	nM	1.7
242927	16331932	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc4c(c3)OCO4)ncnc12		CHEMBL3675353	=	IC50	nM	3.9	CHEMBL2185	Homo sapiens	IC50	nM	3.9
243065	16332010	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3cccc(CNC(=O)C4CCCNC4)c3)ncnc12		CHEMBL3685226	=	IC50	nM	39.0	CHEMBL2185	Homo sapiens	IC50	nM	39.0
242981	16332089	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(c2ccc(NC(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)cc2)CC1		CHEMBL3680440	=	IC50	nM	370.0	CHEMBL2185	Homo sapiens	IC50	nM	370.0
242922	16332107	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1C(CNC(C)=O)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3675330	=	IC50	nM	7.1	CHEMBL2185	Homo sapiens	IC50	nM	7.1
242877	16332572	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(CNc2cncc3c(C(N)=O)cccc23)cc(OC)c1		CHEMBL3670416	=	IC50	nM	8.2	CHEMBL2185	Homo sapiens	IC50	nM	8.2
243050	16333062	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685207	=	IC50	nM	70.0	CHEMBL2185	Homo sapiens	IC50	nM	70.0
243089	16333560	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3685255	=	IC50	nM	1.9	CHEMBL2185	Homo sapiens	IC50	nM	1.9
243018	16334723	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3680550	=	IC50	nM	0.38	CHEMBL2185	Homo sapiens	IC50	nM	0.38
242884	16335084	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)NC(=O)c4ccccc4)c3)ncnc12		CHEMBL3670434	=	IC50	nM	420.0	CHEMBL2185	Homo sapiens	IC50	nM	420.0
243067	16335179	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4n[nH]c5ccc(Br)cc45)c3)ncnc12		CHEMBL3685230	=	IC50	nM	6.4	CHEMBL2185	Homo sapiens	IC50	nM	6.4
242900	16336116	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(SC(F)(F)F)cc4)c3)ncnc12		CHEMBL3670474	=	IC50	nM	1.2	CHEMBL2185	Homo sapiens	IC50	nM	1.2
243072	16336186	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)CCOc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(OC)cc4)c3)c2c1		CHEMBL3685239	=	IC50	nM	6.5	CHEMBL2185	Homo sapiens	IC50	nM	6.5
242978	16336457	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCn1nc(C(F)(F)F)cc1C(=O)Nc1cccc(C(C)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3680421	=	IC50	nM	0.58	CHEMBL2185	Homo sapiens	IC50	nM	0.58
243092	16337569	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(OC(F)(F)F)c4)c3)ncnc12		CHEMBL3685258	=	IC50	nM	2.0	CHEMBL2185	Homo sapiens	IC50	nM	2.0
243000	16337878	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(c2ccc(C(=O)Nc3cccc(CNc4nncc5c(C(N)=O)cccc45)c3)cc2C(F)(F)F)CC1		CHEMBL3680492	=	IC50	nM	5.8	CHEMBL2185	Homo sapiens	IC50	nM	5.8
243108	16338291	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3CC=C/C(=N/C(O)c4ccn[nH]4)C3)ncnc12		CHEMBL4114796	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
243122	16339047	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(O)cc34)c2)cc1		CHEMBL3685307	=	IC50	nM	0.6	CHEMBL2185	Homo sapiens	IC50	nM	0.6
242894	16341445	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3670467	=	IC50	nM	0.35	CHEMBL2185	Homo sapiens	IC50	nM	0.35
242946	16342465	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cncc(N5CCCC5)c4)c3)ncnc12		CHEMBL3675453	=	IC50	nM	1.1	CHEMBL2185	Homo sapiens	IC50	nM	1.1
242929	16342657	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(O)c3)ncnc12		CHEMBL3675363	=	IC50	nM	2500.0	CHEMBL2185	Homo sapiens	IC50	nM	2500.0
243110	16342746	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cccc(OC)c1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685279	=	IC50	nM	9.8	CHEMBL2185	Homo sapiens	IC50	nM	9.8
298023	16343000	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)N4CCC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692213	=	IC50	nM	880.0	CHEMBL2185	Homo sapiens	IC50	nM	880.0
242932	16343448	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4)c3)ncnc12		CHEMBL3675371	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
243047	16343739	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3C=C(NC(=O)c4ccncc4)C=CC3)ncnc12		CHEMBL3685200	=	IC50	nM	8.9	CHEMBL2185	Homo sapiens	IC50	nM	8.9
242972	16344782	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)c(Cl)c4)c3)ncnc12		CHEMBL3680403	=	IC50	nM	0.3	CHEMBL2185	Homo sapiens	IC50	nM	0.3
243058	16344891	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4n[nH]c5ccc(Cl)cc45)c3)ncnc12		CHEMBL3685217	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
242878	16347073	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccco3)ncnc12		CHEMBL3670417	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
243085	16348362	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(Br)c4)c3)ncnc12		CHEMBL3685251	=	IC50	nM	0.79	CHEMBL2185	Homo sapiens	IC50	nM	0.79
243045	16348461	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3cccc(CNC(=O)c4ccc(C(F)(F)F)cc4)c3)ncnc12		CHEMBL3680605	=	IC50	nM	4.7	CHEMBL2185	Homo sapiens	IC50	nM	4.7
243041	16349788	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC2(F)F)c1		CHEMBL3680599	=	IC50	nM	0.54	CHEMBL2185	Homo sapiens	IC50	nM	0.54
242952	16349992	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)nc2)c1		CHEMBL3675487	=	IC50	nM	1.4	CHEMBL2185	Homo sapiens	IC50	nM	1.4
242888	16350093	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H]3CCCc4ccccc43)ncnc12		CHEMBL3670450	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	nM	500.0
242939	16350936	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc3c(c2)OCO3)c1		CHEMBL3675438	=	IC50	nM	0.43	CHEMBL2185	Homo sapiens	IC50	nM	0.43
242948	16351114	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(C(C)(C)C)n[nH]2)c1		CHEMBL3675465	=	IC50	nM	1.3	CHEMBL2185	Homo sapiens	IC50	nM	1.3
243027	16351196	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC(F)(F)C2)c1		CHEMBL3680574	=	IC50	nM	6.5	CHEMBL2185	Homo sapiens	IC50	nM	6.5
242879	16351453	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4F)c3)ncnc12		CHEMBL3670421	=	IC50	nM	200.0	CHEMBL2185	Homo sapiens	IC50	nM	200.0
243013	16351473	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)NC2=CCCC([C@H](C)Nc3ncnc4c(C(N)=O)cccc34)=C2)cc1F		CHEMBL3680539	=	IC50	nM	43.0	CHEMBL2185	Homo sapiens	IC50	nM	43.0
298024	16352744	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(c4noc(C)n4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692214	=	IC50	nM	380.0	CHEMBL2185	Homo sapiens	IC50	nM	380.0
242971	16353304	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680395	=	IC50	nM	2.2	CHEMBL2185	Homo sapiens	IC50	nM	2.2
242913	16353604	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCN(C)CCCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3670504	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	nM	1.0
242907	16353878	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(Cl)c4)c3)ncnc12		CHEMBL3670493	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
242974	16353907	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCN(C)c1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680411	=	IC50	nM	3.5	CHEMBL2185	Homo sapiens	IC50	nM	3.5
243060	16354110	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(CN5CCOCC5)cc34)c2)cc1		CHEMBL3685219	=	IC50	nM	140.0	CHEMBL2185	Homo sapiens	IC50	nM	140.0
243098	16354184	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2ccc(F)c(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685265	=	IC50	nM	2.7	CHEMBL2185	Homo sapiens	IC50	nM	2.7
242969	16354605	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCC5)c4)c3)ncnc12		CHEMBL3680392	=	IC50	nM	2.1	CHEMBL2185	Homo sapiens	IC50	nM	2.1
242887	16354764	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNC(=O)c1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670446	=	IC50	nM	1800.0	CHEMBL2185	Homo sapiens	IC50	nM	1800.0
298022	16354875	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)NC4CC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692212	=	IC50	nM	900.0	CHEMBL2185	Homo sapiens	IC50	nM	900.0
298027	16354946	CHEMBL3707601	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 M), and incubation time was set to 60 minutes.	B	Cc1noc(C2(Cc3ccc(F)c(Nc4cc(C)[nH]n4)n3)CCN(C(=O)c3cccc(Cl)c3F)CC2)n1		CHEMBL3692217	=	IC50	nM	390.0	CHEMBL2185	Homo sapiens	IC50	nM	390.0
242921	16355085	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1C(CN)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3675329	=	IC50	nM	48.0	CHEMBL2185	Homo sapiens	IC50	nM	48.0
243100	16355203	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cc(CNc3ncnc4c(C(N)=O)cccc34)ccc2C)cc1		CHEMBL3685267	=	IC50	nM	0.8	CHEMBL2185	Homo sapiens	IC50	nM	0.8
242918	16355250	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(CCCOc2cc(C(N)=O)c3ncnc(NCc4ccc(C(F)(F)F)cc4)c3c2)CC1		CHEMBL3675323	=	IC50	nM	6.2	CHEMBL2185	Homo sapiens	IC50	nM	6.2
242996	16355542	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680479	=	IC50	nM	5.3	CHEMBL2185	Homo sapiens	IC50	nM	5.3
242881	16355949	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1NC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670424	=	IC50	nM	2.5	CHEMBL2185	Homo sapiens	IC50	nM	2.5
242931	16356148	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(F)cc4)c3)ncnc12		CHEMBL3675368	=	IC50	nM	330.0	CHEMBL2185	Homo sapiens	IC50	nM	330.0
242912	16356550	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(O)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670499	=	IC50	nM	0.24	CHEMBL2185	Homo sapiens	IC50	nM	0.24
	16413407	CHEMBL3743737	Inhibition of Aurora1 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	16424953	CHEMBL3751005	Inhibition of GST-INCENP activated N-terminal 6His-tagged human recombinant full length Aurora B (1 to 344 residues) expressed in baculovirus expression system using 5FAM-LRRASLG as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC		CHEMBL3747305	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	uM	0.016
	16424954	CHEMBL3751005	Inhibition of GST-INCENP activated N-terminal 6His-tagged human recombinant full length Aurora B (1 to 344 residues) expressed in baculovirus expression system using 5FAM-LRRASLG as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)c1		CHEMBL3745954	=	IC50	nM	157.0	CHEMBL2185	Homo sapiens	IC50	uM	0.157
	16424955	CHEMBL3751005	Inhibition of GST-INCENP activated N-terminal 6His-tagged human recombinant full length Aurora B (1 to 344 residues) expressed in baculovirus expression system using 5FAM-LRRASLG as substrate by microfluidic capillary electrophoresis method	B	COc1cc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC		CHEMBL3746463	=	IC50	nM	132.0	CHEMBL2185	Homo sapiens	IC50	uM	0.132
	16425278	CHEMBL3751106	Inhibition of AuroraB (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-0.4	CHEMBL2185	Homo sapiens	INH	%	-0.4
	16431734	CHEMBL3748626	Inhibition of human Aurora B using [H-LRRASLG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	16450765	CHEMBL3762151	Inhibition of Aurora B (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-2.5	CHEMBL2185	Homo sapiens	INH	%	-2.5
	16451699	CHEMBL3762151	Inhibition of Aurora B (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	16.4	CHEMBL2185	Homo sapiens	INH	%	16.4
	16451806	CHEMBL3761304	Inhibition of Aurora B (unknown origin) at 1000 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3C(F)F)nc21		CHEMBL3758739	=	Inhibition	%	-7.0	CHEMBL2185	Homo sapiens	INH	%	-7.0
	16457601	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	2.0	CHEMBL2185	Homo sapiens	INH	%	2.0
	16457602	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	17.0	CHEMBL2185	Homo sapiens	INH	%	17.0
	16457603	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	23.0	CHEMBL2185	Homo sapiens	INH	%	23.0
	16457604	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	6.0	CHEMBL2185	Homo sapiens	INH	%	6.0
	16457605	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	-2.0	CHEMBL2185	Homo sapiens	INH	%	-2.0
	16457606	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL2185	Homo sapiens	INH	%	1.0
	16457607	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	16457608	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	16457609	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	21.0	CHEMBL2185	Homo sapiens	INH	%	21.0
	16457610	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	16457611	CHEMBL3761561	Inhibition of AURKB (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	16474670	CHEMBL3767156	Inhibition of Aurora B (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	16485701	CHEMBL3773982	Inhibition of human recombinant AURKB assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	92.0	CHEMBL2185	Homo sapiens	Activity	%	92.0
Not Active	16492350	CHEMBL3774260	Inhibition of human aurora B at <5 uM by IMAP assay	B	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O		CHEMBL3769507		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16495337	CHEMBL3776884	Inhibition of N-terminal His6-tagged recombinant human AURKB expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-2.0	CHEMBL2185	Homo sapiens	Activity	%	-2.0
Not Active	16496860	CHEMBL3776408	Inhibition of human Aurora B (1 to 344 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16501357	CHEMBL3778046	Inhibition of full length human N-terminal GST-HIS6-tagged Aurora B expressed in sf9 cells by flashplate based radiometric 33pan-quinase assay	B	CS(=O)(=O)O.Cc1oc2c(O)c3c(c(O)c2c1C(=O)N1CC[C@H](N)C1)C(=O)c1ccccc1C3=O		CHEMBL3775181	<	IC50	nM	5000.0	CHEMBL2185	Homo sapiens	IC50	uM	5.0
	16507195	CHEMBL3778981	Inhibition of recombinant Aurora B (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	89.0	CHEMBL2185	Homo sapiens	Activity	%	89.0
	16508106	CHEMBL3776884	Inhibition of N-terminal His6-tagged recombinant human AURKB expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-4.0	CHEMBL2185	Homo sapiens	Activity	%	-4.0
	16509083	CHEMBL3776884	Inhibition of N-terminal His6-tagged recombinant human AURKB expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	11.0	CHEMBL2185	Homo sapiens	Activity	%	11.0
Not Active	16514100	CHEMBL3782148	Inhibition of partial length human Aurora B expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16534411	CHEMBL3789289	Inhibition of human Aurora B at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	97.0	CHEMBL2185	Homo sapiens	INH	%	97.0
	16552237	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	uM	0.007
	16552238	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	IC50	nM	5940.0	CHEMBL2185	Homo sapiens	IC50	uM	5.94
	16552239	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)ccn4)nn3)ccc2O)c1		CHEMBL3792856	=	IC50	nM	16300.0	CHEMBL2185	Homo sapiens	IC50	uM	16.3
	16552240	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccn4)nn3)ccc2O)c1		CHEMBL3793352	=	IC50	nM	32100.0	CHEMBL2185	Homo sapiens	IC50	uM	32.1
	16552241	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)[nH]n4)nn3)ccc2O)c1		CHEMBL3792583	=	IC50	nM	49500.0	CHEMBL2185	Homo sapiens	IC50	uM	49.5
	16552242	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3792712	=	IC50	nM	364.0	CHEMBL2185	Homo sapiens	IC50	uM	0.364
	16552243	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3794018	=	IC50	nM	20100.0	CHEMBL2185	Homo sapiens	IC50	uM	20.1
	16552244	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4nc5ccccc5o4)nn3)ccc2O)c1		CHEMBL3792621	=	IC50	nM	10200.0	CHEMBL2185	Homo sapiens	IC50	uM	10.2
	16552245	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncccn4)nn3)ccc2O)c1		CHEMBL3792988	=	IC50	nM	15200.0	CHEMBL2185	Homo sapiens	IC50	uM	15.2
	16552246	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncccn4)nn3)ccc2O)c1		CHEMBL3794376	=	IC50	nM	40700.0	CHEMBL2185	Homo sapiens	IC50	uM	40.7
	16552247	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)on4)nn3)ccc2O)c1		CHEMBL3794450	=	IC50	nM	54800.0	CHEMBL2185	Homo sapiens	IC50	uM	54.8
	16552248	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccc4)nn3)ccc2O)c1		CHEMBL3792563	=	IC50	nM	36500.0	CHEMBL2185	Homo sapiens	IC50	uM	36.5
	16552249	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5c(c4)OCO5)nn3)ccc2O)c1		CHEMBL3793405	=	IC50	nM	2190.0	CHEMBL2185	Homo sapiens	IC50	uM	2.19
	16552250	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5nccnc5c4)nn3)ccc2O)c1		CHEMBL3793945	=	IC50	nM	7300.0	CHEMBL2185	Homo sapiens	IC50	uM	7.3
	16552251	CHEMBL3795295	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cccc([N+](=O)[O-])c4)nn3)ccc2O)c1		CHEMBL3794572	=	IC50	nM	1330.0	CHEMBL2185	Homo sapiens	IC50	uM	1.33
	16552275	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cccc([N+](=O)[O-])c4)nn3)ccc2O)c1		CHEMBL3794572	=	Inhibition	%	32.3	CHEMBL2185	Homo sapiens	INH	%	32.3
	16552276	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5nccnc5c4)nn3)ccc2O)c1		CHEMBL3793945	=	Inhibition	%	29.4	CHEMBL2185	Homo sapiens	INH	%	29.4
	16552277	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5c(c4)OCCO5)nn3)ccc2O)c1		CHEMBL3793254	=	Inhibition	%	24.6	CHEMBL2185	Homo sapiens	INH	%	24.6
	16552278	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5c(c4)OCO5)nn3)ccc2O)c1		CHEMBL3793405	=	Inhibition	%	26.0	CHEMBL2185	Homo sapiens	INH	%	26.0
	16552279	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccc4)nn3)ccc2O)c1		CHEMBL3792563	=	Inhibition	%	20.4	CHEMBL2185	Homo sapiens	INH	%	20.4
	16552280	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)on4)nn3)ccc2O)c1		CHEMBL3794450	=	Inhibition	%	19.3	CHEMBL2185	Homo sapiens	INH	%	19.3
	16552281	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cccc(C)n4)nn3)ccc2O)c1		CHEMBL3793818	=	Inhibition	%	16.7	CHEMBL2185	Homo sapiens	INH	%	16.7
	16552282	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncccn4)nn3)ccc2O)c1		CHEMBL3794376	=	Inhibition	%	20.2	CHEMBL2185	Homo sapiens	INH	%	20.2
	16552283	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncccn4)nn3)ccc2O)c1		CHEMBL3792988	=	Inhibition	%	23.9	CHEMBL2185	Homo sapiens	INH	%	23.9
	16552284	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncco4)nn3)ccc2O)c1		CHEMBL3794530	=	Inhibition	%	3.54	CHEMBL2185	Homo sapiens	INH	%	3.54
	16552285	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4nc5ccccc5o4)nn3)ccc2O)c1		CHEMBL3792621	=	Inhibition	%	37.3	CHEMBL2185	Homo sapiens	INH	%	37.3
	16552286	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3794018	=	Inhibition	%	-3.61	CHEMBL2185	Homo sapiens	INH	%	-3.61
	16552287	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3792712	=	Inhibition	%	73.7	CHEMBL2185	Homo sapiens	INH	%	73.7
	16552288	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CN4CCOCC4)nn3)ccc2O)c1		CHEMBL3793815	=	Inhibition	%	12.6	CHEMBL2185	Homo sapiens	INH	%	12.6
	16552289	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNCCN4CCOCC4)nn3)ccc2O)c1		CHEMBL3793006	=	Inhibition	%	6.04	CHEMBL2185	Homo sapiens	INH	%	6.04
	16552290	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCN(C)C)nn3)ccc2O)c1		CHEMBL3792798	=	Inhibition	%	6.51	CHEMBL2185	Homo sapiens	INH	%	6.51
	16552291	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNC(C)=O)nn3)ccc2O)c1		CHEMBL3792982	=	Inhibition	%	10.3	CHEMBL2185	Homo sapiens	INH	%	10.3
	16552292	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)[nH]n4)nn3)ccc2O)c1		CHEMBL3792583	=	Inhibition	%	15.5	CHEMBL2185	Homo sapiens	INH	%	15.5
	16552293	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4nccs4)nn3)ccc2O)c1		CHEMBL3794561	=	Inhibition	%	13.8	CHEMBL2185	Homo sapiens	INH	%	13.8
	16552294	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncc[nH]4)nn3)ccc2O)c1		CHEMBL3792760	=	Inhibition	%	10.9	CHEMBL2185	Homo sapiens	INH	%	10.9
	16552295	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccn4)nn3)ccc2O)c1		CHEMBL3793352	=	Inhibition	%	22.6	CHEMBL2185	Homo sapiens	INH	%	22.6
	16552296	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)ccn4)nn3)ccc2O)c1		CHEMBL3792856	=	Inhibition	%	19.8	CHEMBL2185	Homo sapiens	INH	%	19.8
	16552297	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccncc4)nn3)ccc2O)c1		CHEMBL3793284	=	Inhibition	%	6.16	CHEMBL2185	Homo sapiens	INH	%	6.16
	16552298	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccncn4)nn3)ccc2O)c1		CHEMBL3793725	=	Inhibition	%	11.7	CHEMBL2185	Homo sapiens	INH	%	11.7
	16552299	CHEMBL3795297	Inhibition of human Aurora B using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM AT	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	Inhibition	%	39.6	CHEMBL2185	Homo sapiens	INH	%	39.6
	16552315	CHEMBL3795300	Inhibition of human Aurora B using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL2185	Homo sapiens	IC50	uM	0.001
	16562710	CHEMBL3802092	Inhibition of Aurora B (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)NCC2		CHEMBL3800053	=	Inhibition	%	55.0	CHEMBL2185	Homo sapiens	INH	%	55.0
	16562711	CHEMBL3802092	Inhibition of Aurora B (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)N[C@@H](c1ccccc1)C2		CHEMBL3800284	=	Inhibition	%	55.0	CHEMBL2185	Homo sapiens	INH	%	55.0
	16562712	CHEMBL3802092	Inhibition of Aurora B (unknown origin) at 1 uM	B	CC1(C)CC(=O)c2c(SC3CCCC3)sc(-c3cc[nH]n3)c2C1		CHEMBL3800282	<	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	16562717	CHEMBL3802092	Inhibition of Aurora B (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)CCC2		CHEMBL3799347	=	Inhibition	%	55.0	CHEMBL2185	Homo sapiens	INH	%	55.0
	16565472	CHEMBL3804490	Inhibition of N-terminal 6His-tagged Aurora-B (unknown origin) preincubated for 5 mins using Aurora substrate peptide as substrate measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	16580652	CHEMBL3803131	Inhibition of N-terminal 6His-tagged Aurora-B (unknown origin) preincubated for 5 mins using Aurora substrate peptidase substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	Inhibition	%	73.0	CHEMBL2185	Homo sapiens	INH	%	73.0
	16580653	CHEMBL3803131	Inhibition of N-terminal 6His-tagged Aurora-B (unknown origin) preincubated for 5 mins using Aurora substrate peptidase substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	Inhibition	%	12.0	CHEMBL2185	Homo sapiens	INH	%	12.0
Active	16581016	CHEMBL3802146	Inhibition of human recombinant Aurora-B expressed in sf9 cells using kemptide as substrate by radiometric assay in presence of gamma[32P]ATP	B	CC(C)c1nn(C)cc1-c1nc2cc(Br)cnc2[nH]1		CHEMBL3613594		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16587015	CHEMBL3807427	Inhibition of AUR1 (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	16593473	CHEMBL3812157	Inhibition of full length His-tagged human recombinant Aurora B expressed in baculovirus using Fluorescein-CREBtide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	INH	%	40.0
	16594914	CHEMBL3812225	Inhibition of human AURKB (25 to 303 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	72.0	CHEMBL2185	Homo sapiens	Activity	%	72.0
	16604342	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3809855	=	Inhibition	%	74.0	CHEMBL2185	Homo sapiens	INH	%	74.0
	16604343	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1		CHEMBL3809161	=	Inhibition	%	74.0	CHEMBL2185	Homo sapiens	INH	%	74.0
	16604344	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1		CHEMBL3808570	=	Inhibition	%	37.0	CHEMBL2185	Homo sapiens	INH	%	37.0
	16604345	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3808933	=	Inhibition	%	70.0	CHEMBL2185	Homo sapiens	INH	%	70.0
	16604346	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1		CHEMBL3809347	=	Inhibition	%	55.0	CHEMBL2185	Homo sapiens	INH	%	55.0
	16604347	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1		CHEMBL3808569	=	Inhibition	%	94.0	CHEMBL2185	Homo sapiens	INH	%	94.0
	16604348	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1)Nc1cccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)c1		CHEMBL3809982	=	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	16604349	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3cc(OCCN4CCOCC4)ccc3o2)cc1		CHEMBL3810372	=	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	16604350	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3cc(OCCN4CCOCC4)ccc3o2)cc1		CHEMBL3810344	=	Inhibition	%	42.0	CHEMBL2185	Homo sapiens	INH	%	42.0
	16604351	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3808793	=	Inhibition	%	88.0	CHEMBL2185	Homo sapiens	INH	%	88.0
	16604352	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1ccc(Cl)cc1Cl		CHEMBL3809311	=	Inhibition	%	86.0	CHEMBL2185	Homo sapiens	INH	%	86.0
	16604353	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	Cc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4o3)cc2)cc1		CHEMBL3808578	=	Inhibition	%	65.0	CHEMBL2185	Homo sapiens	INH	%	65.0
	16604354	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	COc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4o3)cc2)cc1		CHEMBL3810060	=	Inhibition	%	76.0	CHEMBL2185	Homo sapiens	INH	%	76.0
	16604355	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3809624	=	Inhibition	%	69.0	CHEMBL2185	Homo sapiens	INH	%	69.0
	16604356	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3809709	=	Inhibition	%	66.0	CHEMBL2185	Homo sapiens	INH	%	66.0
	16604357	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(F)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3810263	=	Inhibition	%	34.0	CHEMBL2185	Homo sapiens	INH	%	34.0
	16604358	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1cccc(Cl)c1		CHEMBL3809119	=	Inhibition	%	58.0	CHEMBL2185	Homo sapiens	INH	%	58.0
	16604359	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1cccc(F)c1		CHEMBL3808577	=	Inhibition	%	63.0	CHEMBL2185	Homo sapiens	INH	%	63.0
	16604360	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3808897	=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	INH	%	40.0
	16604361	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3808447	=	Inhibition	%	45.0	CHEMBL2185	Homo sapiens	INH	%	45.0
Not Active	16604362	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3809652		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16604363	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3809747	=	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	16604364	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)c1ccccc1		CHEMBL3809346	=	Inhibition	%	21.0	CHEMBL2185	Homo sapiens	INH	%	21.0
	16604365	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1)c1ccccc1		CHEMBL3808825	=	Inhibition	%	1.0	CHEMBL2185	Homo sapiens	INH	%	1.0
Not Active	16604366	CHEMBL3813581	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1CNc1nc2ccc(OCCN3CCOCC3)cc2o1)c1ccccc1		CHEMBL3809535		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16604367	CHEMBL3813579	Inhibition of Aurora B (unknown origin)	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	IC50	nM	0.37	CHEMBL2185	Homo sapiens	IC50	nM	0.37
	16604381	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
Not Determined	16604382	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccccc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3809747		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604383	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3809652		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604384	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3808447		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604385	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccccc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3808897		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604386	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1cccc(F)c1		CHEMBL3808577		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604387	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1cccc(Cl)c1		CHEMBL3809119		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604388	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(F)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3810263		IC50			CHEMBL2185	Homo sapiens	IC50		
	16604389	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3809709	=	IC50	nM	10200.0	CHEMBL2185	Homo sapiens	IC50	uM	10.2
Not Determined	16604390	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3809624		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604391	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	COc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4o3)cc2)cc1		CHEMBL3810060		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604392	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	Cc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4o3)cc2)cc1		CHEMBL3808578		IC50			CHEMBL2185	Homo sapiens	IC50		
	16604393	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1ccc(Cl)cc1Cl		CHEMBL3809311	=	IC50	nM	700.0	CHEMBL2185	Homo sapiens	IC50	uM	0.7
	16604394	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3808793	=	IC50	nM	600.0	CHEMBL2185	Homo sapiens	IC50	uM	0.6
Not Determined	16604395	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3cc(OCCN4CCOCC4)ccc3o2)cc1		CHEMBL3810344		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604396	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3cc(OCCN4CCOCC4)ccc3o2)cc1		CHEMBL3810372		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604397	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccccc1)Nc1cccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)c1		CHEMBL3809982		IC50			CHEMBL2185	Homo sapiens	IC50		
	16604398	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1		CHEMBL3808569	=	IC50	nM	50400.0	CHEMBL2185	Homo sapiens	IC50	uM	50.4
Not Determined	16604399	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1		CHEMBL3809347		IC50			CHEMBL2185	Homo sapiens	IC50		
	16604400	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3808933	=	IC50	nM	49400.0	CHEMBL2185	Homo sapiens	IC50	uM	49.4
Not Determined	16604401	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1		CHEMBL3808570		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604402	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1		CHEMBL3809161		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16604403	CHEMBL3813580	Inhibition of Aurora B (unknown origin) using myelin protein as substrate assessed as ADP generation after 60 mins by ADP-glo assay	B	O=C(Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3809855		IC50			CHEMBL2185	Homo sapiens	IC50		
	16611815	CHEMBL3816640	Inhibition of human Aurora B (1 to 344 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-31.0	CHEMBL2185	Homo sapiens	Activity	%	-31.0
	16611816	CHEMBL3816640	Inhibition of human Aurora B (1 to 344 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-16.0	CHEMBL2185	Homo sapiens	Activity	%	-16.0
	16611837	CHEMBL3816640	Inhibition of human Aurora B (1 to 344 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-62.0	CHEMBL2185	Homo sapiens	Activity	%	-62.0
	16613773	CHEMBL3817209	Inhibition of human Aurora B at 1 uM using [H-LRRASLG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-5.0	CHEMBL2185	Homo sapiens	INH	%	-5.0
	16618278	CHEMBL3817007	Inhibition of full length recombinant human His-tagged AURKB expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
Not Active	16621199	CHEMBL3819864	Inhibition of Aurora B (unknown origin)	B	COc1cc([C@@H](CC(=O)O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)cc2nnn(C)c12		CHEMBL3819587		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16627484	CHEMBL3820211	Inhibition of recombinant human His-tagged Aurora B expressed in baculovirus infected Sf21 cells coexpressing full length recombinant human N-terminal GST-tagged INCENP (821-end residues) at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1	Outside typical range	CHEMBL3819210	=	Inhibition	%	-22.0	CHEMBL2185	Homo sapiens	INH	%	-22.0
	16627485	CHEMBL3820211	Inhibition of recombinant human His-tagged Aurora B expressed in baculovirus infected Sf21 cells coexpressing full length recombinant human N-terminal GST-tagged INCENP (821-end residues) at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	75.0	CHEMBL2185	Homo sapiens	INH	%	75.0
	16628498	CHEMBL3820310	Inhibition of human recombinant full-length AurKB expressed in insect Sf21 cells at 1 uM using LRRLSLGLRRLSLGLRRLSLGLRRLSLG as substrate after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	16654144	CHEMBL3829179	Inhibition of human Aurora B (1 to 344 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	58.0	CHEMBL2185	Homo sapiens	Activity	%	58.0
	16673534	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	Cc1cc(S(N)(=O)=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL3932938	=	IC50	nM	9400.0	CHEMBL2185	Homo sapiens	IC50	nM	9400.0
	16673535	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)ncc21		CHEMBL3904942	=	IC50	nM	4.6	CHEMBL2185	Homo sapiens	IC50	nM	4.6
	16673536	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		CHEMBL1673047	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	16673537	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3ccc(S(N)(=O)=O)cc3)nc1N2C		CHEMBL3950648	=	IC50	nM	4.2	CHEMBL2185	Homo sapiens	IC50	nM	4.2
	16673538	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351	=	IC50	nM	150.0	CHEMBL2185	Homo sapiens	IC50	nM	150.0
	16673539	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	CCC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3942643	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	nM	120.0
	16673540	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)Nc1cccc(NS(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)c1		CHEMBL3907932	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
	16673541	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)Nc1ccc(NS(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3926951	=	IC50	nM	80.0	CHEMBL2185	Homo sapiens	IC50	nM	80.0
	16673542	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)Nc1ccc(NS(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)cc1		CHEMBL3898901	=	IC50	nM	290.0	CHEMBL2185	Homo sapiens	IC50	nM	290.0
	16673543	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)NC1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3889977	=	IC50	nM	630.0	CHEMBL2185	Homo sapiens	IC50	nM	630.0
	16673544	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)N1CCN(S(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)CC1		CHEMBL3909068	=	IC50	nM	16.0	CHEMBL2185	Homo sapiens	IC50	nM	16.0
	16673545	CHEMBL3855897	Inhibition of human Aurora kinase B (D25 to A303 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3979343	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	nM	120.0
	16737928	CHEMBL3856646	Inhibition of human AURORA B assessed as remaining activity at 10 uM preincubated for 15 mins followed by substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	42.0	CHEMBL2185	Homo sapiens	Activity	%	42.0
	16739483	CHEMBL3857035	Inhibition of His tagged recombinant full length human Aurora B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	20.0	CHEMBL2185	Homo sapiens	INH	%	20.0
	16739484	CHEMBL3857035	Inhibition of His tagged recombinant full length human Aurora B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	INH	%	13.0
	16739485	CHEMBL3857035	Inhibition of His tagged recombinant full length human Aurora B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	16763139	CHEMBL3862728	Binding affinity to human Aurora B kinase expressed in Escherichia coli BL21 cells incubated for 1 hr by active site directed binding competition assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	Kd	nM	10.1	CHEMBL2185	Homo sapiens	Kd	nM	10.1
	16763158	CHEMBL3862744	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as effect on distribution of phspho-histone H3 ser10 level incubated for 20 hrs	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	>	IC50	nM	25000.0	CHEMBL2185	Homo sapiens	IC50	uM	25.0
	16763159	CHEMBL3862744	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as effect on distribution of phspho-histone H3 ser10 level incubated for 20 hrs	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.5	CHEMBL2185	Homo sapiens	IC50	nM	1.5
	16763160	CHEMBL3862744	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as effect on distribution of phspho-histone H3 ser10 level incubated for 20 hrs	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	>	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
Active	16763161	CHEMBL3862744	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as effect on distribution of phspho-histone H3 ser10 level incubated for 20 hrs	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	16763162	CHEMBL3862745	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as induction of accumulation of cells at 8N DNA contant incubated for 48 hrs at 2.5 uM by flow cytometry	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	16763163	CHEMBL3862746	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as induction of accumulation of cells at 16N DNA contant incubated for 48 hrs at 2.5 uM by flow cytometry	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	16763164	CHEMBL3862747	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as induction of accumulation of cells at 8N DNA contant incubated for 48 hrs at 10 uM by flow cytometry	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	16763165	CHEMBL3862748	Inhibition of Aurora B kinase in human HeLa Kyoto cells assessed as induction of accumulation of cells at 16N DNA contant incubated for 48 hrs at 10 uM by flow cytometry	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	16815384	CHEMBL3871596	Inhibition of recombinant N-terminal His6-tagged Aurora B (62 to 344 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	16815387	CHEMBL3871599	Inhibition of human recombinant full-length N-terminal GST-tagged Aurora B (1 to 344 end residues) expressed in baculovirus expression system coexpressing His-tagged INCENP (803 to 918 end residues) using GLRRASLG-NH2 as substrate after 20 mins in presence of [gamma-33P]-ATP by liquid scintillation counting	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
	16815419	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	uM	0.015
	16815420	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	Cc1ccc(S(=O)(=O)Nc2ccc3[nH]nc(-c4cccc(NC(=O)/C=C\C(=O)O)c4)c3c2)cc1		CHEMBL3974375	=	IC50	nM	32.0	CHEMBL2185	Homo sapiens	IC50	uM	0.032
Not Determined	16815421	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccc(-c5ccccc5)cc4)cc23)c1		CHEMBL3964280		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	16815422	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc3[nH]nc(-c4cccc(NC(=O)/C=C\C(=O)O)c4)c3c2)cc1		CHEMBL3946537		IC50			CHEMBL2185	Homo sapiens	IC50		
	16815423	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	COc1ccc(S(=O)(=O)Nc2ccc3[nH]nc(-c4cccc(NC(=O)/C=C\C(=O)O)c4)c3c2)cc1		CHEMBL3894492	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	uM	0.031
	16815424	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc23)c1		CHEMBL3954695	=	IC50	nM	26.0	CHEMBL2185	Homo sapiens	IC50	uM	0.026
	16815425	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccc(F)cc4)cc23)c1		CHEMBL3983327	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	uM	0.03
Not Determined	16815426	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	O=C(O)/C=C/C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3946005		IC50			CHEMBL2185	Homo sapiens	IC50		
	16815427	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	O=C(O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3975342	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	uM	0.028
	16815428	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	NC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3923159	=	IC50	nM	49.0	CHEMBL2185	Homo sapiens	IC50	uM	0.049
	16815429	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	COC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3939365	=	IC50	nM	48.0	CHEMBL2185	Homo sapiens	IC50	uM	0.048
	16815430	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	CCOC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3922175	=	IC50	nM	64.0	CHEMBL2185	Homo sapiens	IC50	uM	0.064
	16815431	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	CC(C)OC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3935219	=	IC50	nM	220.0	CHEMBL2185	Homo sapiens	IC50	uM	0.22
	16815432	CHEMBL3871606	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system	B	CC#CC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3953964	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	16815449	CHEMBL3871610	Inhibition of human recombinant full-length His-tagged Aurora B expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	89.0	CHEMBL2185	Homo sapiens	INH	%	89.0
	16817230	CHEMBL3871907	Activity at Aurora 1 kinase (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Km	nM	30000.0	CHEMBL2185	Homo sapiens	Km	uM	30.0
	16817238	CHEMBL3871915	Inhibition of Aurora 1 kinase (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ki	nM	10.0	CHEMBL2185	Homo sapiens	Ki	uM	0.01
	16817246	CHEMBL3871923	Ratio of Km to Ki for Aurora 1 kinase (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ratio	10'-4No_unit	3.3	CHEMBL2185	Homo sapiens	Ratio	10'-4No_unit	3.3
	16837386	CHEMBL3876039	Inhibition of human recombinant full length His-tagged AURKB expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	163.0	CHEMBL2185	Homo sapiens	IC50	nM	163.0
	16880210	CHEMBL3880810	Inhibition of Aurora-1 (unknown origin) incubated for 10 mins using Kemptide substrate and [gamma-33P]-ATP measured after 3 hrs by liquid scintillation counting based radiometric assay	B	Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)c4cc(Cl)ccc4F)C3)n2)n[nH]1		CHEMBL3545378	<	Ki	nM	25.0	CHEMBL2185	Homo sapiens	Ki	uM	0.025
	16880211	CHEMBL3880810	Inhibition of Aurora-1 (unknown origin) incubated for 10 mins using Kemptide substrate and [gamma-33P]-ATP measured after 3 hrs by liquid scintillation counting based radiometric assay	B	Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)OC(C)(C)C)C3)n2)[nH]n1		CHEMBL3905298	<	Ki	nM	500.0	CHEMBL2185	Homo sapiens	Ki	uM	0.5
	16880212	CHEMBL3880810	Inhibition of Aurora-1 (unknown origin) incubated for 10 mins using Kemptide substrate and [gamma-33P]-ATP measured after 3 hrs by liquid scintillation counting based radiometric assay	B	Cc1cc(Nc2cc(N3CCC3)nc(O[C@H]3CCN(C(=O)OC(C)(C)C)C3)n2)[nH]n1		CHEMBL3936298	<	Ki	nM	500.0	CHEMBL2185	Homo sapiens	Ki	uM	0.5
213296	17602675	CHEMBL3705242	Aurora B Enzyme Assay: Aurora B (2 M) was preactivated by equivalent concentration of GST-INCENP in 30 mM Tris-HCl pH 8.0, 0.4 mM ATP, 2 mM MgCl2, 0.1 mM EGTA, 0.1% BME (beta mercaptoethanol), 0.1 mM sodium vanadate, 10 mM DTT for 3 hours at 30 C. This solution was then dialysed for 5 hours against 50 mM Tris-HCl, pH 7.5, 270 mM sucrose, 150 mM NaCl, 0.1 mM EDTA, 0.1% BME, 1 mM benzamidine and 0.2 mM PMSF at 4 C. Aurora B/INCENP complex was aliquoted and frozen at 80 C. Human INCENP (826-919) clone DU930 was received from University of Dundee, it is a GST N-terminal tagged protein. A final concentration of 2 nM of Aurora B/INCENP complex was added to the assay buffer (25 mM HEPES, 25 mM NaCl 0.0025% Tween-20, pH 7.2 0.015% BSA, 1 M DTT). 3 l of this solution was added to wells containing 0.1 l of various concentrations of compound or DMSO vehicle in Greiner low volume 384 well black plate at room temperature for 30 mins. The reaction was initiated by the presence of 3 l of substrate reagent containing 100 nM 5FAM-PKA-tide (GRTGRRNSI-NH2), 2 M ATP and 2 mM MgCl2 in assay buffer (25 mM HEPES, 25mM NaCl 0.0025% Tween-20, pH 7.2 0.015% BSA, 1 M DTT) with a final DMSO level of 1.7%. The reaction was incubated for a further 120 mins at room temperature, and then terminated by the addition of 6 l of a 1:500 dilution Progressive Binding Reagent solution (Part: R7287) in the manufacturers buffer A (Part: R7285) and manufacturers buffer B (Part R7286) and left to incubate for 120 mins at room temperature. The degree of phosphorylation of the 5FAM-PKA-tide (GRTGRRNSI-NH2) was measured using an Acquest plate reader (Molecular Devices, Sunnyvale, US) with excitation 485 nM, emission at 530 nM and using a 505 nmM dichroic lens.	B	Cc1ccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)cc1		CHEMBL1835071	=	IC50	nM	20000.0	CHEMBL2185	Homo sapiens	IC50	nM	20000.0
243030	17626525	CHEMBL3707758	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(C(O)CO)cc34)c2)cc1		CHEMBL3962025	=	IC50	nM	9.4	CHEMBL2185	Homo sapiens	IC50	nM	9.4
249778	17633014	CHEMBL3705425	Enzyme Inhibtion Assay: To determine Aurora B activity of representative compounds of the invention, Active Aurora B enzyme (recombinant residues 1-344) and INCENP (recombinant GST fusion protein (Upstate)) were incubated in wells of a 384 well plate with biotinylted histone H3 peptide residues 1-21 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a HEPES buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-histone H3 Europium Cryptate (Cis-Bio) and SA-APC (Phycolink, Prozyme) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	6.73	CHEMBL2185	Homo sapiens	IC50	nM	6.73
249779	17633015	CHEMBL3705425	Enzyme Inhibtion Assay: To determine Aurora B activity of representative compounds of the invention, Active Aurora B enzyme (recombinant residues 1-344) and INCENP (recombinant GST fusion protein (Upstate)) were incubated in wells of a 384 well plate with biotinylted histone H3 peptide residues 1-21 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a HEPES buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-histone H3 Europium Cryptate (Cis-Bio) and SA-APC (Phycolink, Prozyme) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	7.87	CHEMBL2185	Homo sapiens	IC50	nM	7.87
249780	17633016	CHEMBL3705425	Enzyme Inhibtion Assay: To determine Aurora B activity of representative compounds of the invention, Active Aurora B enzyme (recombinant residues 1-344) and INCENP (recombinant GST fusion protein (Upstate)) were incubated in wells of a 384 well plate with biotinylted histone H3 peptide residues 1-21 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a HEPES buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-histone H3 Europium Cryptate (Cis-Bio) and SA-APC (Phycolink, Prozyme) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](C)O)c5)cnc(N)c34)cc2)c1		CHEMBL3646210	=	IC50	nM	11.21	CHEMBL2185	Homo sapiens	IC50	nM	11.21
249781	17633017	CHEMBL3705425	Enzyme Inhibtion Assay: To determine Aurora B activity of representative compounds of the invention, Active Aurora B enzyme (recombinant residues 1-344) and INCENP (recombinant GST fusion protein (Upstate)) were incubated in wells of a 384 well plate with biotinylted histone H3 peptide residues 1-21 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a HEPES buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-histone H3 Europium Cryptate (Cis-Bio) and SA-APC (Phycolink, Prozyme) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	IC50	nM	14.84	CHEMBL2185	Homo sapiens	IC50	nM	14.84
249782	17633018	CHEMBL3705425	Enzyme Inhibtion Assay: To determine Aurora B activity of representative compounds of the invention, Active Aurora B enzyme (recombinant residues 1-344) and INCENP (recombinant GST fusion protein (Upstate)) were incubated in wells of a 384 well plate with biotinylted histone H3 peptide residues 1-21 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a HEPES buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-histone H3 Europium Cryptate (Cis-Bio) and SA-APC (Phycolink, Prozyme) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL3646211	=	IC50	nM	28.93	CHEMBL2185	Homo sapiens	IC50	nM	28.93
249783	17633019	CHEMBL3705425	Enzyme Inhibtion Assay: To determine Aurora B activity of representative compounds of the invention, Active Aurora B enzyme (recombinant residues 1-344) and INCENP (recombinant GST fusion protein (Upstate)) were incubated in wells of a 384 well plate with biotinylted histone H3 peptide residues 1-21 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a HEPES buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-histone H3 Europium Cryptate (Cis-Bio) and SA-APC (Phycolink, Prozyme) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	IC50	nM	8.44	CHEMBL2185	Homo sapiens	IC50	nM	8.44
273552	17655874	CHEMBL3887087	Aurora B Kinase Inhibition Assay: The in vitro inhibitory activity of the compound against Aurora B kinase activity was assayed with reference to a method described in patent publication (JP-A-2008-81492). The purified recombinant human Aurora B protein used in the test was purchased from Carna Biosciences, Inc. For the inhibitory activity assay on the compound, the compound of the present invention was first serially diluted with dimethyl sulfoxide (DMSO). Next, the purified human Aurora B protein FL-Peptide 21 (Caliper Life Sciences, Inc., final concentration: 100 nM), magnesium chloride (final concentration: 1 mM), ATP (final concentration: 40 uM), and each DMSO solution of the compound of the present invention (final concentration of DMSO: 5%) were added into a buffer solution for reaction (20 mM HEPES pH 7.4, 2 mM DTT, 0.01% Tween-20), and the mixture was then incubated at 25 C. for 60 minutes to perform kinase reaction. The kinase reaction was stopped by the addition thereto of IMAP.TM.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	nM	110.0
327668	17706394	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4c(F)ccc5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3944825	=	IC50	nM	24.33	CHEMBL2185	Homo sapiens	IC50	nM	24.33
327669	17706395	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1ccc2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1		CHEMBL3970921	=	IC50	nM	5.9	CHEMBL2185	Homo sapiens	IC50	nM	5.9
327670	17706396	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4ccc(F)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3932362	=	IC50	nM	9.36	CHEMBL2185	Homo sapiens	IC50	nM	9.36
327671	17706397	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4ccc(Cl)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3959866	=	IC50	nM	13.87	CHEMBL2185	Homo sapiens	IC50	nM	13.87
327672	17706398	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	COc1ccc(-c2nc(C(N)=O)c(-c3ccc(N4CCNC(C)(C)C4)cc3)o2)c2cc[nH]c12		CHEMBL3923418	=	IC50	nM	8.78	CHEMBL2185	Homo sapiens	IC50	nM	8.78
327673	17706399	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1cc(C)c2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1		CHEMBL3954570	=	IC50	nM	19.62	CHEMBL2185	Homo sapiens	IC50	nM	19.62
327674	17706400	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1cc(F)c2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1		CHEMBL3917983	=	IC50	nM	5.93	CHEMBL2185	Homo sapiens	IC50	nM	5.93
327675	17706401	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1c[nH]c2cccc(-c3nc(C(N)=O)c(-c4ccc(N5CCNC(C)(C)C5)cc4)o3)c12		CHEMBL3945870	=	IC50	nM	14.2	CHEMBL2185	Homo sapiens	IC50	nM	14.2
327676	17706402	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CCc1ccc(-c2nc(C(N)=O)c(-c3ccc(N4CCNC(C)(C)C4)cc3)o2)c2cc[nH]c12		CHEMBL3957869	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
327677	17706403	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4cccc5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3956504	=	IC50	nM	15.21	CHEMBL2185	Homo sapiens	IC50	nM	15.21
327678	17706404	CHEMBL3887268	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4ccc(C(F)(F)F)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3928949	=	IC50	nM	14.0	CHEMBL2185	Homo sapiens	IC50	nM	14.0
330360	17708950	CHEMBL3887087	Aurora B Kinase Inhibition Assay: The in vitro inhibitory activity of the compound against Aurora B kinase activity was assayed with reference to a method described in patent publication (JP-A-2008-81492). The purified recombinant human Aurora B protein used in the test was purchased from Carna Biosciences, Inc. For the inhibitory activity assay on the compound, the compound of the present invention was first serially diluted with dimethyl sulfoxide (DMSO). Next, the purified human Aurora B protein FL-Peptide 21 (Caliper Life Sciences, Inc., final concentration: 100 nM), magnesium chloride (final concentration: 1 mM), ATP (final concentration: 40 uM), and each DMSO solution of the compound of the present invention (final concentration of DMSO: 5%) were added into a buffer solution for reaction (20 mM HEPES pH 7.4, 2 mM DTT, 0.01% Tween-20), and the mixture was then incubated at 25 C. for 60 minutes to perform kinase reaction. The kinase reaction was stopped by the addition thereto of IMAP.TM.	B	NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1ccc2cn(C(F)F)nc2c1		CHEMBL3959686	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
330361	17708951	CHEMBL3887087	Aurora B Kinase Inhibition Assay: The in vitro inhibitory activity of the compound against Aurora B kinase activity was assayed with reference to a method described in patent publication (JP-A-2008-81492). The purified recombinant human Aurora B protein used in the test was purchased from Carna Biosciences, Inc. For the inhibitory activity assay on the compound, the compound of the present invention was first serially diluted with dimethyl sulfoxide (DMSO). Next, the purified human Aurora B protein FL-Peptide 21 (Caliper Life Sciences, Inc., final concentration: 100 nM), magnesium chloride (final concentration: 1 mM), ATP (final concentration: 40 uM), and each DMSO solution of the compound of the present invention (final concentration of DMSO: 5%) were added into a buffer solution for reaction (20 mM HEPES pH 7.4, 2 mM DTT, 0.01% Tween-20), and the mixture was then incubated at 25 C. for 60 minutes to perform kinase reaction. The kinase reaction was stopped by the addition thereto of IMAP.TM.	B	NC(=O)c1nnc(N[C@@H]2CCOC[C@@H]2N)nc1Nc1cccc2c1ccn2C1CC1		CHEMBL3940859	=	IC50	nM	1300.0	CHEMBL2185	Homo sapiens	IC50	nM	1300.0
330362	17708952	CHEMBL3887087	Aurora B Kinase Inhibition Assay: The in vitro inhibitory activity of the compound against Aurora B kinase activity was assayed with reference to a method described in patent publication (JP-A-2008-81492). The purified recombinant human Aurora B protein used in the test was purchased from Carna Biosciences, Inc. For the inhibitory activity assay on the compound, the compound of the present invention was first serially diluted with dimethyl sulfoxide (DMSO). Next, the purified human Aurora B protein FL-Peptide 21 (Caliper Life Sciences, Inc., final concentration: 100 nM), magnesium chloride (final concentration: 1 mM), ATP (final concentration: 40 uM), and each DMSO solution of the compound of the present invention (final concentration of DMSO: 5%) were added into a buffer solution for reaction (20 mM HEPES pH 7.4, 2 mM DTT, 0.01% Tween-20), and the mixture was then incubated at 25 C. for 60 minutes to perform kinase reaction. The kinase reaction was stopped by the addition thereto of IMAP.TM.	B	NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cc2ccccc2s1		CHEMBL3903852	=	IC50	nM	420.0	CHEMBL2185	Homo sapiens	IC50	nM	420.0
403421	17769940	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4Cl)CC3)ccc2F)n[nH]1		CHEMBL3692206	=	IC50	nM	140.0	CHEMBL2185	Homo sapiens	IC50	nM	140.0
403422	17769941	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(C(F)(F)F)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692207	=	IC50	nM	340.0	CHEMBL2185	Homo sapiens	IC50	nM	340.0
403423	17769942	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	COc1ccc(CC2(C(=O)O)CCN(C(=O)c3cccc(Cl)c3F)CC2)nc1Nc1cc(C)[nH]n1		CHEMBL3692208	=	IC50	nM	930.0	CHEMBL2185	Homo sapiens	IC50	nM	930.0
403424	17769943	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2Cl)n[nH]1		CHEMBL3692209	=	IC50	nM	260.0	CHEMBL2185	Homo sapiens	IC50	nM	260.0
403425	17769944	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692210	=	IC50	nM	180.0	CHEMBL2185	Homo sapiens	IC50	nM	180.0
403426	17769945	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	CNC(=O)C1(Cc2ccc(F)c(Nc3cc(C)[nH]n3)n2)CCN(C(=O)c2cccc(Cl)c2F)CC1		CHEMBL3692211	=	IC50	nM	460.0	CHEMBL2185	Homo sapiens	IC50	nM	460.0
403427	17769946	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)NC4CC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692212	=	IC50	nM	900.0	CHEMBL2185	Homo sapiens	IC50	nM	900.0
403428	17769947	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)N4CCC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692213	=	IC50	nM	680.0	CHEMBL2185	Homo sapiens	IC50	nM	680.0
403429	17769948	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(c4noc(C)n4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692214	=	IC50	nM	380.0	CHEMBL2185	Homo sapiens	IC50	nM	380.0
403430	17769949	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(c4ncon4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692215	=	IC50	nM	190.0	CHEMBL2185	Homo sapiens	IC50	nM	190.0
403431	17769950	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(c4nnc(C)o4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692216	=	IC50	nM	450.0	CHEMBL2185	Homo sapiens	IC50	nM	450.0
403432	17769951	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1noc(C2(Cc3ccc(F)c(Nc4cc(C)[nH]n4)n3)CCN(C(=O)c3cccc(Cl)c3F)CC2)n1		CHEMBL3692217	=	IC50	nM	390.0	CHEMBL2185	Homo sapiens	IC50	nM	390.0
403433	17769952	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2C#N)n[nH]1		CHEMBL3953977	=	IC50	nM	320.0	CHEMBL2185	Homo sapiens	IC50	nM	320.0
403434	17769953	CHEMBL3888487	Kinase Assay: The in vitro method for measuring the inhibitory activity of the test compound on the aurora B kinase activity was performed in a similar manner as the above method for aurora A, and purified recombinant human aurora B protein was purchased from Carna Biosciences, Inc. The reaction buffer has the following composition: 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride at a final concentration of 1 mM, and ATP at a final concentration of 40 M, and the incubation time was 60 minutes.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	90.0	CHEMBL2185	Homo sapiens	IC50	nM	90.0
411894	17776710	CHEMBL3888642	Kinase Assay: Aurora-B (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 M AKRRRLSSLRA, 10 mM MgAcetate and [-33PATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cn1cc(Nc2ncc(Cl)c(NC3COC4C(OCCO)COC34)n2)cn1		CHEMBL3943693	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
411895	17776711	CHEMBL3888642	Kinase Assay: Aurora-B (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 M AKRRRLSSLRA, 10 mM MgAcetate and [-33PATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cn1cc(Nc2ncc(Cl)c(NC3COC4C(NS(C)(=O)=O)COC34)n2)cn1		CHEMBL3944875	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
431427	17791535	CHEMBL3889037	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	207.0	CHEMBL2185	Homo sapiens	IC50	nM	207.0
431597	17791705	CHEMBL3889060	KINOMEScan Technology Assays: The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 M using the KINOMEScan technology.28 The S(10) selectivity score that is calculated by dividing the number of non-mutant kinases for which >90% competition was observed in the assay (this is measured as <10% of control) by the total number of non-mutant kinases tested, was determined as 0.057, i.e. 22 hits from the 386 non-mutant kinases tested. Aurora-A, -B, and -C were potently inhibited with % control values determined as 3.4%, 1%, and 16% respectively.	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	Kd	nM	48.0	CHEMBL2185	Homo sapiens	Kd	nM	48.0
Inactive	17884265	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884266	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	20.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	20.0
Inactive	17884267	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884268	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884269	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884270	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884271	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884272	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	119.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	119.0
Inactive	17884273	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884274	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	715.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	715.0
Inactive	17884275	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884276	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884277	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884278	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Kd	nM	257.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	257.0
Inactive	17884279	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884280	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	107.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	107.0
Active	17884281	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1240.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1240.0
Inactive	17884282	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884283	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	126.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	126.0
Inactive	17884284	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884285	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884286	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884287	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884288	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884289	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884290	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2409.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	2409.0
Active	17884291	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	20.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	20.0
Active	17884292	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	1562.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1562.0
Inactive	17884293	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884294	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884295	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884296	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884297	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884298	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884299	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884300	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884301	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884302	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884303	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	120.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	120.0
Uncertain	17884304	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	1672.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1672.0
Inactive	17884305	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884306	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884307	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884308	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	105.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	105.0
Inactive	17884309	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884310	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884311	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884312	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884313	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884314	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884315	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884316	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884317	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Kd	nM	1073.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1073.0
Active	17884318	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	=	Kd	nM	705.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	705.0
Inactive	17884319	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884320	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	3791.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	3791.0
Inactive	17884321	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884322	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884323	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884324	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	131.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	131.0
Inactive	17884325	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884326	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884327	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884328	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884329	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884330	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884331	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884332	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884333	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884334	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884335	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884336	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884337	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884338	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884339	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884340	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	=	Kd	nM	1559.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1559.0
Inactive	17884341	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884342	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	2550.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	2550.0
Inactive	17884343	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884344	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884345	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884346	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884347	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884348	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884349	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884350	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	44.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	44.0
Inactive	17884351	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884352	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884353	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884354	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884355	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884356	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884357	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884358	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884359	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884360	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	=	Kd	nM	1152.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1152.0
Active	17884361	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	68.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	68.0
Active	17884362	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	982.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	982.0
Inactive	17884363	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884364	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	59.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	59.0
Inactive	17884365	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884366	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884367	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884368	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	1503.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1503.0
Inactive	17884369	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884370	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	Kd	nM	22852.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	22852.0
Active	17884371	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	195.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	195.0
Inactive	17884372	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884373	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884374	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884375	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884376	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884377	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884378	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	933.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	933.0
Inactive	17884379	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884380	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884381	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884382	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884383	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884384	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884385	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1817.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1817.0
Inactive	17884386	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884387	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884388	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884389	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884390	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884391	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884392	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884393	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	4.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	4.0
Inactive	17884394	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884395	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	236.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	236.0
Active	17884396	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	100.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	100.0
Inactive	17884397	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884398	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884399	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884400	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884401	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	371.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	371.0
Inactive	17884402	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884403	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884404	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884405	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884406	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884407	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884408	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	1036.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1036.0
Inactive	17884409	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884410	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884411	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884412	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884413	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884414	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884415	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884416	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	17.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	17.0
Inactive	17884417	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884418	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	139.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	139.0
Inactive	17884419	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884420	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17884421	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	670.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	670.0
Inactive	17884422	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884423	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884424	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884425	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884426	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884427	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	1781.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1781.0
Inactive	17884428	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884429	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884430	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884431	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884432	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884433	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884434	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	2.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	2.0
Inactive	17884435	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884436	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884437	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884438	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884439	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884440	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884441	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884442	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884443	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884444	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884445	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	2076.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	2076.0
Inactive	17884446	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884447	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884448	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884449	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884450	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884451	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884452	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	641.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	641.0
Inactive	17884453	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884454	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884455	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884456	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	245.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	245.0
Inactive	17884457	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884458	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884459	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884460	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884461	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	353.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	353.0
Active	17884462	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	1464.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1464.0
Inactive	17884463	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884464	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	164.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	164.0
Inactive	17884465	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884466	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884467	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884468	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2327.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	2327.0
Inactive	17884469	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884470	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884471	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17884472	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	7536.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	7536.0
Inactive	17884473	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884474	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884475	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884476	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884477	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884478	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884479	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884480	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	1783.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1783.0
Inactive	17884481	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884482	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884483	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	910.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	910.0
Inactive	17884484	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884485	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	275.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	275.0
Active	17884486	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	154.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	154.0
Inactive	17884487	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884488	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884489	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884490	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884491	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884492	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884493	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884494	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884495	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884496	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884497	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884498	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884499	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884500	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884501	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1801.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	1801.0
Inactive	17884502	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
Active	17884503	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	525.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	525.0
Inactive	17884504	CHEMBL3991631	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2185	Homo sapiens	Kd apparent	nM	30000.0
	17964875	CHEMBL3994984	Inhibition of human AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	99.0	CHEMBL2185	Homo sapiens	Activity	%	99.0
	17981035	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1cccc(/C=C/C(=O)c2ccccc2O)c1		CHEMBL594853	=	Inhibition	%	-6.6	CHEMBL2185	Homo sapiens	INH	%	-6.6
	17981036	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1cccc(/C=C/C(=O)c2ccc(OC)cc2O)c1	Outside typical range	CHEMBL260597	=	Inhibition	%	-10.6	CHEMBL2185	Homo sapiens	INH	%	-10.6
	17981037	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1cccc(/C=C/C(=O)c2cc(OC)ccc2O)c1	Outside typical range	CHEMBL3125824	=	Inhibition	%	-15.1	CHEMBL2185	Homo sapiens	INH	%	-15.1
	17981038	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1cccc(/C=C/C(=O)c2cc(OC)c(OC)cc2O)c1		CHEMBL4071093	=	Inhibition	%	-6.8	CHEMBL2185	Homo sapiens	INH	%	-6.8
	17981039	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1		CHEMBL229907	=	Inhibition	%	107.2	CHEMBL2185	Homo sapiens	INH	%	107.2
	17981040	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(/C=C/C(=O)c2cc(OC)ccc2O)cc1		CHEMBL4082217	=	Inhibition	%	106.7	CHEMBL2185	Homo sapiens	INH	%	106.7
	17981041	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(C(=O)/C=C/c2c(OC)cccc2OC)c(O)c1		CHEMBL264704	=	Inhibition	%	92.1	CHEMBL2185	Homo sapiens	INH	%	92.1
	17981042	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(O)c(C(=O)/C=C/c2c(OC)cccc2OC)c1		CHEMBL4090067	=	Inhibition	%	103.8	CHEMBL2185	Homo sapiens	INH	%	103.8
	17981043	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(C(=O)/C=C/c2ccc(OC)c(OC)c2)c(O)c1	Outside typical range	CHEMBL262597	=	Inhibition	%	-10.4	CHEMBL2185	Homo sapiens	INH	%	-10.4
	17981044	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(O)c(C(=O)/C=C/c2ccc(OC)c(OC)c2)c1	Outside typical range	CHEMBL4063079	=	Inhibition	%	-10.1	CHEMBL2185	Homo sapiens	INH	%	-10.1
	17981045	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1	Outside typical range	CHEMBL260867	=	Inhibition	%	-23.6	CHEMBL2185	Homo sapiens	INH	%	-23.6
	17981046	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1ccc(O)c(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c1		CHEMBL4071694	=	Inhibition	%	-8.1	CHEMBL2185	Homo sapiens	INH	%	-8.1
	17981047	CHEMBL3998582	Inhibition of N-terminal-GST-tagged recombinant full length human Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using native Swine Myelin Basic Protein as substrate measured after 60 mins by ADP-Glo assay relative to control	A	COc1cc(O)c(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)cc1OC		CHEMBL4098711	=	Inhibition	%	-4.2	CHEMBL2185	Homo sapiens	INH	%	-4.2
	18008668	CHEMBL4003779	Inhibition of human Aurora-B using AKRRRLSSLRA as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21	Outside typical range	CHEMBL4088144	=	Inhibition	%	-15.0	CHEMBL2185	Homo sapiens	INH	%	-15.0
	18008669	CHEMBL4003779	Inhibition of human Aurora-B using AKRRRLSSLRA as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21	Outside typical range	CHEMBL4066861	=	Inhibition	%	-16.0	CHEMBL2185	Homo sapiens	INH	%	-16.0
	18008670	CHEMBL4003779	Inhibition of human Aurora-B using AKRRRLSSLRA as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21	Outside typical range	CHEMBL4078898	=	Inhibition	%	-16.0	CHEMBL2185	Homo sapiens	INH	%	-16.0
	18031615	CHEMBL4007686	Inhibition of AURKB (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	1370.0	CHEMBL2185	Homo sapiens	IC50	uM	1.37
	18031616	CHEMBL4007686	Inhibition of AURKB (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18031617	CHEMBL4007686	Inhibition of AURKB (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18031618	CHEMBL4007686	Inhibition of AURKB (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18031619	CHEMBL4007686	Inhibition of AURKB (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18052750	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)(C)OC(=O)NCC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL4098587	=	IC50	nM	23700.0	CHEMBL2185	Homo sapiens	IC50	uM	23.7
	18052751	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL4080555	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052752	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL4065828	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052753	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL4087241	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052754	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC[C@H](C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL4074450	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052755	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CSCC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL4094922	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052756	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)(C)OC(=O)NCC(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1		CHEMBL4084745	=	IC50	nM	51000.0	CHEMBL2185	Homo sapiens	IC50	uM	51.0
	18052757	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1		CHEMBL4102666	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052758	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1		CHEMBL4092491	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052759	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1		CHEMBL4064791	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052760	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC[C@H](C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1		CHEMBL4100234	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052761	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CSCC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1		CHEMBL4077333	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052762	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)(C)OC(=O)NCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4071058	=	IC50	nM	6200.0	CHEMBL2185	Homo sapiens	IC50	uM	6.2
	18052763	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4083222	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052764	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4070037	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052765	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4091010	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052766	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CC[C@H](C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4061283	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052767	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	CSCC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4075867	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052768	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	Cc1cccc(C)c1Nc1ncnc2ccc(NC(=O)CNC(=O)OC(C)(C)C)cc12		CHEMBL4066232	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18052769	CHEMBL4011796	Inhibition of Aurora B (unknown origin) measured after 40 mins by Kinase Glo luminescence assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	156.0	CHEMBL2185	Homo sapiens	IC50	uM	0.156
	18053058	CHEMBL4011905	Inhibition of AurB (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	17.8	CHEMBL2185	Homo sapiens	INH	%	17.8
Active	18078256	CHEMBL4016720	Inhibition of human N-terminal GST/His6-tagged Aurora B (A2 to A344 residues) expressed in sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	18078257	CHEMBL4016720	Inhibition of human N-terminal GST/His6-tagged Aurora B (A2 to A344 residues) expressed in sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4ccccc43)/Nc3ccccc3/2)CC1.Cl		CHEMBL4084775		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18078258	CHEMBL4016720	Inhibition of human N-terminal GST/His6-tagged Aurora B (A2 to A344 residues) expressed in sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18078259	CHEMBL4016720	Inhibition of human N-terminal GST/His6-tagged Aurora B (A2 to A344 residues) expressed in sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	Cc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2\C1=N/O		CHEMBL4067175		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18114475	CHEMBL4025019	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	98.0	CHEMBL2185	Homo sapiens	Activity	%	98.0
Not Active	18134478	CHEMBL4029529	Inhibition of Aurora B (unknown origin) at <1 uM using aurora peptide as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma33P]ATP by scintillation counter method	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	18134505	CHEMBL4029529	Inhibition of Aurora B (unknown origin) at <1 uM using aurora peptide as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma33P]ATP by scintillation counter method	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18153345	CHEMBL4034267	Inhibition of AUR B Lys 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	9.9	CHEMBL2185	Homo sapiens	INH	%	9.9
	18153346	CHEMBL4034265	Inhibition of AUR B ATP binding site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	10.3	CHEMBL2185	Homo sapiens	INH	%	10.3
	18163585	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4076349	=	Inhibition	%	12.0	CHEMBL2185	Homo sapiens	INH	%	12.0
	18163586	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(F)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4093507	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	INH	%	5.0
	18163587	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4071556	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	18163588	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Br)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4076200	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	18163589	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)c(Cl)c1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4078692	=	Inhibition	%	46.0	CHEMBL2185	Homo sapiens	INH	%	46.0
Not Active	18163590	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1CNc1nc2ccc(OCCN3CCOCC3)cc2s1)c1ccccc1		CHEMBL4077517		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18163591	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccccc1		CHEMBL4075668	=	Inhibition	%	24.0	CHEMBL2185	Homo sapiens	INH	%	24.0
	18163592	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc(F)cc1		CHEMBL4060436	=	Inhibition	%	56.0	CHEMBL2185	Homo sapiens	INH	%	56.0
	18163593	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1cccc(Cl)c1		CHEMBL4096830	=	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	18163594	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc(Cl)cc1		CHEMBL4069612	=	Inhibition	%	42.0	CHEMBL2185	Homo sapiens	INH	%	42.0
	18163595	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL4067950	=	Inhibition	%	17.0	CHEMBL2185	Homo sapiens	INH	%	17.0
	18163596	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccccc1		CHEMBL4085746	=	Inhibition	%	25.0	CHEMBL2185	Homo sapiens	INH	%	25.0
	18163597	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1cccc(Cl)c1		CHEMBL4105537	=	Inhibition	%	91.0	CHEMBL2185	Homo sapiens	INH	%	91.0
	18163598	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(Cl)cc1		CHEMBL4087659	=	Inhibition	%	59.0	CHEMBL2185	Homo sapiens	INH	%	59.0
	18163599	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(C(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4097804	=	Inhibition	%	85.0	CHEMBL2185	Homo sapiens	INH	%	85.0
	18163600	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccccc1		CHEMBL4079776	=	Inhibition	%	16.0	CHEMBL2185	Homo sapiens	INH	%	16.0
	18163601	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(F)cc1		CHEMBL4090089	=	Inhibition	%	30.0	CHEMBL2185	Homo sapiens	INH	%	30.0
	18163602	CHEMBL4036221	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(Cl)cc1		CHEMBL4069011	=	Inhibition	%	28.0	CHEMBL2185	Homo sapiens	INH	%	28.0
Not Determined	18163603	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccccc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4076349		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163604	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(F)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4093507		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163605	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(Cl)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4071556		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163606	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(Br)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4076200		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163607	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4078692		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163608	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccccc1CNc1nc2ccc(OCCN3CCOCC3)cc2s1)c1ccccc1		CHEMBL4077517		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163609	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccccc1		CHEMBL4075668		IC50			CHEMBL2185	Homo sapiens	IC50		
	18163610	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc(F)cc1		CHEMBL4060436	=	IC50	nM	9000.0	CHEMBL2185	Homo sapiens	IC50	uM	9.0
Not Determined	18163611	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1cccc(Cl)c1		CHEMBL4096830		IC50			CHEMBL2185	Homo sapiens	IC50		
	18163612	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc(Cl)cc1		CHEMBL4069612	=	IC50	nM	6200.0	CHEMBL2185	Homo sapiens	IC50	uM	6.2
Not Determined	18163613	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL4067950		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163614	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccccc1		CHEMBL4085746		IC50			CHEMBL2185	Homo sapiens	IC50		
	18163615	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1cccc(Cl)c1		CHEMBL4105537	=	IC50	nM	1400.0	CHEMBL2185	Homo sapiens	IC50	uM	1.4
	18163616	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(Cl)cc1		CHEMBL4087659	=	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	uM	3.0
	18163617	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(C(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4097804	=	IC50	nM	700.0	CHEMBL2185	Homo sapiens	IC50	uM	0.7
Not Determined	18163618	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccccc1		CHEMBL4079776		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163619	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(F)cc1		CHEMBL4090089		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18163620	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(Cl)cc1		CHEMBL4069011		IC50			CHEMBL2185	Homo sapiens	IC50		
	18163621	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccccc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4102159	=	IC50	nM	3100.0	CHEMBL2185	Homo sapiens	IC50	uM	3.1
	18163622	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4084191	=	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	18163623	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4061107	=	IC50	nM	1200.0	CHEMBL2185	Homo sapiens	IC50	uM	1.2
	18163624	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4082990	=	IC50	nM	270.0	CHEMBL2185	Homo sapiens	IC50	uM	0.27
	18163625	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(F)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4099422	=	IC50	nM	700.0	CHEMBL2185	Homo sapiens	IC50	uM	0.7
	18163626	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)Nc1cccc(Cl)c1		CHEMBL4072503	=	IC50	nM	460.0	CHEMBL2185	Homo sapiens	IC50	uM	0.46
	18163627	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4080475	=	IC50	nM	120.0	CHEMBL2185	Homo sapiens	IC50	uM	0.12
	18163628	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	CN(C)CCOc1ccc2nc(NCc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)sc2c1		CHEMBL4098492	=	IC50	nM	320.0	CHEMBL2185	Homo sapiens	IC50	uM	0.32
	18163629	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCC4CCCCN4)cc3s2)cc1		CHEMBL4069775	=	IC50	nM	2300.0	CHEMBL2185	Homo sapiens	IC50	uM	2.3
	18163630	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL4090776	=	IC50	nM	270.0	CHEMBL2185	Homo sapiens	IC50	uM	0.27
	18163631	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4096062	=	IC50	nM	90.0	CHEMBL2185	Homo sapiens	IC50	uM	0.09
	18163632	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4068755	=	IC50	nM	250.0	CHEMBL2185	Homo sapiens	IC50	uM	0.25
	18163633	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	S=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4104452	=	IC50	nM	110.0	CHEMBL2185	Homo sapiens	IC50	uM	0.11
	18163634	CHEMBL4036222	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(NC(=S)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4086553	=	IC50	nM	360.0	CHEMBL2185	Homo sapiens	IC50	uM	0.36
	18163649	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4102159	=	Inhibition	%	37.0	CHEMBL2185	Homo sapiens	INH	%	37.0
	18163650	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4084191	=	Inhibition	%	33.0	CHEMBL2185	Homo sapiens	INH	%	33.0
	18163651	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4061107	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	18163652	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4082990	=	Inhibition	%	91.0	CHEMBL2185	Homo sapiens	INH	%	91.0
	18163653	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(F)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4099422	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	18163654	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)Nc1cccc(Cl)c1		CHEMBL4072503	=	Inhibition	%	67.0	CHEMBL2185	Homo sapiens	INH	%	67.0
	18163655	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4080475	=	Inhibition	%	100.0	CHEMBL2185	Homo sapiens	INH	%	100.0
	18163656	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	CN(C)CCOc1ccc2nc(NCc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)sc2c1		CHEMBL4098492	=	Inhibition	%	65.0	CHEMBL2185	Homo sapiens	INH	%	65.0
	18163657	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCC4CCCCN4)cc3s2)cc1		CHEMBL4069775	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	INH	%	5.0
	18163658	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL4090776	=	Inhibition	%	77.0	CHEMBL2185	Homo sapiens	INH	%	77.0
	18163659	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4096062	=	Inhibition	%	83.0	CHEMBL2185	Homo sapiens	INH	%	83.0
	18163660	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4068755	=	Inhibition	%	79.0	CHEMBL2185	Homo sapiens	INH	%	79.0
	18163661	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	S=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4104452	=	Inhibition	%	94.0	CHEMBL2185	Homo sapiens	INH	%	94.0
	18163662	CHEMBL4036224	Inhibition of recombinant full length human N-terminal GST-tagged Aurora B expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(NC(=S)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4086553	=	Inhibition	%	72.0	CHEMBL2185	Homo sapiens	INH	%	72.0
Dose-dependent effect	18163663	CHEMBL4036225	Inhibition of Aurora B in human HeLa cells assessed as reduction in histone H3 phosphorylation at Ser10 residue after 1 hr by Western blot analysis	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4080475		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	18163664	CHEMBL4036225	Inhibition of Aurora B in human HeLa cells assessed as reduction in histone H3 phosphorylation at Ser10 residue after 1 hr by Western blot analysis	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4096062		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18203409	CHEMBL4043830	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	95.0	CHEMBL2185	Homo sapiens	Activity	%	95.0
	18212142	CHEMBL4046160	Inhibition of AurB (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL2185	Homo sapiens	INH	%	20.0
	18224646	CHEMBL4048564	Inhibition of human recombinant AurKB after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	68.0	CHEMBL2185	Homo sapiens	IC50	uM	0.068
	18224647	CHEMBL4048564	Inhibition of human recombinant AurKB after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCCCC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4069729	=	IC50	nM	959.0	CHEMBL2185	Homo sapiens	IC50	uM	0.959
	18224648	CHEMBL4048564	Inhibition of human recombinant AurKB after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCOCC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4090723	=	IC50	nM	853.0	CHEMBL2185	Homo sapiens	IC50	uM	0.853
	18224649	CHEMBL4048564	Inhibition of human recombinant AurKB after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4105556	=	IC50	nM	1345.0	CHEMBL2185	Homo sapiens	IC50	uM	1.345
	18224650	CHEMBL4048564	Inhibition of human recombinant AurKB after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CCCCC4)cc3)nc(N3CCN(C)CC3)n2)n[nH]1		CHEMBL4064515	=	IC50	nM	229.0	CHEMBL2185	Homo sapiens	IC50	uM	0.229
	18224651	CHEMBL4048564	Inhibition of human recombinant AurKB after 4 hrs by ADP-Glo assay	A	CN1C(=O)NC(Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL381230	>	IC50	nM	3000.0	CHEMBL2185	Homo sapiens	IC50	uM	3.0
	18232149	CHEMBL4050286	Inhibition of human Aurora B assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	86.0	CHEMBL2185	Homo sapiens	Activity	%	86.0
	18253351	CHEMBL4054959	Inhibition of wild-type human partial length AURB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	64.0	CHEMBL2185	Homo sapiens	Activity	%	64.0
	18253352	CHEMBL4054959	Inhibition of wild-type human partial length AURB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	18255292	CHEMBL4055566	Binding affinity to partial length human AURKB expressed in HEK293 cells by active-site-dependent competition assay	B	COc1n[nH]c2ncc(C#Cc3c(F)ccc(NS(=O)(=O)c4cccc(C#N)c4)c3F)cc12		CHEMBL4098896	=	Kd	nM	64.0	CHEMBL2185	Homo sapiens	Kd	nM	64.0
	18255302	CHEMBL4055576	Inhibition of partial length human AURKB expressed in HEK293 cells assessed as remaining activity at 1 uM after 1 hr by KINOMEscan method	B	COc1n[nH]c2ncc(C#Cc3c(F)ccc(NS(=O)(=O)c4cccc(C#N)c4)c3F)cc12		CHEMBL4098896	=	Activity	%	2.4	CHEMBL2185	Homo sapiens	Activity	%	2.4
	18265805	CHEMBL4057255	Inhibition of AurB (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	11.0	CHEMBL2185	Homo sapiens	INH	%	11.0
	18266003	CHEMBL4057453	Inhibition of AurB (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-6.3	CHEMBL2185	Homo sapiens	INH	%	-6.3
	18274764	CHEMBL4118300	Inhibition of AurB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GKFGNVYLAR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	95.1	CHEMBL2185	Homo sapiens	INH	%	95.1
	18274765	CHEMBL4118300	Inhibition of AurB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GKFGNVYLAR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	57.9	CHEMBL2185	Homo sapiens	INH	%	57.9
	18274766	CHEMBL4118300	Inhibition of AurB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GKFGNVYLAR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	55.7	CHEMBL2185	Homo sapiens	INH	%	55.7
	18274770	CHEMBL4118302	Inhibition of AurB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SHFIVALKVLFK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	94.4	CHEMBL2185	Homo sapiens	INH	%	94.4
	18274771	CHEMBL4118302	Inhibition of AurB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SHFIVALKVLFK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	65.4	CHEMBL2185	Homo sapiens	INH	%	65.4
	18274772	CHEMBL4118302	Inhibition of AurB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SHFIVALKVLFK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	58.1	CHEMBL2185	Homo sapiens	INH	%	58.1
Active	18275822	CHEMBL4118782	Binding affinity to AURKB in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2185	Homo sapiens	Activity		
Active	18275965	CHEMBL4118925	Binding affinity to AURKB in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2185	Homo sapiens	Activity		
	18277141	CHEMBL4119264	Inhibition of human Aurora-B assessed as residual activity at 16 uM relative to control	B	O=C1OC2(C(=O)Nc3ccccc32)C2=C1NCCS2(=O)=O		CHEMBL4126937	>	Activity	%	60.0	CHEMBL2185	Homo sapiens	Activity	%	60.0
	18282047	CHEMBL4120002	Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	14.4	CHEMBL2185	Homo sapiens	INH	%	14.4
	18282366	CHEMBL4120002	Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	7.4	CHEMBL2185	Homo sapiens	INH	%	7.4
	18282799	CHEMBL4120384	Inhibition of AurB (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	11.0	CHEMBL2185	Homo sapiens	INH	%	11.0
	18282968	CHEMBL4120553	Inhibition of AurB (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-2.3	CHEMBL2185	Homo sapiens	INH	%	-2.3
	18283192	CHEMBL4120777	Inhibition of AurB (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	1.0	CHEMBL2185	Homo sapiens	INH	%	1.0
	18286285	CHEMBL4121520	Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	8.0	CHEMBL2185	Homo sapiens	INH	%	8.0
	18299090	CHEMBL4124349	Inhibition of human Aurora-B using full-length histone H3 as substrate after 10 mins	B	NC(=O)c1c(O)cc(O)c2c1oc1c(=O)[nH]cnc12		CHEMBL4128587	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18299091	CHEMBL4124349	Inhibition of human Aurora-B using full-length histone H3 as substrate after 10 mins	B	NC(=O)c1c(O)cc(O)c2c1oc1c(=O)[nH]c(=O)[nH]c12		CHEMBL4129279	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18299092	CHEMBL4124349	Inhibition of human Aurora-B using full-length histone H3 as substrate after 10 mins	B	NC(=O)c1c(O)cc(O)c2c1oc1c(N)ncnc12		CHEMBL4127885	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18299093	CHEMBL4124349	Inhibition of human Aurora-B using full-length histone H3 as substrate after 10 mins	B	CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@]2(C)C1=O		CHEMBL475816	=	IC50	nM	2400.0	CHEMBL2185	Homo sapiens	IC50	uM	2.4
	18316973	CHEMBL4133295	Inhibition of AURB (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCOCC4)nc3C)n2)c(OC)c1		CHEMBL4174540	>	Activity	%	40.0	CHEMBL2185	Homo sapiens	Activity	%	40.0
	18316974	CHEMBL4133295	Inhibition of AURB (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067	>	Activity	%	40.0	CHEMBL2185	Homo sapiens	Activity	%	40.0
	18388027	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1F		CHEMBL4164736	=	IC50	nM	145.0	CHEMBL2185	Homo sapiens	IC50	nM	145.0
	18388028	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCOCC3)nc(Nc3ccc(F)c(Cl)c3)n2)n[nH]1		CHEMBL4175359	=	IC50	nM	34.6	CHEMBL2185	Homo sapiens	IC50	nM	34.6
	18388029	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(F)c(Cl)c3)n2)n[nH]1		CHEMBL4168177	=	IC50	nM	25.7	CHEMBL2185	Homo sapiens	IC50	nM	25.7
	18388030	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(Cl)c(F)c3)n2)n[nH]1		CHEMBL4160260	=	IC50	nM	101.0	CHEMBL2185	Homo sapiens	IC50	nM	101.0
	18388031	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(F)c(F)c3)n2)n[nH]1		CHEMBL4174228	=	IC50	nM	89.2	CHEMBL2185	Homo sapiens	IC50	nM	89.2
	18388032	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(F)cc3)n2)n[nH]1		CHEMBL4163531	=	IC50	nM	75.1	CHEMBL2185	Homo sapiens	IC50	nM	75.1
	18388033	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3cccc(F)c3)n2)n[nH]1		CHEMBL4168905	=	IC50	nM	102.0	CHEMBL2185	Homo sapiens	IC50	nM	102.0
	18388034	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(Cl)c(Cl)c3)n2)n[nH]1		CHEMBL4162633	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
	18388035	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COc1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c(OC)c1OC		CHEMBL4164598	=	IC50	nM	188.0	CHEMBL2185	Homo sapiens	IC50	nM	188.0
	18388036	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1OC		CHEMBL4161644	=	IC50	nM	442.0	CHEMBL2185	Homo sapiens	IC50	nM	442.0
	18388037	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc4c(c3)OCO4)n2)n[nH]1		CHEMBL4175679	=	IC50	nM	91.7	CHEMBL2185	Homo sapiens	IC50	nM	91.7
	18388038	CHEMBL4147248	Inhibition of AURKB (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COc1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1OC		CHEMBL4165059	=	IC50	nM	452.0	CHEMBL2185	Homo sapiens	IC50	nM	452.0
	18417155	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CN(C)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4162506	=	IC50	nM	45.0	CHEMBL2185	Homo sapiens	IC50	nM	45.0
	18417156	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4171920	=	IC50	nM	66.3	CHEMBL2185	Homo sapiens	IC50	nM	66.3
	18417157	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4159739	=	IC50	nM	60.2	CHEMBL2185	Homo sapiens	IC50	nM	60.2
	18417158	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CCc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4170043	=	IC50	nM	66.2	CHEMBL2185	Homo sapiens	IC50	nM	66.2
	18417159	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CC(C)c1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4174257	=	IC50	nM	335.9	CHEMBL2185	Homo sapiens	IC50	nM	335.9
	18417160	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CC(C)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4163577	=	IC50	nM	700.3	CHEMBL2185	Homo sapiens	IC50	nM	700.3
	18417161	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CCN(CC)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4171225	=	IC50	nM	526.1	CHEMBL2185	Homo sapiens	IC50	nM	526.1
	18417162	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccccc1CN1CCCCC1		CHEMBL4162996	=	IC50	nM	121.6	CHEMBL2185	Homo sapiens	IC50	nM	121.6
	18417163	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccccc1CN1CCC(O)CC1		CHEMBL4176720	=	IC50	nM	78.9	CHEMBL2185	Homo sapiens	IC50	nM	78.9
	18417164	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4168861	=	IC50	nM	74.9	CHEMBL2185	Homo sapiens	IC50	nM	74.9
	18417165	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CCc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4173353	=	IC50	nM	86.1	CHEMBL2185	Homo sapiens	IC50	nM	86.1
	18417166	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CC(C)c1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4165437	=	IC50	nM	657.1	CHEMBL2185	Homo sapiens	IC50	nM	657.1
	18417167	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CC(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4165021	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	18417168	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4175638	=	IC50	nM	199.0	CHEMBL2185	Homo sapiens	IC50	nM	199.0
	18417169	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CCN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4161600	=	IC50	nM	140.4	CHEMBL2185	Homo sapiens	IC50	nM	140.4
	18417170	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CCN(CC)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4172214	=	IC50	nM	121.5	CHEMBL2185	Homo sapiens	IC50	nM	121.5
	18417171	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1cccc(CN2CCCCC2)c1		CHEMBL4171792	=	IC50	nM	102.3	CHEMBL2185	Homo sapiens	IC50	nM	102.3
	18417172	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1cccc(CN2CCC(O)CC2)c1		CHEMBL4163926	=	IC50	nM	83.6	CHEMBL2185	Homo sapiens	IC50	nM	83.6
	18417173	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4166291	=	IC50	nM	73.3	CHEMBL2185	Homo sapiens	IC50	nM	73.3
	18417174	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CCc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4177362	=	IC50	nM	443.0	CHEMBL2185	Homo sapiens	IC50	nM	443.0
	18417175	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CC(C)c1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4172897	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	18417176	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CC(C)Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4162227	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	18417177	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CN(C)Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4162635	=	IC50	nM	455.5	CHEMBL2185	Homo sapiens	IC50	nM	455.5
	18417178	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	CCN(CC)Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4170570	=	IC50	nM	835.2	CHEMBL2185	Homo sapiens	IC50	nM	835.2
	18417179	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccc(CN2CCCCC2)cc1		CHEMBL4166079	=	IC50	nM	945.9	CHEMBL2185	Homo sapiens	IC50	nM	945.9
	18417180	CHEMBL4153357	Inhibition of human recombinant full length Aurora-B (1 to 344 residues) expressed in Sf9 cells after 90 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccc(CN2CCC(O)CC2)cc1		CHEMBL4174660	=	IC50	nM	352.5	CHEMBL2185	Homo sapiens	IC50	nM	352.5
	18417186	CHEMBL4153359	Inhibition of Aurora-B autophosphorylation at Thr232 in human HCT116 cells after 1 hr by Western blot analysis	B	CN(C)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4162506	=	IC50	nM	23.7	CHEMBL2185	Homo sapiens	IC50	nM	23.7
	18417187	CHEMBL4153359	Inhibition of Aurora-B autophosphorylation at Thr232 in human HCT116 cells after 1 hr by Western blot analysis	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4171920	=	IC50	nM	191.2	CHEMBL2185	Homo sapiens	IC50	nM	191.2
	18417188	CHEMBL4153359	Inhibition of Aurora-B autophosphorylation at Thr232 in human HCT116 cells after 1 hr by Western blot analysis	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccccc1CN1CCC(O)CC1		CHEMBL4176720	=	IC50	nM	132.6	CHEMBL2185	Homo sapiens	IC50	nM	132.6
	18417189	CHEMBL4153359	Inhibition of Aurora-B autophosphorylation at Thr232 in human HCT116 cells after 1 hr by Western blot analysis	B	CN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4175638	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	18417190	CHEMBL4153359	Inhibition of Aurora-B autophosphorylation at Thr232 in human HCT116 cells after 1 hr by Western blot analysis	B	CCN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4161600	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	18431047	CHEMBL4155728	Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	97.0	CHEMBL2185	Homo sapiens	INH	%	97.0
	18431336	CHEMBL4155788	Inhibition of AURKB (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21	Outside typical range	CHEMBL4170025	=	Inhibition	%	-11.6	CHEMBL2185	Homo sapiens	INH	%	-11.6
	18440085	CHEMBL4156909	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	18443287	CHEMBL4157954	Inhibition of human AurB assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	129.0	CHEMBL2185	Homo sapiens	Activity	%	129.0
	18449919	CHEMBL4178153	Inhibition of human Aurora B (1 to 344 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	89.0	CHEMBL2185	Homo sapiens	Activity	%	89.0
	18462159	CHEMBL4180846	Inhibition of recombinant human full length His6-tagged Aurora B expressed in Sf21 insect cells assessed as residual activity at 1 uM using LRRLSLGLRRLSLGLRRLSLGLRRLSLG as substrate after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	47.0	CHEMBL2185	Homo sapiens	Activity	%	47.0
	18484473	CHEMBL4185635	Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system by Z'LYTE assay	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	IC50	nM	41.0	CHEMBL2185	Homo sapiens	IC50	nM	41.0
	18484476	CHEMBL4185638	Inhibition of Aurora B in human HCT116 cells assessed as reduction in histone H3 phosphorylation at S10 residues after 4 hrs by Western blot analysis	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	EC50	nM	11.0	CHEMBL2185	Homo sapiens	EC50	nM	11.0
	18484525	CHEMBL4185688	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	1.9	CHEMBL2185	Homo sapiens	Activity	%	1.9
	18484950	CHEMBL4185638	Inhibition of Aurora B in human HCT116 cells assessed as reduction in histone H3 phosphorylation at S10 residues after 4 hrs by Western blot analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	EC50	nM	27.0	CHEMBL2185	Homo sapiens	EC50	nM	27.0
	18484953	CHEMBL4185635	Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system by Z'LYTE assay	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	IC50	nM	34.0	CHEMBL2185	Homo sapiens	IC50	nM	34.0
	18485096	CHEMBL4185688	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	1.8	CHEMBL2185	Homo sapiens	Activity	%	1.8
	18485145	CHEMBL4185638	Inhibition of Aurora B in human HCT116 cells assessed as reduction in histone H3 phosphorylation at S10 residues after 4 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	EC50	nM	7.1	CHEMBL2185	Homo sapiens	EC50	nM	7.1
	18485148	CHEMBL4185635	Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system by Z'LYTE assay	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	IC50	nM	29.0	CHEMBL2185	Homo sapiens	IC50	nM	29.0
	18489490	CHEMBL4187231	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	91.0	CHEMBL2185	Homo sapiens	Activity	%	91.0
Not Determined	18499370	CHEMBL4188983	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4204515		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	18499371	CHEMBL4188983	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4213775		IC50			CHEMBL2185	Homo sapiens	IC50		
	18499372	CHEMBL4188983	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4208852	=	IC50	nM	170.0	CHEMBL2185	Homo sapiens	IC50	uM	0.17
	18499373	CHEMBL4188983	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	IC50	uM	0.1
	18499374	CHEMBL4188983	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	IC50	uM	0.1
	18507892	CHEMBL4190875	Inhibition of recombinant full-length human Aurora-B at 1 uM using AKRRRLSSLRA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	18535948	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	N/C(S)=N/N=C/c1cccc(Br)c1	Outside typical range	CHEMBL91844	=	Inhibition	%	-16.24	CHEMBL2185	Homo sapiens	INH	%	-16.24
	18535949	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	COc1ccccc1/C=N/NC(N)=S	Outside typical range	CHEMBL398205	=	Inhibition	%	-16.91	CHEMBL2185	Homo sapiens	INH	%	-16.91
	18535950	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	COc1ccc(/C=N/NC(N)=S)cc1OC		CHEMBL242115	=	Inhibition	%	-7.72	CHEMBL2185	Homo sapiens	INH	%	-7.72
	18535951	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	COc1cccc(OC)c1/C=N/NC(N)=S	Outside typical range	CHEMBL4207338	=	Inhibition	%	-18.21	CHEMBL2185	Homo sapiens	INH	%	-18.21
	18535952	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	COc1cc(/C=N/NC(N)=S)cc(OC)c1OC	Outside typical range	CHEMBL499789	=	Inhibition	%	-17.69	CHEMBL2185	Homo sapiens	INH	%	-17.69
	18535953	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccc(O)c(O)c1	Outside typical range	CHEMBL243187	=	Inhibition	%	-12.23	CHEMBL2185	Homo sapiens	INH	%	-12.23
	18535954	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	N/C(S)=N/N=C/c1ccc(Cl)c(Cl)c1		CHEMBL415311	=	Inhibition	%	-9.56	CHEMBL2185	Homo sapiens	INH	%	-9.56
	18535955	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccco1		CHEMBL1818876	=	Inhibition	%	-8.76	CHEMBL2185	Homo sapiens	INH	%	-8.76
	18535956	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/C=C/c1ccccc1		CHEMBL1276230	=	Inhibition	%	-5.47	CHEMBL2185	Homo sapiens	INH	%	-5.47
	18535957	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccc(-c2ccccc2)cc1	Outside typical range	CHEMBL4165401	=	Inhibition	%	-35.71	CHEMBL2185	Homo sapiens	INH	%	-35.71
	18535958	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1cccc(-c2ccccc2)c1		CHEMBL4217990	=	Inhibition	%	-4.25	CHEMBL2185	Homo sapiens	INH	%	-4.25
	18535959	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	COc1ccc(-c2cccc(/C=N/NC(N)=S)c2)cc1OC		CHEMBL4206286	=	Inhibition	%	-2.55	CHEMBL2185	Homo sapiens	INH	%	-2.55
	18535960	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1cccc(-c2ccc3c(c2)OCO3)c1		CHEMBL4205778	=	Inhibition	%	-3.81	CHEMBL2185	Homo sapiens	INH	%	-3.81
	18535961	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccc(OCc2ccc(Cl)c(Cl)c2)cc1		CHEMBL4210646	=	Inhibition	%	-6.24	CHEMBL2185	Homo sapiens	INH	%	-6.24
	18535962	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccc(O)cc1		CHEMBL242113	=	Inhibition	%	-5.27	CHEMBL2185	Homo sapiens	INH	%	-5.27
	18535963	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/C(O)C(O)C(O)CO		CHEMBL4215074	=	Inhibition	%	-7.51	CHEMBL2185	Homo sapiens	INH	%	-7.51
	18535964	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccccc1[N+](=O)[O-]	Outside typical range	CHEMBL3194855	=	Inhibition	%	-22.79	CHEMBL2185	Homo sapiens	INH	%	-22.79
	18535965	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	COc1cc(/C=N/NC(N)=S)ccc1O		CHEMBL242104	=	Inhibition	%	-0.27	CHEMBL2185	Homo sapiens	INH	%	-0.27
	18535966	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccccc1O		CHEMBL242112	=	Inhibition	%	6.53	CHEMBL2185	Homo sapiens	INH	%	6.53
	18535967	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	N/C(S)=N/N=C/c1ccc([N+](=O)[O-])cc1		CHEMBL193804	=	Inhibition	%	-9.68	CHEMBL2185	Homo sapiens	INH	%	-9.68
	18535968	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccc(N)cc1	Outside typical range	CHEMBL4208462	=	Inhibition	%	-10.48	CHEMBL2185	Homo sapiens	INH	%	-10.48
	18535969	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	CSc1ccc(/C=N/NC(N)=S)cc1	Outside typical range	CHEMBL4203577	=	Inhibition	%	-12.15	CHEMBL2185	Homo sapiens	INH	%	-12.15
	18535970	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1ccc2ncccc2c1		CHEMBL4204121	=	Inhibition	%	0.46	CHEMBL2185	Homo sapiens	INH	%	0.46
	18535971	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	CN(C)c1ccc(/C=N/N=C(/N)S)c2ccccc12		CHEMBL330453	=	Inhibition	%	0.89	CHEMBL2185	Homo sapiens	INH	%	0.89
	18535972	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	NC(=S)N/N=C/c1csc2ccccc12		CHEMBL4216320	=	Inhibition	%	-4.29	CHEMBL2185	Homo sapiens	INH	%	-4.29
	18535973	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	Cc1ccsc1/C=N/NC(N)=S		CHEMBL4211350	=	Inhibition	%	-5.27	CHEMBL2185	Homo sapiens	INH	%	-5.27
	18535974	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	C/C(=N\NC(N)=S)c1ccc(O)cc1		CHEMBL4210257	=	Inhibition	%	-0.05	CHEMBL2185	Homo sapiens	INH	%	-0.05
	18535975	CHEMBL4196397	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system at 10 uM using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	C/C(=N\NC(N)=S)c1ccc(N)cc1	Outside typical range	CHEMBL2420104	=	Inhibition	%	-14.24	CHEMBL2185	Homo sapiens	INH	%	-14.24
	18536152	CHEMBL4196415	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		CHEMBL55	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18536153	CHEMBL4196415	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1		CHEMBL110	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18536154	CHEMBL4196415	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C		CHEMBL125	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18536155	CHEMBL4196415	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system using MBP as substrate incubated for 45 mins by ADP-glo kinase assay	A	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL267345	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18578649	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccncc3)ns2)n1		CHEMBL4227349	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
	18578650	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccnc3)ns2)n1		CHEMBL4226232	>	EC50	nM	1000.0	CHEMBL2185	Homo sapiens	EC50	nM	1000.0
	18578651	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	=	EC50	nM	117.0	CHEMBL2185	Homo sapiens	EC50	nM	117.0
	18578652	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cnccn3)ns2)n1		CHEMBL4225385	=	EC50	nM	208.0	CHEMBL2185	Homo sapiens	EC50	nM	208.0
	18578653	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccn3)ns2)n1		CHEMBL4229135	=	EC50	nM	203.0	CHEMBL2185	Homo sapiens	EC50	nM	203.0
	18578654	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3nccs3)ns2)n1		CHEMBL4227538	=	EC50	nM	170.0	CHEMBL2185	Homo sapiens	EC50	nM	170.0
	18578655	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccc(C)c3=O)ns2)n1		CHEMBL4227844	=	EC50	nM	487.0	CHEMBL2185	Homo sapiens	EC50	nM	487.0
	18578656	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccn3)ns2)n1		CHEMBL4228412	=	EC50	nM	184.0	CHEMBL2185	Homo sapiens	EC50	nM	184.0
	18578657	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3ccnc3)ns2)n1		CHEMBL4228135	=	EC50	nM	370.0	CHEMBL2185	Homo sapiens	EC50	nM	370.0
	18578658	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccc3)ns2)n1		CHEMBL4228586	=	EC50	nM	530.0	CHEMBL2185	Homo sapiens	EC50	nM	530.0
	18578659	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	=	EC50	nM	24.0	CHEMBL2185	Homo sapiens	EC50	nM	24.0
	18578660	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578661	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578662	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578663	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC3CCCC3)c3ccccn3)ns2)n1		CHEMBL4227029	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578664	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCC(F)CC3)ns2)n1		CHEMBL4226184	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578665	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCCCC3)ns2)n1		CHEMBL4227284	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578666	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCCC3)ns2)n1		CHEMBL4226438	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578667	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(CN4CCCCC4)n3)ns2)n1		CHEMBL4227557	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578668	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(C(=O)N4CCCCC4)n3)ns2)n1		CHEMBL4226704	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578669	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(CO)n3)ns2)n1		CHEMBL4227818	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578670	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	COc1cccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)n1		CHEMBL4226969	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578671	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(F)n3)ns2)n1		CHEMBL4225181	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578672	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccc(F)cn3)ns2)n1		CHEMBL4226036	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578673	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccc3F)ns2)n1		CHEMBL4225979	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578674	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)n1		CHEMBL4228308	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578675	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1ccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)nc1		CHEMBL4225708	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578676	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1ccnc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)c1		CHEMBL4226657	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578677	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccc3C)ns2)n1		CHEMBL4226494	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578678	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccncc3)ns2)n1		CHEMBL4227349	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578679	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccnc3)ns2)n1		CHEMBL4226232	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578680	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578681	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cnccn3)ns2)n1		CHEMBL4225385	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578682	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccn3)ns2)n1		CHEMBL4229135	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578683	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3nccs3)ns2)n1		CHEMBL4227538	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578684	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccc(C)c3=O)ns2)n1		CHEMBL4227844	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578685	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccn3)ns2)n1		CHEMBL4228412	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578686	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3ccnc3)ns2)n1		CHEMBL4228135	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578687	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccc3)ns2)n1		CHEMBL4228586	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578688	CHEMBL4222440	Inhibition of Aurora B (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	<	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	18578707	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccc3C)ns2)n1		CHEMBL4226494	=	EC50	nM	250.0	CHEMBL2185	Homo sapiens	EC50	nM	250.0
	18578708	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1ccnc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)c1		CHEMBL4226657	=	EC50	nM	376.0	CHEMBL2185	Homo sapiens	EC50	nM	376.0
	18578709	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1ccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)nc1		CHEMBL4225708	=	EC50	nM	475.0	CHEMBL2185	Homo sapiens	EC50	nM	475.0
	18578710	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)n1		CHEMBL4228308	=	EC50	nM	88.0	CHEMBL2185	Homo sapiens	EC50	nM	88.0
	18578711	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccc3F)ns2)n1		CHEMBL4225979	=	EC50	nM	182.0	CHEMBL2185	Homo sapiens	EC50	nM	182.0
	18578712	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccc(F)cn3)ns2)n1		CHEMBL4226036	=	EC50	nM	486.0	CHEMBL2185	Homo sapiens	EC50	nM	486.0
	18578713	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(F)n3)ns2)n1		CHEMBL4225181	=	EC50	nM	100.0	CHEMBL2185	Homo sapiens	EC50	nM	100.0
	18578714	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	COc1cccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)n1		CHEMBL4226969	=	EC50	nM	356.0	CHEMBL2185	Homo sapiens	EC50	nM	356.0
	18578715	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(CO)n3)ns2)n1		CHEMBL4227818	=	EC50	nM	559.0	CHEMBL2185	Homo sapiens	EC50	nM	559.0
	18578716	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(C(=O)N4CCCCC4)n3)ns2)n1		CHEMBL4226704	=	EC50	nM	245.0	CHEMBL2185	Homo sapiens	EC50	nM	245.0
	18578717	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(CN4CCCCC4)n3)ns2)n1		CHEMBL4227557	=	EC50	nM	289.0	CHEMBL2185	Homo sapiens	EC50	nM	289.0
	18578718	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCCC3)ns2)n1		CHEMBL4226438	<	EC50	nM	16.0	CHEMBL2185	Homo sapiens	EC50	nM	16.0
	18578719	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCCCC3)ns2)n1		CHEMBL4227284	<	EC50	nM	16.0	CHEMBL2185	Homo sapiens	EC50	nM	16.0
	18578720	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCC(F)CC3)ns2)n1		CHEMBL4226184	=	EC50	nM	83.0	CHEMBL2185	Homo sapiens	EC50	nM	83.0
	18578721	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC3CCCC3)c3ccccn3)ns2)n1		CHEMBL4227029	<	EC50	nM	16.0	CHEMBL2185	Homo sapiens	EC50	nM	16.0
	18578722	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<	EC50	nM	16.0	CHEMBL2185	Homo sapiens	EC50	nM	16.0
	18578723	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	=	EC50	nM	50.0	CHEMBL2185	Homo sapiens	EC50	nM	50.0
	18578724	CHEMBL4222441	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation of Histone H3 at Ser10 residue incubated for 1 hr by Hoechst 33342 dye-based immunofluorescence microscopic method	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<	EC50	nM	16.0	CHEMBL2185	Homo sapiens	EC50	nM	16.0
	18578766	CHEMBL4222445	Binding affinity to Aurora B (unknown origin) after 45 mins by fluorescence-based thermal stability shift assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	=	Kd	nM	0.1	CHEMBL2185	Homo sapiens	Kd	nM	0.1
	18578767	CHEMBL4222445	Binding affinity to Aurora B (unknown origin) after 45 mins by fluorescence-based thermal stability shift assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	=	Kd	nM	0.01	CHEMBL2185	Homo sapiens	Kd	nM	0.01
	18589532	CHEMBL4224086	Inhibition of Aurora B (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4226724	=	IC50	nM	265.0	CHEMBL2185	Homo sapiens	IC50	nM	265.0
	18589533	CHEMBL4224086	Inhibition of Aurora B (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4225880	=	IC50	nM	80.0	CHEMBL2185	Homo sapiens	IC50	nM	80.0
	18589534	CHEMBL4224086	Inhibition of Aurora B (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	CN1CCC(NC(=O)c2ccc(Cn3nc(-c4cnn(C)c4)c4ccccc4c3=O)cc2)CC1		CHEMBL4227804	=	IC50	nM	105.0	CHEMBL2185	Homo sapiens	IC50	nM	105.0
	18589535	CHEMBL4224086	Inhibition of Aurora B (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4228646	=	IC50	nM	134.0	CHEMBL2185	Homo sapiens	IC50	nM	134.0
	18589536	CHEMBL4224086	Inhibition of Aurora B (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(Nc2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4228067	=	IC50	nM	132.0	CHEMBL2185	Homo sapiens	IC50	nM	132.0
	18589537	CHEMBL4224086	Inhibition of Aurora B (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4228587	=	IC50	nM	15.0	CHEMBL2185	Homo sapiens	IC50	nM	15.0
Dose-dependent effect	18589539	CHEMBL4224088	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells after 6 hrs by Western blot method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4225880		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18589542	CHEMBL4224090	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells at 5 uM after 6 hrs by Western blot method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4225880		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18589543	CHEMBL4224090	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells at 5 uM after 6 hrs by Western blot method	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4228587		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18653761	CHEMBL4230023	Inhibition of AURORA-B (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	82.0	CHEMBL2185	Homo sapiens	INH	%	82.0
	18653762	CHEMBL4230023	Inhibition of AURORA-B (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	27.0	CHEMBL2185	Homo sapiens	INH	%	27.0
	18655632	CHEMBL4230588	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	93.0	CHEMBL2185	Homo sapiens	Activity	%	93.0
	18663899	CHEMBL4232869	Inhibition of human AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	92.0	CHEMBL2185	Homo sapiens	Activity	%	92.0
	18663982	CHEMBL4232966	Binding affinity to human AURKB (D25 to A303 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2185	Homo sapiens	Kd	uM	5.0
	18665492	CHEMBL4233290	Inhibition of AURB (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	5000.0	CHEMBL2185	Homo sapiens	IC50	nM	5000.0
	18665562	CHEMBL4233290	Inhibition of AURB (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	nM	1000.0
	18668230	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL4238971	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668231	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	O=C(O)CCCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241699	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668232	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4244860	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668233	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C2=C(C(=O)N1O)c1cn(c3ccccc13)CCCCCCn1cc2c2ccccc21		CHEMBL4243080	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668234	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C(C)C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4238883	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668235	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4239321	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668236	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4249393	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668237	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC(=O)O)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4240779	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668238	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4245590	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668239	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4246062	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668240	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241803	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668241	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4242235	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668242	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ncccc23)C(=O)N1O		CHEMBL4238093	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668243	CHEMBL4234038	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL52851	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18668343	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL52851	=	Activity	%	84.0	CHEMBL2185	Homo sapiens	Activity	%	84.0
	18668344	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ncccc23)C(=O)N1O		CHEMBL4238093	=	Activity	%	61.0	CHEMBL2185	Homo sapiens	Activity	%	61.0
	18668345	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4242235	=	Activity	%	79.0	CHEMBL2185	Homo sapiens	Activity	%	79.0
	18668346	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241803	=	Activity	%	84.0	CHEMBL2185	Homo sapiens	Activity	%	84.0
	18668347	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4246062	=	Activity	%	98.0	CHEMBL2185	Homo sapiens	Activity	%	98.0
	18668348	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4245590	=	Activity	%	71.0	CHEMBL2185	Homo sapiens	Activity	%	71.0
	18668349	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC(=O)O)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4240779	=	Activity	%	71.0	CHEMBL2185	Homo sapiens	Activity	%	71.0
	18668350	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4249393	=	Activity	%	147.0	CHEMBL2185	Homo sapiens	Activity	%	147.0
	18668351	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4239321	=	Activity	%	95.0	CHEMBL2185	Homo sapiens	Activity	%	95.0
	18668352	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C(C)C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4238883	=	Activity	%	95.0	CHEMBL2185	Homo sapiens	Activity	%	95.0
	18668353	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C2=C(C(=O)N1O)c1cn(c3ccccc13)CCCCCCn1cc2c2ccccc21		CHEMBL4243080	=	Activity	%	97.0	CHEMBL2185	Homo sapiens	Activity	%	97.0
	18668354	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4244860	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	18668355	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	O=C(O)CCCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241699	=	Activity	%	63.0	CHEMBL2185	Homo sapiens	Activity	%	63.0
	18668356	CHEMBL4234048	Inhibition of recombinant full length human aurora B expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL4238971	=	Activity	%	83.0	CHEMBL2185	Homo sapiens	Activity	%	83.0
	18674544	CHEMBL4235315	Inhibition of AurB (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL2185	Homo sapiens	Ki	nM	10000.0
	18674545	CHEMBL4235315	Inhibition of AurB (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	Ki	nM	1000.0
	18674546	CHEMBL4235315	Inhibition of AurB (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	1000.0	CHEMBL2185	Homo sapiens	Ki	nM	1000.0
	18677264	CHEMBL4235948	Inhibition of aurora B (unknown origin)	B	COc1cc(OC)cc(C(=O)N[C@H]2CC[C@H](Nc3nc(C)cc(N(C)C)n3)CC2)c1		CHEMBL4241707	=	IC50	nM	39.81	CHEMBL2185	Homo sapiens	pIC50		7.4
	18693965	CHEMBL4253418	Inhibition of recombinant full length human His-tagged AURKB expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	18694047	CHEMBL4253500	Inhibition of recombinant full length human His-tagged AURKB expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	6.0	CHEMBL2185	Homo sapiens	INH	%	6.0
	18697611	CHEMBL4254284	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	95.0	CHEMBL2185	Homo sapiens	Activity	%	95.0
	18708927	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	20.0	CHEMBL2185	Homo sapiens	INH	%	20.0
	18708956	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	96.0	CHEMBL2185	Homo sapiens	INH	%	96.0
	18708986	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	43.0	CHEMBL2185	Homo sapiens	INH	%	43.0
	18709017	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	18709046	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	61.0	CHEMBL2185	Homo sapiens	INH	%	61.0
	18709075	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	94.0	CHEMBL2185	Homo sapiens	INH	%	94.0
	18709104	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	79.0	CHEMBL2185	Homo sapiens	INH	%	79.0
	18709151	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	77.0	CHEMBL2185	Homo sapiens	INH	%	77.0
	18709181	CHEMBL4256673	Inhibition of Aurora B (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	24.0	CHEMBL2185	Homo sapiens	INH	%	24.0
	18709210	CHEMBL4256647	Inhibition of Aurora B (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	27.0	CHEMBL2185	Homo sapiens	INH	%	27.0
	18709252	CHEMBL4256673	Inhibition of Aurora B (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	71.0	CHEMBL2185	Homo sapiens	INH	%	71.0
	18709285	CHEMBL4256673	Inhibition of Aurora B (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	91.0	CHEMBL2185	Homo sapiens	INH	%	91.0
	18737838	CHEMBL4261401	Inhibition of recombinant full length human Aurora-B using AKRRRLSSLRA as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	210.0	CHEMBL2185	Homo sapiens	IC50	nM	210.0
	18751068	CHEMBL4263737	Inhibition of AURORA-B (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	48.0	CHEMBL2185	Homo sapiens	INH	%	48.0
	18751726	CHEMBL4264177	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	18761191	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	COc1cc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)ncnc2cc1O		CHEMBL4282530	=	IC50	nM	41.0	CHEMBL2185	Homo sapiens	IC50	nM	41.0
	18761192	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	47.0	CHEMBL2185	Homo sapiens	IC50	nM	47.0
	18761193	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	396.5	CHEMBL2185	Homo sapiens	IC50	nM	396.5
	18761194	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	18761195	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	0.37	CHEMBL2185	Homo sapiens	IC50	nM	0.37
	18761196	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	79.0	CHEMBL2185	Homo sapiens	IC50	nM	79.0
	18761197	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	nM	4.0
	18761198	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	O=C(Nc1cccc(Cl)c1)NC1NC=C(CCNc2ncnc3sccc23)S1		CHEMBL4277690	=	IC50	nM	31.0	CHEMBL2185	Homo sapiens	IC50	nM	31.0
	18761199	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	3.5	CHEMBL2185	Homo sapiens	IC50	nM	3.5
	18761200	CHEMBL4266276	Inhibition of recombinant aurora B (unknown origin)	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
	18761203	CHEMBL4266279	Inhibition of NH2-terminal GST-tagged recombinant full length human Aurora B kinase expressed in baculovirus	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	IC50	nM	4.0	CHEMBL2185	Homo sapiens	IC50	nM	4.0
	18761222	CHEMBL4266290	Inhibition of Aurora B kinase in human HCT116 cells assessed as reduction in polyploid phenotype	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	nM	30.0
	18761263	CHEMBL4266328	Inhibition of full-length His-tagged recombinant aurora B (unknown origin) expressed in insect cells using biotinylated LRRWSLG substrate by scintillation proximity assay	B	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL4289017	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	18761265	CHEMBL4266330	Inhibition of aurora B in human MDA-MB-231 cells assessed as reduction in enzyme autophosphorylation incubated for 4 hrs by high-content immunofluorescence imaging	B	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL4289017	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
	18761266	CHEMBL4266331	Inhibition of aurora B in human MDA-MB-231 cells assessed as reduction in phosphorylation of histone H3 on Ser10 incubated for 4 hrs by high-content immunofluorescence imaging	B	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL4289017	=	IC50	nM	50.0	CHEMBL2185	Homo sapiens	IC50	nM	50.0
	18761282	CHEMBL4266347	Inhibition of GST-tagged recombinant human Aurora B kinase expressed in High5 cells using Auroratide substrate and [gamma33-ATP] by scintillation proximity assay	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	135.0	CHEMBL2185	Homo sapiens	IC50	nM	135.0
	18762147	CHEMBL4266679	Inhibition of aurora B (unknown origin) at 50 uM	B	COc1ccc(/C=C/C(=O)c2c(O)cc(OC)cc2OC)cc1		CHEMBL243829	=	Inhibition	%	84.0	CHEMBL2185	Homo sapiens	INH	%	84.0
	18762882	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CC(C)c1cc(NS(=O)(=O)c2ccccc2)cc2c(C(N)=O)c(NC(=O)C3CC3)sc12		CHEMBL4292830	=	IC50	nM	417.0	CHEMBL2185	Homo sapiens	IC50	nM	417.0
	18762946	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3ccccc3)cc2c1C(N)=O		CHEMBL4289877	=	IC50	nM	35.0	CHEMBL2185	Homo sapiens	IC50	nM	35.0
	18762947	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccc(C)c3)cc2c1C(N)=O		CHEMBL4286456	=	IC50	nM	46.0	CHEMBL2185	Homo sapiens	IC50	nM	46.0
	18762948	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CCS(=O)(=O)Nc1cc(C(C)C)c2sc(NC(=O)NC)c(C(N)=O)c2c1		CHEMBL4284087	=	IC50	nM	38.0	CHEMBL2185	Homo sapiens	IC50	nM	38.0
	18762949	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	IC50	nM	23.0	CHEMBL2185	Homo sapiens	IC50	nM	23.0
	18762950	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CCCNS(=O)(=O)Nc1cc(C(C)C)c2sc(NC(=O)NC)c(C(N)=O)c2c1		CHEMBL4277642	=	IC50	nM	11.0	CHEMBL2185	Homo sapiens	IC50	nM	11.0
	18762951	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	IC50	nM	29.0	CHEMBL2185	Homo sapiens	IC50	nM	29.0
	18762952	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cc(C)cs3)cc2c1C(N)=O		CHEMBL4284263	=	IC50	nM	48.0	CHEMBL2185	Homo sapiens	IC50	nM	48.0
	18762953	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3ccn(C)n3)cc2c1C(N)=O		CHEMBL4279747	=	IC50	nM	17.0	CHEMBL2185	Homo sapiens	IC50	nM	17.0
	18762954	CHEMBL4266832	Inhibition of recombinant Aurora B (unknown origin) using TAMRA-PKAtide as substrate after 1 hr by fluorescence polarization assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	43.0	CHEMBL2185	Homo sapiens	IC50	nM	43.0
Active	18762991	CHEMBL4266837	Inhibition of Aurora B in human HCT116 cells assessed as reduction in histone H3 phosphorylation at Ser10 residue up to 1 uM after 3 hrs by Western blot analysis	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18762992	CHEMBL4266837	Inhibition of Aurora B in human HCT116 cells assessed as reduction in histone H3 phosphorylation at Ser10 residue up to 1 uM after 3 hrs by Western blot analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18762995	CHEMBL4266839	Inhibition of Aurora B phosphorylation at Thr232 residue in human HCT116 cells up to 1 uM after 3 hrs by Western blot method	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18762996	CHEMBL4266839	Inhibition of Aurora B phosphorylation at Thr232 residue in human HCT116 cells up to 1 uM after 3 hrs by Western blot method	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18762999	CHEMBL4266841	Inhibition of Aurora B phosphorylation at Thr232 residue in human HCT116 cells over 100 nM after 3 hrs by Western blot method	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18763000	CHEMBL4266841	Inhibition of Aurora B phosphorylation at Thr232 residue in human HCT116 cells over 100 nM after 3 hrs by Western blot method	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18764530	CHEMBL4267079	Inhibition of human Aurora B at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL2185	Homo sapiens	INH	%	70.0
	18764531	CHEMBL4267079	Inhibition of human Aurora B at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL2185	Homo sapiens	INH	%	70.0
	18764532	CHEMBL4267079	Inhibition of human Aurora B at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL2185	Homo sapiens	INH	%	70.0
	18769839	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	IC50	nM	37.6	CHEMBL2185	Homo sapiens	IC50	nM	37.6
	18769840	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCN(C)CC4)ncc32)cc1		CHEMBL4289433	=	IC50	nM	86.0	CHEMBL2185	Homo sapiens	IC50	nM	86.0
	18769841	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CCN(CC)c1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C)cc1		CHEMBL4278759	=	IC50	nM	321.6	CHEMBL2185	Homo sapiens	IC50	nM	321.6
	18769842	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(NC(C)(C)C)ncc32)cc1		CHEMBL4286011	=	IC50	nM	1184.7	CHEMBL2185	Homo sapiens	IC50	nM	1184.7
	18769843	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(NC(C)C)ncc32)cc1		CHEMBL4293912	=	IC50	nM	54.1	CHEMBL2185	Homo sapiens	IC50	nM	54.1
	18769844	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCCCC4)ncc32)cc1		CHEMBL4280932	=	IC50	nM	50.3	CHEMBL2185	Homo sapiens	IC50	nM	50.3
	18769845	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CNc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C)cc1		CHEMBL4291572	=	IC50	nM	352.0	CHEMBL2185	Homo sapiens	IC50	nM	352.0
	18769850	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.8	CHEMBL2185	Homo sapiens	IC50	nM	7.8
	18769851	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C(F)(F)F)cc1		CHEMBL4282864	=	IC50	nM	854.4	CHEMBL2185	Homo sapiens	IC50	nM	854.4
	18769852	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1C(F)(F)F		CHEMBL4293467	=	IC50	nM	307.4	CHEMBL2185	Homo sapiens	IC50	nM	307.4
	18769853	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	COc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(SC)ncc32)cc1		CHEMBL4291146	=	IC50	nM	2681.5	CHEMBL2185	Homo sapiens	IC50	nM	2681.5
	18769854	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	COc1ccccc1C1=Nc2c(n[nH]c2C)Nc2nc(SC)ncc21		CHEMBL4283293	=	IC50	nM	2320.6	CHEMBL2185	Homo sapiens	IC50	nM	2320.6
	18769855	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C)cc1		CHEMBL4294551	=	IC50	nM	99.8	CHEMBL2185	Homo sapiens	IC50	nM	99.8
	18769856	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1C		CHEMBL4286642	=	IC50	nM	610.5	CHEMBL2185	Homo sapiens	IC50	nM	610.5
	18769857	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1cccc(F)c1		CHEMBL4282473	=	IC50	nM	611.0	CHEMBL2185	Homo sapiens	IC50	nM	611.0
	18769858	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(Cl)cc1		CHEMBL4290345	=	IC50	nM	1620.0	CHEMBL2185	Homo sapiens	IC50	nM	1620.0
	18769859	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1cccc(Cl)c1		CHEMBL4290758	=	IC50	nM	1003.6	CHEMBL2185	Homo sapiens	IC50	nM	1003.6
	18769860	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1Cl		CHEMBL4280119	=	IC50	nM	278.1	CHEMBL2185	Homo sapiens	IC50	nM	278.1
	18769861	CHEMBL4268023	Inhibition of Aurora B (unknown origin) using STK S2 as substrate after 30 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1		CHEMBL4294161	=	IC50	nM	894.0	CHEMBL2185	Homo sapiens	IC50	nM	894.0
	18769957	CHEMBL4268071	Inhibition of recombinant human full length His-tagged Aurora B expressed in baculovirus expression system using peptide substrate after 1 hr by Z'-Lyte assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	350.0	CHEMBL2185	Homo sapiens	IC50	nM	350.0
Active	18780177	CHEMBL4269923	Binding affinity to human AURKB at 1 uM after 1 hr by KINOMEscan assay	B	CO/C=C/C(=O)c1cc2c3c(c(N)cc(NC(=O)C(C)C)c3n1)N=C2		CHEMBL4293970		Activity			CHEMBL2185	Homo sapiens	Activity		
	18782831	CHEMBL4270697	Inhibition of Aurora B (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL2185	Homo sapiens	Activity	%	80.0
	18810289	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	CN1CCN(c2ccc3c(Nc4cc[nH]n4)nc(-c4ccccc4)nc3c2)CC1		CHEMBL4286550	=	IC50	nM	14360.0	CHEMBL2185	Homo sapiens	IC50	uM	14.36
	18810290	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	COc1cccc(OC)c1C(=O)c1nc(Nc2cc(C)[nH]n2)c2ccc(N3CCC(C(=O)OC(C)(C)C)CC3)cc2n1		CHEMBL4276766	>	IC50	nM	60000.0	CHEMBL2185	Homo sapiens	IC50	uM	60.0
	18810291	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(N4CCC(C(=O)O)CC4)ccc23)n[nH]1		CHEMBL4287422	=	IC50	nM	127.0	CHEMBL2185	Homo sapiens	IC50	uM	0.127
	18810292	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	CCOC(=O)C1CCN(c2ccc3c(Nc4cc(C)[nH]n4)nc(-c4ccccc4)nc3c2)CC1		CHEMBL4282148	=	IC50	nM	2522.0	CHEMBL2185	Homo sapiens	IC50	uM	2.522
	18810293	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(N4CCN(C)CC4)ccc23)n[nH]1		CHEMBL4292755	=	IC50	nM	270.0	CHEMBL2185	Homo sapiens	IC50	uM	0.27
	18810294	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	COc1ccc2c(Nc3cc(C)[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL4278681	=	IC50	nM	773.0	CHEMBL2185	Homo sapiens	IC50	uM	0.773
	18810295	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccccc3)nc3cc([N+](=O)[O-])ccc23)n[nH]1		CHEMBL4289343	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18810296	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(F)ccc23)n[nH]1		CHEMBL4293828	=	IC50	nM	6282.0	CHEMBL2185	Homo sapiens	IC50	uM	6.282
	18810297	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1ccc(C(=O)c2nc(Nc3cc(C)[nH]n3)c3ccc(Cl)cc3n2)cc1		CHEMBL4285937	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18810298	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	COc1ccc(C(=O)c2nc(Nc3cc(C)[nH]n3)c3ccc(Cl)cc3n2)cc1		CHEMBL4290414	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18810299	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(Cl)ccc23)n[nH]1		CHEMBL4282545	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	18810300	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccccc3)nc3c([N+](=O)[O-])cccc23)n[nH]1		CHEMBL4282268	=	IC50	nM	4594.0	CHEMBL2185	Homo sapiens	IC50	uM	4.594
	18810301	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	COc1cccc2c(Nc3cc(C)[nH]n3)nc(Cc3ccccc3)nc12		CHEMBL4290132	=	IC50	nM	893.0	CHEMBL2185	Homo sapiens	IC50	uM	0.893
	18810302	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	COc1cccc2c(Nc3cc(C)[nH]n3)nc(-c3ccccc3)nc12		CHEMBL4292474	=	IC50	nM	547.0	CHEMBL2185	Homo sapiens	IC50	uM	0.547
	18810303	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(C(=O)c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL4281846	=	IC50	nM	11500.0	CHEMBL2185	Homo sapiens	IC50	uM	11.5
	18810304	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(C(C)C)nc3ccccc23)n[nH]1		CHEMBL4289062	=	IC50	nM	1147.0	CHEMBL2185	Homo sapiens	IC50	uM	1.147
	18810305	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccc4ccccc4c3)nc3ccccc23)n[nH]1		CHEMBL4278387	=	IC50	nM	5070.0	CHEMBL2185	Homo sapiens	IC50	uM	5.07
	18810306	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(Cc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL4280722	=	IC50	nM	1271.0	CHEMBL2185	Homo sapiens	IC50	uM	1.271
	18810307	CHEMBL4275816	Inhibition of Aurora B (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	A	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	IC50	nM	858.0	CHEMBL2185	Homo sapiens	IC50	uM	0.858
Not Active	18810461	CHEMBL4275826	Inhibition of Aurora B in human 293T cells assessed as reduction in histone H3 phosphorylation at Ser10 residue at 1 to 2 uM after 24 hrs by Western blot analysis	A	CCOC(=O)C1CCN(c2ccc3c(Nc4cc(C)[nH]n4)nc(-c4ccccc4)nc3c2)CC1		CHEMBL4282148		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	18847342	CHEMBL4304878	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18851334	CHEMBL4305826	Inhibition of AURB (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	=	IC50	nM	8580.0	CHEMBL2185	Homo sapiens	IC50	nM	8580.0
	18857704	CHEMBL4307644	Inhibition of full length His-tagged recombinant human AURKB expressed in Baculovirus expression system at 0.1 uM using Fluorescein-PKC as substrate incubated for 1 hr by TR-FRET assay relative to control	B	CNC(=O)c1c(C(N)=O)nc2n1C1CC(C1)c1ccc(C#CC(C)(C)c3ncc(C)o3)cc1-2		CHEMBL4444206	=	Inhibition	%	45.0	CHEMBL2185	Homo sapiens	INH	%	45.0
	18857705	CHEMBL4307644	Inhibition of full length His-tagged recombinant human AURKB expressed in Baculovirus expression system at 0.1 uM using Fluorescein-PKC as substrate incubated for 1 hr by TR-FRET assay relative to control	B	Cc1cnc(C(C)(C)C#Cc2ccc3c(c2)-c2nc(C(N)=O)c(C4CC4)n2C2CC3C2)o1		CHEMBL4517096	>	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	INH	%	40.0
	18857848	CHEMBL4307694	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	84.0	CHEMBL2185	Homo sapiens	Activity	%	84.0
	18871007	CHEMBL4309982	Inhibition of GST-tagged AURORA B (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1		CHEMBL393929	=	IC50	nM	815.0	CHEMBL2185	Homo sapiens	IC50	uM	0.815
	18871008	CHEMBL4309982	Inhibition of GST-tagged AURORA B (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	IC50	nM	15600.0	CHEMBL2185	Homo sapiens	IC50	uM	15.6
	18871009	CHEMBL4309982	Inhibition of GST-tagged AURORA B (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	IC50	nM	35.0	CHEMBL2185	Homo sapiens	IC50	uM	0.035
	18871010	CHEMBL4309982	Inhibition of GST-tagged AURORA B (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	NS(=O)(=O)c1ccc(Nc2ncn(C(=O)c3c(F)cccc3F)n2)cc1		CHEMBL4474459	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	uM	0.013
Not Determined	18871011	CHEMBL4309982	Inhibition of GST-tagged AURORA B (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		IC50			CHEMBL2185	Homo sapiens	IC50		
Dose-dependent effect	18871017	CHEMBL4309988	Inhibition of AURORA B in human HCT116 cells assessed as reduction in histone H3 phosphorylation at S10 residues after 24 hrs by Western blot analysis	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18878175	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	14.7	CHEMBL2185	Homo sapiens	IC50	nM	14.7
	18878176	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4451940	=	IC50	nM	1.11	CHEMBL2185	Homo sapiens	IC50	nM	1.11
	18878177	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4455202	=	IC50	nM	0.29	CHEMBL2185	Homo sapiens	IC50	nM	0.29
	18878178	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(Br)c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4471448	=	IC50	nM	2.67	CHEMBL2185	Homo sapiens	IC50	nM	2.67
	18878179	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4520619	=	IC50	nM	3.29	CHEMBL2185	Homo sapiens	IC50	nM	3.29
	18878180	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4cccc(Cl)c4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4457980	=	IC50	nM	19.5	CHEMBL2185	Homo sapiens	IC50	nM	19.5
	18878181	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4443125	=	IC50	nM	0.34	CHEMBL2185	Homo sapiens	IC50	nM	0.34
	18878182	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccccc4O)n3)cc2)CC(C)(C)N1[O]		CHEMBL4525614	=	IC50	nM	11.3	CHEMBL2185	Homo sapiens	IC50	nM	11.3
	18878183	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4cccc(O)c4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4440617	=	IC50	nM	3.5	CHEMBL2185	Homo sapiens	IC50	nM	3.5
	18878184	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(O)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4447241	=	IC50	nM	3.5	CHEMBL2185	Homo sapiens	IC50	nM	3.5
	18878185	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026	=	IC50	nM	2.55	CHEMBL2185	Homo sapiens	IC50	nM	2.55
	18878186	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4442043	=	IC50	nM	3.07	CHEMBL2185	Homo sapiens	IC50	nM	3.07
	18878187	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(C(=O)Nc5cccc(Cl)c5)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4460717	=	IC50	nM	27.0	CHEMBL2185	Homo sapiens	IC50	nM	27.0
	18878188	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(C(=O)Nc5ccc(Cl)cc5)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4516770	=	IC50	nM	0.67	CHEMBL2185	Homo sapiens	IC50	nM	0.67
	18878189	CHEMBL4311509	Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL4528809	=	IC50	nM	49.1	CHEMBL2185	Homo sapiens	IC50	nM	49.1
Dose-dependent effect	18878191	CHEMBL4311511	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells after 12 hrs by Western blot analysis	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	18878193	CHEMBL4311513	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells at 5 uM after 12 hrs by Western blot analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	18878195	CHEMBL4311515	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells at <10 nM after 12 hrs by ELISA	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	18878198	CHEMBL4311517	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells after 12 hrs by ELISA	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	148.0	CHEMBL2185	Homo sapiens	IC50	uM	0.148
	18878199	CHEMBL4311517	Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells after 12 hrs by ELISA	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026	=	IC50	nM	538.0	CHEMBL2185	Homo sapiens	IC50	uM	0.538
	18878204	CHEMBL4311521	Inhibition of recombinant N-terminal His6-tagged Aurora B (1 to 403 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	18878210	CHEMBL4311527	Inhibition of recombinant full-length His-tagged Aurora B (unknown origin) expressed in insect cells using biotinylated LRRWSLG as substrate measured over 60 mins by Z-LYTE assay	B	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL4289017	=	IC50	nM	5.0	CHEMBL2185	Homo sapiens	IC50	nM	5.0
	18892756	CHEMBL4314652	Inhibition of recombinant full-length human AURKB assessed as residual activity at 10 uM using AKRRRLSSLRA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	143.0	CHEMBL2185	Homo sapiens	Activity	%	143.0
	18934904	CHEMBL4326803	Inhibition of Aurora B (unknown origin)	B	O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cc(C2CCC2)[nH]n1		CHEMBL4439395	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	18937719	CHEMBL4327589	Inhibition of human Aurora B assessed as residual activity at 1 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	103.9	CHEMBL2185	Homo sapiens	Activity	%	103.9
	18937720	CHEMBL4327589	Inhibition of human Aurora B assessed as residual activity at 1 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.11	CHEMBL2185	Homo sapiens	Activity	%	95.11
	18938430	CHEMBL4327950	Inhibition of human Aurora B assessed as residual activity at 100 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2185	Homo sapiens	Activity	%	65.0
	18938802	CHEMBL4328314	Inhibition of human Aurora B using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	10.6	CHEMBL2185	Homo sapiens	IC50	10'-8M	1.06
	18953711	CHEMBL4331906	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	18953777	CHEMBL4331906	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	18953820	CHEMBL4331906	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	88.0	CHEMBL2185	Homo sapiens	INH	%	88.0
	18953912	CHEMBL4331965	Inhibition of Aurora B (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	38.0	CHEMBL2185	Homo sapiens	INH	%	38.0
	18953976	CHEMBL4331965	Inhibition of Aurora B (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	18954043	CHEMBL4331906	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	57.0	CHEMBL2185	Homo sapiens	INH	%	57.0
	18958677	CHEMBL4333286	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	18964076	CHEMBL4334972	Inhibition of recombinant full length human Aurora B assessed as residual activity at 1 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	94.0	CHEMBL2185	Homo sapiens	Activity	%	94.0
	18964077	CHEMBL4334972	Inhibition of recombinant full length human Aurora B assessed as residual activity at 1 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	110.0	CHEMBL2185	Homo sapiens	Activity	%	110.0
	18971790	CHEMBL4336800	Inhibition of recombinant full length human Aurora B assessed as residual activity at 10 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	34.0	CHEMBL2185	Homo sapiens	Activity	%	34.0
	18976046	CHEMBL4338199	Inhibition of Aurora B (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12		CHEMBL4555884	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18976047	CHEMBL4338199	Inhibition of Aurora B (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12		CHEMBL4475097	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	18976048	CHEMBL4338199	Inhibition of Aurora B (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	IC50	nM	800.0	CHEMBL2185	Homo sapiens	IC50	uM	0.8
	18976049	CHEMBL4338199	Inhibition of Aurora B (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4446434	=	IC50	nM	900.0	CHEMBL2185	Homo sapiens	IC50	uM	0.9
	18976050	CHEMBL4338199	Inhibition of Aurora B (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12		CHEMBL4476426	=	IC50	nM	7800.0	CHEMBL2185	Homo sapiens	IC50	uM	7.8
	18976051	CHEMBL4338199	Inhibition of Aurora B (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4548361	=	IC50	nM	31000.0	CHEMBL2185	Homo sapiens	IC50	uM	31.0
	18976058	CHEMBL4338206	Inhibition of Aurora B (unknown origin) assessed as residual enzyme activity at 50 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	6.0	CHEMBL2185	Homo sapiens	Activity	%	6.0
	18976064	CHEMBL4338212	Inhibition of Aurora B (unknown origin) assessed as residual enzyme activity at 1 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	33.0	CHEMBL2185	Homo sapiens	Activity	%	33.0
	18976089	CHEMBL4338236	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	50.0	CHEMBL2185	Homo sapiens	Activity	%	50.0
	18997590	CHEMBL4342898	Inhibition of human recombinant His6-tagged Aurora B expressed in baculovirus using Biotinyl-Ahx-tetra (LRRWSLG) as substrate incubated for 60 mins by beta scintillation counter	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	nM	130.0
	18997591	CHEMBL4342895	Inhibition of Aurora B (unknown origin)	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	0.37	CHEMBL2185	Homo sapiens	IC50	nM	0.37
	18997616	CHEMBL4342914	Inhibition of Aurora B in human MCF7 cells	B	COc1cc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)ncnc2cc1O		CHEMBL4282530	=	IC50	nM	41.0	CHEMBL2185	Homo sapiens	IC50	nM	41.0
	19030032	CHEMBL4349171	Inhibition of recombinant full length human His-tagged Aurora B expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	36.0	CHEMBL2185	Homo sapiens	Activity	%	36.0
	19035288	CHEMBL4350384	Inhibition of human Aurora B assessed as residual activity at 10 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
Not Active	19039892	CHEMBL4351749	Inhibition of recombinant full-length human AURKB at 10 uM using AKRRRLSSLRA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	19041015	CHEMBL4352276	Inhibition of human Aurora B at 10 uM using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	19052188	CHEMBL4355255	Inhibition of Aurora B (unknown origin)	B	Cc1ccc2c(c1)nc(CCN1C(=O)c3cccc4cccc(c34)C1=O)n2-c1ccncc1		CHEMBL4558162	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	19059465	CHEMBL4357766	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	79.0	CHEMBL2185	Homo sapiens	Activity	%	79.0
	19090038	CHEMBL4365612	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	87.0	CHEMBL2185	Homo sapiens	Activity	%	87.0
	19091818	CHEMBL4366292	Inhibition of human Aurora B at 100 nM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.21	CHEMBL2185	Homo sapiens	INH	%	-2.21
	19092264	CHEMBL4366684	Inhibition of AuroraB (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	19111744	CHEMBL4370590	Inhibition of aurora B (unknown origin) using Kemptide as substrate at 1 uM after 60 mins by ADP-Glo luminescence assay relative to control	B	Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)no1		CHEMBL4522901	=	Inhibition	%	76.5	CHEMBL2185	Homo sapiens	INH	%	76.5
	19111745	CHEMBL4370590	Inhibition of aurora B (unknown origin) using Kemptide as substrate at 1 uM after 60 mins by ADP-Glo luminescence assay relative to control	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086	=	Inhibition	%	90.5	CHEMBL2185	Homo sapiens	INH	%	90.5
	19111757	CHEMBL4370596	Inhibition of aurora B (unknown origin) using Kemptide as substrate after 60 mins by ADP-Glo luminescence assay	B	Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)no1		CHEMBL4522901	=	IC50	nM	17.3	CHEMBL2185	Homo sapiens	IC50	nM	17.3
	19111758	CHEMBL4370596	Inhibition of aurora B (unknown origin) using Kemptide as substrate after 60 mins by ADP-Glo luminescence assay	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086	=	IC50	nM	2.8	CHEMBL2185	Homo sapiens	IC50	nM	2.8
	19111759	CHEMBL4370596	Inhibition of aurora B (unknown origin) using Kemptide as substrate after 60 mins by ADP-Glo luminescence assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	14.7	CHEMBL2185	Homo sapiens	IC50	nM	14.7
Dose-dependent effect	19111761	CHEMBL4370598	Inhibition of aurora B phosphorylation at Thr232 residues in human HeLa cells after 24 hrs by immunofluorescence assay	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	19111762	CHEMBL4370599	Inhibition of aurora B in human HeLa cells assessed as decrease in HisH3 phosphorylation at ser10 residues after 24 hrs by Western blot analysis	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	19114507	CHEMBL4371413	Binding affinity to AURKB in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	>	Kd	nM	69.0	CHEMBL2185	Homo sapiens	Kd(free)	uM	0.069
	19114685	CHEMBL4371413	Binding affinity to AURKB in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	34.0	CHEMBL2185	Homo sapiens	Kd(free)	uM	0.034
	19133363	CHEMBL4375352	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system measured after 1 hr by Kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	78.0	CHEMBL2185	Homo sapiens	Kd	nM	78.0
	19140805	CHEMBL4376569	Inhibition of recombinant full length human His-tagged Aurora B expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	19144619	CHEMBL4377635	Inhibition of recombinant full-length human AURKB at 1 uM using AKRRRLSSLRA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	99.0	CHEMBL2185	Homo sapiens	INH	%	99.0
	19146828	CHEMBL4378964	Inhibition of recombinant full length human Aurora B at 10 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1	Outside typical range	CHEMBL4459587	=	Inhibition	%	-18.0	CHEMBL2185	Homo sapiens	INH	%	-18.0
	19147684	CHEMBL4379079	Inhibition of recombinant full length human AURORA-B using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33P]ATP and 10 uM ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	=	IC50	nM	1239.0	CHEMBL2185	Homo sapiens	IC50	uM	1.239
	19159293	CHEMBL4382397	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	39.0	CHEMBL2185	Homo sapiens	Activity	%	39.0
	19172311	CHEMBL4385135	Inhibition of Aurora B (unknown origin)	B	CS(=O)(=O)Nc1cc(-c2ccncc2)cnc1Cl		CHEMBL4474208	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	19180707	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c[nH]c(=O)cc4Nc4ccccc4)cc3)c2cc1OC		CHEMBL4448864	=	Inhibition	%	38.7	CHEMBL2185	Homo sapiens	INH	%	38.7
	19180708	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cn(C)c(=O)cc4Nc4ccccc4)cc3)c2cc1OC		CHEMBL4452889	=	Inhibition	%	31.1	CHEMBL2185	Homo sapiens	INH	%	31.1
	19180709	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4)cc3)c2cc1OC		CHEMBL4443473	=	Inhibition	%	52.1	CHEMBL2185	Homo sapiens	INH	%	52.1
	19180710	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4cccc(F)c4)cc3)c2cc1OC		CHEMBL4538251	=	Inhibition	%	49.6	CHEMBL2185	Homo sapiens	INH	%	49.6
	19180711	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(F)cc4)cc3)c2cc1OC		CHEMBL4457034	=	Inhibition	%	51.6	CHEMBL2185	Homo sapiens	INH	%	51.6
	19180712	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4F)cc3)c2cc1OC		CHEMBL4434827	=	Inhibition	%	50.1	CHEMBL2185	Homo sapiens	INH	%	50.1
	19180713	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4Cl)cc3)c2cc1OC		CHEMBL4470480	=	Inhibition	%	57.1	CHEMBL2185	Homo sapiens	INH	%	57.1
	19180714	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4cccc(Cl)c4)cc3)c2cc1OC		CHEMBL4439851	=	Inhibition	%	31.9	CHEMBL2185	Homo sapiens	INH	%	31.9
	19180715	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(Cl)cc4)cc3)c2cc1OC		CHEMBL4436133	=	Inhibition	%	38.5	CHEMBL2185	Homo sapiens	INH	%	38.5
	19180716	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4Br)cc3)c2cc1OC		CHEMBL4585471	=	Inhibition	%	56.1	CHEMBL2185	Homo sapiens	INH	%	56.1
	19180717	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(F)c(Br)c4)cc3)c2cc1OC		CHEMBL4559686	=	Inhibition	%	30.1	CHEMBL2185	Homo sapiens	INH	%	30.1
	19180718	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(Br)cc4F)cc3)c2cc1OC		CHEMBL4449328	=	Inhibition	%	31.6	CHEMBL2185	Homo sapiens	INH	%	31.6
	19180719	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4cccc5ccccc45)cc3)c2cc1OC		CHEMBL4459876	=	Inhibition	%	46.3	CHEMBL2185	Homo sapiens	INH	%	46.3
	19180720	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(F)c(Br)c4)cc3F)c2cc1OC		CHEMBL4592677	=	Inhibition	%	30.5	CHEMBL2185	Homo sapiens	INH	%	30.5
	19180721	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc5ccc(Br)cc5c4Nc4ccc(F)c(Br)c4)cc3F)c2cc1OC		CHEMBL4582046	=	Inhibition	%	13.7	CHEMBL2185	Homo sapiens	INH	%	13.7
	19180722	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cccnc4Nc4ccc(F)c(Br)c4)cc3F)c2cc1OC		CHEMBL4581386	=	Inhibition	%	40.7	CHEMBL2185	Homo sapiens	INH	%	40.7
	19180723	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(Nc5ccc(F)c(Br)c5)cc(C)nc4Cl)cc3F)c2cc1OC		CHEMBL4468608	=	Inhibition	%	17.7	CHEMBL2185	Homo sapiens	INH	%	17.7
	19180724	CHEMBL4387126	Inhibition of Aurora B (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Inhibition	%	38.3	CHEMBL2185	Homo sapiens	INH	%	38.3
	19180963	CHEMBL4387173	Inhibition of recombinant full length human His-tagged Aurora B expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	14.5	CHEMBL2185	Homo sapiens	INH	%	14.5
	19181189	CHEMBL4387173	Inhibition of recombinant full length human His-tagged Aurora B expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	7.5	CHEMBL2185	Homo sapiens	INH	%	7.5
	19191232	CHEMBL4389593	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	4.4	CHEMBL2185	Homo sapiens	INH	%	4.4
	19191714	CHEMBL4389116	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	1.1	CHEMBL2185	Homo sapiens	INH	%	1.1
	19200003	CHEMBL4391219	Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	5.6	CHEMBL2185	Homo sapiens	Activity	%	5.6
Active	19218922	CHEMBL4394535	Binding affinity to AURKB in human SUM159 cell lysates by multiplexed inhibitor bead profiling-based LC-MS/MS analysis	B	COc1cc2nccc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC		CHEMBL4447797		Activity			CHEMBL2185	Homo sapiens	Activity		
	19230868	CHEMBL4397153	Inhibition of N-terminal His6-tagged AuroraB (unknown origin) expressed in baculovirus expression system at 100 nM using aurora peptide as substrate preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 60 mins by topcount scintillation counting method relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	21.0	CHEMBL2185	Homo sapiens	INH	%	21.0
Not Active	19253995	CHEMBL4402283	Inhibition of AuroraB (unknown origin) up to 10000 nM	B	CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc3cc(OC(F)F)ccc3c2)CC1		CHEMBL4473072		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	19266315	CHEMBL4405265	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	19275934	CHEMBL4407937	Inhibition of recombinant full length human Aurora-B at 1 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	64.0	CHEMBL2185	Homo sapiens	INH	%	64.0
	19303746	CHEMBL4414155	Inhibition of recombinant full length human His-tagged AURKB expressed in baculovirus expression system assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control	B	O=C(O)c1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1O		CHEMBL4520531	=	Inhibition	%	62.0	CHEMBL2185	Homo sapiens	INH	%	62.0
	19303764	CHEMBL4414216	Inhibition of aurora B (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	74.0	CHEMBL2185	Homo sapiens	Activity	%	74.0
	19303766	CHEMBL4414218	Inhibition of aurora A (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	79.0	CHEMBL2185	Homo sapiens	Activity	%	79.0
	19407719	CHEMBL4426898	Inhibition of aurora B (unknown origin)	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	IC50	nM	114.4	CHEMBL2185	Homo sapiens	IC50	nM	114.4
Tde	19411835	CHEMBL4427796	Inhibition of aurora B in human HCT116 cells assessed as decrease in histone H3 phosphorylation at Ser-10 at 20 uM by Western blot analysis	B	COc1ccc(C2CC(c3ccc4ccccc4c3O)=NN2C(=S)Nc2cccc(OC)c2)cc1		CHEMBL4514298		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Tde	19411838	CHEMBL4427792	Inhibition of aurora B phosphorylation at Thr-232 in human HCT116 cells at 20 uM by Western blot analysis	B	COc1ccc(C2CC(c3ccc4ccccc4c3O)=NN2C(=S)Nc2cccc(OC)c2)cc1		CHEMBL4514298		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	19411840	CHEMBL4427791	Inhibition of human recombinant His-tagged aurora B expressed in baculovirus infected Sf21 insect cells by Western blot analysis	B	COc1ccc(C2CC(c3ccc4ccccc4c3O)=NN2C(=S)Nc2cccc(OC)c2)cc1		CHEMBL4514298	=	IC50	nM	8530.0	CHEMBL2185	Homo sapiens	IC50	uM	8.53
	19435664	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)C(=Cc1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4434704	=	IC50	nM	35.0	CHEMBL2185	Homo sapiens	IC50	uM	0.035
	19435665	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	uM	0.01
	19435666	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	IC50	nM	6.9	CHEMBL2185	Homo sapiens	IC50	uM	0.0069
	19435667	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4553351	=	IC50	nM	6.9	CHEMBL2185	Homo sapiens	IC50	uM	0.0069
	19435668	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4440053	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	uM	0.013
Not Determined	19435669	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(C5(F)CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4437913		IC50			CHEMBL2185	Homo sapiens	IC50		
	19435670	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	CCN1CCN(c2ccc(-c3n[nH]c4cc([C@@H]5C[C@@]56C(=O)Nc5ccc(OC)cc56)ccc34)cc2)CC1		CHEMBL4440812	=	IC50	nM	8.5	CHEMBL2185	Homo sapiens	IC50	uM	0.0085
	19435671	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(CCO)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4470693	=	IC50	nM	7.0	CHEMBL2185	Homo sapiens	IC50	uM	0.007
	19435672	CHEMBL4430369	Inhibition of AURKB (unknown origin)	B	COc1ccc2c(c1)[C@@]1(C[C@@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4467348	=	IC50	nM	2100.0	CHEMBL2185	Homo sapiens	IC50	uM	2.1
	19439578	CHEMBL4431133	Inhibition of Aurora kinase B (unknown origin) assessed as remaining enzyme activity at 1 uM	B	CC(=O)c1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCCc4ccccn4)cc23)cc1		CHEMBL4521500	=	Activity	%	23.0	CHEMBL2185	Homo sapiens	Activity	%	23.0
Active	19442459	CHEMBL4432009	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system using MBP as substrate at 10 uM incubated for 45 mins by ADP-glo kinase assay	B	O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)ccc12		CHEMBL170405		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	19442460	CHEMBL4432009	Inhibition of recombinant full-length human aurora B kinase expressed in baculovirus system using MBP as substrate at 10 uM incubated for 45 mins by ADP-glo kinase assay	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12		CHEMBL31574		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	19448299	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3nccnc3c(NCCCCN)n2)cc1		CHEMBL4436576	=	IC50	nM	1258.93	CHEMBL2185	Homo sapiens	pIC50		5.9
	19448300	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NCCCCN)n2)cn1		CHEMBL4437415	=	IC50	nM	50.12	CHEMBL2185	Homo sapiens	pIC50		7.3
	19448301	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NCC(F)(F)F)n2)cn1		CHEMBL4444533	=	IC50	nM	50.12	CHEMBL2185	Homo sapiens	pIC50		7.3
	19448302	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NCCCCO)n2)cn1		CHEMBL4439653	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	pIC50		7.0
	19448303	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NCCC(N)=O)n2)cn1		CHEMBL4469541	=	IC50	nM	79.43	CHEMBL2185	Homo sapiens	pIC50		7.1
	19448304	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)cn1		CHEMBL4528289	=	IC50	nM	251.19	CHEMBL2185	Homo sapiens	pIC50		6.6
	19448305	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NC[C@@H]3CNCCO3)n2)cn1		CHEMBL4570588	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	pIC50		7.0
	19448306	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CNCCO3)n2)cn1		CHEMBL4448695	=	IC50	nM	79.43	CHEMBL2185	Homo sapiens	pIC50		7.1
	19448307	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NC[C@@H]3CNCCC3(F)F)n2)cn1		CHEMBL4460676	=	IC50	nM	79.43	CHEMBL2185	Homo sapiens	pIC50		7.1
	19448308	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CNCCC3(F)F)n2)cn1		CHEMBL4556378	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	pIC50		7.0
	19448309	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NCC3CNCC(F)(F)C3)n2)cn1		CHEMBL4571227	=	IC50	nM	501.19	CHEMBL2185	Homo sapiens	pIC50		6.3
	19448310	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NC[C@@H]3CNCCN3C)n2)cn1		CHEMBL4469408	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	19448311	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CNCCN3C)n2)cn1		CHEMBL4468195	=	IC50	nM	398.11	CHEMBL2185	Homo sapiens	pIC50		6.4
	19448312	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)cc1		CHEMBL4460283	=	IC50	nM	630.96	CHEMBL2185	Homo sapiens	pIC50		6.2
	19448313	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3ncccc3c(NC[C@H]3CCCNC3)n2)cc1		CHEMBL4455268	=	IC50	nM	1584.89	CHEMBL2185	Homo sapiens	pIC50		5.8
	19448314	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3ncncc3c(NC[C@H]3CCCNC3)n2)cc1		CHEMBL4570737	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	19448315	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3nc[nH]c(=O)c3c(NC[C@H]3CCCNC3)n2)cc1		CHEMBL4449815	=	IC50	nM	5011.87	CHEMBL2185	Homo sapiens	pIC50		5.3
	19448316	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3ncn(C)c(=O)c3c(NC[C@H]3CCCNC3)n2)cc1		CHEMBL4526150	=	IC50	nM	199.53	CHEMBL2185	Homo sapiens	pIC50		6.7
	19448317	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3ncccc3c(NC[C@H]3CCCNC3)n2)cn1		CHEMBL4468047	=	IC50	nM	316.23	CHEMBL2185	Homo sapiens	pIC50		6.5
	19448318	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc(NC[C@H]3CCCNC3)c3cccnc3c2)cn1		CHEMBL4472827	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	pIC50		7.0
	19448319	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(CCC3CCCNC3)n2)cn1		CHEMBL4560963	=	IC50	nM	158.49	CHEMBL2185	Homo sapiens	pIC50		6.8
	19448320	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(OC[C@H]3CCCNC3)n2)cn1		CHEMBL3546703	=	IC50	nM	63.1	CHEMBL2185	Homo sapiens	pIC50		7.2
	19448321	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN(C)c1ccc(-c2cc3nccnc3c(OC[C@@H]3CCCNC3)n2)cn1		CHEMBL4583779	=	IC50	nM	31.62	CHEMBL2185	Homo sapiens	pIC50		7.5
	19448322	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	c1cnc2c(NC[C@H]3CCCNC3)nc(N3CCNCC3)cc2n1		CHEMBL4454171	=	IC50	nM	3981.07	CHEMBL2185	Homo sapiens	pIC50		5.4
	19448323	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	O=C1CN(c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)CCN1		CHEMBL4436508	=	IC50	nM	7943.28	CHEMBL2185	Homo sapiens	pIC50		5.1
	19448324	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)s1		CHEMBL4584789	=	IC50	nM	316.23	CHEMBL2185	Homo sapiens	pIC50		6.5
	19448325	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)o1		CHEMBL4453218	=	IC50	nM	630.96	CHEMBL2185	Homo sapiens	pIC50		6.2
	19448326	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	c1cnc2c(NC[C@H]3CCCNC3)nc(-c3cc[nH]n3)cc2n1		CHEMBL4445992	=	IC50	nM	2511.89	CHEMBL2185	Homo sapiens	pIC50		5.6
	19448327	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	c1cnc2c(NC[C@H]3CCCNC3)nc(-c3cn[nH]c3)cc2n1		CHEMBL4570285	=	IC50	nM	398.11	CHEMBL2185	Homo sapiens	pIC50		6.4
	19448328	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cn1cc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)cn1		CHEMBL4458845	=	IC50	nM	251.19	CHEMBL2185	Homo sapiens	pIC50		6.6
	19448329	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cn1cc(-c2cc3nccnc3c(OC[C@H]3CCCNC3)n2)cn1		CHEMBL4590420	=	IC50	nM	158.49	CHEMBL2185	Homo sapiens	pIC50		6.8
	19448330	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cn1cc(-c2cc3nccnc3c(NC[C@@H]3CNCCO3)n2)cn1		CHEMBL4466696	=	IC50	nM	100.0	CHEMBL2185	Homo sapiens	pIC50		7.0
	19448331	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cn1cc(-c2cc3nccnc3c(NC[C@@H]3CNCCC3(F)F)n2)cn1		CHEMBL4439328	=	IC50	nM	63.1	CHEMBL2185	Homo sapiens	pIC50		7.2
	19448332	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cn1cc(-c2cc3nccnc3c(OCC3CNCCC3(F)F)n2)cn1		CHEMBL4561098	=	IC50	nM	50.12	CHEMBL2185	Homo sapiens	pIC50		7.3
	19448333	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cn1cc(-c2cc3nccnc3c(NCC3CNCC(F)(F)C3)n2)cn1		CHEMBL4520397	=	IC50	nM	501.19	CHEMBL2185	Homo sapiens	pIC50		6.3
	19448334	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	Cn1cc(-c2cc3nccnc3c(OCC3CNCC(F)(F)C3)n2)cn1		CHEMBL4473150	=	IC50	nM	63.1	CHEMBL2185	Homo sapiens	pIC50		7.2
	19448335	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN1CCNC[C@H]1CNc1nc(-c2cnn(C)c2)cc2nccnc12		CHEMBL4455149	=	IC50	nM	1995.26	CHEMBL2185	Homo sapiens	pIC50		5.7
	19448336	CHEMBL4433044	Inhibition of N-terminal-6His-tagged full length human Aurora B expressed in baculovirus using 5FAM-PKA-tide as substrate after 120 mins by fluorescence polarization assay	B	CN1CCNC[C@H]1COc1nc(-c2cnn(C)c2)cc2nccnc12		CHEMBL4455093	=	IC50	nM	630.96	CHEMBL2185	Homo sapiens	pIC50		6.2
	19448501	CHEMBL4433066	Inhibition of Aurora B in calyculin stimulated human HT29 cells assessed as reduction in phosphorylation of histone H3 at ser10	B	Cn1cc(-c2cc3nccnc3c(NC[C@@H]3CNCCO3)n2)cn1		CHEMBL4466696	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	19474676	CHEMBL4479365	Inhibition of Aurora B (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	pIC50		5.0
	19476549	CHEMBL4479697	Inhibition of full-length recombinant human His-tagged AURKB expressed in baculovirus expression system by LanthaScreen assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	33.0	CHEMBL2185	Homo sapiens	IC50	nM	33.0
	19476649	CHEMBL4479697	Inhibition of full-length recombinant human His-tagged AURKB expressed in baculovirus expression system by LanthaScreen assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	<	IC50	nM	10.0	CHEMBL2185	Homo sapiens	IC50	nM	10.0
	19476749	CHEMBL4479697	Inhibition of full-length recombinant human His-tagged AURKB expressed in baculovirus expression system by LanthaScreen assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	28.0	CHEMBL2185	Homo sapiens	IC50	nM	28.0
	19476849	CHEMBL4479697	Inhibition of full-length recombinant human His-tagged AURKB expressed in baculovirus expression system by LanthaScreen assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	4600.0	CHEMBL2185	Homo sapiens	IC50	nM	4600.0
	20600465	CHEMBL4603284	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2185	Homo sapiens	IC50	uM	100.0
	20601659	CHEMBL4603791	Inhibition of recombinant human His-tagged full length Aurora B expressed in baculovirus expression system using Ser/Thr01 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	40.0	CHEMBL2185	Homo sapiens	INH	%	40.0
	20629075	CHEMBL4610389	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 500 nM by Kinomescan method relative to control	B	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Activity	%	67.0	CHEMBL2185	Homo sapiens	Activity	%	67.0
	20629083	CHEMBL4610397	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 100 nM by Kinomescan method relative to control	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Activity	%	0.65	CHEMBL2185	Homo sapiens	Activity	%	0.65
Not Active	20629087	CHEMBL4610401	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 30 to 70 nM measured after 48 hrs	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	20629088	CHEMBL4610402	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 40 nM measured after 48 hrs relative to control	A	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Inhibition	%	41.0	CHEMBL2185	Homo sapiens	INH	%	41.0
	20629089	CHEMBL4610402	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 40 nM measured after 48 hrs relative to control	A	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Inhibition	%	22.0	CHEMBL2185	Homo sapiens	INH	%	22.0
	20629090	CHEMBL4610403	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 90 to 270 nM measured after 48 hrs in presence of 40 nM AZD-1152-HQPA relative to control	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Inhibition	%	67.0	CHEMBL2185	Homo sapiens	INH	%	67.0
	20629091	CHEMBL4610404	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 90 to 270 nM measured after 48 hrs in presence of 40 nM MLN-8054 relative to control	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	>	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	20629092	CHEMBL4610405	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 3 uM measured after 48 hrs relative to control	A	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	Inhibition	%	24.0	CHEMBL2185	Homo sapiens	INH	%	24.0
	20629093	CHEMBL4610406	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 30 nM measured after 48 hrs in presence of 3 uM MK-5108 relative to control	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Inhibition	%	31.0	CHEMBL2185	Homo sapiens	INH	%	31.0
	20629094	CHEMBL4610407	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 90 nM measured after 48 hrs in presence of 3 uM MK-5108 relative to control	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Inhibition	%	36.0	CHEMBL2185	Homo sapiens	INH	%	36.0
	20629095	CHEMBL4610408	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 270 nM measured after 48 hrs in presence of 3 uM MK-5108 relative to control	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Inhibition	%	34.0	CHEMBL2185	Homo sapiens	INH	%	34.0
Not Active	20629096	CHEMBL4610409	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 10 uM measured after 48 hrs	A	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	20629097	CHEMBL4610410	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 270 nM measured after 48 hrs in presence of 10 uM TAK-733	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	20629098	CHEMBL4610411	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 10 uM measured after 48 hrs relative to control	A	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	=	Inhibition	%	10.0	CHEMBL2185	Homo sapiens	INH	%	10.0
	20629191	CHEMBL4610412	Inhibition of AURKB in human HEK293T cells assessed as reduction in cell viability at 270 nM measured after 48 hrs in presence of 10 uM AS-703026 relative to control	A	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Inhibition	%	6.0	CHEMBL2185	Homo sapiens	INH	%	6.0
	20631970	CHEMBL4610923	Inhibition of Aurora B (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	O=C(Nc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4643443	=	Inhibition	%	73.7	CHEMBL2185	Homo sapiens	INH	%	73.7
	20631971	CHEMBL4610923	Inhibition of Aurora B (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	O=C(Cc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4646386	=	Inhibition	%	66.3	CHEMBL2185	Homo sapiens	INH	%	66.3
	20631972	CHEMBL4610923	Inhibition of Aurora B (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	98.1	CHEMBL2185	Homo sapiens	INH	%	98.1
	20631973	CHEMBL4610924	Inhibition of Aurora B (unknown origin) after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	O=C(Nc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4643443	=	IC50	nM	329.0	CHEMBL2185	Homo sapiens	IC50	nM	329.0
	20631974	CHEMBL4610924	Inhibition of Aurora B (unknown origin) after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	O=C(Cc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4646386	=	IC50	nM	293.0	CHEMBL2185	Homo sapiens	IC50	nM	293.0
	20631975	CHEMBL4610924	Inhibition of Aurora B (unknown origin) after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	14.7	CHEMBL2185	Homo sapiens	IC50	nM	14.7
Active	20631985	CHEMBL4610929	Inhibition of Aurora B in human HCT116 cells assessed as reduction in phosphorylation at Thr232 residue at 0.5 to 5 uM after 12 hrs by Western blot analysis	B	O=C(Cc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4646386		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	20632001	CHEMBL4610945	Inhibition of Aurora B (unknown origin)	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	0.37	CHEMBL2185	Homo sapiens	IC50	nM	0.37
	20632003	CHEMBL4610947	Inhibition of N-terminal His6-tagged Aurora B (1 to 403 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	18.0	CHEMBL2185	Homo sapiens	Ki	nM	18.0
	20632006	CHEMBL4610950	Inhibition of recombinant full-length His-tagged human Aurora B expressed in baculovirus expression system	B	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1		CHEMBL188343	=	IC50	nM	500.0	CHEMBL2185	Homo sapiens	IC50	nM	500.0
	20661616	CHEMBL4618348	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma33P]ATP by hotspot assay	B	CC(O)(C#Cc1ccc(N2CCOCC2)c(Nc2ncnc3[nH]ccc23)c1)c1nccs1		CHEMBL4645565	=	IC50	nM	43.2	CHEMBL2185	Homo sapiens	IC50	nM	43.2
	20680932	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CCCCC3)cc2)n1		CHEMBL4635731	=	IC50	nM	320.0	CHEMBL2185	Homo sapiens	IC50	nM	320.0
	20680933	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4647800	=	IC50	nM	360.0	CHEMBL2185	Homo sapiens	IC50	nM	360.0
	20680934	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCN(C)CC3)cc2)n1		CHEMBL4633273	=	IC50	nM	189.0	CHEMBL2185	Homo sapiens	IC50	nM	189.0
	20680935	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccccc3)cc2)n1		CHEMBL4640055	=	IC50	nM	538.0	CHEMBL2185	Homo sapiens	IC50	nM	538.0
	20680936	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccc(Cl)cc3)cc2)n1		CHEMBL4636044	=	IC50	nM	260.0	CHEMBL2185	Homo sapiens	IC50	nM	260.0
	20680937	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)c3)cc2)n1		CHEMBL4647086	=	IC50	nM	152.0	CHEMBL2185	Homo sapiens	IC50	nM	152.0
	20680938	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccccc4)cc3)n2)cn1		CHEMBL4646357	=	IC50	nM	164.0	CHEMBL2185	Homo sapiens	IC50	nM	164.0
	20680939	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccc(Cl)cc4)cc3)n2)cn1		CHEMBL4642258	=	IC50	nM	175.0	CHEMBL2185	Homo sapiens	IC50	nM	175.0
	20680940	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cccc(Cl)c4)cc3)n2)cn1		CHEMBL4644226	=	IC50	nM	272.0	CHEMBL2185	Homo sapiens	IC50	nM	272.0
	20680941	CHEMBL4623060	Inhibition of Aurora kinase B (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	15.7	CHEMBL2185	Homo sapiens	IC50	nM	15.7
Dose-dependent effect	20680943	CHEMBL4623058	Inhibition of Aurora kinase B in human HeLa cells assessed as reduction in phosphorylation at Thr232 residue incubated for 24 hrs by western blot analysis	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)c3)cc2)n1		CHEMBL4647086		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	20680953	CHEMBL4623071	Inhibition of Aurora B in human B-NHL cells assessed as inhibition of histone H3 phosphorylation on Ser10 by immunoblotting analysis	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	30.0	CHEMBL2185	Homo sapiens	IC50	nM	30.0
	20680954	CHEMBL4623056	Inhibition of Aurora B in human SW620 cells assessed as reduction in histone H3 phosphorylation on Ser10 by Alexafluor-488 goat anti-rabbit antibody/Hoechst staining based array scan method	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCP(=O)(O)O		CHEMBL4633715	=	IC50	nM	0.37	CHEMBL2185	Homo sapiens	IC50	nM	0.37
	20680956	CHEMBL4623077	Inhibition of recombinant human N-terminal His6-tagged Aurora B expressed in baculovirus expression system by enzyme coupled assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	20680958	CHEMBL4623075	Inhibition of Aurora B (unknown origin) by biochemical kinase assay	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	79.0	CHEMBL2185	Homo sapiens	IC50	nM	79.0
	20683681	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4645551	=	Inhibition	%	60.9	CHEMBL2185	Homo sapiens	INH	%	60.9
	20683682	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4648901	=	Inhibition	%	87.42	CHEMBL2185	Homo sapiens	INH	%	87.42
	20683683	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4644959	=	Inhibition	%	57.69	CHEMBL2185	Homo sapiens	INH	%	57.69
	20683684	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4635411	=	Inhibition	%	71.8	CHEMBL2185	Homo sapiens	INH	%	71.8
	20683685	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4632919	=	Inhibition	%	33.7	CHEMBL2185	Homo sapiens	INH	%	33.7
	20683686	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4638407	=	Inhibition	%	21.35	CHEMBL2185	Homo sapiens	INH	%	21.35
	20683687	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4642062	=	Inhibition	%	18.73	CHEMBL2185	Homo sapiens	INH	%	18.73
	20683688	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4637300	=	Inhibition	%	90.78	CHEMBL2185	Homo sapiens	INH	%	90.78
	20683689	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4641064	=	Inhibition	%	56.62	CHEMBL2185	Homo sapiens	INH	%	56.62
	20683690	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4640153	=	Inhibition	%	91.61	CHEMBL2185	Homo sapiens	INH	%	91.61
	20683691	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4645713	=	Inhibition	%	80.97	CHEMBL2185	Homo sapiens	INH	%	80.97
	20683692	CHEMBL4623650	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2c(Cl)ccc(Cl)c2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4639147	=	Inhibition	%	53.97	CHEMBL2185	Homo sapiens	INH	%	53.97
	20683704	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4645551	=	IC50	nM	12500.0	CHEMBL2185	Homo sapiens	IC50	uM	12.5
	20683705	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4648901	=	IC50	nM	1620.0	CHEMBL2185	Homo sapiens	IC50	uM	1.62
	20683706	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4644959	=	IC50	nM	8330.0	CHEMBL2185	Homo sapiens	IC50	uM	8.33
	20683707	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4635411	=	IC50	nM	6890.0	CHEMBL2185	Homo sapiens	IC50	uM	6.89
	20683708	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4637300	=	IC50	nM	90.0	CHEMBL2185	Homo sapiens	IC50	uM	0.09
	20683709	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4641064	=	IC50	nM	13200.0	CHEMBL2185	Homo sapiens	IC50	uM	13.2
	20683710	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4640153	=	IC50	nM	1350.0	CHEMBL2185	Homo sapiens	IC50	uM	1.35
	20683711	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4645713	=	IC50	nM	2990.0	CHEMBL2185	Homo sapiens	IC50	uM	2.99
	20683712	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2c(Cl)ccc(Cl)c2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4639147	=	IC50	nM	11500.0	CHEMBL2185	Homo sapiens	IC50	uM	11.5
	20683715	CHEMBL4623652	Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.0	CHEMBL2185	Homo sapiens	IC50	uM	0.006
Not Determined	20683790	CHEMBL4623694	Inhibition of AURKB (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(S(N)(=O)=O)cc3)n2)n[nH]1		CHEMBL3237167		IC50			CHEMBL2185	Homo sapiens	IC50		
	20683791	CHEMBL4623694	Inhibition of AURKB (unknown origin)	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	130.0	CHEMBL2185	Homo sapiens	IC50	uM	0.13
	22391734	CHEMBL4666984	Inhibition of recombinant human His-tagged full length Aurora B expressed in baculovirus expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	3.0	CHEMBL2185	Homo sapiens	INH	%	3.0
	22391735	CHEMBL4666984	Inhibition of recombinant human His-tagged full length Aurora B expressed in baculovirus expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	1.0	CHEMBL2185	Homo sapiens	INH	%	1.0
	22391736	CHEMBL4666984	Inhibition of recombinant human His-tagged full length Aurora B expressed in baculovirus expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	INH	%	5.0
	22391928	CHEMBL4667079	Inhibition of recombinant human His-tagged full length Aurora B expressed in baculovirus expression system using Ser/Thr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	2.5	CHEMBL2185	Homo sapiens	INH	%	2.5
	22408918	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4785054	=	Inhibition	%	14.2	CHEMBL2185	Homo sapiens	INH	%	14.2
	22408919	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4751001	=	Inhibition	%	3.0	CHEMBL2185	Homo sapiens	INH	%	3.0
	22408920	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4757792	=	Inhibition	%	7.6	CHEMBL2185	Homo sapiens	INH	%	7.6
	22408921	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(F)cc4F)cc3)c(=O)c3ccccc23)cn1		CHEMBL4757774	=	Inhibition	%	3.6	CHEMBL2185	Homo sapiens	INH	%	3.6
	22408922	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(Nc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4794671	=	Inhibition	%	65.4	CHEMBL2185	Homo sapiens	INH	%	65.4
	22408923	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(Nc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4795345	=	Inhibition	%	69.5	CHEMBL2185	Homo sapiens	INH	%	69.5
	22408924	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CNc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4785603	=	Inhibition	%	24.7	CHEMBL2185	Homo sapiens	INH	%	24.7
	22408925	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CNc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4754133	=	Inhibition	%	39.9	CHEMBL2185	Homo sapiens	INH	%	39.9
	22408926	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4758452	=	Inhibition	%	68.1	CHEMBL2185	Homo sapiens	INH	%	68.1
	22408927	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4755343	=	Inhibition	%	82.5	CHEMBL2185	Homo sapiens	INH	%	82.5
	22408928	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4763465	=	Inhibition	%	97.2	CHEMBL2185	Homo sapiens	INH	%	97.2
	22408929	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)NC1CCCCC1		CHEMBL4761521	=	Inhibition	%	99.5	CHEMBL2185	Homo sapiens	INH	%	99.5
	22408930	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)c1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4745882	=	Inhibition	%	68.4	CHEMBL2185	Homo sapiens	INH	%	68.4
	22408931	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)c1cccc(C(F)(F)F)c1		CHEMBL4761439	=	Inhibition	%	81.6	CHEMBL2185	Homo sapiens	INH	%	81.6
	22408932	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4784626	=	Inhibition	%	53.7	CHEMBL2185	Homo sapiens	INH	%	53.7
	22408933	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(CC1CCCCC1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4790560	=	Inhibition	%	94.8	CHEMBL2185	Homo sapiens	INH	%	94.8
	22408934	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)C1CCCCC1		CHEMBL4744828	=	Inhibition	%	91.6	CHEMBL2185	Homo sapiens	INH	%	91.6
	22408935	CHEMBL4671025	Inhibition of AuroraB (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	98.1	CHEMBL2185	Homo sapiens	INH	%	98.1
	22408937	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(Nc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4794671	=	IC50	nM	294.0	CHEMBL2185	Homo sapiens	IC50	nM	294.0
	22408938	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(Nc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4795345	=	IC50	nM	360.0	CHEMBL2185	Homo sapiens	IC50	nM	360.0
	22408939	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4758452	=	IC50	nM	282.0	CHEMBL2185	Homo sapiens	IC50	nM	282.0
	22408940	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4755343	=	IC50	nM	142.0	CHEMBL2185	Homo sapiens	IC50	nM	142.0
	22408941	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4763465	=	IC50	nM	21.0	CHEMBL2185	Homo sapiens	IC50	nM	21.0
	22408942	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)NC1CCCCC1		CHEMBL4761521	=	IC50	nM	3.4	CHEMBL2185	Homo sapiens	IC50	nM	3.4
	22408943	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)c1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4745882	=	IC50	nM	295.0	CHEMBL2185	Homo sapiens	IC50	nM	295.0
	22408944	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)c1cccc(C(F)(F)F)c1		CHEMBL4761439	=	IC50	nM	206.0	CHEMBL2185	Homo sapiens	IC50	nM	206.0
	22408945	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4784626	=	IC50	nM	364.0	CHEMBL2185	Homo sapiens	IC50	nM	364.0
	22408946	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(CC1CCCCC1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4790560	=	IC50	nM	42.0	CHEMBL2185	Homo sapiens	IC50	nM	42.0
	22408947	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)C1CCCCC1		CHEMBL4744828	=	IC50	nM	68.0	CHEMBL2185	Homo sapiens	IC50	nM	68.0
Not Determined	22408948	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4785054		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22408949	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4751001		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22408950	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4757792		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22408951	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(F)cc4F)cc3)c(=O)c3ccccc23)cn1		CHEMBL4757774		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22408952	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CNc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4785603		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22408953	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	O=C(Nc1ccc(CNc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4754133		IC50			CHEMBL2185	Homo sapiens	IC50		
	22408954	CHEMBL4671027	Inhibition of AuroraB (unknown origin) by Kinase-Glo luminescent kinase assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	14.7	CHEMBL2185	Homo sapiens	IC50	nM	14.7
Dose-dependent effect	22409005	CHEMBL4671034	Inhibition of Aurora B phosphorylation at Th232 residue in human HCT116 cells after 24 hrs by Western blot analysis	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4755343		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	22409028	CHEMBL4671057	Inhibition of AuroraB (unknown origin)	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	12.0	CHEMBL2185	Homo sapiens	IC50	nM	12.0
	22423122	CHEMBL4674135	Inhibition of human Aurora B using [H-LRRASLG] as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	22423823	CHEMBL4674487	Inhibition of human Aurora B using [H-LRRASLG] as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	88.02	CHEMBL2185	Homo sapiens	Activity	%	88.02
	22423824	CHEMBL4674487	Inhibition of human Aurora B using [H-LRRASLG] as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	67.51	CHEMBL2185	Homo sapiens	Activity	%	67.51
	22458821	CHEMBL4682598	Inhibition of Aurora-B (unknown origin) at 200 nM relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4764463	>	Inhibition	%	80.0	CHEMBL2185	Homo sapiens	INH	%	80.0
	22464723	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(O)cc1		CHEMBL4778737	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464724	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(N)cc1		CHEMBL4790769	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464725	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	Nc1ccc(Cc2ccc(OCC(=O)O)cc2F)cc1		CHEMBL4757446	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464726	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	NCCOc1ccc(Cc2ccc(N)cc2)c(C(F)(F)F)c1		CHEMBL4740833	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464727	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	Cc1cc(OCCN)cc(C)c1Cc1ccc(O)cc1		CHEMBL4753224	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464728	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	CCNc1ccc(Cc2ccc(OCC(=O)O)cc2)cc1C(C)C		CHEMBL4744643	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464729	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	CCNc1ccc(Cc2c(C)cc(OCC(=O)O)cc2C)cc1C(C)C		CHEMBL4799761	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464730	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	CC(C)c1cc(Cc2ccc(OCC(=O)O)cc2)ccc1N		CHEMBL4750819	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464731	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(N)c(C(C)C)c1		CHEMBL4792416	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464732	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	CC(=O)Nc1ccc(Cc2ccc(OCC(=O)O)cc2)cc1C(C)C		CHEMBL4756150	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22464733	CHEMBL4683759	Inhibition of Aurora B (unknown origin) at 10 uM relative to control	A	CC(=O)Nc1ccc(Cc2c(C)cc(OCC(=O)O)cc2C)cc1C(C)C		CHEMBL4764051	<	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	22782807	CHEMBL4707748	Inhibition of recombinant full length human His-tagged AURKB expressed in baculovirus expression system at 1 uM by Z-lyte assay relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N(C)CCN(C)C		CHEMBL4798177	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	INH	%	13.0
	22801906	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Delta Tm	degrees C	4.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.0
	22801907	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccccc2)n1		CHEMBL312873	=	Delta Tm	degrees C	-3.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	-3.0
	22801908	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccccc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4790278	=	Delta Tm	degrees C	2.7	CHEMBL2185	Homo sapiens	deltaTm	degrees C	2.7
	22801909	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(-c2ccccc2)n1		CHEMBL102547	=	Delta Tm	degrees C	4.3	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.3
	22801910	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4751695	=	Delta Tm	degrees C	3.5	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.5
	22801911	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)n(-c2ccccc2)n1		CHEMBL4741055	=	Delta Tm	degrees C	4.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.0
	22801912	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccccc2)n1		CHEMBL4762688	=	Delta Tm	degrees C	4.1	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.1
	22801913	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCc3ccccc3)cc2)n(-c2ccccc2)n1		CHEMBL4785824	=	Delta Tm	degrees C	3.9	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.9
	22801914	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1cc(C)cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4783603	=	Delta Tm	degrees C	4.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.0
	22801915	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(F)cc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4759399	=	Delta Tm	degrees C	4.2	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.2
	22801916	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)c(F)c2)n(-c2ccccc2)n1		CHEMBL4765042	=	Delta Tm	degrees C	2.3	CHEMBL2185	Homo sapiens	deltaTm	degrees C	2.3
	22801917	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2ccccc2)n1		CHEMBL314023	=	Delta Tm	degrees C	4.4	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.4
	22801918	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(S(=O)(=O)NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4750748	=	Delta Tm	degrees C	3.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.0
	22801919	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	COc1cccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4746299	=	Delta Tm	degrees C	4.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.0
	22801920	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Delta Tm	degrees C	3.6	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.6
	22801921	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1		CHEMBL4759890	=	Delta Tm	degrees C	2.4	CHEMBL2185	Homo sapiens	deltaTm	degrees C	2.4
	22801922	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4784705	=	Delta Tm	degrees C	3.3	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.3
	22801923	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4784725	=	Delta Tm	degrees C	3.4	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.4
	22801924	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4744374	=	Delta Tm	degrees C	4.1	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.1
	22801925	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(C(C)(C)C)n1		CHEMBL4742158	=	Delta Tm	degrees C	4.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.0
	22801926	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4797231	=	Delta Tm	degrees C	3.1	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.1
	22801927	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4787226	=	Delta Tm	degrees C	4.1	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.1
	22801928	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4777689	=	Delta Tm	degrees C	3.9	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.9
	22801929	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccccc2)n1		CHEMBL4764223	=	Delta Tm	degrees C	2.3	CHEMBL2185	Homo sapiens	deltaTm	degrees C	2.3
	22801930	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(F)cc(F)c2)cc1		CHEMBL4741029	=	Delta Tm	degrees C	-0.1	CHEMBL2185	Homo sapiens	deltaTm	degrees C	-0.1
	22801931	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4754583	=	Delta Tm	degrees C	3.4	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.4
	22801932	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4780554	=	Delta Tm	degrees C	4.5	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.5
	22801933	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4798321	=	Delta Tm	degrees C	4.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.0
	22801934	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(C(C)(C)C)n1		CHEMBL4791471	=	Delta Tm	degrees C	1.6	CHEMBL2185	Homo sapiens	deltaTm	degrees C	1.6
	22801935	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4757882	=	Delta Tm	degrees C	4.0	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.0
	22801936	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4740104	=	Delta Tm	degrees C	3.5	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.5
	22801937	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(F)cc(F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4789547	=	Delta Tm	degrees C	4.2	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.2
	22801938	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Delta Tm	degrees C	9.9	CHEMBL2185	Homo sapiens	deltaTm	degrees C	9.9
	22801939	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4787113	=	Delta Tm	degrees C	3.6	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.6
	22801940	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(N)cc2)n1		CHEMBL4756419	=	Delta Tm	degrees C	3.8	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.8
	22801941	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4740208	=	Delta Tm	degrees C	-3.8	CHEMBL2185	Homo sapiens	deltaTm	degrees C	-3.8
	22801942	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(OC(F)(F)F)cc2)n1		CHEMBL4756465	=	Delta Tm	degrees C	4.1	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.1
	22801943	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C#N)cc2)n1		CHEMBL4786417	=	Delta Tm	degrees C	4.5	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.5
	22801944	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL4757100	=	Delta Tm	degrees C	3.7	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.7
	22801945	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NC(=O)C3CC3)cc2)n1		CHEMBL4788823	=	Delta Tm	degrees C	4.1	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.1
	22801946	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NS(C)(=O)=O)cc2)n1		CHEMBL4754044	=	Delta Tm	degrees C	3.7	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.7
	22801947	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)C(=O)Nc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4782612	=	Delta Tm	degrees C	3.9	CHEMBL2185	Homo sapiens	deltaTm	degrees C	3.9
	22801948	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc(OC(F)(F)F)cc1		CHEMBL4790434	=	Delta Tm	degrees C	2.2	CHEMBL2185	Homo sapiens	deltaTm	degrees C	2.2
	22801949	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	N#Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4742987	=	Delta Tm	degrees C	-2.3	CHEMBL2185	Homo sapiens	deltaTm	degrees C	-2.3
	22801950	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4755558	=	Delta Tm	degrees C	-2.5	CHEMBL2185	Homo sapiens	deltaTm	degrees C	-2.5
	22801951	CHEMBL4711695	Inhibition of AURKB (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C(F)(F)F)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4794564	=	Delta Tm	degrees C	4.2	CHEMBL2185	Homo sapiens	deltaTm	degrees C	4.2
Not Determined	22803265	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccccc1		CHEMBL4778011		IC50			CHEMBL2185	Homo sapiens	IC50		
	22803266	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	COc1ccc(C(=O)Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCOCC4)cc3)c[nH]2)cc1		CHEMBL4782433	>	IC50	nM	1000.0	CHEMBL2185	Homo sapiens	IC50	uM	1.0
	22803267	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccc([N+](=O)[O-])cc1		CHEMBL4744513	=	IC50	nM	650.0	CHEMBL2185	Homo sapiens	IC50	uM	0.65
Not Determined	22803268	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccc(Cl)cc1		CHEMBL4763483		IC50			CHEMBL2185	Homo sapiens	IC50		
	22803269	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4758261	=	IC50	nM	583.0	CHEMBL2185	Homo sapiens	IC50	uM	0.583
Not Determined	22803270	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCC3)cc2)c[nH]1)c1ccc([N+](=O)[O-])cc1		CHEMBL4761780		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22803271	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	COc1ccc(C(=O)Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCCCC4)cc3)c[nH]2)cc1		CHEMBL4750823		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22803272	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCCC3)cc2)c[nH]1)c1ccc(Cl)cc1		CHEMBL4797744		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22803273	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4795804		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	22803274	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	Cc1nc(Cl)cc(Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCOCC4)cc3)c[nH]2)n1		CHEMBL4794655		IC50			CHEMBL2185	Homo sapiens	IC50		
	22803275	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	62.0	CHEMBL2185	Homo sapiens	IC50	uM	0.062
Not Determined	22803276	CHEMBL4711873	Inhibition of Aurora B (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	CSc1nc(Cl)c(C)c(Nc2c[nH]nc2-c2ncc(-c3ccc(OCCCN4CCOCC4)cc3)[nH]2)n1		CHEMBL4789251		IC50			CHEMBL2185	Homo sapiens	IC50		
Dose-dependent effect	22803310	CHEMBL4711883	Inhibition of Aurora B phosphorylation in human K562 cells incubated for 48 hrs by Western blot analysis	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4758261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Dose-dependent effect	22803312	CHEMBL4711885	Inhibition of Aurora B phosphorylation in human HCT116 cells incubated for 48 hrs by Western blot analysis	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4758261		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	22836138	CHEMBL4718845	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	22836139	CHEMBL4718845	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	22836140	CHEMBL4718845	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	17.0	CHEMBL2185	Homo sapiens	INH	%	17.0
	22836141	CHEMBL4718845	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	1.0	CHEMBL2185	Homo sapiens	INH	%	1.0
	22836142	CHEMBL4718845	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	5.0	CHEMBL2185	Homo sapiens	INH	%	5.0
	22836143	CHEMBL4718845	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	13.0	CHEMBL2185	Homo sapiens	INH	%	13.0
	22843495	CHEMBL4720492	Inhibition of human Aurora B assessed as residual activity using [H-LRRASLG] as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	98.76	CHEMBL2185	Homo sapiens	Activity	%	98.76
	22843845	CHEMBL4720831	Inhibition of human Aurora B using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.04	CHEMBL2185	Homo sapiens	IC50	10^-9M	6.04
	22844624	CHEMBL4721299	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	90.69	CHEMBL2185	Homo sapiens	Activity	%	90.69
	22851513	CHEMBL4723769	Binding affinity to human AURKB assessed as displacement of immobilized ligand at 1 uM by KINOMEscan scanMAX assay relative to control	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	=	Inhibition	%	86.0	CHEMBL2185	Homo sapiens	INH	%	86.0
	22851523	CHEMBL4723779	Binding affinity to human AURKB assessed as displacement of immobilized ligand by KINOMEscan scanMAX assay relative to control	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	=	Kd	nM	110.0	CHEMBL2185	Homo sapiens	Kd	nM	110.0
	22851533	CHEMBL4723789	Inhibition of human AURKB in presence of ATP at Km level	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	=	IC50	nM	8900.0	CHEMBL2185	Homo sapiens	IC50	nM	8900.0
	22851538	CHEMBL4723794	Binding affinity to human AURKB incubated for 2 hrs by nano-BRET assay based cellular target engagement assay	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	nM	10000.0
	22876514	CHEMBL4725967	Inhibition of N- terminal GST-tagged/His6-tagged human recombinant full length Aurora kinase B (821 to end residues) expressed in baculovirus sf21 cells at 1 uM relative to control	B	C=CC(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3901151	>	Inhibition	%	75.0	CHEMBL2185	Homo sapiens	INH	%	75.0
	22876515	CHEMBL4725967	Inhibition of N- terminal GST-tagged/His6-tagged human recombinant full length Aurora kinase B (821 to end residues) expressed in baculovirus sf21 cells at 1 uM relative to control	B	C=CC(=O)Nc1cccc(-c2n[nH]c3cc(C)ccc23)c1		CHEMBL4749823	>	Inhibition	%	75.0	CHEMBL2185	Homo sapiens	INH	%	75.0
Not Active	22889486	CHEMBL4729005	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	22909796	CHEMBL4734040	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	22909797	CHEMBL4734040	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	22909798	CHEMBL4734040	Inhibition of recombinant full length His-tagged human AURKB expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	22949012	CHEMBL4765729	Inhibition of human Aurora-B assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	74.0	CHEMBL2185	Homo sapiens	Activity	%	74.0
	22949013	CHEMBL4765729	Inhibition of human Aurora-B assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	43.0	CHEMBL2185	Homo sapiens	Activity	%	43.0
	22949014	CHEMBL4765729	Inhibition of human Aurora-B assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	85.0	CHEMBL2185	Homo sapiens	Activity	%	85.0
	22949015	CHEMBL4765729	Inhibition of human Aurora-B assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	95.0	CHEMBL2185	Homo sapiens	Activity	%	95.0
	22949016	CHEMBL4765729	Inhibition of human Aurora-B assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	79.0	CHEMBL2185	Homo sapiens	Activity	%	79.0
	22949017	CHEMBL4765729	Inhibition of human Aurora-B assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	59.0	CHEMBL2185	Homo sapiens	Activity	%	59.0
	22949018	CHEMBL4765730	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	76.0	CHEMBL2185	Homo sapiens	Activity	%	76.0
	22949019	CHEMBL4765730	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	11.0	CHEMBL2185	Homo sapiens	Activity	%	11.0
	22949020	CHEMBL4765730	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	71.0	CHEMBL2185	Homo sapiens	Activity	%	71.0
	22949021	CHEMBL4765730	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	48.0	CHEMBL2185	Homo sapiens	Activity	%	48.0
	22949022	CHEMBL4765730	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	50.0	CHEMBL2185	Homo sapiens	Activity	%	50.0
	22949023	CHEMBL4765730	Inhibition of human Aurora-B assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	42.0	CHEMBL2185	Homo sapiens	Activity	%	42.0
	22952758	CHEMBL4766695	Inhibition of recombinant full length human Aurora B assessed as residual activity at 10 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	6.0	CHEMBL2185	Homo sapiens	Activity	%	6.0
	22953060	CHEMBL4766997	Inhibition of recombinant full length human Aurora B using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	1630.0	CHEMBL2185	Homo sapiens	IC50	uM	1.63
	22957740	CHEMBL4768049	Inhibition of Aurora B (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	350.0	CHEMBL2185	Homo sapiens	IC50	nM	350.0
	22957741	CHEMBL4768049	Inhibition of Aurora B (unknown origin)	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	25.0	CHEMBL2185	Homo sapiens	IC50	nM	25.0
	22957819	CHEMBL4768061	Inhibition of Aurora B (unknown origin) incubated for 1 hrs by HTRF assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	293.72	CHEMBL2185	Homo sapiens	IC50	nM	293.72
	22957820	CHEMBL4768061	Inhibition of Aurora B (unknown origin) incubated for 1 hrs by HTRF assay	B	CCC(=O)Nc1nc2ccc(-c3ccc4ncn(CCN5CCOCC5)c(=O)c4c3)cc2[nH]1		CHEMBL4785479	=	IC50	nM	273.18	CHEMBL2185	Homo sapiens	IC50	nM	273.18
	22957821	CHEMBL4768061	Inhibition of Aurora B (unknown origin) incubated for 1 hrs by HTRF assay	B	CCC(=O)Nc1nc2ccc(-c3ccc4ncn(CCc5c[nH]c6ccccc56)c(=O)c4c3)cc2[nH]1		CHEMBL4794556	=	IC50	nM	329.81	CHEMBL2185	Homo sapiens	IC50	nM	329.81
	22957822	CHEMBL4768061	Inhibition of Aurora B (unknown origin) incubated for 1 hrs by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	26.13	CHEMBL2185	Homo sapiens	IC50	nM	26.13
	22977639	CHEMBL4772147	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 insect cells using myelin basic protein as substrate by ADP-Glo assay	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	22977640	CHEMBL4772147	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 insect cells using myelin basic protein as substrate by ADP-Glo assay	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622	>	IC50	nM	10000.0	CHEMBL2185	Homo sapiens	IC50	uM	10.0
	22981463	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3ncnc(Nc4cccc(NC(=O)Nc5ccc(F)cc5)c4)c3c2)cn1		CHEMBL4778166	>	IC50	nM	15000.0	CHEMBL2185	Homo sapiens	IC50	uM	15.0
	22981464	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3ncnc(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)c3c2)cn1		CHEMBL4794161	=	IC50	nM	6580.6	CHEMBL2185	Homo sapiens	IC50	nM	6580.6
	22981465	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4cccc(NC(=O)Nc5ccc(F)cc5)c4)ncnc3c2)cc1		CHEMBL4789795	=	IC50	nM	63.07	CHEMBL2185	Homo sapiens	IC50	nM	63.07
	22981466	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)ncnc3c2)cc1		CHEMBL4796319	=	IC50	nM	9.968	CHEMBL2185	Homo sapiens	IC50	nM	9.968
	22981467	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(-c2ccc3c(Nc4cccc(NC(=O)Nc5ccc(F)cc5)c4)ncnc3c2)cc1		CHEMBL4776476	=	IC50	nM	2150.6	CHEMBL2185	Homo sapiens	IC50	nM	2150.6
	22981468	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)ncnc3c2)cc1		CHEMBL4789271	=	IC50	nM	185.3	CHEMBL2185	Homo sapiens	IC50	nM	185.3
	22981469	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Nc1ccc(F)cc1)Nc1cccc(Nc2ncnc3cc(-c4cccs4)ccc23)c1		CHEMBL4785707	=	IC50	nM	1008.0	CHEMBL2185	Homo sapiens	IC50	nM	1008.0
	22981470	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	O=C(Nc1cccc(F)c1)Nc1cccc(Nc2ncnc3cc(-c4cccs4)ccc23)c1		CHEMBL4788491	=	IC50	nM	75.87	CHEMBL2185	Homo sapiens	IC50	nM	75.87
	22981471	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5ccc(F)c(Cl)c5)c4)ncnc3c2)cn1		CHEMBL4796460	=	IC50	nM	29.82	CHEMBL2185	Homo sapiens	IC50	nM	29.823
	22981472	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cc1ccc(NC(=O)Nc2cccc(Nc3ncnc4cc(-c5cnn(C)c5)ccc34)c2)cc1F		CHEMBL4776298	=	IC50	nM	35.3	CHEMBL2185	Homo sapiens	IC50	nM	35.3
	22981473	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5ccc(F)cc5)c4)ncnc3c2)cn1		CHEMBL4785614	=	IC50	nM	15.08	CHEMBL2185	Homo sapiens	IC50	nM	15.083
	22981474	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)ncnc3c2)cn1		CHEMBL4799738	=	IC50	nM	0.316	CHEMBL2185	Homo sapiens	IC50	nM	0.316
	22981475	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5ccccc5F)c4)ncnc3c2)cn1		CHEMBL4799497	=	IC50	nM	2.981	CHEMBL2185	Homo sapiens	IC50	nM	2.9810000000000003
	22981476	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(Cl)c5)c4)ncnc3c2)cn1		CHEMBL4784119	=	IC50	nM	22.84	CHEMBL2185	Homo sapiens	IC50	nM	22.836
	22981477	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5ccc(Cl)cc5)c4)ncnc3c2)cn1		CHEMBL4776475	=	IC50	nM	209.53	CHEMBL2185	Homo sapiens	IC50	nM	209.53
	22981478	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(Br)c5)c4)ncnc3c2)cn1		CHEMBL4779005	=	IC50	nM	90.62	CHEMBL2185	Homo sapiens	IC50	nM	90.62299999999999
	22981479	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(NC(=O)Nc2cccc(Nc3ncnc4cc(-c5cnn(C)c5)ccc34)c2)cc1		CHEMBL4786894	=	IC50	nM	222.1	CHEMBL2185	Homo sapiens	IC50	nM	222.1
	22981480	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5ccc(C(C)(C)C)cc5)c4)ncnc3c2)cn1		CHEMBL4777770	=	IC50	nM	939.1	CHEMBL2185	Homo sapiens	IC50	nM	939.1
	22981481	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)c1ccc(NC(=O)Nc2cccc(Nc3ncnc4cc(-c5cnn(C)c5)ccc34)c2)cc1		CHEMBL4796509	=	IC50	nM	197.03	CHEMBL2185	Homo sapiens	IC50	nM	197.03
	22981482	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(C(F)(F)F)c5)c4)ncnc3c2)cn1		CHEMBL4780095	=	IC50	nM	29.89	CHEMBL2185	Homo sapiens	IC50	nM	29.893
	22981483	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	COc1ccc(C(=O)Nc2cccc(Nc3ncnc4cc(-c5cnn(C)c5)ccc34)c2)cc1		CHEMBL4799187	=	IC50	nM	141.8	CHEMBL2185	Homo sapiens	IC50	nM	141.8
	22981484	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)c5cccc(F)c5)c4)ncnc3c2)cn1		CHEMBL4779701	=	IC50	nM	61.2	CHEMBL2185	Homo sapiens	IC50	nM	61.2
	22981485	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)c5cccc(Br)c5)c4)ncnc3c2)cn1		CHEMBL4781573	=	IC50	nM	238.45	CHEMBL2185	Homo sapiens	IC50	nM	238.45
	22981486	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CC(C)c1ccc(NC(=O)c2cccc(Nc3ncnc4cc(-c5cnn(C)c5)ccc34)c2)cc1		CHEMBL4789341	=	IC50	nM	944.2	CHEMBL2185	Homo sapiens	IC50	nM	944.2
	22981487	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(C(=O)Nc5cccc(F)c5)c4)ncnc3c2)cn1		CHEMBL4776505	=	IC50	nM	71.63	CHEMBL2185	Homo sapiens	IC50	nM	71.63
	22981488	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(C(=O)Nc5ccc(F)cc5)c4)ncnc3c2)cn1		CHEMBL4799236	=	IC50	nM	310.6	CHEMBL2185	Homo sapiens	IC50	nM	310.6
	22981489	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	0.326	CHEMBL2185	Homo sapiens	IC50	nM	0.326
	22981490	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	IC50	nM	250.0	CHEMBL2185	Homo sapiens	IC50	nM	250.0
	22981491	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	IC50	nM	3.0	CHEMBL2185	Homo sapiens	IC50	nM	3.0
	22981492	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	18.0	CHEMBL2185	Homo sapiens	IC50	nM	18.0
	22981493	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4cccc(N)c4)ncnc3c2)cn1		CHEMBL4794846	=	IC50	nM	116.0	CHEMBL2185	Homo sapiens	IC50	nM	116.0
	22981494	CHEMBL4773000	Inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate preincubated for 60 mins followed by substrate addition by microfluidic assay	B	Cn1cc(-c2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)cn1		CHEMBL4784002	=	IC50	nM	0.336	CHEMBL2185	Homo sapiens	IC50	nM	0.336
Active	22981506	CHEMBL4773007	Non ATP-competitive inhibition of recombinant human full-length His-tagged Aurora B expressed in baculovirus expression system using 5-FAM-LRRASLG-CONH2 as substrate in presence of varying levels of ATP	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)ncnc3c2)cn1		CHEMBL4799738		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Active	22981507	CHEMBL4773008	Inhibition of Aurora B in human NCI-H460 cells assessed as increase in DNA content at 63.2 nM	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)ncnc3c2)cn1		CHEMBL4799738		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	22986118	CHEMBL4774185	Inhibition of Aurora B (unknown origin)	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1		CHEMBL4791960	=	IC50	nM	536.0	CHEMBL2185	Homo sapiens	IC50	uM	0.536
	23120193	CHEMBL4804346	Inhibition of AURB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	17700.0	CHEMBL2185	Homo sapiens	IC50	uM	17.7
	23120194	CHEMBL4804346	Inhibition of AURB in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	21400.0	CHEMBL2185	Homo sapiens	IC50	uM	21.4
	23120195	CHEMBL4804346	Inhibition of AURB in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	7700.0	CHEMBL2185	Homo sapiens	IC50	uM	7.7
	23120196	CHEMBL4804346	Inhibition of AURB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	31800.0	CHEMBL2185	Homo sapiens	IC50	uM	31.8
	23120197	CHEMBL4804346	Inhibition of AURB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	21000.0	CHEMBL2185	Homo sapiens	IC50	uM	21.0
	23120198	CHEMBL4804346	Inhibition of AURB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	53400.0	CHEMBL2185	Homo sapiens	IC50	uM	53.4
	23121237	CHEMBL4804528	Inhibition of AURB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	23121238	CHEMBL4804528	Inhibition of AURB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	23121239	CHEMBL4804528	Inhibition of AURB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2185	Homo sapiens	INH	%	0.0
	23121240	CHEMBL4804528	Inhibition of AURB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	23121241	CHEMBL4804528	Inhibition of AURB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	23121242	CHEMBL4804528	Inhibition of AURB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	23122451	CHEMBL4804802	Inhibition of human AURKB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	23123146	CHEMBL4805390	Inhibition of human AURKB assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	84.0	CHEMBL2185	Homo sapiens	Activity	%	84.0
	23123741	CHEMBL4805985	Inhibition of DNA-tagged human AURKB assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2185	Homo sapiens	Activity	%	100.0
	23124382	CHEMBL4806407	Inhibition of human AURKB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	91.0	CHEMBL2185	Homo sapiens	Activity	%	91.0
	23124383	CHEMBL4806407	Inhibition of human AURKB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	90.0	CHEMBL2185	Homo sapiens	Activity	%	90.0
	23127463	CHEMBL4807620	Inhibition of Aurora B (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	49.0	CHEMBL2185	Homo sapiens	Activity	%	49.0
	23127464	CHEMBL4807620	Inhibition of Aurora B (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	90.0	CHEMBL2185	Homo sapiens	Activity	%	90.0
	23127825	CHEMBL4807750	Inhibition of AuroraB (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	25.0	CHEMBL2185	Homo sapiens	Activity	%	25.0
	23127826	CHEMBL4807750	Inhibition of AuroraB (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	23127827	CHEMBL4807750	Inhibition of AuroraB (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	23149786	CHEMBL4810179	Inhibition of AURKB (unknown origin) incubated for 90 mins in presence of ATP by HTRF assay	A	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]c(-c5cnn(C)c5)cc4c3N(C)C2=O)c1F		CHEMBL4871581	=	IC50	nM	2.5	CHEMBL2185	Homo sapiens	IC50	nM	2.5
	23159959	CHEMBL4812277	Binding affinity to AURKB (unknown origin) assessed as residual binding level at 1 uM scanEDGE assay relative to control	B	NS(=O)(=O)c1ccc(-c2cnc3[nH]nc(C(=O)c4c(F)ccc(NS(=O)(=O)Cc5ccccc5)c4F)c3c2)cc1		CHEMBL4798975	<	Activity	%	35.0	CHEMBL2185	Homo sapiens	Activity	%	35.0
Not Active	23171313	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N)nccn23)n1		CHEMBL4877608		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171314	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	Nc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N)nccn23)n1		CHEMBL4853288		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171315	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	CSc1nccc(-c2c(-c3ccccc3)nc3c(Cl)nccn23)n1		CHEMBL4875029		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171316	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	CSc1nccc(-c2c(-c3ccccc3)nc3c(N(C)C)nccn23)n1		CHEMBL4872681		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171317	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccccc3)nc12		CHEMBL4860872		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171318	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL4851634		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171319	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N(C)C)nccn23)n1		CHEMBL4875986		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171320	CHEMBL4814507	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP measured by radiometric assay	A	CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccc(F)cc3)nc12		CHEMBL4870529		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171330	CHEMBL4814510	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cnc(N)nc3)c(-c3ccc(F)cc3)nc12		CHEMBL4871059		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171331	CHEMBL4814510	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cncnc3)c(-c3ccc(F)cc3)nc12		CHEMBL4848621		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171332	CHEMBL4814510	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cccnc3)c(-c3ccc(F)cc3)nc12		CHEMBL4860515		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171333	CHEMBL4814510	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3ccncc3)c(-c3ccc(F)cc3)nc12		CHEMBL3634367		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171334	CHEMBL4814510	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3ccc4[nH]ncc4c3)c(-c3ccc(F)cc3)nc12		CHEMBL4866187		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Active	23171335	CHEMBL4814510	Inhibition of recombinant human AURKB expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cnn(C)c3)c(-c3ccc(F)cc3)nc12		CHEMBL4861720		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23178056	CHEMBL4815838	Inhibition of Aurora B (unknown origin)	B	Cn1cc(-c2cc3ncnc(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)c3s2)cn1		CHEMBL4868797	=	IC50	nM	1990.0	CHEMBL2185	Homo sapiens	IC50	uM	1.99
	23208875	CHEMBL4822239	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	CCc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(N)c(C(=O)NC(C)C)c1		CHEMBL4857782	=	Activity	%	75.0	CHEMBL2185	Homo sapiens	Activity	%	75.0
	23208876	CHEMBL4822239	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441340	=	Activity	%	5.3	CHEMBL2185	Homo sapiens	Activity	%	5.3
Active	23297333	CHEMBL4841149	Inhibition of AURKB (unknown origin) in HRPE cells overexpressing MYC/Bcl2 assessed as decrease in H3PS10 fluorescence intensity at 20 uM measured for 6 hrs by immunostaining based fluorescence microscopic analysis	B	COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2		CHEMBL1235966		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23314935	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877247	=	Inhibition	%	61.0	CHEMBL2185	Homo sapiens	INH	%	61.0
	23314936	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(F)cc4)cc3)ncnc2c1		CHEMBL4851635	=	Inhibition	%	27.0	CHEMBL2185	Homo sapiens	INH	%	27.0
	23314937	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3cc(F)ccc23)s1		CHEMBL4867079	=	Inhibition	%	83.0	CHEMBL2185	Homo sapiens	INH	%	83.0
	23314938	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1		CHEMBL4861838	=	Inhibition	%	89.0	CHEMBL2185	Homo sapiens	INH	%	89.0
	23314939	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877038	=	Inhibition	%	24.0	CHEMBL2185	Homo sapiens	INH	%	24.0
	23314940	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4872597	=	Inhibition	%	48.0	CHEMBL2185	Homo sapiens	INH	%	48.0
	23314941	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	O=C(Nc1ccccc1)Nc1ccc(Oc2ncnc3cc(F)ccc23)cc1		CHEMBL4871510	=	Inhibition	%	27.0	CHEMBL2185	Homo sapiens	INH	%	27.0
	23314942	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	Nc1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4851294	=	Inhibition	%	74.0	CHEMBL2185	Homo sapiens	INH	%	74.0
	23314943	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CNc1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877828	=	Inhibition	%	76.0	CHEMBL2185	Homo sapiens	INH	%	76.0
	23314944	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4871756	=	Inhibition	%	27.0	CHEMBL2185	Homo sapiens	INH	%	27.0
	23314945	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	O=C(Nc1ccccc1)Nc1ccc(Oc2ncnc3cc(N4CCCC4)ccc23)cc1		CHEMBL4871989	=	Inhibition	%	43.0	CHEMBL2185	Homo sapiens	INH	%	43.0
Not Determined	23314946	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)c2cc1OC		CHEMBL1277162		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Determined	23314947	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2ncnc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)c2c1		CHEMBL4876562		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
Not Determined	23314948	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	O=C(Nc1ccccc1)Nc1ccc(Oc2ncnc3ccc(N4CCCC4)cc23)cc1		CHEMBL4850463		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23314949	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4Cl)cc3)ncnc2c1		CHEMBL4864248	=	Inhibition	%	79.0	CHEMBL2185	Homo sapiens	INH	%	79.0
	23314950	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ncnc2c1		CHEMBL4860468	=	Inhibition	%	82.0	CHEMBL2185	Homo sapiens	INH	%	82.0
	23314951	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ncnc2c1		CHEMBL4846414	=	Inhibition	%	50.0	CHEMBL2185	Homo sapiens	INH	%	50.0
	23314952	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccccc1NC(=O)Nc1ccc(Oc2ncnc3cc(N(C)C)ccc23)cc1		CHEMBL4857617	=	Inhibition	%	53.0	CHEMBL2185	Homo sapiens	INH	%	53.0
	23314953	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1cccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)c1		CHEMBL4857271	=	Inhibition	%	79.0	CHEMBL2185	Homo sapiens	INH	%	79.0
	23314954	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1		CHEMBL4877440	=	Inhibition	%	34.0	CHEMBL2185	Homo sapiens	INH	%	34.0
	23314955	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ncnc2c1		CHEMBL4878431	=	Inhibition	%	60.0	CHEMBL2185	Homo sapiens	INH	%	60.0
	23314956	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)ncnc2c1		CHEMBL4874053	=	Inhibition	%	37.0	CHEMBL2185	Homo sapiens	INH	%	37.0
	23314957	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1Cl		CHEMBL4877148	=	Inhibition	%	44.0	CHEMBL2185	Homo sapiens	INH	%	44.0
	23314958	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc(Cl)cc1NC(=O)Nc1ccc(Oc2ncnc3cc(N(C)C)ccc23)cc1		CHEMBL4859405	=	Inhibition	%	41.0	CHEMBL2185	Homo sapiens	INH	%	41.0
	23314959	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL4873828	=	Inhibition	%	7.0	CHEMBL2185	Homo sapiens	INH	%	7.0
	23314960	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCCc4ccccc4)cc3)ncnc2c1		CHEMBL4849425	=	Inhibition	%	35.0	CHEMBL2185	Homo sapiens	INH	%	35.0
	23314961	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(S(N)(=O)=O)cc4)cc3)ncnc2c1		CHEMBL4857690	=	Inhibition	%	62.0	CHEMBL2185	Homo sapiens	INH	%	62.0
Not Determined	23314962	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C#N)cc4)cc3)ncnc2c1		CHEMBL4846051		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23314963	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)cc4)cc3)ncnc2c1		CHEMBL4854210	=	Inhibition	%	25.0	CHEMBL2185	Homo sapiens	INH	%	25.0
	23314964	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1		CHEMBL4870448	=	Inhibition	%	29.0	CHEMBL2185	Homo sapiens	INH	%	29.0
Not Determined	23314965	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1OC		CHEMBL4876396		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23314966	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4c(F)c(F)c(F)c(F)c4F)cc3)ncnc2c1		CHEMBL4866196	=	Inhibition	%	34.0	CHEMBL2185	Homo sapiens	INH	%	34.0
	23314967	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4cccnc4)cc3)ncnc2c1		CHEMBL4878471	=	Inhibition	%	15.0	CHEMBL2185	Homo sapiens	INH	%	15.0
	23314968	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	Cc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cn1		CHEMBL4846384	=	Inhibition	%	9.0	CHEMBL2185	Homo sapiens	INH	%	9.0
	23314969	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cn1		CHEMBL4870360	=	Inhibition	%	18.0	CHEMBL2185	Homo sapiens	INH	%	18.0
Not Determined	23314970	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CC(NC(=O)Nc1ccc(Oc2ncnc3cc(N(C)C)ccc23)cc1)c1nccs1		CHEMBL4851545		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23314971	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4nccs4)cc3)ncnc2c1		CHEMBL4863584	=	Inhibition	%	19.0	CHEMBL2185	Homo sapiens	INH	%	19.0
Not Determined	23314972	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccn(C)n4)cc3)ncnc2c1		CHEMBL4878293		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23314973	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)nc4)cc3)ncnc2c1		CHEMBL4847875	=	Inhibition	%	16.0	CHEMBL2185	Homo sapiens	INH	%	16.0
Not Determined	23314974	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)CCCOc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1		CHEMBL4864729		Inhibition	%		CHEMBL2185	Homo sapiens	INH		
	23314975	CHEMBL4845010	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate at 0.1 uM incubated for 20 mins by ATP Kinase Glo assay	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Inhibition	%	47.0	CHEMBL2185	Homo sapiens	INH	%	47.0
	23314984	CHEMBL4845012	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate incubated for 20 mins by ATP Kinase Glo assay	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	=	IC50	nM	643.0	CHEMBL2185	Homo sapiens	IC50	nM	643.0
Not Determined	23314985	CHEMBL4845012	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877247		IC50			CHEMBL2185	Homo sapiens	IC50		
Not Determined	23314986	CHEMBL4845012	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(F)cc4)cc3)ncnc2c1		CHEMBL4851635		IC50			CHEMBL2185	Homo sapiens	IC50		
	23314987	CHEMBL4845012	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate incubated for 20 mins by ATP Kinase Glo assay	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1		CHEMBL4877440	=	IC50	nM	22.2	CHEMBL2185	Homo sapiens	IC50	nM	22.2
	23314988	CHEMBL4845012	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)nc4)cc3)ncnc2c1		CHEMBL4847875	=	IC50	nM	1400.0	CHEMBL2185	Homo sapiens	IC50	uM	1.4
	23314989	CHEMBL4845012	Inhibition of human recombinant full length GST-AURKB using tetra(-LRRASLG) peptide as substrate incubated for 20 mins by ATP Kinase Glo assay	B	CN(C)CCCOc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1		CHEMBL4864729	=	IC50	nM	13.0	CHEMBL2185	Homo sapiens	IC50	nM	13.0
	23315117	CHEMBL4845030	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system by Kinomescan method	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)nc4)cc3)ncnc2c1		CHEMBL4847875	=	IC50	nM	226.0	CHEMBL2185	Homo sapiens	IC50	nM	226.0
Not Active	23317286	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	68.0	CHEMBL2185	Homo sapiens	% Control	%	68.0
Not Active	23317754	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23318851	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23318852	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794	>	Kd	nM	10000.0	CHEMBL2185	Homo sapiens	Kd	nM	10000.0
Not Active	23318904	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23319544	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23320016	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Active	23320694	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	18.0	CHEMBL2185	Homo sapiens	% Control	%	18.0
Not Active	23321162	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	67.0	CHEMBL2185	Homo sapiens	% Control	%	67.0
Not Active	23321792	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	72.0	CHEMBL2185	Homo sapiens	% Control	%	72.0
Not Active	23322260	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	77.0	CHEMBL2185	Homo sapiens	% Control	%	77.0
Not Active	23322949	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	84.0	CHEMBL2185	Homo sapiens	% Control	%	84.0
Not Active	23323417	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	98.0	CHEMBL2185	Homo sapiens	% Control	%	98.0
Not Active	23324271	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	82.9	CHEMBL2185	Homo sapiens	% Control	%	82.9
Not Active	23324906	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23325374	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23326021	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	58.0	CHEMBL2185	Homo sapiens	% Control	%	58.0
Not Active	23326489	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	84.0	CHEMBL2185	Homo sapiens	% Control	%	84.0
Not Active	23327189	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	66.0	CHEMBL2185	Homo sapiens	% Control	%	66.0
Not Active	23327657	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	66.0	CHEMBL2185	Homo sapiens	% Control	%	66.0
Not Active	23328244	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	72.0	CHEMBL2185	Homo sapiens	% Control	%	72.0
Not Active	23328712	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23329252	CHEMBL4880959	Aurora-B(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	94.0	CHEMBL2185	Homo sapiens	% residual kinase activity	%	94.0
Not Active	23329658	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	90.0	CHEMBL2185	Homo sapiens	% Control	%	90.0
Not Active	23330126	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	88.0	CHEMBL2185	Homo sapiens	% Control	%	88.0
Not Active	23330882	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23331350	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23331937	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	98.8	CHEMBL2185	Homo sapiens	% Control	%	98.8
Not Active	23332405	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	82.0	CHEMBL2185	Homo sapiens	% Control	%	82.0
Not Active	23333121	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23333760	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	77.0	CHEMBL2185	Homo sapiens	% Control	%	77.0
Not Active	23334228	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	99.0	CHEMBL2185	Homo sapiens	% Control	%	99.0
Not Active	23335207	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	82.0	CHEMBL2185	Homo sapiens	% Control	%	82.0
Not Active	23335675	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	78.0	CHEMBL2185	Homo sapiens	% Control	%	78.0
Not Active	23336302	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	84.0	CHEMBL2185	Homo sapiens	% Control	%	84.0
Not Active	23336770	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	93.0	CHEMBL2185	Homo sapiens	% Control	%	93.0
Not Active	23337517	CHEMBL4881888	AURKB Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	92.0	CHEMBL2185	Homo sapiens	% Ctrl	%	92.0
Not Active	23337851	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	96.0	CHEMBL2185	Homo sapiens	% Control	%	96.0
Slightly Active	23338319	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	41.0	CHEMBL2185	Homo sapiens	% Control	%	41.0
Not Active	23338931	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	92.0	CHEMBL2185	Homo sapiens	% Control	%	92.0
Not Active	23339399	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	71.0	CHEMBL2185	Homo sapiens	% Control	%	71.0
Not Active	23340036	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	88.0	CHEMBL2185	Homo sapiens	% Control	%	88.0
Not Active	23340504	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23341161	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23341629	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23342245	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	83.0	CHEMBL2185	Homo sapiens	% Control	%	83.0
Not Active	23342713	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	96.0	CHEMBL2185	Homo sapiens	% Control	%	96.0
Not Active	23343343	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23343811	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	92.0	CHEMBL2185	Homo sapiens	% Control	%	92.0
Not Active	23344449	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23345022	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	91.0	CHEMBL2185	Homo sapiens	% Control	%	91.0
Not Active	23345490	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	89.0	CHEMBL2185	Homo sapiens	% Control	%	89.0
Not Active	23346067	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	89.0	CHEMBL2185	Homo sapiens	% Control	%	89.0
Not Active	23346536	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	93.1	CHEMBL2185	Homo sapiens	% Control	%	93.1
Not Active	23347146	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23347627	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	79.8	CHEMBL2185	Homo sapiens	% Control	%	79.8
Not Active	23348206	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	92.0	CHEMBL2185	Homo sapiens	% Control	%	92.0
Not Active	23348674	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23349261	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23349879	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23350347	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	89.0	CHEMBL2185	Homo sapiens	% Control	%	89.0
Not Active	23350952	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	91.0	CHEMBL2185	Homo sapiens	% Control	%	91.0
Not Active	23351420	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	83.0	CHEMBL2185	Homo sapiens	% Control	%	83.0
Not Active	23351966	CHEMBL4882659	AURKB (Aurora B) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	16.17	CHEMBL2185	Homo sapiens	% Inhibition	%	16.1739
Not Active	23352444	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	73.0	CHEMBL2185	Homo sapiens	% Control	%	73.0
Not Active	23352912	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	94.0	CHEMBL2185	Homo sapiens	% Control	%	94.0
Not Active	23353794	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23354262	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23354994	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	97.0	CHEMBL2185	Homo sapiens	% Control	%	97.0
Not Active	23355462	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	92.0	CHEMBL2185	Homo sapiens	% Control	%	92.0
Not Active	23356098	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23356566	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23357175	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23357822	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23358290	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	59.0	CHEMBL2185	Homo sapiens	% Control	%	59.0
Not Active	23358876	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	71.3	CHEMBL2185	Homo sapiens	% Control	%	71.3
Not Active	23359474	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23359942	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23360527	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	86.0	CHEMBL2185	Homo sapiens	% Control	%	86.0
Not Active	23360995	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	98.0	CHEMBL2185	Homo sapiens	% Control	%	98.0
Not Active	23361568	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23362104	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	87.0	CHEMBL2185	Homo sapiens	% Control	%	87.0
Not Active	23362572	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23363214	CHEMBL4883223	AURKB (Aurora B) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	16.14	CHEMBL2185	Homo sapiens	% inhibition	%	16.137
Not Active	23363215	CHEMBL4883223	AURKB (Aurora B) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	6.773	CHEMBL2185	Homo sapiens	% inhibition	%	6.7732
Not Active	23364214	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23364682	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23365421	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	79.0	CHEMBL2185	Homo sapiens	% Control	%	79.0
Not Active	23365964	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	93.0	CHEMBL2185	Homo sapiens	% Control	%	93.0
Not Active	23366554	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	81.0	CHEMBL2185	Homo sapiens	% Control	%	81.0
Not Active	23367022	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	95.0	CHEMBL2185	Homo sapiens	% Control	%	95.0
Not Active	23367475	CHEMBL4883828	Aurora-B ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	96.0	CHEMBL2185	Homo sapiens	% Residual activity with Skepinone-L	%	96.0
Not Active	23367900	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	80.0	CHEMBL2185	Homo sapiens	% Control	%	80.0
Not Active	23368368	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	89.0	CHEMBL2185	Homo sapiens	% Control	%	89.0
Not Active	23368967	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23369435	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	85.0	CHEMBL2185	Homo sapiens	% Control	%	85.0
Not Active	23369980	CHEMBL4884224	Aurora-B(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	76.0	CHEMBL2185	Homo sapiens	% residual kinase activity	%	76.0
Not Active	23370403	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	88.0	CHEMBL2185	Homo sapiens	% Control	%	88.0
Not Active	23370871	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	66.0	CHEMBL2185	Homo sapiens	% Control	%	66.0
Not Active	23371680	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	95.0	CHEMBL2185	Homo sapiens	% Control	%	95.0
Not Active	23372148	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
	23372662	CHEMBL4884627	AurB [Aur1(AURBPGE1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2185	Homo sapiens	pIC50		6.0
	23373071	CHEMBL4884918	AurB [Aur1(AURBPGE1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2185	Homo sapiens	pIC50		6.0
	23373432	CHEMBL4885209	AurB [Aur1(AURBPGE1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2185	Homo sapiens	pIC50		6.0
Not Active	23374919	CHEMBL4885913	Aurora_B Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	21.3	CHEMBL2185	Homo sapiens	% Inhibition	%	21.3
Not Active	23375575	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	86.0	CHEMBL2185	Homo sapiens	% Control	%	86.0
Not Active	23376043	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	85.0	CHEMBL2185	Homo sapiens	% Control	%	85.0
Not Active	23376621	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	82.0	CHEMBL2185	Homo sapiens	% Control	%	82.0
Not Active	23377090	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23377948	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	86.0	CHEMBL2185	Homo sapiens	% Control	%	86.0
Not Active	23378416	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	93.0	CHEMBL2185	Homo sapiens	% Control	%	93.0
Not Active	23379583	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	76.0	CHEMBL2185	Homo sapiens	% Control	%	76.0
Not Active	23380051	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	92.0	CHEMBL2185	Homo sapiens	% Control	%	92.0
Not Active	23380745	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23381393	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23381861	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2185	Homo sapiens	% Control	%	100.0
Not Active	23382485	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	73.0	CHEMBL2185	Homo sapiens	% Control	%	73.0
Active	23382953	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	9.9	CHEMBL2185	Homo sapiens	% Control	%	9.9
Not Active	23383703	CHEMBL4887354	AURKB Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	98.0	CHEMBL2185	Homo sapiens	% Ctrl	%	98.0
Not Active	23384028	CHEMBL4887626	AURORA B DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	60.9	CHEMBL2185	Homo sapiens	% Ctrl	%	60.9
Not Active	23384186	CHEMBL4887781	Aurora_B(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-23.74	CHEMBL2185	Homo sapiens	% inhibition	%	-23.74
Not Active	23384634	CHEMBL4888160	AURKB (Aurora B) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	7.0	CHEMBL2185	Homo sapiens	% Inhibition	%	7.0
Not Active	23384868	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL2185	Homo sapiens	% Control	%	91.0
Not Active	23385335	CHEMBL4879592	KinomeScan assay: inhibition of AURKB	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	74.0	CHEMBL2185	Homo sapiens	% Control	%	74.0
Not Active	23385863	CHEMBL4888336	Aurora_B Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	21.0	CHEMBL2185	Homo sapiens	% inhibition	%	21.0
